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Abstract 
Disc displacement without reduction (DDwoR), also known as “closed lock” (CL), is a 
temporomandibular disorder that may cause painful and limited mouth opening. Patients 
with DDwoR may present to any clinician in practice, but in the acute phase, patients 
often seek care immediately from clinicians at the frontline in emergency or primary 
care. There is, however, a lack of understanding on how frontline clinicians behave and 
what decisions they make when initially presented with a DDwoR patient. The 
suggested therapeutic interventions for DDwoR vary considerably in invasiveness with 
contradictory opinions about the appropriate conservative or surgical intervention, and 
their timing, for managing DDwoR. This may cause confusion for clinicians and lead 
management of DDwoR to become based more on experience than evidence. The aim 
of this project is to inform and facilitate the development of a virtually delivered, 
evidence-informed, behavioural intervention for clinicians to aid management of 
DDwoR, through the identification of: the best available evidence for timing of 
intervention, and the intervention itself, for DDwoR; the influences on clinicians’ 
decision-making processes in the management of DDwoR. 
This project involved three separate, but sequential, studies. The first study was a 
systematic review of closed lock studies to investigate the effects of locking duration on 
DDwoR management. The second study was a systematic review of randomised trials to 
examine the therapeutic effects of interventions on DDwoR. The third study was a 
qualitative study interviewing clinicians at the frontline and specialist services in order 
to understand the decision-making processes in DDwoR management.  
The two systematic reviews suggest that the best available evidence for managing 
DDwoR is by intervening early with the simplest and least invasive intervention. The 
qualitative data suggest that the main behavioural influences on frontline clinicians’ 
decision to refer DDwoR early were their lack of condition-specific knowledge, skills, 
and experience which represent the theoretically-based core targets for a future 
intervention to support their decisions. 
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Orofacial pain and TMD 
VAS: Visual Analogue Scale 
VGIR: Visually Guided Irrigation 
W: Wilkes staging of internal derangement 
wk: week 
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Chapter 1. Introduction and Outline of Thesis 
1.1 Introduction 
The management protocols for temporomandibular disorders are vast and confusing but 
there is increasing evidence that these disorders are best managed initially with 
conservative reversible treatment (List and Axelsson, 2010), a standpoint which is  
supported and advised by a number of authorities from within the field (De Boever et 
al., 2008; Greene, 2010a). Temporomandibular disorders (TMD), however, are a 
collection of heterogeneous disorders rather than being a singular “catch-all” entity and 
grouping the patients and managing them under the generic ‘TMD’ term1 may rather 
cause further confusion in the field (Laskin, 2008; Benoliel, 2010). In a specific subtype 
of TMD such as disc displacement without reduction (DDwoR), which may intuitively 
be considered as a predominantly biomechanical disorder, a conservative approach may 
be considered somewhat counter-intuitive.  
In its acute stage, DDwoR can be associated with sudden-onset painful/limited mouth 
opening (closed lock) symptom. There is, however, a lack of understanding on the 
duration of closed lock symptoms and their effects on DDwoR management. It is 
reasonable to hypothesise that there should be a difference if the clinicians intervene 
early as opposed to intervening late in terms of both the possibility of recapturing the 
displaced disc and reducing symptom-related disability. This is addressed in the first 
systematic review of this thesis which examines locking duration effects on clinical 
outcome of DDwoR management. However, understanding whether to intervene early 
is not enough because there are contradictory opinions about the most appropriate 
therapeutic intervention that should be employed.  
For acute and chronic DDwoR management, where therapeutic interventions vary 
considerably in invasiveness, opinions are contradictory in the literature. In terms of the 
clinical decision-making process, the contradictory opinions around DDwoR 
management may lead management to become based more on subjective experience 
than evidence (Durham et al., 2007). Subjective decision-making, however, may 
decrease the probability of making optimal therapeutic risk-benefit and cost-benefit 
                                                 
1 For the purpose of discussing these disorders and readability, however, the singular term ‘TMD’ will be 
used throughout this thesis. 
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decisions. As a consequence, patients may not receive the most appropriate treatment 
and some may receive unnecessary investigations, which delay their active treatment 
and waste resources. It is also possible that some may experience, unnecessary, or even 
more importantly, harmful treatment. Management should, therefore, be examined 
based on the best and most up-to-date available evidence in order to optimise patients’ 
healthcare. This is addressed in the second systematic review of this thesis which 
examines the therapeutic effects of interventions on DDwoR.  
In clinical practice, however, research evidence alone is not sufficient to make a 
decision. Clinical decision-making is a complex adaptive process in which various 
clinical and non-clinical factors can influence clinicians’ decisions (Kay and Nuttall, 
1995c). For evidence-based clinical decisions, clinicians relate the evidence to some 
extent to their practical experience, clinical circumstances, and patient wishes and 
values prior to making a decision on whether or not to apply the research evidence 
(Haynes et al., 2002a). Knowledge of the most appropriate intervention, therefore, is 
insufficient without an understanding of how clinicians behave if they are confronted 
with a patient having DDwoR and what might influence the decisions they make. The 
factors influencing clinicians’ decision-making processes around DDwoR management 
are examined in the third and final part of this thesis. 
In summary, this research project is the initial step in the development process of a 
future intervention aiding clinicians when managing DDwoR at the first point of 
contact. It involves two systematic reviews and one qualitative study. The systematic 
review studies provided the best available evidence to-date for timing and therapeutic 
effects of interventions for DDwoR management whilst the qualitative study provides 
insights into clinicians’ decision-making processes in DDwoR management and the 
influences on the processes. The findings from the data in this thesis will help to 
provide evidence and layout the components for the proposed intervention to be 
implemented in the future. 
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1.2 Thesis layout  
The layout of this thesis involves eight main chapters. Following this introductory first 
chapter, a second chapter reviews the current available literature around TMD and 
DDwoR, clinical decision-making processes, and outlines the development process of 
complex behavioural interventions. The third chapter describes the project aim and 
objectives. The following three chapters report both systematic reviews and the 
qualitative study examining clinical decision-making in DDwoR management. The 
penultimate chapter summarises the conclusions of the three studies whilst the final 
chapter outlines the recommendations for clinical practice and implications for future 
intervention design and future research. 
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Chapter 2. Literature Review 
2.1 Introduction 
The literature review’s chapter is divided into three main sections:  
 Section 2.2 contains a generic description of the temporomandibular disorders 
but focuses specifically on the pathophysiology, differential diagnosis, and 
management of the disc displacement without reduction disorder. 
 Section 2.3 covers the clinical decision-making process and the factors 
influencing this process. 
 Section 2.4 reviews briefly the implementation of research evidence in clinical 
practice and the development of behaviour change interventions for 
professionals.  
Each of these sections will be presented separately with its own distinct conclusion but 
the sections will complement each other to reach the final conclusion.    
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2.2 Temporomandibular disorders 
2.2.1 Introduction  
Temporomandibular disorders are a collection of heterogeneous disorders (Peck et al., 
2014). It is, therefore, more appropriate to refer to these disorders according to the 
‘exact’ diagnosis of each disorder or at least according to subgroups of these disorders 
(e.g., muscular, degenerative, or derangement joint disorders) rather than referring to 
them using the ‘catch-all’ plural ‘TMDs’ or singular ‘TMD’ terms (Laskin, 2007; 
Benoliel, 2010). For the purposes of discussing these disorders and readability of the 
text, however, the singular term ‘TMD’ will be used throughout the thesis.  
This section will cover broadly the whole temporomandibular disorders (TMD) in 
general, but throughout this section the focus will be on disc displacement disorders, 
specifically on the main topic of this thesis: disc displacement without reduction 
(DDwoR) disorder.  
Before reviewing the disorders involving the temporomandibular joint and its associated 
masticatory structures, it is important to have an idea about the basic anatomy and 
unique characteristics of the temporomandibular joint. 
2.2.2 Anatomy of the temporomandibular joint and associated masticatory structures 
The temporomandibular joint (TMJ) is a complex synovial joint consisting of temporal 
bone, mandibular bone, articular disc, synovial membrane, and associated ligaments and 
muscles. Anatomically, the TMJ is a ‘diarthrodial’ joint articulating two bones: the 
mandibular condyle and the squamous portion of the temporal bone (Figure 2.1). 
Functionally, the TMJ is a ‘ginglymoarthrodial’ joint permitting two motions: a hinge or 
rotatory motion (ginglymoid) and a gliding or translatory motion (arthrodial) (Figure 
2.2) (Fletcher et al., 2004; Alomar et al., 2007; Molinari et al., 2007). 
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Figure 2.1: Normal anatomy of the TMJ and masticatory muscles. (A) Lateral view of 
the skull showing the normal position of the mandible in relation to the maxilla, the 
TMJ capsule, and the muscles associated with mandibular function (temporalis, 
masseter, mylohyoid, anterior and posterior digastric, hyoglossus, and stylohyoid). (B 
and C) showing the deep muscles associated with mandibular function (lateral and 
medial pterygoid) and the articular disc. Reproduced from Scrivani et al. (2008) with 
permission from Massachusetts Medical Society. 
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Figure 2.2: Opening movement of the TMJ. (A) Early opening rotatory movement. (B) 
Late opening translatory movement. Note the normal disc position and function during 
mouth opening. Reproduced from Neumann (2010) and Magee (2014) with permissions 
from Elsevier. 
The TMJ is a unique joint. It has several distinctive features which differentiate it from 
other joints in the human body (Alomar et al., 2007; Fanghanel and Gedrange, 2007): 
 TMJ articular surfaces are covered by fibrocartilage instead of hyaline cartilage.  
 TMJ movements have additional guidance through the occlusion of the teeth. 
 TMJ has two principle motions: rotation and translation. 
 Two joints function together and cannot move independently of each other.  
 TMJ is ‘two joints in one’ with upper and lower joint compartments, acting 
synchronously. 
 TMJ is a load-bearing joint (heavily loaded joint: 5-15 kg biting force). 
 TMJ condylar cartilage represents a chondrogenic growth centre in children. 
These peculiar characteristics of the TMJ may have several clinical implications when 
diagnosing and treating temporomandibular disorders. 
2.2.3 Defining TMD and DDwoR 
Temporomandibular disorders (TMD) are a collective group of musculoskeletal 
disorders that include painful and/or functional problems relating to the TMJ and/or its 
related musculoskeletal structures (McNeill et al., 1990; Laskin, 2008). The disorders 
are many but encompass broadly three main subgroups, those primarily involving the 
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muscles (muscle disorders), those primarily involving the TMJ (joint disorders), and 
those associated with headache attributed to these disorders (Peck et al., 2014). The 
TMJ disorders include different subtypes, mainly joint pain and intra-articular 
degenerative and derangement disorders as well as other hypo/hyper-mobility disorders 
(de Leeuw and Klasser, 2013).  
In the healthy TMJ, the disc is normally positioned between the condylar head and the 
articular eminence during mandibular movements resulting in normal jaw function 
(Figure 2.2). The disc, however, may sometimes displace from its normal position 
resulting in disc derangement disorders. 
Disc derangement disorders of the TMJ are a group of intra-articular biomechanical 
disorders in which there is an abnormal relationship in the functional ‘articular 
cartilaginous’ condyle-disc complex (Okeson, 2007). In comparison with the other 
joints in the human body, a clear classification of disc derangement disorders seems to 
be only identified for TMJ. In the orthopaedic literature, the ‘disc displacement’ term is 
rarely used; for example, the displacement of intervertebral disc between adjacent 
vertebral bodies in mobile tri-joint complex of spine is often referred to using other 
terminologies such as disc herniation, prolapse, protrusion, or bulging (Santilli et al., 
2006; Manchikanti et al., 2010). In contrast, the TMJ disc derangement disorders are 
recently classified functionally into three main types of disc displacements in the Axis 1 
of newly recommended diagnostic criteria (DC/TMD) (Table 2.1) (Schiffman et al., 
2014a), as follows: 
1. Disc displacement with reduction (DDwR) 
DDwR is a disorder involving the condyle-disc complex in which the disc is displaced 
in an anterior position relative to the condylar head when the mouth is closed but the 
disc reduces upon mouth opening resulting ‘clinically’ in clicking, popping, or snapping 
sounds (Schiffman et al., 2014a) (Figure 2.3-A). 
2. Disc displacement with reduction with intermittent locking (DDwRwIL) 
DDwRwIL is a disorder involving the condyle-disc complex in which the disc is 
displaced in an anterior position relative to the condylar head when the mouth is closed 
but the disc intermittently reduces upon mouth opening resulting ‘clinically’ in 
intermittent locking (Schiffman et al., 2014a). 
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3. Disc displacement without reduction (DDwoR) 
DDwoR is a disorder involving the condyle-disc complex in which the disc is displaced 
in an anterior position relative to the condylar head when the mouth is closed and the 
disc does not reduce upon mouth opening resulting ‘clinically’ in permanent locking 
(Schiffman et al., 2014a) (Figure 2.3-B). This disorder has two subtypes related to 
presence or absence of mouth opening limitation symptom: DDwoR with limited 
opening disorder also referred to as ‘closed lock’ and DDwoR without limited opening 
disorder and both subtypes of DDwoR (with/without limited opening) can be associated 
with or without TMJ pain. 
A    B  
Figure 2.3: Anatomical disc displacement and its clinical implications. (A) DDwR on 
mouth opening resulting ‘clinically’ in reciprocal ‘opening and closing’ clicking sounds. 
(B) DDwoR on attempted mouth opening resulting ‘clinically’ in limited mouth opening 
‘closed lock’ because the displaced disc blocks complete translation of the condyle. 
Reproduced from McCarty (1980) and Firestein and Kelley (2008) with permissions 
from Quintessence Publishing Company Inc. and Elsevier respectively. 
In DDwoR, the disc is most frequently permanently displaced anteriorly to the condyle 
resulting in a ‘closed lock’ condition (i.e., inability to open mouth fully due to anterior 
DDwoR) (Santos et al., 2013), but it may rarely displace posteriorly to the condyle 
resulting in an ‘open lock’ condition (i.e., inability to close mouth fully due to posterior 
DDwoR) (Huddleston Slater et al., 2005; Chiba et al., 2007). The latter, however, will 
not be considered further in this thesis due to its rarity and different symptomatology 
(Westesson et al., 1998; Nitzan et al., 2008). Further description about disc 
displacements classification is detailed in Section 2.2.7. 
10 
 
Axis 1 Diagnostic Criteria for TMD (DC/TMD)  
 Most common pain-related TMD 
 Myalgia  
- Local myalgia 
- Myofacial pain 
- Myofacial pain with referral 
 Arthralgia  
 Headache attributed to TMD 
 Most common intra-articular TMD 
 Disc derangement disorders 
- Disc displacement with reduction 
Clinical History Positive for at least one of the following:  
1. In the last 30 days*, any TMJ noise(s) present with jaw movement or 
function; OR  
2. Patient report of any noise present during the exam.  
Exam Positive for at least one of the following:  
1. Clicking, popping, and/or snapping noise during both opening and 
closing movements, detected with palpation during at least one of three 
repetitions of jaw opening and closing movements; OR  
2a. Clicking, popping, and/or snapping noise detected with palpation 
during at least one of three repetitions of opening or closing 
movement(s); AND  
2b. Clicking, popping, and/or snapping noise detected with palpation 
during at least one of three repetitions of right or left lateral, or 
protrusive movement(s). 
Validity Without imaging: sensitivity 0.34; specificity 0.92.  
Imaging is the reference standard for this diagnosis. 
Imaging When this diagnosis needs to be confirmed, TMJ MRI criteria are 
positive for both of the following:  
1. In the maximum intercuspal position, the posterior band of the disc is 
located anterior to the 11:30 position and the intermediate zone of the 
disc is anterior to the condylar head; AND  
2. On full opening, the intermediate zone of the disc is located between 
the condylar head and the articular eminence. 
- Disc displacement with reduction with intermittent locking 
Clinical History Positive for both of the following:  
1a. In the last 30 days*, any TMJ noise(s) present with jaw movement or 
function; OR  
1b. Patient report of any noise present during the exam; AND  
2. In the last 30 days*, jaw locks with limited mouth opening, even for a 
moment, and then unlocks. 
Exam Positive for at least one of the following:  
1. Clicking, popping, and/or snapping noise detected during both 
opening and closing movements, detected with palpation during at least 
one of three repetitions of jaw opening and closing movements; OR  
2a. Clicking, popping, and/or snapping noise detected with palpation 
during at least one of three repetitions of opening or closing 
movement(s); AND  
2b. Clicking, popping, and/or snapping noise detected with palpation 
during at least one of three repetitions of right or left lateral, or 
protrusive movement(s). 
Validity Without imaging: sensitivity 0.38; specificity 0.98.  
Imaging is the reference standard for this diagnosis. 
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Axis 1 Diagnostic Criteria for TMD (DC/TMD)  
Imaging When this diagnosis needs to be confirmed, the imaging criteria are the 
same as for DDwR if intermittent locking is not present at the time of 
imaging. If locking occurs during imaging, an imaging-based diagnosis 
of DDwoR will be rendered and clinical confirmation of reversion to 
intermittent locking is needed. 
Note: Although not required, when this disorder is present clinically, examination is positive for 
inability to open to a normal amount, even momentarily, without the clinician or patient performing a 
maneuver to reduce the lock. 
- Disc displacement without reduction with limited opening** 
Clinical History Positive for both of the following:  
1. Jaw locked so that the mouth would not open all the way; AND  
2. Limitation in jaw opening severe enough to limit jaw opening and 
interfere with ability to eat.  
Exam Positive for the following:  
1. Maximum assisted opening (passive stretch) movement including 
vertical incisal overlap < 40 mm. 
Validity Without imaging: sensitivity 80%; specificity 97%.  
Imaging is the reference standard for this diagnosis. 
Imaging When this diagnosis needs to be confirmed, TMJ MRI criteria are 
positive for both of the following:  
1. In the maximum intercuspal position, the posterior band of the disc is 
located anterior to the 11:30 position and the intermediate zone of the 
disc is anterior to the condylar head, AND  
2. On full opening, the intermediate zone of the disc is located anterior 
to the condylar head.  
Note: Maximum assisted opening of < 40 mm is determined clinically.  
Note: Presence of TMJ noise (e.g., click during opening) does not exclude this diagnosis. 
- Disc displacement without reduction without limited opening** 
Clinical History  Positive for both of the following in the past:  
1. Jaw locked so that the mouth would not open all the way; AND  
2. Limitation in jaw opening severe enough to limit jaw opening and 
interfere with ability to eat.  
Exam  
 
Positive for the following:  
1. Maximum assisted opening (passive stretch) movement including 
vertical incisal overlap ≥ 40 mm. 
Validity Without imaging: sensitivity 54%; specificity 79%.  
Imaging is the reference standard for this diagnosis. 
Imaging When this diagnosis needs to be confirmed, TMJ MRI criteria are the 
same as for disc displacement without reduction with limited opening.  
Note: Maximum assisted opening of ≥ 40 mm is determined clinically.  
Note: Presence of TMJ noise (e.g., click during opening) does not exclude this diagnosis. 
 Degenerative joint disease  
 Dislocation  
- Luxation 
- Subluxation 
* The time frame for assessing selected biomechanical intra-articular disorders is in “the last 30 days” 
since the stated sensitivity and specificity of these criteria were established using this time frame. 
Although the specific time frame can be dependent on the context in which the noise or biomechanical 
complaints are being assessed, the validity of this diagnosis based on different time frames has not been 
established. 
** Both types of DDwoR (with/without limited opening) can be associated with or without TMJ pain.  
Table 2.1: Axis 1 diagnostic criteria for TMD (DC/TMD). Adapted from Schiffman et 
al. (2014a). 
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2.2.4 Prevalence and incidence 
TMD has been identified as the most common cause of non-odontogenic pain in the oral 
and maxillofacial region and it is the commonest condition among other chronic 
orofacial pain (COFP) conditions such as trigeminal neuralgia, burning mouth 
syndrome, and atypical facial pain or persistent dentoalveolar pain (Yazdi et al., 2012).  
Epidemiologic studies about TMD prevalence report variable rates (5%-50%) of TMD 
signs and symptoms at any particular time amongst the general population (de Oliveira 
et al., 2006; NIDCR, 2008; Visscher et al., 2015). A meta-analysis of TMD prevalence 
studies shows a rate of 30% perceived dysfunction among participants of 23 studies and 
a rate of 44% clinically assessed dysfunction among participants of 22 studies (de 
Kanter et al., 1993). This difference between people’s perceptions and professionals’ 
clinical assessment may reflect the difference in treatment need/demand by people; that 
is, only individuals with moderate to severe clinically assessed pain/dysfunction 
perceived some need or demand for treatment. The authors, therefore, concluded that 
the TMD prevalence studies are appropriate only for quantification of TMD signs and 
symptoms and cannot reflect the TMD patients’ need and demand for treatment (de 
Kanter et al., 1993). Several studies, therefore, showed that only 5% to 17% of the 
general population have severe TMD symptoms that need treatment (Solberg et al., 
1979; Schiffman et al., 1990; Nassif et al., 2003). 
Many studies found that TMD is most prevalent in young females (LeResche, 1997; 
Kohler et al., 2012). However, in a cohort of 2737 initially TMD-free participants (aged 
18-44 years), 260 developed first-onset TMD during a follow-up average of 2.8 years, 
yielding an average annual incidence rate of 3.5% (Greenspan et al., 2013; Slade et al., 
2013a). This incidence of first-onset TMD was more common among older age adults 
with only slightly greater incidence in females than males (Slade et al., 2013a). The 
differences in reported prevalence and incidence rates among the studies, however, are 
probably attributed to studies’ methodological differences; one of these is the difference 
in inclusion/exclusion criteria of the targeted population. For example, in Slade et al. 
(2013a), the participants were volunteers of a specific age cohort (18-44 years) with no 
significant history of TMD whereas the defined populations in many other studies were 
randomly sampled of a wider age range (Yekkalam and Wanman, 2014; Visscher et al., 
2015). 
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The prevalence of different subgroups of TMD is also quite variable and difficult to 
determine. A systematic review on the prevalence of different TMD subgroups 
according to research diagnostic criteria for TMD (RDC/TMD) axis I diagnoses 
reported an overall prevalence of up to: 13% for muscle disorders, 16% for disc 
derangement disorders, and 9% for joint pain and degenerative disorders among general 
population and found an overall prevalence of: 45% for muscle disorders, 41% for disc 
derangement disorders, and 30% for joint pain and degenerative disorders among TMD 
patients (Manfredini et al., 2011).  
The exact rate of occurrence of symptomatic DDwoR is not fully determined but its 
incidence amongst TMD patients is estimated to occur in about 2-8% (List and 
Dworkin, 1996; Lee et al., 2008; Manfredini et al., 2012; Poveda-Roda et al., 2012) 
whist its prevalence amongst young population is estimated to occur in about 4% 
(Wieckiewicz et al., 2014). DDwoR, however, is also diagnosed radiographically by 
magnetic resonance imaging (MRI) in people without any clinical signs and symptoms 
with a reported prevalence of 3% amongst the asymptomatic general population 
(Katzberg et al., 1996; Kecik et al., 2005; Naeije et al., 2013).  
The prevalence and incidence of TMJ dislocation is undetermined but seems to be 
comparable to that of DDwoR. In a meta-analysis of TMD prevalence studies, the 
prevalence of TMJ dislocation and jaw ‘locking’ conditions was found to be less than 
1% of all participants in included studies’ samples (de Kanter et al., 1993). In one study, 
the incidence of acute and chronic TMJ dislocation (luxation and subluxation) was 
found to be about 22% as opposed to 71% TMD patients attending emergency service 
during 6 months period (Luz and Oliveira, 1994). In another study, however, among 
1500 COFP patients referred over 4 years and a half to specialist service, 94 patients 
have ‘closed lock’ (i.e., DDwoR) (6%) whilst only 13 patients have acute or recurrent 
TMJ dislocation (1%) (Dahlstrom, 1998).  
2.2.5 Aetiology and pathophysiology 
This subsection will be presented in two parts. Firstly, a brief summary of the aetiology 
of TMD in general and secondly a more detailed part of the pathophysiology of disc 
derangement disorders in particular.  
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TMD aetiology 
TMD aetiology is undetermined but considered to be multifactorial. In the literature, 
various aetiological factors have been proposed as risk factors for TMD development. 
These include: traumatic (macrotrauma and microtrauma), anatomical (skeletal and 
occlusal), pathophysiological (systemic, local, and genetic), and psychosocial 
(psychological and social) factors (de Leeuw and Klasser, 2013). However, direct 
causation of any of these factors has not been confirmed and generally there is only 
weak/modest evidence to support any of the systematically reviewed risk factors for 
TMD development (Oakley and Vieira, 2008; Lindenmeyer et al., 2010; Luther et al., 
2010; Manfredini and Lobbezoo, 2010; Iodice et al., 2013; Rocha et al., 2013; 
Haggman-Henrikson et al., 2014; Visscher and Lobbezoo, 2014). 
In the last decade, the aetiology of TMD has been the subject of a multimillion dollar 
National Institute of Dental and Craniofacial Research (NIDCR) program called 
“Orofacial Pain: Prospective Evaluation and Risk Assessment” (OPPERA) (NIDCR, 
2006). In this prospective clinical series of studies, multiple phenotypic domains which 
may have a role in TMD aetiology have been investigated including: sociodemographic 
profiles (Slade et al., 2013a), clinical findings and pain symptoms (Ohrbach et al., 
2013), psychosocial factors (Fillingim et al., 2013), pain sensitivity (Greenspan et al., 
2013), autonomic profiles (Maixner et al., 2011), and genetic factors (Smith et al., 
2013). The project’s initial findings are that a broad range of phenotypic variables 
contributed to the first-onset development of TMD. The greatest contribution was from 
the health status domain followed by psychological and clinical orofacial domains, the 
modest contribution was from pain sensitivity and cardiac autonomic responses 
domains, whilst there were several genetic associations with intermediate phenotypes 
‘risk factors’ contributing to TMD incidence (Slade et al., 2013b). This broad range of 
phenotypic risk factors influencing TMD incidence and distinguishing TMD patients 
from controls (non-TMD) reflects the complex and multidimensional nature of TMD 
aetiology which is consistent with the biopsychosocial model of illness often applied to 
TMD (Suvinen et al., 2005). These findings show promise for advancing our 
understanding of the aetiology of TMD and may have future clinical implications for 
TMD diagnosis and treatment. However, despite these advances, a singular ‘direct’ 
causative factor for developing TMD has yet to be identified. At present, TMD 
aetiology remains controversial with its multifactorial aetiology being best represented 
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by a biopsychosocial framework of initiating, predisposing, and perpetuating factors 
(Greene, 1995). 
Pathophysiology of disc derangement disorders 
The pathophysiology of TMJ disorders is a multifaceted complex process involving 
numerous intra-articular biomechanical and biochemical events and several extra-
articular factors resulting in joint derangement and/or degenerative disorders. These 
events and factors are discussed in-detail in Nitzan et al. (2008). This part will focus on 
the aetiology and the clinical course progression (pathogenesis) of disc derangement 
disorders in general and DDwoR in particular. 
Pathogenesis of disc displacement 
Aetiology of disc displacement  
The aetiology of TMD in general is controversial and the aetiology of disc displacement 
is no exception. Controversies have been reported in determination the causes of disc 
displacement and various aetiological factors have been suggested to play a role in the 
genesis of disc displacement including: trauma (direct or indirect ‘whiplash’ trauma) 
(Yun and Kim, 2005; Sale et al., 2014), functional overloading (parafunctional habits 
and parafunctional masticatory activity) (Israel et al., 1999; Michelotti et al., 2010), 
ligaments laxity and joint hypermobility (Ogren et al., 2012), joint effusion (Manfredini 
et al., 2009), degenerative joint disease (osteoarthritis) (Stegenga, 2001), increased 
friction between the moving TMJ parts (Nitzan, 2001; del Pozo et al., 2003; Tanaka et 
al., 2008b), lateral pterygoid muscle spasm (Taskaya-Yilmaz et al., 2005), as well as 
skeletal discrepancy and occlusal factors (Nebbe and Major, 2000; Kwon et al., 2013; 
Matsumoto et al., 2013; Chang et al., 2015a).  
Most of these factors, however, are not well established and still debatable. For example 
the cause-and-effect relationship between disc displacement and osteoarthritis is 
undetermined because osteoarthritis can be regarded as an initiating cause in the 
development of disc displacement (Stegenga et al., 1991; de Bont and Stegenga, 1993) 
but it can be also a consequence of disc displacement (Eriksson and Westesson, 1983; 
Kalladka et al., 2014). In addition, the osteoarthritis initiating role does not explain the 
displacement of the disc in joints without degenerative changes (Stegenga, 2001).  
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Another example is the possible aetiological role of the attached muscle to the TMJ 
disc. Anterior displacement of the disc has been attributed to spasm of the superior head 
of the lateral pterygoid muscle (SLPM) attached to the disc (Fujita et al., 2001; 
Taskaya-Yilmaz et al., 2005). Different hypotheses have been proposed for the 
aetiological role of the dysfunction of the lateral pterygoid muscle in displacement of 
TMJ disc such as: muscle hyperactivity (resulting from myofascial pain) or hypoactivity 
(muscle pathologic changes: hypertrophy or atrophy), lack of coordination between the 
superior and inferior heads of the muscle, and/or a disturbance in the normal function of 
the muscle in stabilising and controlling the movements of the disc (Mahan et al., 1983; 
Juniper, 1984; Liu et al., 1989; Hiraba et al., 2000). Most of these hypotheses, however, 
are not supported currently by sufficient evidence (Murray et al., 2004). This is in 
addition to the fact that the SLPM has a variable attachment to the disc (Carpentier et 
al., 1988; Naidoo, 1996; Antonopoulou et al., 2013). In a review about the percentage 
of SLPM insertion into the disc, highly variable insertion percentages were found 
ranging from 2% to 70% (Contreras et al., 2011). Although Taskaya-Yilmaz et al. 
(2005) found that the SLPM attached solely to the disc in 86% of all the joints with 
DDwoR suggesting that the contraction of this muscle may easily displace the disc 
anteriorly, a recent study invalidated this finding and found no difference between 
DDwoR, DDwR, and normal disc position in patients having a SLPM attached only to 
the disc (Park et al., 2012). Furthermore, other studies found no difference between the 
type of muscle attachment and the presence or absence of disc displacement (Dergin et 
al., 2012; Imanimoghaddam et al., 2013). All these findings suggest that the explanation 
of anterior disc displacement based on anatomic SLPM attachment, muscle spastic 
activity, and/or dysfunction is not probable. 
Joint hypermobility, whether generalised or localised, has also been reported to have a 
role in the aetiology of disc displacement of the TMJ (Kavuncu et al., 2006; Ogren et 
al., 2012). Generalised Joint hypermobility (GJH) is a systemic disorder characterized 
by the increase in range of motion of multiple joints in the human body (Conti et al., 
2000; Winocur et al., 2000) and it can be associated with a variety of complaints of the 
locomotor system such as joints dislocation and soft tissue lesions (Kirk et al., 1967). 
GJH is mostly attributed to hereditary disorders of the connective tissue (collagen 
defect) (Child, 1986; Westling et al., 1992), but it can occur without collagen defect 
(Beighton et al., 2012). The sequence of events resulting in disc displacement in TMJ 
involved in GJH is hypothesised as follows: biochemical changes to the structure of 
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collagen and elastin; causing a loss of resistance to traction and laxity of capsular or 
ligamentous structure of the TMJ; resulting in increase in joint mobility; increasing 
propensity to mechanical overloading due to joint hypermobility; the joint overloading 
associated with parafunctions and/or trauma resulting in degenerative changes, joint 
inflammation, and disc derangements (Dijkstra et al., 1992; Kavuncu et al., 2006; 
Pasinato et al., 2011). However, a systematic review of the studies analysing the 
association between TMJ disorders and GJH performed up to 2001 found conflicting 
evidence of this association (Dijkstra et al., 2002). Several studies have been conducted 
after this systematic review and have reported conflicting results. Some studies found 
there is an association between GJH and disc displacement (Hirsch et al., 2008; Ogren 
et al., 2012), whilst others found there is no such association (Saez-Yuguero Mdel et al., 
2009; Wang et al., 2012). In fact, the observations of absence of joint hypermobility in 
many patients with disc displacement supports the multifactorial aetiology of disc 
displacement (Khan and Pedlar, 1996). Currently, GJH is regarded as one of the 
important predisposing factors for developing disc displacement and, therefore, 
individuals with GJH involving the TMJ should be carefully evaluated and monitored 
for the potential increased risk of disc displacement (Chang et al., 2015b). 
Overall, most of the studies investigating the aetiology of disc displacement had the 
shortcoming of not controlling the other ‘risk’ factors that can play a potential role in 
disc displacement initiation. In fact, the aetiology of disc displacement, as the whole 
TMD, is multifactorial and many aetiological factors can contribute not only to the 
genesis of disc displacement but also to the type and direction of disc displacement. 
Progression of disc displacement 
The classical clinical progression sequence in disc derangement of TMJ has been 
described to progress from reciprocal clicking (DDwR) to intermittent locking 
‘catching’ (DDwRwIL) to permanent locking ‘closed lock’ (DDwoR) culminating in an 
end stage of degenerative joint disease (osteoarthritis) (Rasmussen, 1981; Wilkes, 1989; 
Kalladka et al., 2014). Although these progressive changes may happen in some 
patients with disc displacement, the findings from several studies suggest that this is far 
from a fait accompli in disc derangement disorders (Greene and Laskin, 1988; de Leeuw 
et al., 1994), and even if this progression sequence occurs, it may not be clinically 
relevant to patients’ symptoms in terms of jaw pain, function, and disability 
(Chantaracherd et al., 2015).  
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Numerous observational studies on patients with DDwR reported different progression 
rates from DDwR to DDwoR ranging from 0% to 69% over varying periods of 
observation ranging from 3 months to 15 years (Lundh et al., 1987; Westesson and 
Lundh, 1989; Kononen et al., 1996; Sato et al., 2003; Kalaykova et al., 2010; Cai et al., 
2011; Manfredini et al., 2013; Sale et al., 2014). A systematic review about disc 
displacement disorders found that the progression to permanent locking (closed lock) 
occurred in only (12–30%) of patients who had lost reciprocal clicking sounds over the 
observation period (Naeije et al., 2013). In a recent study, significant osseous 
organisational differences were found between most clicking and locking joints 
suggesting that DDwR and DDwoR can be two distinct disorders and not necessarily a 
single disease continuum (i.e., a sequence progression from one to another) and there 
were only a subset of clicking joints contain characteristics of locking joints that may 
contribute to symptom progression (Pullinger, 2013). All these findings indicate that the 
‘clicking’ is not always a reliable predictor for ‘locking’ and there could be a lot of 
predisposing factors leading to initiation of symptomatic DDwoR and the closed lock 
condition.  
Pathogenesis of DDwoR 
Aetiology of DDwoR 
In addition to various aetiological factors suggested earlier for disc displacement 
genesis, several factors have been also discussed in the literature that can be involved 
specifically in initiation or predisposition of jaw locking (DDwoR or closed lock) such 
as: frequent intermittent locking (Friedman, 1993; Yoda et al., 2006; Kalaykova et al., 
2010; Takahara et al., 2014), bruxism (Katzberg et al., 1996; Ghanem, 2011), genetic 
(Huang et al., 2011), skeletal (Ooi et al., 2013; Ooi et al., 2014), and traumatic (Knibbe 
et al., 1989; Gould and Banes, 1995) factors. These ‘risk’ factors may be regarded as 
important predictors for progressing clicking into locking. 
Progression of DDwoR 
The progression of DDwoR has been studied in several observational studies and shown 
to be ‘favourable’. In studies on the long-term natural course of ‘chronic’ DDwoR, 
about two thirds of patients have resolution or spontaneous improvement in their 
clinical signs and symptoms without any therapeutic intervention over an observation 
period of 1 to 2.5 years, whilst the other one third did not improve or became worse 
19 
 
during the observation period (Lundh et al., 1992; Sato et al., 1997a; Kurita et al., 
1998b). In a recent study on the short-term natural course of ‘acute’ DDwoR, 95% of 
patients have resolution in their signs and symptoms over 3 months period of 
observation (Yura, 2012). These findings suggest that any treatment offered for patients 
with symptomatic DDwoR must be easier and more effective than waiting for 
symptoms resolution during the natural course of the disorder. 
The improvement in some patients with DDwoR over time is often attributed to 
retrodiscal tissues’ stretching, remodelling, and ‘pseudo’ disc adaptation (Isberg and 
Isacsson, 1986; Pereira Junior et al., 1996). Several studies, however, have proved that 
the deformity of the condyle-disc complex and the displacement of the disc increases 
despite the improved symptoms (Sato et al., 1999a; Kurita et al., 2006; Cai et al., 2011). 
Some studies have also pointed out that the permanently displaced disc can result in 
changes in maxillofacial skeletal morphology over the long-term (Gidarakou et al., 
2004; Bertram et al., 2011; Xie et al., 2015).   
Adaptation versus degeneration  
The TMJ is a load-bearing joint (Smith et al., 1986). Its articular tissues have an 
impressive adaptive capacity to mechanical loading (Milam and Schmitz, 1995). This 
capacity, however, is not infinite because continued overloading may raise the 
susceptibility to degenerative joint disease (Kai et al., 1998; Milam, 2005). In addition, 
several ‘risk’ factors may adversely influence the joint adaptive capacity such as: age, 
systemic illness, nutritional, hormonal, mechanical, traumatic, and genetic factors 
(Milam and Schmitz, 1995; Nitzan et al., 2008; Tanaka et al., 2008a). Hence, a 
degenerative state may ensue if functional demands surpass the joint adaptive capacity 
or if the affected individual is susceptible to maladaptive responses (Milam, 2005).  
Milam (2003) proposed three models that may be involved in the pathogenesis of 
degenerative TMJ disorders: direct mechanical trauma model, hypoxia reperfusion 
model, and neurogenic inflammation model. In these models, the molecular events and 
cascades in response to mechanical overloading may result in an imbalance between 
catabolic and anabolic events leading ultimately to catabolism (i.e., degeneration) of the 
articular tissues in the susceptible joints (Milam and Schmitz, 1995; Milam, 2003; 
Milam, 2005). In one study, the risk of degenerative changes has been shown to be four 
times greater in joints with DDwoR than in joints with normal disc position and 
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suggestions have been made to the susceptibility for degenerative disease initiation by 
an imbalance in the patient’s adaptive capacity and functional loading of the TMJ (Roh 
et al., 2012). Many studies have also provided biochemical evidence of increasing 
susceptibility to osteoarthritic degenerative changes in ‘chronic’ DDwoR patients 
(Kubota et al., 1997; Paegle et al., 2003; Sicurezza et al., 2013).  
All these findings suggest the need for a thorough individualised assessment of each 
patient with DDwoR in order to evaluate the various potential ‘risk’ factors that may 
play a role in DDwoR prognosis and contribute towards the progression to degenerative 
disorder. At present, however, the borderline separating ‘healthy’ remodelling adaptive 
responses from ‘pathological’ degenerative responses is ill-defined which means it is 
difficult to predict the DDwoR prognosis in an individual patient.  
In fact, DDwoR is a disorder with two possible scenarios: it is either a benign self-
limiting disorder in which most patients’ symptoms improve with time and not 
necessarily progress to degenerative joint disease (de Leeuw et al., 1994; Murakami et 
al., 2002; Imirzalioglu et al., 2005), or it can be also a debilitating disorder resulting in 
significant pain and dysfunction leading to patients’ disability and disturbing their 
quality of life with the potential for persistence of symptoms and progression to 
degenerative disease in susceptible patients over the long-term (Chiba and Echigo, 
2005; Paegle et al., 2005; Holmlund, 2007; Ishimaru et al., 2015; Millon-Cruz et al., 
2015). Both scenarios are possible in patients with DDwoR and it is still yet unclear 
which patients have, or which bio-mechanical/chemical factors predict, the greatest risk 
for progressing to the more advanced stages. This is in addition to the fact that there are 
other risk factors that can be involved in developing chronic pain in some individuals 
such as: increasing age at presentation, gender (females with concurrent myogenous 
TMD), higher pain intensity and disability (graded chronic pain scale (GCPS) score of 3 
or 4), non-specific widespread symptoms, genetics, phenotype, and psychosocial 
(concurrent psychiatric diagnosis or mood disturbance such as depression, anxiety, 
anger) factors (Denk et al., 2014; Durham et al., 2015). Therefore, it is important to 
treat all DDwoR patients early in order to prevent degenerative disease progress in 
susceptible patients and to mitigate progression from an acute to a chronic condition and 
hopefully avoid the development of chronic pain/disability and its psychosocial 
consequences (Gatchel et al., 2006). Nevertheless, any early intervention must be 
simple and non-invasive to allow for potential healing (adaptation) and symptomatic 
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resolution during the ‘favourable’ natural course of the DDwoR disorder (Yura, 2012; 
Tajima et al., 2013). 
In recent years, numerous synovial fluid analyses and investigations have been 
conducted to further comprehend the pathogenesis of disc derangement and 
degenerative joint disorders (Bouloux, 2009; Wei et al., 2010; Li et al., 2014). Despite 
these investigative advances, at present, the events that underlie TMJ adaptation versus 
degeneration are still not fully understood (Wang et al., 2015) and the molecular and 
cellular basis of DDwoR pathophysiology is still unclear.  
In summary, the aetiology and pathophysiology of the TMD is yet to be completely 
revealed and their clinical implications on TMD management are still undefined. 
Nevertheless, this brief review provides some evidence from a pathophysiological 
perspective of the need for early intervention in the DDwoR management pathway. 
2.2.6 Presenting signs and symptoms 
TMD may present with a multitude of overlapping signs and symptoms including pain 
in the masticatory musculature and/or joint, limitation of mandibular movements (e.g., 
locking), TMJ sounds (e.g., clicking, snapping, popping, grating or crepitus), and 
occasionally headaches (Wassell et al., 2004; de Leeuw and Klasser, 2013). The natural 
course of TMD is not yet well understood but most TMD symptoms are often remitting 
and self-limiting but can recur or fluctuate over time (de Bont et al., 1997; Manfredini 
et al., 2013). 
Patients with DDwoR are usually characterised by distinct combinations of signs and 
symptoms: history of clicking followed by sudden-onset TMJ pain and limited mouth 
opening (locking without clicking), impaired mandibular lateral movement towards the 
opposite ‘unaffected’ side, and deflection towards the same ‘affected’ side during mouth 
opening (Farrar, 1972; Okeson, 2007). These characteristic symptoms are usually 
present in ‘acute’ rather than ‘chronic’ DDwoR (Naeije et al., 2013).  
In its acute stage, DDwoR is often associated with severe symptoms that have 
considerable negative impact on patient’s quality of life (Reissmann et al., 2007). The 
two biomedical complaints which are often predominant in ‘acute’ DDwoR (i.e., closed 
lock) are: TMJ pain and limited mouth opening (Farrar, 1978; Eriksson and Westesson, 
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1983; Okeson, 2007). The causes of these symptoms in DDwoR, however, are unclear 
and controversial with various putative theories suggested. 
The first biomedical complaint predominant in DDwoR is the sudden-onset TMJ pain. 
The exact cause of pain is still not fully understood (Fujiwara et al., 2013). The 
displaced disc has been thought to play an important role in the pain process due to 
overstretching and pulling the highly vascularized and innervated retrodiscal tissues and 
joint capsule in addition to condylar impingement on the capsule and/or compression to 
the retrodiscal tissue (Isberg et al., 1986; Lin et al., 2012). This, however, is unlikely to 
be the sole reason of pain because disc displacement is not always associated with pain 
and several studies have shown that DDwoR can be asymptomatic and some considered 
it as an anatomic variant rather than a pathologic abnormality (Katzberg et al., 1996; 
Peroz et al., 2011). In addition to alteration in disc position, other factors have been 
suggested in the development of pain in patients with DDwoR such as joint effusion and 
inflammatory reactions including synovitis, capsulitis, or retrodiscitis (Murakami et al., 
1991; Westesson and Brooks, 1992; Segami et al., 2001), as well as accompanied 
muscular spasm and pain (Murakami et al., 1992; Manfredini, 2009). 
The other biomedical complaint predominant in DDwoR is the abrupt restriction in 
mouth opening (Mariz et al., 2005; Campos et al., 2008). It is widely accepted that the 
restriction in mouth opening in DDwoR is mostly attributed to mechanical obstruction 
by the displaced disc to the translating condylar movement (Farrar, 1972; Rammelsberg 
et al., 1997). This limitation in mouth opening is often termed, almost colloquially, 
since early 1980s as ‘closed lock’ (CL) (Katzberg et al., 1980; Weisberg and Friedman, 
1981). This term, however, describes a clinical symptom not an anatomic diagnosis and 
the CL condition is not always exclusively refer to DDwoR. Several studies by Nitzan 
and co-authors suggested various putative biomechanical and biochemical processes 
within the joint resulting in a phenomenon of anchoring the articular disc to the glenoid 
fossa termed ‘anchored disc phenomenon’ (ADP) as potentially responsible for mouth 
opening limitation in some of the cases of CL (Nitzan and Dolwick, 1991; Nitzan and 
Marmary, 1997). The putative pathogenic sequential processes underpinning ADP 
involve the following: joint overloading resulting in direct mechanical injury, hypoxia-
reperfusion injury, resulting in free radicals release into the synovial fluid, causing 
hyaluronic acid degradation, resulting ultimately in a vacuum effect (suction cup effect). 
The culmination of these proposed sequential pathological processes collectively leads 
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to tight disc adherence to the roof of the glenoid fossa, thereby preventing the condylar 
sliding movement and producing more pronounced jaw locking but that responds better 
to arthrocentesis than DDwoR (Nitzan and Dolwick, 1991; Nitzan et al., 1992; Nitzan 
and Marmary, 1997; Nitzan and Etsion, 2002; Nitzan et al., 2002; Nitzan, 2003). 
According to Nitzan, ADP has been mistakenly included with DDwoR. Nitzan’s claim 
is that ADP differs from DDwoR disorder in its origin, clinical presentation, and 
treatment required (Table 2.2) and, therefore, she suggests that there is a need to 
identify ADP as a distinct entity within the group of TMJ disorders (Nitzan et al., 
1997).  
Characteristics ADP DDwoR 
History: 
Occurrence (Onset of limitation) Sudden  Gradual  
Nature of limitation Persistent Pliable 
Past clicks (History of clicking) No (30%) Yes 
Clinical signs and symptoms: 
Main complaint Severe LMO Pain + LMO 
Pain (self-assessment) - + 
Dysfunction (self-assessment) + - 
Maximum mouth opening (mm) 15-25 mm 30-45 mm 
Contralateral movement Limited Limited 
Ipsilateral movement Normal Normal 
Occlusal changes  - - 
Imaging:  
Bony changes on radiographs, 
computed tomography (CT) 
No No 
Magnetic resonance imaging (MRI) 
(open mouth position) 
Stuck disc, located 
above and behind the 
condyle 
Displaced-deformed 
disc, located in front 
of the condyle 
Treatment:  
Efficacy of conservative treatments Poor 10% Excellent 90% 
Effect of arthrocentesis Excellent 90% Moderate 40% 
Table 2.2: Summary of comparison of history, clinical signs and symptoms, imaging, 
and treatment required between ADP and DDwoR. Adapted from (Nitzan and Marmary, 
1997; Nitzan, 2002; Nitzan et al., 2008). 
Despite these attempts to differentiate ADP from DDwoR, it is still unclear if ADP is a 
distinct entity from DDwoR or a differing stage of the same clinical entity due to 
considerable similarity in signs and symptoms between the two conditions. This 
similarity makes it virtually impossible to differentiate the two conditions on the basis 
of clinical diagnosis alone. Although there is still a possibility to differentiate the 
adhered fixed or ‘stuck’ disc from displaced disc on the basis of MRI (Rao et al., 1993) 
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(Figure 2.4), it is doubtful and questionable as apart from very few ADP studies 
involving exclusively patients with normally positioned discs (Kaneyama et al., 2007b), 
most ADP studies involve patients with displaced discs as well as normally positioned 
discs (Nitzan et al., 1997; Casares et al., 1999; Sanroman, 2004). Further studies with 
MRI evidence of normally positioned discs in CL patients are needed to gain a better 
understanding whether ADP is a separate entity within the ‘closed lock’ category 
(Hoffman, 1997; Kaneyama et al., 2007b). 
A   B  
Figure 2.4: MRI sagittal views of anteriorly displaced disc and normally positioned 
adhered disc. (A) Anterior DDwoR on closed and opened mouth positions. (B) ADP 
during mouth opening movement. The images show: condylar hypomobility, normally 
positioned disc with limited mobility, and apparent fibrous adhesion band between the 
posterior band of the disc and the glenoid fossa (arrows). Reproduced from Galhardo et 
al. (2013) and de Melo et al. (2014) with permissions from Elsevier and Revista Gaúcha 
de Odontologia (RGO) respectively. 
Overall, the role of disc displacement in the development of clinical signs and 
symptoms in DDwoR is yet to be determined; whether disc displacement is the result, 
the cause, or an accompanying factor of TMJ-related pain and dysfunction is unclear 
(Dolwick, 1995; Hall, 1995). Many studies emphasised the importance of disc position 
as an underlying causative factor of TMJ-related pain and dysfunction suggesting that 
the disc requires repositioning in order to improve DDwoR signs and symptoms 
(Okeson, 1988; McCain et al., 1992a; Jiang et al., 2013; He et al., 2015). This is, 
however, proven to be unnecessary as high success rates have been reported by 
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conservative and surgical interventions without influencing the disc position and 
repositioning (recapturing) the displaced disc (Montgomery et al., 1989; Choi et al., 
1994; Nitzan, 2001). Currently, it is generally agreed that the disc mobility rather than 
disc position is more important to improve patients’ signs and symptoms when 
managing DDwoR (Takatsuka et al., 2005; Ohnuki et al., 2006). 
2.2.7 Diagnosis 
Diagnostic classification systems of TMD 
Several diagnostic and screening systems have been suggested for TMD such as: Bell's 
classification (Bell, 1970), Helkimo's anamnestic and dysfunction indices (Helkimo, 
1974), American Academy of Orofacial Pain (AAOP) guidelines (de Leeuw, 2008), and 
Research Diagnostic Criteria for TMD (RDC/TMD) (Dworkin and LeResche, 1992). 
Ideally, any diagnostic classification system should be based on the aetiology of the 
disease. For TMD, however, all the diagnostic classifications are generally based solely 
on signs and symptoms of the disorders rather than their ‘actual’ aetiological factors due 
to limited knowledge about TMD aetiology (Section 2.2.5).  
Amongst all diagnostic classification systems suggested for TMD, the most widely 
accepted is the RDC/TMD (Dworkin and LeResche, 1992) because it uses a 
biopsychosocial approach including biological, psychological, and social factors for 
TMD diagnosis (Zakrzewska, 2004; Suvinen et al., 2005). The RDC/TMD applies a 
dual-axis system to diagnose and classify patients with TMD. The physical axis 1 
distinguishes between groups of TMD patients with (I) myofascial pain, (II) disc 
displacement with/without reduction, and (III) arthralgia, osteoarthritis, and 
osteoarthrosis. The psychosocial axis 2 includes a 31-item questionnaire that assesses 
TMD-related pain and psychosocial factors (Dworkin and LeResche, 1992). This multi-
axial approach allows better characterization of the patient from several standpoints 
(Zakrzewska, 2004).  
Satisfactory reliability and validity (specificity and sensitivity) are the prerequisites for 
the use of any diagnostic measures (Turp and Minagi, 2001). The validation project 
examined the reliability and validity of RDC/TMD (Anderson et al., 2010). The main 
finding of this project was that the RDC/TMD axis 1 has the reliability but not the 
‘target’ validity (i.e., sensitivity < 70% and specificity < 95%) (Look et al., 2010; 
Schiffman et al., 2010; Truelove et al., 2010), and that the axis 2 had both reliability 
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and validity (Ohrbach et al., 2010). The RDC/TMD is also criticised for being too 
complex and takes a lot of time to be used in routine clinical practice and is more 
suitable for research purposes (Zakrzewska, 2004; Hasanain et al., 2009). For all these 
shortcomings, the RDC/TMD has been recently revised to the diagnostic criteria for 
TMD (DC/TMD) (Schiffman et al., 2014a). 
The newly recommended DC/TMD also include two axes. The new axis 1 (Table 2.1) 
includes reliable and valid criteria for differentiating ‘clinically’ the common pain-
related TMD as well as one intra-articular disorder (DDwoR with limited opening) but 
still lacks adequate validity to clinically diagnose other intra-articular disorders without 
using TMJ imaging. The new axis 2 is expanded by adding further instruments to assess 
pain, jaw function, behavioural and psychological status, and psychosocial functioning. 
It involves two self-report instrument sets: a simple screening set of different 
psychometric instruments, to be used initially, includes a 41-item questions that assesses 
TMD-related pain intensity, disability, and location as well as jaw functional 
limitations, psychosocial distress, and parafunctional behaviour; a more comprehensive 
set of psychometric instruments, to be used when indicated, includes an 81-item 
questions that assesses in further detail jaw functional limitations and psychosocial 
distress as well as anxiety and presence of comorbid pain conditions. The new 
DC/TMD has been suggested to have more clinical utility than the ‘original’ RDC/TMD 
and are more appropriate for use in clinical and research settings (Schiffman et al., 
2014a). 
Diagnostic classification of disc displacement 
The classification of disc displacement in relation to disc position and function and its 
clinical relevance has been studied and documented by clinical, anatomic, radiographic, 
and surgical observations (Wilkes, 1989).  
Precise localisation of disc position on TMJ imaging is crucial for disc displacement 
diagnosis (Drace and Enzmann, 1990). Normal disc position has been defined according 
to the radiological location of either the posterior band of the disc (i.e., the junction of 
the posterior band of the disc and the bilaminar zone) or the intermediate zone of the 
disc using different reference criteria. Many studies used the traditional 12 o’clock 
criterion to define the normal position of the posterior band of the disc on MRI (Rao et 
al., 1993; Tasaki et al., 1996; Katzberg and Tallents, 2005) (Figure 2.5-A). However, 
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the normal position of the junction of the posterior band of the disc and the bilaminar 
zone was identified by Drace and Enzmann (1990) to be anywhere up to 10° from the 
12 o’clock position (Figure 2.5-B).  
A    B  
Figure 2.5: Disc position according to 12 o’clock criterion. (A) Diagram illustrating the 
normal disc position defined according to 12 o’clock criterion at the junction of the 
posterior band of the disc and the bilaminar zone. (B) Diagram illustrating the 
quantification of degree of disc displacement. The angle from the 12 O’clock criterion 
represents the amount of displacement, specified in degrees: A=anterior, P=posterior. 
Reproduced from Styles and Whyte (2002) and Drace and Enzmann (1990) with 
permissions from Elsevier and Radiological Society of North America (RSNA) 
respectively. 
Orsini and colleagues evaluated four different criteria for normal disc position on MRI: 
three clock positions of the posterior band (12, 11, and 10 o’clock) and one intermediate 
zone criterion (Figure 2.6) in order to identify the best reference criterion for disc 
position on MRI that reflects the clinical findings of the joint (i.e., signs and symptoms) 
(Orsini et al., 1998; Orsini et al., 1999). The study found that the intermediate zone 
criterion is the most rigorous criterion having fewest false positives and false negatives 
(Orsini et al., 1998; Orsini et al., 1999). Therefore, the intermediate zone criterion is 
preferred over the other suggested criteria and used currently by the new DC/TMD 
because it avoids the possibility of over-diagnosis/over-treatment and under-
diagnosis/under-treatment (Orsini et al., 1999; Provenzano Mde et al., 2012). 
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A     B    C  
Figure 2.6: Normal disc position according to four different criteria. (A) 12, 11, and 10 
o’clock posterior band criteria in the closed-mouth position (if the posterior band of the 
disc touched the line of the criterion zone, the disc position considered normal for that 
criterion). (B) Intermediate zone criterion in the closed-mouth position (if the 
intermediate zone of the disc located between the anterosuperior aspect of the condyle 
and the posteroinferior aspect of the articular eminence in the middle of the line, the 
disc position considered normal). (C) Intermediate zone criterion in the opened-mouth 
position (if the intermediate zone of the disc located between the condyle and the 
articular eminence when the mouth is wide open in the middle of the line, the disc 
position considered normal). Reproduced from Orsini et al. (1998) with permission 
from Elsevier. 
On the basis of the MRI sagittal and coronal images analysis, Tasaki et al. (1996) 
propose a classification system for TMJ disc displacement involving ten different 
categories of disc position into which normal and abnormal joints can be classified. The 
ten disc positions are summarised in Table 2.3 and illustrated in Figure 2.7.  
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Disc position category Criteria for classification of disc positions 
Superior disc position 
(normal anatomical disc 
position) 
Posterior band of disc superior to condyle or central 
thin zone (intermediate zone) of disc located between 
anterior prominence of condyle and posterior aspect of 
articular eminence (Figure 2.3-1). 
Anterior disc displacement Posterior band of disc anterior to anterior prominence 
of condyle throughout mediolateral dimension of joint 
(Figure 2.3-2). 
Partial anterior disc 
displacement in lateral part 
of joint 
Disc anteriorly displaced in lateral part of joint and 
disc in superior position in medial part of joint with no 
sideways component to displacement (Figure 2.3-3). 
Partial anterior disc 
displacement in medial 
part of joint 
Disc anteriorly displaced in medial part of joint and in 
superior position in lateral part of joint with no 
sideways component to displacement (Figure 2.3-4). 
Rotational anterolateral 
disc displacement 
Disc anteriorly and laterally displaced (Figure 2.3-5). 
Rotational anteromedial 
disc displacement 
Disc anteriorly and medially displaced (Figure 2.3-6). 
Lateral disc displacement Disc displaced lateral to lateral pole of condyle (Figure 
2.3-7). 
Medial disc displacement Disc displaced medial to medial pole of condyle 
(Figure 2.3-8). 
Posterior disc displacement Disc displaced posterior to 12 o'clock position on top 
of condyle (Figure 2.3-9). 
Indeterminate This category was used when a large perforation, prior 
surgical therapy or no clear image of the disc 
prevented classification into any of the above 
categories. 
Table 2.3: Criteria for classification of disc positions. Adapted from Tasaki et al. 
(1996). 
 
30 
 
 
Figure 2.7: Schematic figures illustrate nine categories of disk position described in 
Table 2.3. Reproduced from Tasaki et al. (1996) with permission from Elsevier. 
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Among the different directions of disc displacement, ‘pure’ anterior disc displacement 
has been consistently reported as the most common type of disc displacement (Tasaki et 
al., 1996; Foucart et al., 1998; Whyte et al., 2006). The second commonest type of disc 
displacement, however, is not generally agreed. Many studies found it is anteromedial 
(Nebbe and Major, 2000; Ogutcen-Toller et al., 2002; Schmitter et al., 2005a), whilst 
others found it is anterolateral disc displacement (Katzberg et al., 1996; Tasaki et al., 
1996; Emshoff et al., 2002b). Other types of disc displacement such as posterior or 
‘pure’ lateral or medial disc displacements are generally uncommon (Katzberg et al., 
1988; Westesson et al., 1998). 
Despite the importance of classifying and identifying the different disc positions, in 
clinical practice increasing the diagnostic options may result in reducing the diagnostic 
reliability (Ahmad et al., 2009). In practice, the most important is the disc function 
rather than its position. In this regard, Ahmad et al. (2009) develop comprehensive 
criteria for image analysis using panoramic, computed tomography (CT), and MRI 
imaging techniques as a part of axis 1 RDC/TMD diagnostic system. The RDC/TMD 
image analysis recommended criteria for disc position were based on Orsini et al. 
(1999) and classify the disc position in relation to the osseous joint components simply 
into 5 (Table 2.4) instead of 10 types (Table 2.3). The RDC/TMD image analysis 
criteria have good reliability and it can be used in both clinical as well as research 
settings (Ahmad et al., 2009). Recently, on the basis of MRI images evaluation and 
classification according to Ahmad et al. (2009), a strong correlation was found between 
severe stage of disc displacement (i.e., bilateral DDwoR) and both osseous 
abnormalities and pain in symptomatic young patients (de Melo et al., 2015). 
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Disc diagnosis MRI findings 
A. Normal Disc location is normal on closed- and open-mouth 
images. 
B. Disc displacement 
with reduction 
Disc location is displaced on closed-mouth images but 
normal in open-mouth images. 
C. Disc displacement 
without reduction 
Disc location is displaced on closed-mouth and open-
mouth images. 
D. Indeterminate Disc location is not clearly normal or displaced in the 
closed-mouth position. 
E. Disc not visible Neither signal intensity nor outlines make it possible to 
define a structure as the disc in the closed-mouth and 
open-mouth views. If the images are of adequate quality 
in visualizing other structures in the TMJ, then this 
finding is interpreted to indicate a deterioration of the 
disc, which is associated with advanced disc pathology. 
Table 2.4: Disc diagnosis for TMJ using MRI. Adapted from Ahmad et al. (2009). 
This image analysis means that the clinician in clinical practice can simply categorise 
the disc displacement positions according to disc function into three distinct categories: 
normal, abnormal (displaced with or without reduction), or indeterminate. According to 
Tasaki et al. (1996), these disc functions are defined as follows:  
 Normal disc function: “when a disc in the superior position in the closed mouth 
position maintained a position interposed between the condyle and the articular 
eminence in the open mouth position”.  
 Reduction: “when a displaced disc in the closed mouth position assumed a 
position interposed between the condyle and the articular eminence in the open 
mouth position”.  
 No reduction: “when a displaced disc in the closed mouth position did not 
achieve a position between the condyle and the articular eminence in the open 
mouth position”.  
 Indeterminate disc function: “when the disc cannot be identified by imaging 
because of surgical removal, metallic artifacts, or postsurgical scarring”. 
Currently, three main types of disc displacements are classified clinically in the newly 
recommended DC/TMD: disc displacement with reduction (DDwR), disc displacement 
with reduction with intermittent locking (DDwRwIL), and disc displacement without 
reduction (DDwoR) (Schiffman et al., 2014a).  
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To-date, the most widely used criteria for DDwoR diagnosis in clinical trials are: 
RDC/TMD (Dworkin and LeResche, 1992), AAOP diagnostic guidelines (de Leeuw, 
2008), and Wilkes staging for TMJ internal derangement (Wilkes, 1989; Wilkes, 1991). 
All the three diagnostic classifications have some general agreement about the presence 
of pain and limited mouth opening as common complaints in DDwoR patients (Table 
2.5). 
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AAOP Criteria (de Leeuw, 2008) 
Criteria for acute DDwoR: 
Clinical  All the following must be present: 
1. Persistent markedly limited mouth opening ≤ 35mm with history of sudden onset. 
2. Deflection to the affected side on mouth opening. 
3. Markedly limited laterotrusion to the contralateral side (if unilateral disorder). 
Any of the following may accompany the preceding items: 
- Pain precipitated by forced mouth opening. 
- History of clicking that ceases with locking. 
- Pain with palpation of the affected joint. 
- Ipsilateral hyper occlusion 
Imaging  Optional soft tissue imaging reveals DDwoR. Can be accompanied with:  
No or mild osteoarthritic changes with hard tissue imaging. 
Criteria for chronic DDwoR: 
Clinical  1. History of sudden onset of limited mouth opening. 
Any of the following may accompany the preceding item: 
- Pain, when present, is markedly reduced from the acute stage. 
- History of clicking that resolved with sudden onset of the locking. 
- Crepitation on mandibular movement. 
- Gradual resolution of limited mouth opening.  
Imaging  Soft tissue imaging reveals DDwoR. Can be accompanied with:  
Mild to moderate osteoarthritic changes with imaging of hard tissues. 
RDC/TMD (Dworkin and LeResche, 1992) 
Criteria for DDwoR with limited mouth opening:  
Clinical  All the following must be present: 
• History of locking or catching that interfered with eating. 
• Absence of TMJ clicking or presence of TMJ sounds not meeting criteria for DDwR. 
• Maximum unassisted opening ≤ 35mm. 
• Passive stretch < 5mm (from unassisted opening to assisted opening < 40mm). 
• Contralateral excursion < 7mm and/or uncorrected ipsilateral deviation on opening. 
Imaging  No need for TMJ imaging investigation. 
Criteria for DDwoR without limited mouth opening:  
Clinical  All the following must be present: 
• History of locking or catching that interfered with eating (history of previously limited 
opening). 
• Presence of TMJ sounds not meeting criteria for DDwR ‘clicking’. 
• Maximum unassisted opening > 35mm. 
• Passive stretch ≥ 5mm (from unassisted opening to assisted opening > 40mm). 
• Contralateral excursion ≥ 7mm. 
Imaging  Optional TMJ imaging (arthrography or MRI) to confirm disc displacement in closed and 
opened mouth positions. 
Wilkes staging (Wilkes, 1989) 
Stage III criteria: Intermediate stage of internal derangement 
Clinical Multiple frequent episodes of pain, joint tenderness, headaches; Major mechanical 
symptoms consisting of locking (closed lock): restriction of motion; Functional difficulties 
(pain with function: painful chewing). 
Imaging Anterior disc displacement (non-reducing disc when the mouth is open) with significant 
anatomic deformity or prolapse of disc, moderate to marked thickening of posterior band of 
disc, no hard tissue changes and normal osseous contours. 
Stage IV criteria: Late intermediate stage of internal derangement 
Clinical Chronicity with variable and episodic pain, headaches, and variable restriction of motion 
(increase in severity over intermediate stage). 
Imaging Anterior disc displacement (non-reducing), marked disc thickening, early to moderate 
degenerative changes of articulating surfaces (e.g., flattening of eminence, deformation of 
condylar head, osteophytes, erosions, sclerosis) and abnormal hard tissue changes and 
abnormal osseous contours (increase in severity over intermediate stage). 
Table 2.5: Clinical and imaging diagnostic criteria of different systems for DDwoR 
diagnosis. Adapted from (Wilkes, 1989; Dworkin and LeResche, 1992; de Leeuw, 
2008). 
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The newly developed diagnostic criteria for DDwoR (Table 2.1) have been 
recommended for use in clinical practice and research instead of RDC/TMD and AAOP 
criteria (Table 2.5) (Schiffman et al., 2014a). The main changes to the ‘original’ 
RDC/TMD in the ‘new’ DC/TMD for DDwoR are summarised in Table 2.6. 
Changes from RDC/TMD to DC/TMD for DDwoR with or without limited opening 
History RDC DC 
“Ever have jaw lock or catch so that it would not open all the way” and 
"interfered with eating" applicable to disc displacement without 
reduction with and without limited opening 
    
Examination 
Disc displacement without reduction with limited opening: 
Unassisted opening* ≤ 35 mm and assisted opening ≤ 5 mm more than 
unassisted opening. 
   
Assisted opening* < 40 mm.     
Contralateral movements < 7 mm and/or uncorrected deviation to the 
ipsilateral side on opening.  
   
Absence of noise, or noise not meeting criteria for disc displacement 
with reduction  
   
Disc displacement without reduction without limited opening: 
Unassisted opening* > 35 mm and assisted opening > 5 mm more than 
unassisted opening. 
   
Assisted opening* ≥ 40 mm.     
Contralateral and protrusive movements ≥ 7 mm.     
Noise not meeting criteria for disc displacement with reduction    
* Measurement of opening includes interincisal opening plus vertical incisal overlap.  
Table 2.6: Changes from RDC/TMD to DC/TMD for DDwoR with or without limited 
opening. Adapted from Schiffman et al. (2014a). 
Diagnostic process 
History and clinical examination  
The diagnosis of TMD is based primarily on the presenting signs and symptoms 
depending largely on thorough history and careful intra-oral hard/soft tissue and 
occlusal examination and extra-oral clinical examination (Baba et al., 2001). However, 
multiple diagnostic devices have been used in many studies for TMD diagnosis such as 
pressure algometers, surface electromyography (EMG), sound/vibration detection, and 
jaw tracking devices (Sato et al., 1998; Yilmaz et al., 2008; Santana-Mora et al., 2014). 
The studies claimed that such investigative devices serve as a diagnostic aid to the 
clinical diagnosis of TMD. However, systematic reviews about their diagnostic efficacy 
demonstrate little benefit of these devices over the traditional TMD diagnosis by history 
and clinical examination in terms of both overall validity (reproducibility and accuracy) 
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and practical use (ease of use and cost versus benefit) (Baba et al., 2001; Klasser and 
Okeson, 2006; Armijo-Olivo et al., 2007; Suvinen and Kemppainen, 2007; Al-Saleh et 
al., 2012; Sharma et al., 2013). 
The clinical diagnosis for patients with DDwoR focuses mainly on common symptoms 
of pain and limited opening. These painful-limited opening symptoms, however, are 
usually present in ‘acute’ DDwoR (i.e. closed lock) as opposed to decreased pain-
improved opening in ‘chronic’ DDwoR (see DDwoR pathogenesis). This makes the 
clinical diagnosis of the former more readily achievable in clinical practice without the 
need for imaging the joint (Dworkin and LeResche, 1992). The latter, however, may be 
difficult to diagnose clinically without TMJ imaging investigation (Suarez and Ourique, 
2000; Naeije et al., 2013). 
Imaging investigations 
Several imaging modalities have been used for imaging the hard and soft tissues of TMJ 
with the aim of adding information to the clinical findings, including: plain radiography, 
panoramic radiography, arthrography, ultrasonography (US), MRI, conventional CT 
and cone-beam CT (CBCT) scan (Tvrdy, 2007; Petersson, 2010; Bakke et al., 2014). 
Among these, three main imaging techniques have been considered to visualise the TMJ 
intra-articular soft tissue changes and to identify the position of the displaced disc: 
arthrography, US, and MRI (Anderson et al., 1989; Habashi et al., 2015).  
Arthrography has been used in the past to determine disc position, disc perforation, and 
intra-articular adhesions (Donlon and Moon, 1987; Zhang et al., 2007), but its invasive 
nature, potential for complications, and the emergence of less invasive advanced soft 
tissue imaging techniques such as US and MRI limits its use as a routine soft tissue 
TMJ imaging technique (Trumpy et al., 1997). 
Another suggested TMJ soft tissue imaging technique is ultrasonography (US). This 
technique has several advantages and disadvantages (Sharma et al., 2014). It is usually 
regarded a non-invasive, low cost, easy, simple, quick, and dynamic technique to 
identify disc position (Emshoff et al., 2002a; Tognini et al., 2003; Manfredini and 
Guarda-Nardini, 2009). US main advantage over MRI is that it is a dynamic 
investigation allowing the possibility of direct observation of TMJ disc mobility during 
mouth opening and closing movements which may help the clinician to determine the 
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disc position more clearly than in a singular static investigation (Bas et al., 2011; 
Barchetti et al., 2014). The disc observation ‘visualisation’ can also be repeated if the 
disc is unclear by asking the patient to move his jaw again and can be performed by the 
dentist or surgeon himself to confirm his/her provisional clinical diagnosis (Jank et al., 
2005) or to guide needle positioning during intra-articular injection (Levorova et al., 
2015). 
Many studies examined the sensitivity, specificity, and accuracy of US in determining 
disc position in relation to MRI findings and/or clinical diagnosis (Tognini et al., 2005; 
Cakir-Ozkan et al., 2010; Kaya et al., 2010; Bas et al., 2011; Habashi et al., 2015). 
Most studies found that US is an acceptable tool in detecting disc displacement but not 
as effective as MRI in differentiating DDwR from DDwoR (Tognini et al., 2005; Kaya 
et al., 2010). US has also some limitations such as its operators’ dependant accuracy 
and its insufficiency in detecting all disc displacement positions (Jank et al., 2001; Jank 
et al., 2005; Manfredini and Guarda-Nardini, 2009; Bas et al., 2011). These 
shortcomings make it difficult for US to replace MRI as a routine soft tissue TMJ 
imaging method at the moment. However, rather than being an alternative to MRI, US 
has several advantages and acceptable diagnostic efficacy permits its use as a quick 
preliminary diagnostic investigation to exclude any clinical suspicion which can be 
confirmed afterwards by MRI (Li et al., 2012; Kundu et al., 2013; Dong et al., 2015). 
MRI is widely accepted as a TMJ soft tissue imaging technique for disc displacement 
diagnosis. MRI technique allows the analysis of joint imaging using both sagittal and 
coronal planes (Whyte et al., 2006). This two plane analysis allows more accurate 
evaluation of disc position. MRI has widely replaced arthrography as a main adjunct to 
DDwoR clinical diagnosis due to its several advantages: non-invasiveness, no ionizing 
radiation, excellent soft tissue visualization and differentiation of tissue types, and can 
be performed simply with little technical expertise (Tasaki and Westesson, 1993; 
Okochi et al., 2008; Butzke et al., 2010). MRI, however, is not without its 
disadvantages: false positives, potentially low therapeutic benefit, high cost, limited 
clinical availability in every practice setting, and may be contraindicated in some 
patients such as those with pacemakers or metal particles in the vital structures, 
claustrophobia, small children or those unable to remain motionless during the imaging 
investigation which may take several minutes (about 20-40 min) to complete (Emshoff 
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et al., 2003a; Jank et al., 2005; Manfredini and Guarda-Nardini, 2009; Park et al., 
2012). 
The sensitivity, specificity, and accuracy of MRI have been demonstrated to be good to 
excellent in the assessment of disc position of the TMJ (Santler et al., 1993; Tasaki and 
Westesson, 1993) but it should be performed with closed mouth to diagnose disc 
displacement and with closed and opened mouth to differentiate type of disc 
displacement (with or without reduction) on sagittal view (Figure 2.4-A) (Drace and 
Enzmann, 1990; Benbelaid and Fleiter, 2006). MRI has been shown to be as accurate as 
arthrography or diagnostic arthroscopy in confirming disc displacement whilst its 
diagnostic accuracy for intra-articular adhesions and disc perforation has been reported 
to be poor and less than that of arthrography or arthroscopy (Schellhas et al., 1988; Rao 
et al., 1990; Nitzan et al., 1991a). However with recent advances, fat-saturated T2-
weighted MRI has been shown to be as accurate as arthrography or arthroscopy in 
detection intra-articular adhesions and disc perforation (Zhang et al., 2009b; Yura et al., 
2012b; Yura et al., 2012a).   
Another advanced technique reported, is the three-dimensional reconstruction of two-
dimensional MRI or CT scan. The 3D reconstruction technique from 2D imaging is 
indicated for understanding TMJ anatomical structures and as a useful and accurate 
prediction of disc displacement (Chirani et al., 2004; Kitai et al., 2004). It can also be 
used as a complementary tool to assist the TMJ surgeons in clinical decision-making 
and surgical planning (Costa et al., 2008). 
Limchaichana et al. (2006) specified three goals for TMJ imaging: evaluation of the 
suspected structures’ integrity, confirmation of the extent and stage of the disorders’ 
progression, and evaluation of the effects of treatment. Many of the advanced imaging 
techniques of TMJ can achieve these goals and can confirm the clinical diagnosis of 
derangement and degenerative joint disorders. Any requested TMJ image, however, 
must have diagnostic and therapeutic efficacy, that is: “the value of imaging methods 
for supporting clinicians in their diagnoses and treatment decisions” (Fryback and 
Thornbury, 1991). Efficacy is also defined as “the probability of benefit to individuals 
in a defined population from a medical technology applied for a given medical problem 
under ideal conditions of use” (Ribeiro-Rotta et al., 2011). In comparison with the other 
imaging techniques, MRI of the TMJ is currently regarded as the gold standard for disc 
position determination (Liedberg et al., 1996; Park et al., 2012). The diagnostic and 
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therapeutic efficacy of MRI for DDwoR, however, remains unclear (Limchaichana et 
al., 2006). Systematic reviews about diagnostic and therapeutic efficacy of TMJ 
imaging techniques demonstrated insufficient evidence to support their use for TMJ 
disorders diagnosis (Limchaichana et al., 2006; Koh et al., 2009; Ribeiro-Rotta et al., 
2011; Li et al., 2012). 
Although guidelines for requesting imaging for TMJ disorders’ diagnosis, treatment 
plan, and follow-up have been reported to aid clinician’s decision (Brooks et al., 1997; 
White et al., 2001), to-date, the decision for when to request a TMJ imaging for 
DDwoR diagnosis is still controversial due to lack of evidence to base decision on. 
Some authors suggested it has an important role in the diagnosis of DDwoR (Benbelaid 
and Fleiter, 2006; Dias et al., 2012) especially for patients without limited opening 
(Park et al., 2012). Others, however, pointed out that DDwoR can be usually diagnosed 
in clinical practice through a thorough history and clinical examination and the TMJ 
imaging findings do not necessarily correlate with the clinical signs and symptoms 
(Emshoff et al., 2002b; Usumez et al., 2004; Muhtarogullari et al., 2013; de Melo et al., 
2015). Soft tissue imaging is only, therefore, an optional tool to confirm the clinical 
diagnosis of DDwoR and is unnecessary in most cases. 
Overall, the decision to request a TMJ imaging for patients with DDwoR should depend 
on a number of factors and should only be made after careful consideration of patient’s 
history, clinical findings and differential diagnosis, imaging cost, radiation exposure, 
previous examination results, response to previous conservative treatment, treatment 
plan, and expected treatment outcomes (prognosis) (Ribeiro-Rotta et al., 2011; Bakke et 
al., 2014).  
Differential diagnosis of DDwoR 
Patients with DDwoR are often present to clinicians in clinical practice complaining of 
pain and limited mouth opening. These symptoms, however, are not specific because 
numerous pathological conditions can present clinically with a chief complain of painful 
limited opening (Kouyoumdjian et al., 1988; Luyk and Steinberg, 1990; Eanes, 1991; 
Marien, 1997). Table 2.7 summarises the aetiology and differential diagnosis of mouth 
opening limitation. The conditions in the table are roughly divided according to 
aetiology into nine main themes: TMD-related, infective, traumatic, treatment-related or 
reactive, neoplastic, congenital, psychogenic, systemic, and neurologic causes. Clearly, 
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most of the causes can fall into more than one theme, but each is listed in the most 
common category. Although the list can help clinicians to make a differential diagnosis 
of DDwoR, it is not exhaustive. 
Conditions causing the symptom of limited mouth opening 
1. Temporomandibular Disorders (TMD) 
- Joint disorders including: disc derangement disorders (DDwoR with limited 
opening and ADP), degenerative disorders (arthralgia and osteoarthritis ‘OA’), 
intra-articular adhesions, fibrous and bony ankylosis, and other rare conditions 
such as synovial chondromatosis, pigmented villonodular synovitis, gout and 
pseudogout. 
- Muscular disorders including: myofascial pain with limited opening, myospasm 
(muscle spasm), and tendonitis and myositis (of non-infective or infective 
origin) and polymyositis. 
2. Infections 
- Odontogenic including: pulpal, periodontal, and pericoronal (pericoronitis: 
mostly related to mandibular third molars causing submasseteric space abscess). 
- Non-odontogenic including: tonsillitis and peritonsillar abscess, tetanus, 
meningitis, encephalitis, brain abscess, parotitis (parotid abscess), mumps, 
Cancrum oris (gangrenous stomatitis), osteomyelitis of the mandible and 
temporal bone, and abscesses of the submasseteric, lateral pharyngeal, 
pterygomandibular, submandibular, and temporal spaces.  
3. Trauma 
- Bony trauma: fractures of mandible (particularly: condyle, coronoid, or ramus), 
zygoma (especially zygomatic arch) (depressed fracture cause coronoid 
interference/impingement or bony union), or temporal bones. 
- Muscular trauma: myositis ossificans traumatica (i.e., injury to the masticatory 
muscles or ligaments causing myositis ossificans due to scarring and 
calcification). 
- Mucosal trauma: due to buccally placed upper molar teeth (particularly third 
molars) 
- Others: foreign bodies (penetrating injuries), paradoxical muscle spasm 
following head injury, scar contracture post-thermal injury (burn), general 
anaesthesia and birth trauma. 
4. Treatment related 
- Local anaesthetic dental injection-treatment related: post-local anaesthetic 
dental block injection. 
- Oral and maxillofacial surgical-treatment related: post-
dental/oral/maxillofacial/neuro-surgical treatment. 
- Radiotherapy and chemotherapy: post-chemo/radiotherapy fibrosis. 
- Drug-related (pharmacologic) (drug toxicity): drug induced (extrapyramidal 
reaction or facial dyskinesia) such as Phenothiazine, Succinyl choline, Tricyclic 
antidepressant, Metaclopramide, Halothane, Strychnine poisoning, Statins.  
5. Neoplastic lesions 
- Benign or malignant primary or metastatic head and neck tumours: 
nasopharyngeal and oropharyngeal regions, infra-temporal fossa, base of skull, 
parotid region, jaws joint, masticatory muscles, mandibular condyle or coronoid 
process, brain stem. 
- Pre-cancerous submucous fibrosis (oral submucous fibrosis) 
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Conditions causing the symptom of limited mouth opening 
6. Congenital/Developmental 
- Hypertrophy of: coronoid process (coronoid hyperplasia) or Jacob’s disease 
(exostoses at posterior aspect of zygoma) or condylar process (condylar 
hyperplasia). 
- Atrophy with degenerative changes within the temporalis muscle connected to 
the coronoid process of unknown cause (idiopathic) 
- Elongated styloid process (Eagles’ syndrome) 
- Trismus-pseudo-camptodactyly syndrome 
- Birth injury/trauma 
- Other congenital diseases: Hecht, Beals, and Wilson syndrome, arthrogryposis 
multiplex congenital, craniocarpotarsal dysplasia, hemifacial microsomia, 
fibrodysplasia ossificans progressive, popliteal pterygium syndrome. 
7. Psychogenic 
- Hysteria (hysterical trismus). 
8. Systemic diseases 
- Neuromuscular disorders such as Parkinson’s disease. 
- Autoimmune connective tissue diseases such as lupus erythematosus, 
scleroderma, systemic sclerosis.  
- Inflammatory diseases such as rheumatoid arthritis, Still’s disease, ankylosing 
spondylitis, Marie-Strümpell disease, psoriatic arthritis, infectious arthritis or 
septic arthritis. 
- Neurologic diseases such as Epilepsy, Guillain-Barre syndrome and CNS 
lesions such as cerebral lesions 
- Centrally mediated myalgia, fibromyalgia, and multifocal idiopathic fibrosis 
9. Neurologic 
- Hyperventilation syndrome: Tetany related to reduced calcium concentration 
(hypocalcemia) 
- Extrapyramidal reactions (drug-related) 
Table 2.7: Aetiology and differential diagnosis of limited mouth opening. The causes of 
trismus are summarised by reviewing the relevant literature but adapted primarily from 
(Poulsen, 1984; Kouyoumdjian et al., 1988; Luyk and Steinberg, 1990; Eanes, 1991; 
Marien, 1997; Leonard, 1999; Dhanrajani and Jonaidel, 2002; Garnett et al., 2008). 
Most conditions shown in Table 2.7 can be readily diagnosed from careful patient 
history and examination such as trauma and treatment-related trismus (Luyk and 
Steinberg, 1990). Others, however, can be difficult to diagnose and may cause a 
diagnostic dilemma, diagnostic delay, improper initial treatment, and multiple referrals 
causing prolongation of disease state with possible fatal results (Cohen and Quinn, 
1988; Gobetti and Turp, 1998; Tahery et al., 2004). Unfortunately, those conditions that 
usually have delayed diagnosis, delayed treatment, and delayed referral are the most 
potentially life-threatening conditions such as tetanus and malignant tumours. Patients 
with shrouded neoplasia presenting as TMD patients are, however, unusual and rare 
(Luyk et al., 1991). In one study, over 10 years only 16 out of 2000 patients present 
with facial pain (0.8%) were found to harbour intracranial tumours (Bullitt et al., 1986). 
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Similarly, in a more recent study, the rate of incidentally found malignant tumours by 
TMJ MRI was very low (0.07%) because only two malignant tumours were discovered 
in 2776 MRIs examined for suspicion of TMJ arthrosis over 6 years and a half (Yanagi 
et al., 2003). Although neoplasia very rarely presents mimicking TMD/DDwoR signs 
and symptoms, it is often the thing that clinicians and patients are most concerned 
about. In the literature, several case reports have been published about different 
underlying pathologies, including malignancy, misdiagnosed initially as ‘DDwoR or 
ADP’; some of these are detailed in Table 2.8. 
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Author (year)  
Age  
yrs 
Gender Chief complaint  Initial diagnosis  
Key signs necessitating further 
examination & investigation  
Definitive diagnosis  
Trumpy and 
Lyberg (1993) 
[3 cases] 
29 Female TMJ pain, LMO 
DDwoR by 
tomography and 
arthrography 
No improvement of symptoms after 
discectomy 
Benign meningioma 
involving infra-temporal 
fossa by CT 
45 Male 
 
Intermittent hearing 
loss, TMJ pain, LMO 
DDwoR by 
arthrography 
No improvement of symptoms after 
discectomy, facial swelling  
Nasopharyngeal 
carcinoma by CT 
39 Male TMJ pain, LMO 
DDwoR by 
arthrography 
No improvement of symptoms after 
discectomy, facial swelling  
Adenoid cystic carcinoma 
of parotid gland by needle 
biopsy 
Heo et al. 
(2003) 
45 Male 
TMJ pain, swelling, 
LMO 
Chronic DDwoR by 
plain radiographs 
No improvement of symptoms after 
conservative therapy   
Pigmented villonodular 
synovitis by MRI 
Honda et al. 
(2006) 
62 Female 
TMJ and muscle pain, 
LMO 
ADP by MRI 
No improvement of symptoms after 
conservative therapy and 
arthrocentesis, swelling of temporal 
region, paraesthesia extending from 
lower eyelid to upper lip 
Mucinous 
adenocarcinoma of the 
temporal region by MRI, 
bone scintigraphy, and 
biopsy 
Hasegawa et 
al. (2008) 
62 Female TMJ pain, LMO 
Bilateral DDwoR by 
MRI 
Increased severity of symptoms 
Submasseteric space 
abscess by MRI  
Kruse et al. 
(2010) 
75 Female TMJ pain, LMO DDwoR clinically 
No improvement of symptoms after 
conservative therapy  
Metastatic 
adenocarcinoma of parotid 
gland by MRI 
Beddis et al. 
(2014) 
[2 cases] 
NR NR 
Pain in muscles, ear, 
and neck, no clicking, 
LMO 
DDwoR by 
arthrography 
No improvement of symptoms after 
conservative therapy and 
arthrocentesis   
Adenoid cystic carcinoma 
of maxillary sinus by MRI 
NR NR 
Pain in muscles and ear, 
LMO 
DDwoR 
No improvement of symptoms after 
conservative therapy   
Oral squamous cell 
carcinoma of mandible by 
OPG 
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Author (year)  
Age  
yrs 
Gender Chief complaint  Initial diagnosis  
Key signs necessitating further 
examination & investigation  
Definitive diagnosis  
Kim et al. 
(2014) 
[2 cases] 
43 Male 
LMO, stiffness of the 
bilateral masseter 
muscles 
DDwoR clinically No DDwoR on MRI 
Coronoid hyperplasia by 
OPG and CT 
21 Male TMJ pain, LMO DDwoR clinically 
No DDwoR on MRI 
No improvement of symptoms after 
conservative therapy and arthroplasty 
Coronoid hyperplasia by 
CT 
Kang et al. 
(2015) 
[4 cases] 
80 Female 
TMJ and muscle pain, 
LMO 
DDwoR clinically 
and then by MRI 
No improvement of symptoms after 
conservative therapy 
Non-infectious myositis of 
the lateral pterygoid 
muscle by CT 
25 Female 
TMJ and muscle pain, 
LMO, limited lateral 
movement, crepitus 
DDwoR clinically 
No improvement of symptoms after 
conservative therapy and 
arthrocentesis 
Non-infectious myositis of 
the lateral pterygoid 
muscle by MRI 
49 Female 
LMO, limited bilateral 
movements 
DDwoR clinically NR 
Non-infectious myositis of 
the lateral pterygoid 
muscle by MRI 
19 Male 
Bilateral TMJ and 
muscle pain, limited 
lateral and protrusive 
movements, headache, 
tinnitus 
DDwoR clinically NR 
Non-infectious myositis of 
the lateral pterygoid 
muscle by MRI 
Table 2.8: Summary data of misdiagnosed cases as DDwoR or ADP reported in the literature.
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This brief review about some misdiagnosed malignant tumours shown in Table 2.8, 
emphasises that the clinicians should maintain a high index of suspicion for the 
presence of malignancy whenever there is a mouth opening limitation. In fact, limited 
opening can be sometimes the only presenting symptom of malignancy that induces the 
patient to seek care (Kristensen and Tveteras, 1984; Ozyar et al., 2005; Patrocinio et al., 
2008). The medical and dental practitioners, therefore, should be familiar with 
establishing a differential diagnosis of mouth opening limitation symptom (Eanes, 1991; 
Azaz et al., 1994; Marien, 1997). Failure to establish an adequate differential diagnosis 
may cause considerable delay in proper treatment which can be life threatening for 
patients with neoplastic diseases (Gomez et al., 2009; Cleveland and Thornton-Evans, 
2012; Seoane et al., 2012). This is because “the most important prognostic factor in oral 
cancer is the stage of the tumour at the time of diagnosis” (Dave, 2013). Therefore, 
early diagnosis of head and neck malignancy without referral delay is especially crucial 
for patient’s survival (Seoane et al., 2012). Important risk factors in the development of 
malignancy such as age, gender, history of cancer, tobacco, alcohol, betel quid, candida 
and the human papilloma virus infections are all needed to be routinely assessed from 
the patient’s medical history (Scully and Bagan, 2009; Brocklehurst et al., 2010). 
Besides these, the presence of red flags’ signs and symptoms should alert the clinician 
to a serious pathology other than TMD/DDwoR. The red flags summarised in Table 2.9 
can help the clinician to differentiate TMD/DDwoR from serious pathological 
conditions to rule out their possibility in patients initially presenting with TMD pain 
and/or limited mouth opening symptoms. 
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Red flags  Possible neoplasia 
Neurologic signs Unexplained sensory changes (in the distribution of the ‘V’ 
trigeminal nerve) such as numbness, altered sensation, lack 
of feeling, or reduced sensation. This may suggest an 
enlarged tumour mass pressing on, or affecting, the 
peripheral nerve branches or other intracranial pathology 
causing nerve injury. 
Auditory complaints (related to sensory changes in the 
distribution of the vestibulocochlear ‘VIII’ nerve) such as 
decreased hearing or progressive hearing loss, ringing, 
dizziness, and plugging sensation. This may suggest a 
nasopharyngeal tumour or acoustic neuroma or other ear 
diseases. 
Motor facial function changes (related to motor changes in 
the distribution of the facial ‘VII’ nerve). This may suggest a 
tumour or intracranial pathology or infection. 
Otologic (ear, nose, 
and throat) signs and 
symptoms 
ENT signs and symptoms such as nosebleed (recurrent 
epistaxis), nasal stuffiness (nasal blockage/obstruction), 
hemoptysis, altered olfactory function (persistent loss of 
smell ‘anosmia’), runny nose (purulent nasal discharge), ear 
drainage, otalgia, cough, and dysphagia. This may suggest a 
nasopharyngeal tumour or chronic sinusitis. 
Pain that is sudden-
onset, severe, 
interrupts sleep, or 
precipitated by 
exertion, coughing, or 
sneezing 
This may indicate intracranial pathology or cardiac 
ischaemia. 
Progressive decrease 
in mouth opening 
In DDwoR diagnosis, the limitation in mouth opening (about 
20 to 30 mm) is of sudden-onset that gradually improves 
over time. In contrast, most other conditions such as 
tumours, infections, sub-mucous fibrosis, coronoid 
hyperplasia, intra-articular adhesion or fibrous ankylosis 
cause progressive ‘gradual’ decrease in mouth opening.   
Persistent or 
worsening symptoms 
despite initial 
management (pain 
and/or limited opening 
symptoms remaining 
unchanged or 
increasing in severity) 
No relief or progressively worsening symptoms over time 
despite management may suggest a misdiagnosis of tumour 
and, therefore, reassessment the presumptive diagnosis is 
essential. 
Patient’s age and 
gender 
TMD is more common in the second to fourth decades 
female patients whilst neoplastic diseases are more common 
in elderly people (> 50 years). 
History of malignancy This may suggest recurrence or metastasis. 
Facial asymmetry This is uncommon in TMD unless there is masseteric 
hypertrophy and may indicate a tumour, infection, or 
inflammation. 
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Red flags  Possible neoplasia 
Neck masses or 
swelling including 
lymphadenopathy 
This may suggest tumour, infection, inflammation, or 
autoimmune condition. 
Systemic symptoms of 
unexplained pyrexia, 
anorexia, weight loss, 
malaise, myalgia, 
chills, or sweating  
This may suggest malignant tumours, immunosuppression, 
or an infection in the maxillofacial region such as septic 
arthritis, osteomyelitis, intracranial abscess, tooth abscess, or 
mastoiditis. 
Occlusal changes 
(change in bite) 
This can be seen in TMD but it may also suggest a tumour, 
bone growth disturbance of condyle, inflammatory or 
rheumatoid arthritis, or facial bones fractures. 
Red flags  Other serious pathologies 
History of head and 
neck trauma (apart 
from recent trauma) 
This may suggest a fracture of one of the facial bones. 
Recent trauma may cause limitation in mouth opening as 
well as physical functional changes due to muscular spasm 
and/or fractures of the oral and maxillofacial skeleton. 
Paroxysmal unilateral 
lancinating pain with 
or without autonomic 
features 
This is more likely associated with trigeminal neuralgia or 
one of the trigeminal autonomic cephalagias. 
First episode in 
patient over 50 years 
of age with unilateral 
headache or scalp 
tenderness 
accompanied by jaw 
claudication, visual 
symptoms, and 
general malaise  
This may suggest giant cell arteritis (temporal arteritis). 
Table 2.9: Red flags that may mimic TMD/DDwoR signs and symptoms. These are 
concluded from the reviewed case reports misdiagnosed initially as TMD/DDwoR and 
adapted further from (Epstein and Jones, 1993; Huntley and Wiesenfeld, 1994; Gobetti 
and Turp, 1998; Heo et al., 2003; Wassell and Durham, 2010; Durham, 2012; Renton et 
al., 2012; Durham et al., 2015). 
Recently a ‘trismus’ checklist has been proposed as an ‘aide-memoire’ to alert the 
clinicians to red flags for an alternative underlying pathology possibility to DDwoR 
including malignancy (Table 2.10) (Beddis et al., 2014).  
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Trismus checklist: for completion in patients with limited opening* Yes No 
 Opening less than 15 mm   
 Progressively worsening trismus   
 Absence of history of clicking   
 Pain of non-myofascial origin (neuralgia etc.)   
 Swollen lymph glands   
 Suspicious intra-oral soft tissue lesion   
* If any of the answers are yes, consider radiograph and/or arrange review/referral to a senior clinician. 
Table 2.10: Trismus checklist for patients with limited mouth opening. Adapted from 
Beddis et al. (2014).  
Beddis et al. (2014) stated that the annual audits of the checklist use within their 
departments show successful results in terms of both: increase use and completion of 
the checklist for patients attended with mouth opening limitation symptom and early 
identification of malignancy in a patient presenting initially with trismus. The authors 
advocated the use of the checklist within general practice by general practitioners to 
help them avoid risk of delayed- or mis-diagnosis and determine the need for referral 
urgency (Beddis et al., 2014). This trismus checklist, however, is incomplete and needs 
further refinement to be more comprehensive in order to help the clinicians address and 
identify all the potential red flags (Table 2.9).   
In summary, the professionals must have a thorough knowledge about the differential 
diagnosis of the multiple conditions causing limited mouth opening (Table 2.7) and 
must apply a systematic diagnostic approach in order to achieve an accurate diagnosis 
for a patient presented with a chief complain of painful/limited opening. The 
professionals’ diagnosis process should involve the following: obtaining a complete 
history; performing a full careful head and neck clinical examination; giving particular 
attention to the presence of red flags (alarming signs or symptoms) (Table 2.9); ordering 
the appropriate investigations as deemed necessary. Consequently, the patient will more 
likely receive an appropriate treatment and a better prognosis.  
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2.2.8 Management 
The literature about the management of TMD and DDwoR is vast and confusing with 
various treatment protocols and divergent opinions. One of the reasons for the 
controversy is attributed to that fact that all the treatment approaches claim success and 
the majority of patients are reported to improve (Okeson, 1997b). This makes the 
rationale behind the selection of different treatment options constitute one of the most 
controversial areas in the field of TMD (Forssell and Kalso, 2004).  
Evidence-based management means the use of best available evidence from research 
findings to improve patient care (Haynes and Haines, 1998). The most reliable sources 
of research evidence are high-quality systematic reviews and meta-analyses based on 
methodologically-robust randomised controlled trials (RCTs) (Levels of Evidence, 
2009). In TMD field, where controversial and conflicting ideas about management are 
common, an evidence-based approach could be particularly useful (Forssell and Kalso, 
2004).  
There are three basic treatment goals for patients with TMD or DDwoR: reducing pain, 
restoring function, and optimising patients’ quality of life (QoL) (de Leeuw and 
Klasser, 2013). In the literature, however, the treatment approaches used to achieve 
these goals are highly variable in invasiveness ranging from non-invasive reversible 
interventions to minimally-invasive and invasive irreversible interventions. Given that 
the effects of the therapeutic interventions used for DDwoR are systematically reviewed 
in Chapters 4 and 5, this subsection will briefly review the available evidence for the 
various treatment modalities used in TMD management and discusses the technique and 
rationale of each treatment modality used for DDwoR.  
Reversible treatment modalities 
The non-invasive conservative treatment is often the first choice in TMD management. 
In the literature, different conservative treatment options have been suggested, most 
commonly: patient education and self-management, psychosocial therapy, 
pharmacotherapy, splint therapy, and physiotherapy. 
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Patient education and self-management  
Patient education is the simplest treatment approach and involve an explanation to the 
patient about: the clinical condition; its signs and symptoms; its potential causative 
biopsychosocial factors; the normal TMJ and masticatory muscles functions in simple 
understandable terms. The clinician should seek to reassure the patient that the 
symptoms of TMD are not an indication of serious or sinister pathology and it is benign 
and self-limiting in the majority of cases with a generally favourable prognosis, but it is 
not always curable and can therefore recur or fluctuate in symptomatology (Dimitroulis 
et al., 1995b; Michelotti et al., 2012). For DDwoR, patient education should also 
involve clear explanation of the mechanism of the articular disc in TMJ with 
reassurance about the ‘favourable’ natural course of the disorder which may improve 
with time alone without any active therapeutic intervention or with simple self-care 
(Minakuchi et al., 2004; Imirzalioglu et al., 2005; Craane et al., 2012a).  
Self-management programme involves activities required by patient for personal care. 
Different self-care strategies are described in the literature but all generally involve 
instructing and advising the patients for: rest (jaw and muscle relaxation); ‘pain-free’ 
soft diet and balanced chewing; parafunctional habits awareness and modification; 
diaphragmatic breath training, sleep improving, and posture training. They occasionally 
include also the following therapies: home physiotherapy programme such as self-
exercises, self-massages, and hot or cold packs application; pharmacotherapy such as 
oral and/or topical analgesics and anti-inflammatories; psychosocial therapy such as 
optimistic counselling and biofeedback with an explanation of the advantages of each 
(Wright and Schiffman, 1995; Mulet et al., 2007; Wright, 2010; DeVocht et al., 2013). 
Each component of self-management has a different mechanism of action but in general 
the main aim of a self-care programme is to prevent further injury to the 
musculoskeletal structures thereby allowing for healing to occur (Dimitroulis et al., 
1995b). 
The success of self-management depends largely on patients themselves, particularly 
patients’ motivation, cooperation, compliance, adherence, and active participation. The 
outcome of self-management also depends on clinicians’ communication skills, 
appropriate choice of treatment, self-support, being empathetic, as well as their ability 
to explore patients’ beliefs, expectations, and own goals before initiating long-term 
51 
 
management strategies in order to clarify that TMD/DDwoR cannot always be ‘totally’ 
cured (Zakrzewska, 2002; Wig et al., 2004; de Leeuw and Klasser, 2013).  
A number of RCTs investigated the effect of this treatment modality in patients with 
TMD/DDwoR and all found that patient education and/or self-management is as 
effective or slightly more effective in comparison with other active treatment modalities 
(Dworkin et al., 2002; Michelotti et al., 2004; Minakuchi et al., 2004; Truelove et al., 
2006; Craane et al., 2012a; Michelotti et al., 2012). A recent systematic review of self-
management shows that self-care strategies were as effective as other active treatments 
and found promising evidence to support using this non-invasive low-cost treatment 
modality to manage TMD patients (de Freitas et al., 2013). 
Psychosocial therapy  
The biopsychosocial model of TMD mandates the psychosocial therapy to be one of the 
therapeutic interventions used for TMD management (Dworkin, 1996). A variety of 
psychological and behavioural interventions have been reported to effectively manage 
patients with chronic pain related-TMD such as biofeedback and cognitive behavioural 
therapy (Sherman and Turk, 2001; Turner et al., 2006; Calderon et al., 2011). 
Cognitive behavioural therapy (CBT) is a multi-component treatment that involves 
different cognitive-behavioural techniques such as relaxation training, problem-solving 
training, behavioural activation and modification, behavioural goals setting and 
targeting, activity pacing, and cognitive restructuring. CBT aims to reduce pain, 
anxiety, and distress and improve function by helping TMD patients to increase their 
self-efficacy, adapt and cope with their pain, identify and correct their negative thoughts 
and beliefs, and modify their behaviours (i.e., decreasing maladaptive behaviours and 
increasing adaptive behaviours) (Ehde et al., 2014). Behavioural modification, however, 
can be done easily for simple habits but changing persistent habits may be more 
difficult and require a tailored individualised program with different structured 
strategies such as: lifestyle counselling, progressive relaxation, hypnosis, and habit 
reversal strategies (Rugh, 1987; Liu et al., 2012a; de Leeuw and Klasser, 2013). For 
patients with DDwoR, CBT was also used as an adjunctive to other conservative 
therapies (Schiffman et al., 2007) 
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Systematic reviews performed in this area suggest that there is some evidence for the 
effectiveness of the psychosocial therapy in TMD management (Crider et al., 2005; 
Turp et al., 2007a; Kroner-Herwig, 2009; Aggarwal et al., 2011; Liu et al., 2012a; 
Kotiranta et al., 2014; Roldan-Barraza et al., 2014; Zhang et al., 2015). 
Pharmacological therapy 
A wide range of pharmacological medications are available for treating TMD/DDwoR 
patients. The main aim of pharmacotherapy is to aid TMD/DDwoR patients to manage 
their pain and/or jaw dysfunction rather than to ‘cure’ the pain (Dionne, 1997). Each of 
the medications suggested in the literature has a specific indication for use in TMD 
management (Kopp et al., 1985; Mejersjo and Wenneberg, 2008; Cascos-Romero et al., 
2009; Majid, 2010; de Leeuw and Klasser, 2013) but, in summary, the most common 
uses of these medications are as follows: 
 For acute TMD pain: analgesics, corticosteroids, and benzodiazepines;  
 For both acute and chronic TMD: anti-inflammatories and muscle relaxants;  
 For chronic TMD pain: tricyclic antidepressants, particularly amitriptyline, due 
to their analgesic properties aside from their antidepressant effect;  
 For muscular pain: intra-muscular Botulinum toxin type A (Botox);  
 For joint pain and/or dysfunction: intra-articular glucocorticoids and sodium 
hyaluronate. The use of these intra-articular medications for DDwoR will be 
covered in further detail later on in this subsection.  
In spite of the fact that these medications are currently used in common for the 
management of pain in patients with TMD, limited numbers of high-quality RCTs were 
performed to investigate their effectiveness. Therefore, systematic reviews about the 
effectiveness of the pharmacological interventions found insufficient and limited 
evidence to support the efficacy of many medications used for TMD management (List 
et al., 2003; Shi et al., 2003; Ihde and Konstantinovic, 2007; Cascos-Romero et al., 
2009; Manfredini et al., 2010; Mujakperuo et al., 2010; Linde et al., 2011; de Souza et 
al., 2012; Senye et al., 2012; Machado et al., 2013; Stoustrup et al., 2013; Chen et al., 
2015b; Vidya and Felicita, 2015). In the absence of sufficient evidence, the clinicians 
must fully understand the medications’ side effects in order to avoid unnecessary 
harmful adverse effects to TMD/DDwoR patients with little beneficial outcome.   
53 
 
Physical therapy 
A wide variety of physiotherapeutic techniques have been used either alone or as 
adjunct to other treatments for TMD and DDwoR management, most commonly: active 
and passive jaw exercises and manual therapy, posture training, and other 
physiotherapeutic modalities including iontophoresis, electrotherapy, ultrasound 
therapy, and laser therapy (Gray et al., 1994b; Nicolakis et al., 2001; Kato et al., 2006; 
Ahrari et al., 2014; Ucar et al., 2014). Although acupuncture and trigger point injections 
is not a physical therapy per se, it is considered a specialty field within the scope of 
practice for many physiotherapists working in the United Kingdom (Medlicott and 
Harris, 2006; Rashid et al., 2013). 
The aforementioned physiotherapeutic techniques have different mechanisms of actions 
(Rashid et al., 2013) but all aimed mainly to restore normal jaw function by improving 
the range of mandibular movements and relieving joint/muscular pain. Physiotherapy is 
usually regarded as an effective treatment modality to achieve these goals and there is, 
currently, some evidence supporting its use (Chortis et al., 2006; McNeely et al., 2006; 
Medlicott and Harris, 2006; Brantingham et al., 2013; Moraes Ada et al., 2013; 
Chipaila et al., 2014; Calixtre et al., 2015; Martins et al., 2015). There is also good 
evidence supporting the use of acupuncture and laser therapy for treating TMD (Rosted, 
1998; Ernst and White, 1999; Fink et al., 2006; Cho and Whang, 2010; La Touche et 
al., 2010; Jung et al., 2011; Petrucci et al., 2011; Maia et al., 2012; Melis et al., 2012; 
Tengrungsun et al., 2012; Herranz-Aparicio et al., 2013; Chen et al., 2015a; Doeuk et 
al., 2015; Herpich et al., 2015). 
Among wide variety of physiotherapeutic interventions used, mandibular manipulation 
(MM) has been suggested specifically to ‘unlock’ the ‘locked’ jaws in patients with 
‘acute’ DDwoR (Wright, 2010; Okeson, 2013). The first manual manipulation 
technique was reported in 1971 by Farrar (Farrar, 1971). This technique is described 
and depicted in Figure 2.8. 
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Figure 2.8: Farrar’s manipulation technique to ‘unlock’ the jaw. Farrar’s method 
involves instructing the patient to move the jaw as far as possible toward the opposite 
‘unaffected’ side; grasping the mandible firmly with the clinician’s thumb placed intra-
orally over the occlusal surfaces of the mandibular molar teeth at the affected side and 
the fingers grasp the inferior border of the mandible extra-orally; stabilizing the cranium 
with the other hand; and applying gentle but firm force downward on the molar teeth at 
the affected side by the thumb and upward on the chin with the fingers; and then pulling 
the mandible downward and forward and to the opposite ‘unaffected‘ side, to enable the 
condyle to move under the ‘thick’ posterior band of the displaced disc, and the disc 
returns back to its normal position above the condyle (Farrar, 1971; Farrar, 1972; 
Farrar, 1978). Reproduced from Farrar (1978) with permission from Elsevier. 
Farrar’s technique, however, may not be practicable in patients with severe mouth 
opening limitation. A more practical technique is depicted in Figure 2.9 and can be 
more appropriately applied in such cases.  
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Figure 2.9: Modified manipulation technique to ‘unlock’ the jaw. A modified technique 
to ‘unlock’ the jaw in which the clinician’s thumb is placed intra-orally at the affected 
side over the external oblique ridge rather than on the occlusal surfaces of the 
mandibular molar teeth in order to enable manual manipulation in severely limited 
mouth opening cases. Modified from Farrar (1978) with permission from Elsevier. 
Since the manipulation technique was first reported by Farrar, various other techniques 
have been described in the literature (Harkins et al., 1987; Van Dyke and Goldman, 
1990; Jagger, 1991; Minagi et al., 1991; Mongini, 1995; Martini et al., 1996; Suarez 
and Ourique, 2000; Sugisaki et al., 2005; Yoshida et al., 2011). Nevertheless, Farrar’s 
manipulation remains the most widely used technique in many clinical trials for 
DDwoR management. It was either performed without anaesthesia (Segami et al., 1990; 
Friedman, 1993; Chiba and Echigo, 2005), or under different anaesthetic approaches 
such as: local anaesthesia (Correa et al., 2009), sedation (Helkimo and Hugoson, 1988), 
or general anaesthesia (Foster et al., 2000), or with different adjunctive techniques such 
as hydraulic pumping (Murakami et al., 1987; Totsuka et al., 1989; Ozawa et al., 1996; 
Ohnuki et al., 2006), or lavage (Ross, 1989; Sembronio et al., 2008a). 
In general, all the manual manipulation techniques and procedures used share similar 
aim to help restore the displaced disc into its normal anatomical position. Several 
studies, however, investigated the efficacy of manipulation techniques in recapturing the 
displaced disc and most found that complete anatomic reduction (recapturing) of the 
disc by manipulation is difficult to achieve and even if achieved (unlocking) many 
patients may experience recurrence of disc displacement (relocking) (Totsuka et al., 
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1989; Segami et al., 1990; Kurita et al., 1999). In one study using Farrar’s technique, 
MM has been found to be successful in recapturing only about 9% of permanently 
anteriorly displaced discs ‘DDwoR’ (Kurita et al., 1999). Different factors have been 
attributed to influence the possibility of recapturing the displaced disc by manipulation 
such as duration of locking (Segami et al., 1990; Sembronio et al., 2008a), and stage of 
intra-articular derangement of the TMJ and articular and skeletal morphological 
variations (Kurita et al., 1999). Okeson (2007) identified three factors that could 
influence the success of manipulation in reducing the displaced disc in ‘acute’ DDwoR: 
level of superior lateral pterygoid muscle (SLPM) activity, intra-articular joint space 
size, and condylar position. The author claimed that disc ‘recapturing’ can be achieved 
when the SLPM is relaxed, the joint space is increased, and the condyle is in the 
maximum forward protrusive position (Okeson, 2007). In fact, the success of MM in 
recapturing the displaced disc may depend primarily on determining the exact direction 
of the displaced disc to manipulate the jaw. Unfortunately, most manipulation 
techniques reported in the literature are often described to recapture a disc displaced 
anteromedially because the disc is assumed to be displaced commonly in an 
anteromedial direction. This, however, is not always correct as the disc can be displaced 
in any direction (see diagnostic classification of disc displacement).  
Overall, the necessity to recapture the displaced disc for successful treatment of 
DDwoR remains questionable and may be unnecessary because improvement in clinical 
symptoms of DDwoR have been shown to be unrelated to disc position (disc 
recapturing) (Segami et al., 1990; Nicolakis et al., 2001; Sembronio et al., 2008b) and 
may be related more to disc mobilisation and/or ligaments stretching. 
Splint therapy 
Splint therapy is one of the most widely used treatment modalities for managing 
patients with TMD and DDwoR (Pierce et al., 1995; Tegelberg et al., 2001). Various 
types of occlusal splints have been described in the literature but in terms of their 
hypothesised function, the full-coverage splints are classified into three main groups: 
relaxation/stabilization soft or hard splints, distraction/pivot splints, and repositioning 
splints, in addition to partial-coverage splints (Klasser and Greene, 2009; 
Muhtarogullari et al., 2014). Although the mechanism of action of these splints is still 
controversial and yet to be fully determined (Lickteig et al., 2012; Lickteig et al., 2013), 
their beneficial effects are usually attributed to a combination of behavioural and 
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mechanical interventions increasing the joint space and reducing TMJ overload, 
articular disc strain, and forces to the retrodiscal tissues (Kreiner et al., 2001; Ettlin et 
al., 2008; Klasser and Greene, 2009; Ok et al., 2014). Each splint has different 
indications and proposed functions and a summary of their aims would include: 
protections from tooth surface loss; reducing patients’ bruxism and parafunctional 
habits; redistributing occlusal forces and providing ideal occlusion; reducing pain and 
abnormal muscle activity; alter structural relationships in the TMJ; in addition to 
distraction and mobilisation of the joint (Glaros et al., 2007; Ettlin et al., 2008; Klasser 
and Greene, 2009; Muhtarogullari et al., 2014). Furthermore, occlusal splints, mostly 
anterior repositioning splints, are often used for acute DDwoR management with a 
proposed aim to help retain the condyle-disc relationship after disc ‘recapturing’ by 
mandibular manipulation (Okeson, 2007). 
Occlusal splints are generally regarded as non-invasive treatment approach. Despite 
their non-invasive nature, these appliances may be costly and may cause potential 
complications such as teeth decay, periodontal disease, mouth odours, speech 
difficulties, psychological dependence on the appliance, and more importantly 
irreversible occlusal changes which may arise from their excessive use or incorrect 
design (Abbott and Bush, 1991; Lundh et al., 1992; Brown et al., 1994; de Leeuw and 
Klasser, 2013). 
Many trials reported the effectiveness of occlusal splints in improving symptoms 
(Stiesch-Scholz et al., 2005; Al Quran and Kamal, 2006; Wassell et al., 2006) whilst 
others showed no additional benefit of such appliances (Lundh et al., 1992; Truelove et 
al., 2006; Michelotti et al., 2012). To-date, controversy about TMD/DDwoR 
management by occlusal splints still exists as well as about what is the most effective 
splint design for treatment. Currently, the evidence supporting the splints therapy for 
TMD is promising but is still weak and limited and needs to be confirmed in future 
research (Santacatterina et al., 1998; Kreiner et al., 2001; Al-Ani et al., 2004; Forssell 
and Kalso, 2004; Turp et al., 2004; Stapelmann and Turp, 2008; Fricton et al., 2010; 
Ebrahim et al., 2012). 
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Irreversible treatment modalities  
Occlusal therapy 
TMD management by occlusal therapy such as occlusal adjustment, restorative therapy, 
orthodontic treatment, or orthognathic surgery is a subject of considerable debate 
(Kirveskari et al., 1998; Tsukiyama et al., 2001; Huang, 2004). This debate is because it 
is difficult to establish a cause-and-effect relationship between the occlusion and the 
TMD; that is, malocclusion can be the result of TMD rather than being its cause 
(Michelotti and Iodice, 2010; Turp and Schindler, 2012).  
In general, there is a lack of evidence that irreversible occlusal therapy providing an 
‘ideal’ occlusion is necessary for management of TMD (Koh and Robinson, 2003; 
Forssell and Kalso, 2004; Fricton, 2006; Abrahamsson et al., 2007; Al-Riyami et al., 
2009; Lindenmeyer et al., 2010; Luther et al., 2010; Machado et al., 2012). Therefore, 
based on current lack of evidence and because definitive occlusal therapy is an 
irreversible treatment modality, treatment by occlusal adjustment, restorative dental 
rehabilitation, orthodontics, or orthognathic surgery should never be the primary 
treatment option for TMD management. Nevertheless, occlusal therapy may be 
considered only for a specific minority of cases that have a severe unstable occlusal 
relationship or are of recent onset following a restorative dentistry procedure (de Leeuw 
and Klasser, 2013).   
TMJ surgery 
TMJ surgical treatment encompasses generally one of two main approaches: closed 
joint surgical approach by needles or an arthroscope and open joint surgical approach by 
a skin incision (Dimitroulis, 2005a). There is no role for this treatment modality in 
managing patients with muscular disorders, but for patients with a biomechanical joint 
disorder such as DDwoR, a variety of minimally-invasive and invasive surgical 
interventions are suggested and used. 
Minimally-invasive interventions 
A minimally-invasive treatment option suggested widely for DDwoR management is 
the intervention inside the joint by needles for intra-articular medication injection and/or 
lavage. Although intra-articular intervention by needles is not a surgical therapy per se, 
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it is considered in this part of the review due to its more invasive nature than the 
conservative interventions and to compare it with the surgical interventions.  
Therapeutic injections 
Intra-articular injection of medications is one of the least invasive interventions into the 
joint interior. Numerous medications have been injected into the joint for disc 
displacement management (Daif, 2012; Hanci et al., 2015; Sipahi et al., 2015), but the 
most widely used are local anaesthetics, glucocorticoids, and sodium hyaluronate (Long 
et al., 2009; Samiee et al., 2011; Nascimento et al., 2013). 
Local anaesthetics (LA) are generally used as a diagnostic approach for differential 
diagnosis of joint pain or as an adjunct prior to manipulation or arthrocentesis 
treatments but are sometimes used as a sole therapeutic modality (Nascimento et al., 
2013; Sahlstrom et al., 2013). Two main approaches are generally used to achieve 
analgesia of TMJ pain by LA: local analgesia by intra-articular infiltration into the 
superior joint space to anaesthetise the terminal branches of auriculotemporal and 
masseteric nerves, and regional analgesia by extra-articular auriculotemporal nerve 
(ATN) trunk block (Figure 2.10) (Donlon et al., 1984; DuPont, 2004).  
A B  
Figure 2.10: Therapeutic injections. (A) Intra-articular injection technique for local 
analgesia of TMJ. (B) Extra-articular injection technique for auriculotemporal nerve 
block for regional analgesia of TMJ. Reproduced from Waldman (2013) and Buescher 
(2007) with permissions from Elsevier and both the American Academy of Family 
Physicians (AAFP) and the figure illustrator respectively. 
The rationale for an ATN block therapeutic effect was attributed to short-term 
anaesthetic blockage of acute TMJ pain thereby leading to reestablishment of ‘painless’ 
joint function which enables its lubrication, nutrition, and waste products removal 
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(Nascimento et al., 2011). However, the long-term therapeutic effect of this approach is 
questionable. In a RCT assessing the effects of LA on mechanical and thermal 
sensitivity in the TMJ area of healthy people, the intra-articular infiltration has been 
found to have no effect on the sensitivity of the TMJ or surrounding area whilst the 
ATN block has been found to cause a more pronounced effect on deep mechanical 
sensitivity than on superficial mechanical sensitivity and thermal sensitivity (Ayesh et 
al., 2007). The anaesthetic blockage of the ATN is a non-invasive, low-cost technique 
that can be used in routine clinical practice as a diagnostic and therapeutic tool for acute 
joint pain (Buescher, 2007), but it may be associated with transient complications such 
as temporary facial nerve anaesthesia and haematoma (Donlon et al., 1984; Nascimento 
et al., 2013). 
Another option available for managing DDwoR is the intra-articular injection of 
glucocorticosteriods (GC) such as methylprednisolone, hydrocortisone, or 
betamethasone (Samiee et al., 2011). These are mainly used to reduce inflammation and 
relieve acute joint pain as a result of steroids’ anti-inflammatory mechanisms of actions 
(Bjornland et al., 2007). However, the long-term adverse effects of intra-articular 
injection of GC are questionable. Some studies report good short- and long- term 
prognosis of intra-articular GC injections with no or minimal radiographically 
demonstrable side effects of the medication (Wenneberg et al., 1991; Moystad et al., 
2008). Others, however, show that intra-articular injections of GC cause destruction to 
fibrous, cartilaginous, and osseous surfaces of TMJ (Haddad, 2000) which may be 
aggravated by multiple intra-articular injections of this medication (Toller, 1977).  
The other medication widely used for DDwoR management is sodium hyaluronate 
(HS). Hyaluronic acid (HA) is one of the natural components of synovial fluid in 
healthy joints. It has three main suggested functions: nutritional, lubrication, and 
biomechanical stabilising functions of the joint components (Cascone et al., 2002; Shi 
et al., 2003; Guarda-Nardini et al., 2005). The short- and long- term effects of intra-
articular injection of HS are often attributed to these functions plus its anti-
inflammatory function (Kopp et al., 1987; Sato et al., 1999b). HS injection has been 
reported to be safe and effective (Yeung et al., 2006; Basterzi et al., 2009) but it is 
relatively expensive medication and can be associated with potential complications such 
as articular surface destruction and localized inflammation (lida et al., 1998; Chen et al., 
2002; Gencer et al., 2014).  
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Arthrocentesis 
Arthrocentesis is a joint washing and lavage procedure suggested widely in the 
literature for DDwoR management (Carvajal and Laskin, 2000). The technique involves 
using needles rather than arthroscope and it was originally emerged from the 
observation that arthroscopic lysis and lavage of the superior joint compartment without 
complex arthroscopic surgeries such as disc repositioning or condylar recontouring is 
sufficient to produce a ‘desirable’ outcome of reducing the pain and improving the 
mandibular movements (Nitzan et al., 1990). Hence, it is also named as ‘non-
arthroscopic lysis and lavage’ (Geist, 2001).  
Murakami and colleagues was the first to describe the joint washing technique via a 
single needle used for frequent injection and aspiration of about 4 ml saline fluid inside 
the superior joint compartment (Murakami et al., 1987). This technique was used to 
inflate and distend the joint space by hydraulic pressure in order to aid jaw manipulation 
in recapturing the displaced disc, a procedure called ‘hydraulic pumping’ (Figure 2.11) 
(Murakami et al., 1987; Totsuka et al., 1989). The procedure was then further 
developed by Ross (1989) and popularised by Nitzan et al. (1991b) to involve also 
washing the superior joint compartment with larger volume (30-200 ml) of saline fluid 
via two ‘inflow and outflow’ needles (Figure 2.12). Since then, various techniques of 
arthrocentesis have been described in the literature (Tozoglu et al., 2011; Senturk and 
Cambazoglu, 2015) and different lavage fluid volumes (50-500 ml), instruments 
(needles or catheters), needle gauges (sizes and types), and adjunct medications were 
used (Al-Belasy and Dolwick, 2007; Monje-Gil et al., 2012).  
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Figure 2.11: Pumping technique with mandibular manipulation for ‘unlocking’ the jaw. 
Reproduced from Totsuka et al. (1989) with permission from Elsevier. 
A  B  
Figure 2.12: Positioning of two needles in arthrocentesis. (A) Placement of two needles 
for TMJ lavage. (B) Two needles’ entry into the superior joint space for joint lavage 
visualised fluoroscopically (one needle in the posterosuperior sulcus and the other in the 
anterosuperior sulcus). Reproduced from Guarda-Nardini et al. (2008) and Ross (1989) 
with permissions from Elsevier and Quintessence Publishing Company Ltd. 
respectively. 
The mechanisms by which arthrocentesis achieves its therapeutic effect are still not 
fully interpreted but its main effect on reducing pain and improving mouth opening is 
often attributed to washing-out inflammatory mediators in the joint’s synovial fluid 
(lavage) and breaking down intra-articular adhesions (lysis) respectively (Yura et al., 
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2003; Gulen et al., 2009; Tvrdy et al., 2014). Its therapeutic lavage volume has been 
studied and determined to be within an ideal lavage volume range of 100 ml to 400 ml 
necessary to wash-out proteins and inflammatory mediators (Zardeneta et al., 1997; 
Kaneyama et al., 2004); although this may also cause lavage to beneficial components 
of synovial fluid such as hyaluronic acid and lubricin (Laskin, 2009). In addition this 
treatment modality has been also claimed to help increase disc mobility, reduce synovial 
fluid viscosity and surface friction, and naturalise and release the negative intra-articular 
pressure inside the superior compartment of the ‘locked’ joints (Nitzan and Etsion, 
2002). There is still, however, limited evidence to support many of the proposed 
mechanisms of action of arthrocentesis (Frost and Kendell, 1999; Ethunandan and 
Wilson, 2006; Al-Belasy and Dolwick, 2007).  
Currently, arthrocentesis is recognized by many as first-line surgical intervention in 
TMD/DDwoR patients who do not respond to conservative management (Emes et al., 
2013; Murakami, 2013). Several advantages were reported to the use of this minimally-
invasive procedure as an intermediate treatment modality between non-invasive 
conservative and more invasive surgical interventions (Nitzan, 2006; Grossmann, 2012; 
Tvrdy et al., 2013). Arthrocentesis, however, is a ‘blind’ procedure not enabling the 
operator to directly observe intra-articular pathology or to perform sweeping and other 
arthroscopic actions (Murakami, 2013). Despite its minimally-invasive nature, 
arthrocentesis may cause potential complications (Carroll et al., 2000; Etoz et al., 
2011). Its complication rate is not defined in the literature but considered to be less than 
that for TMJ arthroscopy (Tozoglu et al., 2011). A comparison of the advantages, 
disadvantages, and surgical complications of each surgical modality used for DDwoR 
(arthrocentesis, arthroscopy, and open surgery) is summarised in Table 2.11. 
Invasive surgical interventions 
Invasive surgical management by arthroscopic or open joint surgery is one of the 
suggested options for DDwoR management.  
Arthroscopy 
The first use of arthroscopy to visualise the human TMJ was reported by Ohnishi in 
1975 (Ohnishi, 1975). Thereafter, the techniques for diagnostic and therapeutic TMJ 
arthroscopy were further described in the literature (Sanders, 1986; McCain, 1988a; 
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Tarro, 1988). Over the years, various arthroscopic techniques have been developed with 
the advancement in equipment technology (Kim et al., 2009; Weedon et al., 2013).   
A variety of arthroscopic surgical procedures have been described in the literature 
ranging from simple arthroscopic lysis and lavage to more complex operative 
arthroscopic procedures of disc repair, disc repositioning and suturing, disc removal, 
capsule release, and muscle release (McCain et al., 1992a; Miyamoto et al., 1999; 
Machon et al., 2012; Yang et al., 2012). These procedures are often accomplished via 
using three arthroscopic approaches to access the TMJ: inferolateral, endaural, and 
anterolateral (Figure 2.13) (Holmlund, 2010). Although the operative arthroscopy may 
have some additional advantages over simple lysis and lavage (McCain and de la Rua, 
1989), the lysis and lavage arthroscopy seemed to be the preferred technique to many 
surgeons due to comparable results (Gonzalez-Garcia and Rodriguez-Campo, 2011) and 
difficulty to master the triangulation method (McCain, 1988a) mandatory for 
performing operative arthroscopy (Indresano, 2001; White, 2001). 
 
Figure 2.13: Arthroscopic puncture directions for the TMJ.  (1) Inferolateral. (2) 
Endaural. (3) Anterolateral. Reproduced from Holmlund (2010) with permission from 
Wiley-Blackwell. 
The arthroscopic lysis and lavage technique is consisted of arthroscopic sweep of 
adhesions in the superior joint compartment by blunt trocar and lavage of joint space 
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(Murakami, 1990). Its main therapeutic effects, therefore, attributed to lavage of 
inflammatory mediators and lysis of adhesions which are equivalent to those achieved 
with arthrocentesis. However, its main value over arthrocentesis is the direct 
arthroscopic visualisation of the joint interior and the potential for instrumentation (Hori 
et al., 1999; Kim et al., 2009). When compared to open surgery, arthroscopic closed 
surgery has some obvious advantages related mainly to its relatively less invasive nature 
(Zhu et al., 2012; Murakami, 2013). Arthroscopic surgery, however, can be associated 
with several potential intra- and post- operative complications (McCain, 1988b). Its 
reported complication rate is ranged from 1% to 10% (McCain et al., 1992b; Carls et 
al., 1996; Tsuyama et al., 2000; Indresano, 2001; Gonzalez-Garcia et al., 2006).  
Open surgery 
Various open joint surgical procedures were described in the literature such as 
discectomy (with or without replacement), discoplasty, condylotomy, and eminenctomy 
(Trumpy and Lyberg, 1995). These procedures are accomplished via using different 
surgical approaches to gain access to the TMJ, most commonly preauricular and 
endaural and less commonly postauricular, submandibular, and retromandibular (Figure 
2.14) (Kreutziger, 1984).  
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Figure 2.14: Surgical approaches to the TMJ. (a) Standard preauricular approach; (b) 
endaural approach; (c) postauricular approach; (d) submandibular approach; (e) 
retromandibular approach. Reproduced from Laskin (2006) with permission from 
Quintessence Publishing Company Ltd. 
Historically, open surgery for managing patients with disc derangement was associated 
with multiple failures and reoperations leading to catastrophic sequelea (Moody and 
Clark, 1995; Milam, 1997; Schliephake et al., 1999; Fricton et al., 2002). Although 
open surgery is still recommended for disc derangement management by many surgeons 
to-date (Abramowicz and Dolwick, 2010; Miloro and Henriksen, 2010; Dimitroulis, 
2013; Holmlund et al., 2013), it is an irreversible invasive treatment modality that can 
be associated with several potential complications which should be taken in 
consideration before planning this invasive treatment approach (Keith, 2003; do Egito 
Vasconcelos et al., 2007).  
In fact, there are absolute and relative indications for TMJ disorders’ surgical 
management (Moore, 2006; Dimitroulis, 2013). Before considering irreversible invasive 
TMJ surgical treatment to patients, the patients must have an adequate, and appropriate, 
course of reversible non-surgical conservative treatment (Moore, 2006). Elective 
orthopaedic surgery has also been recommended for refractory cases of other joints in 
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the human body. To give an example, the available evidence suggests surgical 
intervention for patients with intervertebral disc herniation causing intolerable pain and 
persistent neurological deficit after 4-6 weeks of conservative treatment if there is no 
response to treatment (Atlas and Nardin, 2003; Schoenfeld and Weiner, 2010). For 
TMJ, a combination of factors have been identified by de Leeuw and Klasser (2013) 
and can be used as a guide to determine the appropriate duration and complexity of non-
surgical treatment prior to proceeding to TMJ surgery including: the actual 
improvement and expected prognosis, the degree of impairment, and the patient 
compliance. In general, the decision to perform TMJ surgery and its rationale depends 
on multiple factors including: the degree of derangement and/or degenerative changes 
within the joint; the potential for repair of the condition and likely improvement; the 
outcome of adequate and appropriate non-surgical treatment; the degree of impairment 
and disability the problem creates for the patient; and the presence or absence of other 
complicating factors, such as psychosocial factors or previous TMJ surgeries, which 
may lead to poor surgical prognosis (Moore, 2006; de Leeuw and Klasser, 2013). In 
addition, the patient should only undergo surgery having given informed consent 
involving realistic discussion of the disorder prognosis, patient’s expectations, and 
surgical complicating factors. Furthermore, the TMJ surgeon must have full knowledge 
about the biopsychosocial nature of TMD and the necessity to integrate the preoperative 
and postoperative conservative treatment into the overall surgical treatment plan and 
should also have full appreciation of the potential for surgical failure and complications 
(Razook, 2006; de Leeuw and Klasser, 2013).  
Overall, there is high success rate reported in most surgical trials for TMJ disorders 
management and TMJ surgery may be claimed as an effective approach (Reston and 
Turkelson, 2003; Monje-Gil et al., 2012). However, the complexity of surgical 
techniques, potential complications, the biopsychosocial nature of TMD, and the high 
success rate with the non-surgical conservative approaches suggest that the TMJ surgery 
should only be used in specific, carefully selected cases not responding to conservative 
management (AAOMS ParCare TMD, 2012; de Leeuw and Klasser, 2013) with the 
least invasive surgical procedure should be applied first (Dimitroulis, 2005b). At the 
moment, there is insufficient evidence to support the use of any of the systematically 
reviewed surgical interventions for TMJ disorders management (Kropmans et al., 1999; 
Al-Belasy and Dolwick, 2007; Guo et al., 2009; Rigon et al., 2011; Vos et al., 2013).  
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Characteristics 
Minimally-invasive and invasive surgical interventions 
Arthrocentesis (AC) Arthroscopy (AS) Open surgery (OS) 
Advantages   Simple 
 Least invasive  
 Less financial costs 
 Not leave scars 
 Performed on an out-patient basis under local 
anaesthesia with or without sedation  
 Less operating time 
 Early patients’ recovery 
 Less stress for the patient  
 Not demanding sophisticated instruments and 
require only common equipment in an out-
patient clinic 
 Sampling of synovial fluid for biochemical 
synovial fluid analysis 
 Performed repeatedly and tried before TMJ 
surgery  
Advantages over AC: 
 Visualisation of joint interior thereby enabling 
the surgeon to: 
- Examine, resect, and investigate the intra-
articular tissue pathology  
- Release with reliability the fibrous adhesions  
- Mobilise the disc under direct arthroscopic 
vision  
- Perform disc repositioning and suturing and 
other procedures such as capsular stretching 
and/or muscular release 
Advantages over OS: 
 No surgical dissection  
 Less operating time and shortened general 
anaesthesia  
 Possibility to be performed under LA 
 Early jaw mobilization 
 Early patient’s recovery 
 Lower financial cost 
 Less invasive   
Advantages over AS: 
 Some open joint procedures can leave the 
lateral capsule intact or primarily repaired  
 Can predictably avoid vital structures 
 No risk of extra-capsular leakage of irrigation 
solutions or instrument breakage 
Disadvantages  ‘Blind’ procedure not enabling the operator to 
directly observe intra-articular pathology or to 
take a biopsy of pathological tissue  
 Difficult to treat mature adhesions or perform 
sweeping and other arthroscopic actions.  
 Difficult to enter narrow joint spaces in severe 
degenerative joints 
 Challenging for inexperienced surgeons to find 
the exact places for the needles  
 Difficult to maintain the exact place of the 
needles during lavage procedure 
 Repetitive insertions of needles to find the 
right place can damage capsular tissues, 
increase the risk of fluid leakage, aggregate 
TMJ inflammation, and increase the risk of 
facial nerve injury 
 Equipment-dependent procedure depending 
largely on expensive and unique instruments 
and complex equipment technology 
 Needs a skillful arthroscopic surgeon and 
requires extensive training and can be difficult 
for many surgeons to develop this expertise 
Disadvantages over OS: 
 Causes perforation of the lateral capsule  
 Cannot predictably avoid vital structures  
 Multiple port procedures cannot predictably 
circumvent vital structures.  
 Extra-complications such as fluid leakage or 
instrument breakage   
 Most invasive   
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Characteristics 
Minimally-invasive and invasive surgical interventions 
Arthrocentesis (AC) Arthroscopy (AS) Open surgery (OS) 
Complications  Neurologic: temporary facial nerve deficit  due 
to local anaesthesia, needle trauma, or swelling 
of the surrounding tissues; reflex bradycardia 
(trigeminocardiac reflex) 
 Vascular: haemorrhage; haematoma 
(extradural hematoma and periauricular 
hematoma) 
 Otologic: otitis; partial or complete hearing 
impairment; external auditory canal 
perforation 
 Leakage of irrigation fluid and extravasation 
of fluid into surrounding tissues and tissue 
spaces 
 Iatrogenic damage to the joint structures 
 Infection 
 Instruments breakage 
 Malocclusion (occlusal bite changes) 
 Neurologic: temporary or permanent facial, 
trigeminal, oculomotor, or trochlear nerves 
deficit; damage of auriculotemporal or 
masseteric nerves; reflex bradycardia 
(trigeminocardiac reflex) 
 Vascular: traumatic aneurysm; haemorrhage; 
haematoma; arteriovenous fistula 
 Otologic: otitis; partial or complete hearing 
loss; blood clots in external auditory canal; 
perforation of tympanic membrane; laceration 
of external auditory canal; ear fullness; vertigo 
 Ocular: alteration of visual accuracy; Horner 
syndrome (eye ptosis, miosis, and 
enophthalmos) 
 Leakage of irrigation fluid: extravasation of 
fluid into surrounding tissues and tissue spaces 
 Upper airway compression due to 
parapharyngeal swelling requiring prolonged 
intubation 
 Iatrogenic damage to the joint structures such 
as perforation of the disc or rupture; scuffing 
or laceration of articular fibrocartilage 
surfaces; perforation of the glenoid fossa 
 Infection 
 Instruments breakage 
 Malocclusion (occlusal bite changes) 
 Post-operation tissue reactions such as local 
soft tissue swelling; condylar resorption; 
marked fibrosis and adhesions 
 Neurologic: mostly damage to facial nerve and 
occasionally to trigeminal and 
vestibulocochlear nerves; injury to 
auriculotemporal nerve (Frey’s syndrome) 
 Vascular: haemorrhage 
 Otologic: middle ear damage 
 Subcutaneous pneumomediastinum or 
emphysema  
 Cranial fossa perforation 
 Infection 
 Postoperative fibrous adhesions and ankylosis 
 Degenerative joint disease (osteoarthritis),  
 Malocclusion (occlusal bite changes) 
 Sialocele and parotid gland injury and fistula 
 Implant failure 
Table 2.11: Comparison between invasiveness of closed and open surgical interventions used for DDwoR management. Adapted from reviewing the 
relevant literature, mainly (McCain, 1988b; McCain et al., 1992b; Carls et al., 1996; Tsuyama et al., 2000; Indresano, 2001; Keith, 2003; Gonzalez-
Garcia et al., 2006; Nitzan, 2006; Al-Belasy and Dolwick, 2007; Grossmann, 2012; Monje-Gil et al., 2012; Murakami, 2013). 
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In summary, the interventions used differ widely in their mechanisms of actions to 
produce a therapeutic effect on temporomandibular disorders. Nevertheless all the 
interventions share a generally similar treatment goal to improve patients’ symptoms 
and all appear to be ‘successful’ in achieving this goal. The current available evidence 
suggests that the best primary approach for TMD management is 'to not do harm to the 
patients' via treating them initially by reversible non-invasive conservative treatments 
(List and Axelsson, 2010; Durham et al., 2015) while irreversible invasive surgical 
treatments should only be used, if indicated, on specific, selected not-responding cases. 
The failure of reversible treatments, however, should not be taken as a signal to pursue 
irreversible treatments. For DDwoR, however, where evidence is lacking, this 
conservative approach remains controversial with a multitude conflicting and 
contradictory opinions in clinical research on how and when to manage DDwoR 
conservatively or surgically (Murakami et al., 1995; de Bont et al., 1997). 
2.2.9 Management outcomes 
Although TMD is not a life-threatening disease, its chronic pain nature, in addition to 
dysfunction, can reduce the patients’ quality of life (QoL) (Dahlstrom and Carlsson, 
2010; Liu et al., 2012a) leading to psychosocial consequences and considerable 
suffering (Durham et al., 2011). This can be aggravated by delayed diagnosis and 
inappropriate treatment (Durham et al., 2010). As far as is possible management of 
patients with TMD/DDwoR, therefore, should be based on evidence rather than 
subjective experience with its main goal is to reduce patients’ suffering and improve 
patients’ QoL (Turp et al., 2007b; Dahlstrom and Carlsson, 2010).  
Various valid and reliable tools are available to measure subjective and objective 
outcomes of TMD/DDwoR management in relation to patients’ pain, and mandibular 
movements and function (Helkimo, 1974; Joyce et al., 1975; Fricton and Schiffman, 
1986; Von Korff et al., 1992; Stegenga et al., 1993a; Nixdorf et al., 2010), but there is 
dearth of valid patient-centred tools to measure multidimensional nature of patients’ 
QoL (Durham et al., 2007; Locker and Allen, 2007). Recently, a validated and reliable 
patient-based outcome measure (Oral Health Impact Profile for TMD ‘OHIP-TMD’) is 
suggested to measure QoL of TMD patients (Yule et al., 2015). The OHIP-TMD, 
however, is labour and time intensive and may not be used widely in clinical practice. 
There is still a need to develop a valid reproducible, but simple and practical, patient-
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centred outcome measure that can be used in clinical practice in order to base 
TMD/DDwoR management on. 
2.2.10 Management barriers 
A range of barriers to patients’ care have been identified by different research methods 
in both the dental and medical fields. The identified barriers of care are broadly related 
to three general elements of management: clinician factors, patient factors, and practice 
factors (McColl et al., 1999; Pitt et al., 2008). In the TMD field, these three elements 
can also provide barriers to TMD care. Nevertheless, there are additional barriers of 
TMD care related specifically to the biopsychosocial nature of TMD and its 
controversial aetiology, diagnosis, and treatment. 
One of the reasons for the difficulties in providing management for TMD is the 
difficulty in making a differential diagnosis of painful conditions in the orofacial region 
and the potential overlap between the signs and symptoms of differing putative 
diagnoses (Aaron and Buchwald, 2001). The diagnostic process can be even more 
challenging for the rarer conditions not usually encountered in general clinical practice 
such as DDwoR (Zakrzewska, 2002; Hegarty and Zakrzewska, 2011). 
The considerable controversy surrounding the aetiology and treatment of TMD is 
another obvious reason for management difficulty. This controversy, coupled with the 
lack of agreed outcome measures to base management on, undoubtedly leads to 
increased uncertainty in TMD management (Durham et al., 2007). 
Another challenging aspect of TMD management is the biopsychosocial nature of TMD 
which often means it requires a slightly different approach to more ‘standard’ 
biomedical conditions (Dworkin, 2001; Suvinen et al., 2005). This, however, is usually 
out of the remit of most dental and medical practitioners and it may be that the 
clinicians try to avoid approaching psychosocial issues because of inadequate training, 
insufficient incentives, and lack of time and interest (Astin et al., 2005; Astin et al., 
2006; Astin, 2007; Turp et al., 2007a; Astin et al., 2008). The nature of clinicians’ 
current clinical environment may favour quick remedies which may be difficult to 
achieve in some ‘chronic’ TMD cases that ideally require long-term therapy. Despite 
this, clinicians’ awareness of the psychological ramifications of pain in acute or chronic 
72 
 
TMD patients is important to avoid inadequate focus on dental or surgical ‘biomedical’ 
management approaches (Turp et al., 2007a).  
2.2.11 Referral 
In any healthcare system, there are usually different steps of patients care, mostly: 
primary, secondary, and tertiary care. In the UK, the National Health Service (NHS) 
defines these terms as follows:  
 Primary care: “the activity of healthcare providers who are the first point of 
health system contact for patients and who are based in a community, rather than 
in a hospital” (Makeham et al., 2008).  
 Secondary care: a “hospital or specialist care to which a patient is referred to 
from a primary care provider” (NHS terms, 2013). 
 Tertiary care: “the third and highly specialised stage of treatment, usually 
provided in a specialist hospital centre” (Health encyclopedia, 2013) and 
indicated mainly to any further point of specialist care within the hospital setting 
to which a patient is referred from a secondary care provider (Beecroft et al., 
2013). 
Patients with TMD often seek care first in community-based primary care setting 
serviced mainly by general dental and medical practitioners (GDPs & GMPs) rather 
than hospital-based secondary care setting serviced mainly by specialists (Field et al., 
2013). The GDPs and GMPs, therefore, have an important role in the diagnosis and 
treatment of TMD patients at the first point of contact (Okeson and de Kanter, 1996; 
Dimitroulis, 1998) to avoid potential consequences of delayed diagnosis and treatment 
(Durham et al., 2010). However, several studies in different parts of the world show that 
most general practitioners lack adequate education and training in TMD (Le Resche et 
al., 1993; Glaros et al., 1994; Siritapetawee and Kositbowornchai, 1999; Lee et al., 
2000; Baharvand et al., 2010) and, therefore, often prefer to refer TMD patient to 
specialists. In a recent survey-based study in Germany, the frequency of clinicians’ 
referrals of TMD patients to specialists was about 22.5% (Reissmann et al., 2015). In 
the UK, one study found that about 75% of referred COFP patients have TMD (Beecroft 
et al., 2013).  
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Several studies reported the referral rates of subgroups of TMD. Amongst all the 
referred TMD patients, referrals of patients with DDwoR were relatively high (11%-
22%), specifically 9% to 14% had DDwoR with limited opening and 8% had DDwoR 
without limited opening (Dahlstrom, 1998; Anastassaki and Magnusson, 2004; Vallon 
and Nilner, 2009; Kraus, 2014). This proportionally high referral rate of DDwoR is 
probably linked to severe symptoms and complaints of patients with DDwoR.  
Clearly the onward referral of TMD/DDwoR patients from general to specialist service 
is a problem that requires further attention because a rapid and appropriate diagnosis 
and treatment at the initial consultation is essential for patients’ management to relieve 
patients’ suffering early and achieve optimal outcomes avoiding ‘chronic’ disability 
(Gatchel et al., 2006).  
2.2.12 Conclusion 
The subject of TMD is still one of the most controversial topics in dentistry. The 
literature about TMD management is enormous and contradictory. Overall, there is 
increasing evidence from systematic reviews that TMD is best managed initially with 
non-invasive conservative reversible treatments and currently there is general consensus 
about this approach and it is advised by many authorities in the TMD field to avoid any 
harm to TMD patients (De Boever et al., 2008; Greene, 2010b; Yuasa et al., 2013). 
As seen in this section, many systematic reviews have been conducted on TMD 
management. Although this is a good start to improve understanding of this 
controversial topic, it is also questionable because most of the systematic reviews 
focused mainly on specific therapeutic intervention applied to generic TMD patients. 
This may result in different treatment responses and may not depict the real practice 
which usually involves different treatment combinations (Poggio et al., 2010). In fact, 
TMD are a collection of disorders rather than being a singular “catch-all” entity and 
grouping the patients and managing them under this generic ‘TMD’ term may rather 
cause further confusion in the field (Laskin, 2008; Benoliel, 2010). In a specific subtype 
of TMD ‘DDwoR’, this conservative management remains controversial with a 
multitude conflicting and contradictory opinions in clinical research. In terms of clinical 
decision-making in the management of TMD/DDwoR, the competing concepts and 
diverse opinions may increase the degree of uncertainty in the therapeutic decision-
making process among clinicians. This therapeutic decision-making is dependent, to 
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some extent, on evidence quality (Gordon and Dionne, 2005). At the moment, for 
TMD/DDwoR management, where opinion is divided, evidence is of poor quality. 
Professionals’ clinical decisions may, as a result, be based on experiential-based 
knowledge rather than research evidence-based knowledge (Durham et al., 2007). The 
next section will discuss the clinicians’ decision-making process. 
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2.3 Clinical decision-making 
2.3.1 Introduction 
Clinical decision-making is a complex process involving many interacting clinical and 
non-clinical factors leading to variability in clinicians’ decisions (Kay and Nuttall, 
1995c). The process of decision-making is a critical important area in all disciplines in 
medicine (Croskerry, 2005a) because clinical decisions are taken several times daily in 
clinical practice. This section aims to help understanding how the clinicians make 
decisions in clinical practice, what influences these decisions, and what can be done to 
improve the clinicians’ decisions. 
2.3.2 How the clinicians make decisions? 
Theoretically, there are two different views on how the clinicians make their decisions 
in clinical practice: perspective and descriptive. The prescriptive view prescribes how 
decisions ought to be made and demonstrates how medicine or dentistry should be 
practiced and offers a way for improving decision-making whilst the descriptive view 
describes how decisions are made in ‘real’ clinical practice and demonstrates how 
medicine or dentistry is ‘actually’ practiced and offers a way for understanding 
decision-making (McKinlay et al., 1996; Thompson, 1999).  
Prescriptive decision-making 
This is a scientific formalised model of decision-making based on mathematical 
calculations of probabilities and rates of decisions’ outcomes (Schwartz et al., 1973; 
Kassirer, 1976). This model often involves a logical analysis of the pros and cons of 
each decision by the decision-maker from the various options available in complex 
decision-making using a branching decision tree (a visual representation map of all 
possible decisions available in which decisions lead to outcomes) (Luker et al., 1998; 
Elstein and Schwartz, 2002). In each step of the decision tree, the ratios and 
probabilities of the outcome of each decision (e.g., benefits-risks) are calculated and 
assigned a numerical value (Kassirer, 1976).  
This formal quantitative decision analysis involves two variables: the probabilities (the 
probability or likelihood of clinical outcomes that treatments will have the same 
absolute or relative effects as those measured in clinical trial), and the values or utilities 
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(a utility is a numerical value representing a patient's preference for one outcome over 
others) (Schwartz et al., 1973). It uses the Bayesian2 probabilities (probability 
calculations of each individual outcome) together with the utilities related to different 
decision outcomes to determine the best course of action (i.e., best decision) (Lilford et 
al., 1998). The strength of decision analysis, therefore, is attributed to its ability to 
combine both medical facts (probabilities) and human values (utilities) together to 
determine the best available option with maximum expected utility ‘optimum decision’ 
(Swales, 1997; Lilford et al., 1998). 
This mathematical model can be used to guide the clinical decision-making process and 
formalise the clinicians’ decisions but it has several limitations to be implemented in 
‘real’ clinical practice. First, performing a clinical decision analysis for each patient is 
time-consuming and less practical in the busy clinical practice (Lilford et al., 1998; 
Straus, 2002). Second, it depends heavily on availability of objective sources of 
knowledge such as rationalised research-based knowledge to optimise a decision which 
is not always available (Luker et al., 1998). Third, it is more ‘biomedical’ based 
exclusively on the objective findings of the presenting clinical condition and the 
probability of that condition and may be less useful in complex conditions where 
psychological and social factors influence a clinical condition such as biopsychosocial 
TMD. Fourth, it does not take in consideration other factors (e.g., environmental 
factors) that may influence decision-making (McKinlay et al., 1996). Despite all these 
limitations, using sensitivity analysis by knowing how sensitive a decision it is via 
varying the utilities and outcome probabilities to determine the robustness of a choice 
made by generic decision analysis may make it possible to provide basis for developing 
clinical guidelines (Lilford et al., 1998); but again, having a guideline does not simply 
mean that the clinicians will use it in their decision-making process (van der Sanden et 
al., 2005). This will be discussed further in Section 2.4. 
The sequence of events followed in performing a decision analysis and developing a 
guideline based on that analysis and then implementing that guideline has been 
described by Lilford et al. (1998) and is presented in Figure 2.15. 
                                                 
2 Bayesian statistics: is a branch of statistics that utilises prior knowledge from research data to predict 
future outcomes. 
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Figure 2.15: The sequence of events followed in performing a decision analysis, 
developing a clinical guideline based on the analysis, and implementing the guideline. 
Reproduced from Lilford et al. (1998) with permission from BMJ Publishing Group 
Ltd. 
Descriptive decision-making 
This is a more subjective model of decision-making than the ‘objective’ prescriptive 
one because it depicts how the clinicians use their knowledge and experience in ‘real’ 
practice to make a decision. In clinical practice, the clinicians often use two proposed 
modes of thinking in order to make clinical decisions: analytical and intuitive, each of 
78 
 
which has quite different and distinctive properties and advantages and disadvantages 
(Dawson, 1993; Croskerry, 2005a; Evans, 2008; Croskerry and Nimmo, 2011). Intuitive 
decision-making relies upon experiential knowledge and wide range of intuitive 
thinking which is not ‘formally’ rationalised (Benner, 1982). This mode of thinking is 
fast, impulsive, less reproducible, reflexive, multi-channelled, and needs less effort but 
it is highly context dependent, has low confidence, is less reliable, and is more prone to 
error (Dawson, 1993; Croskerry and Nimmo, 2011). In contrast, analytical decision-
making is based on scientific knowledge and rationalistic thinking that follows rational 
logic (Hedberg and Satterlund Larsson, 2003; Banning, 2008). This mode of thinking is 
slow, explicit, reproducible, deliberate, purposeful, single-channelled, and it is relatively 
independent of context, has high confidence, is more reliable, and has few errors but it 
requires more effort (Dawson, 1993; Croskerry and Nimmo, 2011). Further description 
about the characteristics of analytical and intuitive approaches to decision-making are 
detailed in Croskerry and Nimmo (2011). 
In clinical practice, the clinicians may use these cognitive processes (i.e., modes of 
thinking) to develop different decision-making strategies which they can use singularly 
or in combination (Charles et al., 1997; Croskerry, 2002). The strategies are: 
 Pattern recognition 
 Exhaustive method 
 Hypothetico-deductive method 
 Rule out worst-case scenario (ROWS) 
 Heuristics 
 Informed and Shared decision-making 
Clinical decision-making by pattern recognition method 
This strategy involves the recognition of the pattern of a new condition from previously 
known or encountered conditions with similar pattern (categorisation). Pattern 
recognition can be done either analytically when the condition is recognised slowly via 
data collection and analysis or intuitively when the condition is recognised quickly 
(Offredy, 1998). For example, in intuitive process, the clinician compares the signs and 
symptoms of a presenting patient with patterns of patients previously seen and held in 
the clinician’s memory from past experience to recognise ‘quickly’ the category or 
pattern in which the new patient fits (pattern matching) (Manias et al., 2004; Banning, 
79 
 
2008); while in analytical process, the clinician begins with insufficient information 
from data-gathering (e.g., history and/or clinical examination) (bottom-up) but further 
additional data are needed (e.g., imaging investigations) to supplement the process to 
become more goal-directed (top-down), and thereafter the combination and continuous 
interplay of data collection and analysis enables the condition to be recognized ‘slowly’ 
and the decision to be made (problem solving) (Figure 2.16) (Croskerry, 2002).  
The pattern recognition strategy is often developed with the growing experience of the 
clinician (Cioffi and Markham, 1997) but it has the drawback for the possibility of 
making incorrect decisions due to possibility of decision-maker overreliance on 
memory to recognise a pattern that may be inaccurate (Banning, 2008). 
 
Figure 2.16: Cognitive influences on top-down and bottom-up processing in clinical 
decision-making. Reproduced from Croskerry (2002) with permission from John Wiley 
and Sons. 
Clinical decision-making by hypothetico-deductive method 
This decision-making strategy uses mainly analytical process and depends on the 
clinician’s intellectual ability to make clinical decisions by problem solving using 
previous knowledge to create new solutions (hypothesis deduction) (Kovacs and 
Croskerry, 1999; Croskerry, 2000). It involves four basic sequential stages: cue 
recognition (‘initial’ hypothesis generation), hypothesis testing, cue interpretation 
(‘final’ hypothesis generation), and hypothesis evaluation (Tanner et al., 1987; Offredy, 
1998). In practice, the clinicians use this approach to help them transform a seemingly 
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unmanageable problem into a manageable one by: generating ‘initial’ hypotheses, 
testing their appropriateness via further data collection and assessment, modifying these 
hypotheses according to the outcome of the test, generating the ‘final’ hypothesis and 
making a decision, and evaluating the outcome of their decision (Figure 2.17) (Groen 
and Patel, 1985; Offredy, 1998).  
 
Figure 2.17: Hypothesis testing in clinical decision making. Reproduced from Offredy 
(1998) with permission from John Wiley and Sons. 
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The hypothetico-deductive approach may also involve the top-down (goal-directed 
‘knowledge-based’) and bottom-up (data-driven) processes (Figure 2.16). The top-down 
process predominates when there are little data available (e.g., patient in coma), but 
when more data become available (e.g., laboratory investigations), bottom-up process 
predominates (Croskerry, 2002). Elstein and Schwartz (2002) pointed out that the 
clinicians usually approach and solve the problems flexibly and the method they select 
depends largely upon the problem’s characteristics as well as their experience; that is, 
easy straightforward cases can be solved by pattern recognition whilst difficult complex 
cases need testing of hypotheses and it is probable that experienced clinicians use a 
hypothetico-deductive strategy only with difficult cases (Elstein and Schwartz, 2002).  
Clinical decision-making by exhaustive method 
This strategy involves seeking all possible data related to the presenting condition, 
followed by sifting through the data to reach a decision (Croskerry, 2002). It is common 
amongst novice or inexperienced clinicians who may attempt to make a diagnosis by 
inappropriate exhaustive data gathering and resources utilisation. This exhaustive 
approach reflects a high degree of uncertainty due to lack of experience, but with 
clinical experience, data searching and gathering becomes more focused and directed. 
Exhaustive approach, however, may also be used by experienced clinicians in their 
decision-making when there are high levels of uncertainty such as when a particularly 
rare condition presented and the clinician requires additional thinking time to rule out 
all possibilities or when the clinician becomes fatigued and stressed which can have a 
negative impact on cognitive processes of decision-maker (Croskerry, 2002).  
Clinical decision-making by rule out worst-case scenario (ROWS) 
The ROWS decision-making strategy is important specifically to clinicians 
encountering emergency or critical acute clinical conditions. The ROWS “is a strategy 
of safety and errs on the side of caution” (Croskerry, 2002). It requires the emergency 
clinicians not to miss critical diagnoses and, therefore, they must hold in their working 
memory a number of worst-case scenarios that they should exclude when presented 
with an urgent clinical situation (Croskerry, 2002).  
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Clinical decision-making by heuristic method 
Heuristic method is a cognitive process that simplifies the clinicians’ decision-making 
(Gigerenzer et al., 1999). Heuristics are intuitive decisions that the clinicians make 
without resorting to a logical decision analysis (Croskerry, 2000). They are “rules of 
thumb, intuitions, abbreviations, simple judgements, and shortcuts” (Croskerry, 2005a). 
The use of the heuristic method in clinical decision-making requires the clinicians to 
explore, investigate, discover, and learn things from experience leading to the 
development of rules learned from clinical practice; that is making personal decision 
rules based on experiential knowledge (Cioffi, 2001; Croskerry, 2002). This strategy is 
a quick practical method in decision-making that can provide usually economical, 
resourceful, effective and successful solutions in clinical problem-solving and decision-
making. It is, however, inferential, subjective, and imprecise and can be influenced 
occasionally by a variety of cognitive biases (errors) leading to failure (Tversky and 
Kahneman, 1974; Croskerry, 2002).  
In clinical practice, the clinicians develop heuristics with growing experience as a part 
of intuitive decision-making to cope with decision-making complexity. Intuitive 
decision-making in pattern recognition and heuristics is very similar but the main 
difference is that the pattern matching occurs at the conscious level of thinking whilst 
heuristics occurs at the unconscious level of thinking (Offredy, 1998). The clinicians 
often use these heuristic rules under conditions of uncertainty to make complex 
decisions simpler but sometimes it may not be the ‘best’ decision resulting in errors and 
biases (Cioffi and Markham, 1997; Cioffi, 1998; Hall, 2002). Biases in decision-making 
process will be discussed further in Section 2.3.3.  
Informed and Shared decision-making  
The clinicians may sometimes incorporate patients in decision-making process (i.e., 
shared decision-making) or give them the responsibility to make a decision about their 
own healthcare (i.e., informed decision-making). Theoretically, there are three types of 
clinician-patient partnerships in making decisions: paternalistic, informed, and shared 
(Charles et al., 1999). The key differences between the three approaches are 
summarised in Table 2.12.  
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Analytical 
stages 
Paternalistic  
decision-making 
Informed  
decision-making 
Shared  
decision-making 
Information 
exchange 
One way (largely) 
from clinician to 
patient 
One way (largely) 
from clinician to 
patient 
Two way between 
clinician and patient 
Deliberation Clinician alone or 
with other clinicians 
Patient (plus 
potential others) 
Clinician and patient 
(plus potential 
others) 
Who decides 
what 
treatment to 
implement? 
Clinician Patient  Clinician and patient 
Table 2.12: Types of clinician-patient partnerships in making decisions. Modified from 
Charles et al. (1999). 
All the previously discussed decision-making strategies have a passive role from the 
patient in decision-making process representing the traditional paternalistic decision-
making. In the last few decades, however, there was an increasing emphasis from 
healthcare authorities on active involvement of patients in decision-making process 
about their own healthcare (GMC, 2008; DOH, 2010b). This leads to rapidly growing 
literature around informed and shared decision-making strategies and models with great 
intention on implementation of shared decision-making (Elwyn et al., 2010b; Coulter et 
al., 2011). This is in part due to recognition of appropriateness to ‘ethically’ involve 
patients in decisions about their own care (Mulley, 2009) and in part because active 
patient involvement in decision-making has been shown to be beneficial to patients’ 
healthcare from several aspects: increasing patients’ compliance and satisfaction with 
treatment, reducing  patients’ anxiety, and improving treatment outcomes (Street et al., 
2009; Vicente et al., 2013); however, the evidence for the effects of this involvement on 
quality of care is still unclear (Crawford et al., 2002). 
To promote shared decision-making, two things are required: communication training 
between clinicians and patients and decision aids to support patient decisions (Adams 
and Drake, 2006). Decision aid tools and boxes have been developed to support difficult 
decisions (Elwyn et al., 2010a; Giguere et al., 2012). A recent Cochrane review found 
that decision aids, compared to usual care, have several advantages: improving patients’ 
knowledge regarding options; reducing patients’ decisional conflict; stimulating patients 
to take a more active role in decision-making; improving accuracy of risk perceptions; 
improving congruence between the chosen option and the patient’s values; achieving 
more informed, value-based, choices, and improved clinician-patient communication 
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(Stacey et al., 2014). There are, however, several obstacles limiting the use of the 
shared decision-making strategies in clinical practice related to both: variability in 
patients’ preferences for participating and taking responsibility in decision-making 
(Levinson et al., 2005; Say et al., 2006) and the multitude challenges for clinicians to 
implement these strategies (Say and Thomson, 2003). In a systematic review on the 
barriers and facilitators to implementing shared decision-making in clinical practice, the 
most common barriers perceived by healthcare professionals were time constraints and 
lack of applicability due to patient characteristics or clinical situation. The most 
common perceived facilitators were: provider motivation and positive impact on the 
clinical process and patient outcomes (Legare et al., 2008).  
In summary, the process of decision-making by clinicians is a highly dynamic, 
complicated multifaceted process involving different strategies. In the reality of clinical 
decision-making of everyday practice, a hybrid approach of several strategies based on 
mixtures of intuitive and analytical cognitive processes can be implemented by the 
clinician during the decision-making process according to clinical situation. In general, 
however, experienced clinicians tend to use more intuitive experiential knowledge-
based decision-making whilst inexperienced clinicians use more analytical knowledge-
based decision-making. At the moment, both prescriptive and descriptive approaches 
may be used in decision-making, but both have shortcomings. The prescriptive 
decision-making is more objective and impractical, whilst the descriptive decision-
making is more subjective, prone to bias, and depends largely on clinicians’ levels of 
knowledge and experience and can be affected by numerous influences. 
2.3.3 Influences on clinicians’ decisions  
In clinical practice, the clinician cannot analyse a clinical condition solely in terms of 
risks and likelihoods to make a decision. This is because there are usually too many 
variables or unknowns in the clinical setting that may influence the clinician, 
consciously or subconsciously, during the decision-making process (Croskerry and 
Sinclair, 2001; Croskerry, 2005a). Potential influences on clinicians’ decision-making 
include both clinical (related to medical condition) and non-clinical (not directly related 
to medical condition) factors. While it is not always possible to categorise the 
influential factors into either ‘clinical’ or ‘non-clinical’ due to overlap (e.g., patient’s 
age, clinician’s specialty), the non-clinical influences are grouped in the literature into 
three general categories related to characteristics of patient, clinician, and practice 
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(McKinlay et al., 1996; Hajjaj et al., 2010). The three inter-relating factors are depicted 
in Figure 2.18, in which, the clinician as the decision-maker is the central player in the 
clinical decision-making process but the decision-maker is not isolated from the patient 
and environmental factors (Kay and Nuttall, 1995a). 
 
Figure 2.18: Influences on clinical decision-making process. Modified from Kay and 
Nuttall (1995a) with permission from Nature Publishing Group. 
Patient characteristics 
Different patient characteristics have been identified to consistently influence the 
clinical decisions including: patients’ age, gender, race, health insurance, education, and 
socioeconomic level (Perkoff and Anderson, 1970; Verbrugge and Steiner, 1985; 
Hohmann, 1989). In addition to these, each individual patient has unique characteristics 
that differ from others. Studies have shown that all the following factors can influence 
the clinicians’ decisions: the patient-clinician relationship, patient attendance pattern, 
patient’s level of involvement, patient’s level of trust in clinician, patient personality, 
and patient preferences, values, wishes, attitudes, and expectations (Kay and Nuttall, 
1995b; Luker et al., 1998; Levinson et al., 2005). Therefore, the patient characteristics 
should always be taken in consideration in decision-making process. 
Clinician characteristics 
Various characteristics of clinicians can influence their decisions. The clinicians’ 
experience has been shown to be the most important influential factor on clinicians’ 
decision-making process in several studies (Stolley et al., 1972; Hadsall et al., 1982; 
Croskerry, 2005a). In fact, many studies have shown that the clinicians’ experiences are 
intrinsic to decision-making because the clinicians often use their past experiences in 
the decision-making process “by comparing the current situation to previously 
Patient 
factors 
Clinician 
factors 
Environmental 
factors 
Decision-maker 
(Clinician) 
 
Decision 
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experienced situations held in their memory” (Cioffi, 2001) and, therefore, they often 
perform better over time (Benner, 1982; Dawson et al., 1988). 
In addition to experience, the clinician’s knowledge also plays an important and integral 
part in decision-making process. Specifically, the clinician’s speciality, level of 
qualification and education, and level of training influence their decisions (McCaul et 
al., 2001). Furthermore, clinicians’ interactions with their professional community and 
their accumulated knowledge about their patients also influence the clinical decision-
making process (Hemminki, 1975; Hjortdahl, 1992). 
Ideally, the clinicians’ personal characteristics such as age, gender, race or ethnicity, 
and character or personality should not typically influence decision-making process 
with respect to diagnosis and treatment of a medical condition (McKinlay et al., 1996). 
In reality, however, as the clinicians are human, these personal characteristics do 
influence their decision-making process (Sexton et al., 2000; Cyran et al., 2001; Tracy 
et al., 2005; Risberg et al., 2008). 
Furthermore, different forms of diagnostic and treatment biases have been described in 
the literature to influence clinicians’ decisions (Tversky and Kahneman, 1974; Dawson, 
1993; Croskerry, 2000; Croskerry, 2003a; Croskerry, 2005b). These come in multiple 
forms and are in a steady increase. A total in excess of 100 cognitive biases have been 
identified and reported in the literature and there are probably more (Croskerry et al., 
2010; Croskerry and Nimmo, 2011). Table 2.13 represents the summary of common 
biases discussed by authors in this area (Bornstein and Emler, 2001; Croskerry, 2002; 
Croskerry, 2005a). 
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Types of biases affecting decision-making process* 
Aggregate bias Gambler’s fallacy Psych-out error 
Anchoring bias Gender bias Regret/outcome bias 
Anticipated regret Hindsight bias Zebra retreat  
Ascertainment bias Posterior probability error  Search satisfying 
Availability Premature closure  Sutton’s slip 
Base-rate neglect Omission bias Triage-cueing 
Commission bias Order effects Unpacking principle 
Confirmation bias Outcome bias Vertical line failure 
Diagnosis momentum Overconfidence bias Visceral bias 
Ego bias Playing the odds Ying-Yang out 
Framing Ignoring negative 
evidence 
Representativeness 
restraint 
Fundamental attribution 
error 
Number of alternatives 
bias 
Cognitive/affective biases 
and other biases 
* For further details, please see Croskerry (2002). 
Table 2.13: Different types of biases affecting decision-making process. Adapted from 
(Bornstein and Emler, 2001; Croskerry, 2002; Croskerry, 2005a). 
Practice characteristics 
The environment of clinical practice in which care is provided can also have an 
influence on a clinician’s decision. Different characteristics of clinical practice can be 
involved in clinical decision-making process including: practice setting features such as 
geographical location, the organization of the practice, and type of practice (e.g., private 
versus public); environmental circumstances such as work load or pressure, time 
constraints, and resources availability; financial issues such as type of clinicians’ 
compensation (entrepreneurial or salaried), insurance schemes for management and 
reimbursement, clinicians’ financial investment, and management policies and therapy 
cost (Mechanic, 1975; Luker and Kenrick, 1992). The latter financial factor can play a 
major role in changing clinicians’ practice (Chaix-Couturier et al., 2000; Brocklehurst 
et al., 2013) especially for TMD management (Katsoulis et al., 2012). In the UK NHS 
system, the splint therapy cost and the current lack of financial incentives for the 
clinicians to compensate for the relatively long time required to manage TMD is a major 
barrier for primary TMD care (Durham et al., 2007). The ongoing process for changing 
the current dental contracts in addition to ‘smart’ healthcare commissioning may 
expectedly help change, and probably improve, healthcare delivery if implemented in 
the future (NHS Commissioning Board, 2013; DOH, 2015).   
In summary, numerous non-clinical factors can influence the clinician decision-making 
process. These are summarised in Table 2.14. 
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Examples of non-clinical influences on clinical decision-making process 
Patient-related factors 
- Patient’s demographic features such as age, gender, race or ethnicity, and 
socioeconomic status 
- Patient’s health insurance 
- Patient’s education 
- Patient’s personal characteristics such as patient personality, attitudes, and 
behaviour 
- Patient’s preferences, values, wishes, expectations 
- Patient’s concerns and worries (medical and non-medical concerns) 
- Patient-clinician relationship, patient’s level of involvement, and patient’s level 
of trust in clinician 
- Patient’s attendance pattern and adherence to treatment  
- Others influences of patient’s family members and friends, faith, culture, and 
quality of life 
Clinician-related factors 
- Clinician’s personal characteristics such as age, gender, culture, faith, and race or 
ethnicity 
- Clinician’s knowledge and experience 
- Clinician’s accumulated knowledge about their patients 
- Clinician’s interaction with professional community such as relationship with 
colleagues, hospital staff and with pharmaceutical industry 
Practice-related factors 
- Practice setting features such as practice organization, geographical location, 
size, and type (e.g. private vs. public ‘NHS’ practice) 
- Environmental circumstances such as work load or pressure in the clinic, time 
factor, and availability of health resources 
- Financial issues such as type of clinicians’ compensation (entrepreneurial or 
salaried), insurance schemes for management and reimbursement, clinicians 
financial investment, and management policies/ implication of treatment cost 
Table 2.14: Non-clinical influences on clinical decision-making process. Adapted from 
reviewing the relevant literature, mainly (Kay and Nuttall, 1995c; McKinlay et al., 
1996; Hajjaj et al., 2010). 
2.3.4 Improving clinicians’ decisions 
In clinical decision-making, there are some factors that can be enhanced to improve 
clinicians’ decisions thereby improving patients’ care. While some perceived factors 
can improve clinician decision-making over time (e.g., clinician’s experience), other 
factors can be used to enhance clinician decision-making (e.g., reducing uncertainty and 
bias).  
Experience in clinician decision-making is very important (Cioffi, 2001). This, 
however, is not a thing that can be learned ‘theoretically’ but rather gained ‘practically’ 
over time. Despite the fact that there is no substitute for clinical experience, simulation 
practical courses (e.g., simulated patients and then receiving feedback) may help the 
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clinicians to imagine and hold the ‘non-experienced’ events in their memory to be used 
during the clinical decision-making process (Bornstein and Emler, 2001; Croskerry, 
2005a). Apart from the clinician’s experience, other influential methods can also be 
used to improve clinical decisions, most commonly, reducing uncertainty and bias. 
Reducing bias 
In clinical practice, several biases can affect clinicians’ decisions (Table 2.13). To 
minimise the effect of these biases, a variety of cognitive ‘de-biasing’ strategies have 
been suggested in the literature (Bornstein and Emler, 2001; Croskerry, 2003a; 
Croskerry, 2003b; Croskerry and Nimmo, 2011). Each strategy is specified to avoid a 
particular bias but all strategies, in general, are based simply on the assumption that 
educating the clinicians about these biases and making them aware of their existence 
will permit them to monitor their decision-making (metacognition) and to avoid these 
biases in their clinical decisions, thereby improving the decision-making process 
(Gruppen et al., 1994; Bornstein and Emler, 2001). Recently, checklists have been 
proposed for use in clinical practice to help reduce clinicians’ diagnostic errors (Ely et 
al., 2011). These checklists can be useful in reducing clinicians’ biases in decision-
making process as they can provide an alternative to overreliance on intuition and 
memory in situations of high uncertainty and/or limited time (Ely et al., 2011).  
Reducing uncertainty 
Uncertainty is inevitable in clinicians’ decision-making process and can never be 
entirely eliminated (Logan and Scott, 1996; Hall, 2002) but it is to some extent 
discipline-specific and there are different levels of uncertainty in each medical 
speciality and each clinical setting (Croskerry, 2005a). Reducing uncertainty can be 
difficult to achieve in clinical practice but different methods have been suggested to 
reduce it (Logan and Scott, 1996). One of the main methods used in the last few 
decades to decrease uncertainty is the application of “evidence-base” concept (Sackett 
et al., 1996). 
Evidence-base concept 
In clinical practice, treatment plans are traditionally based on a mixture of clinician 
knowledge gained through education, training, practice traditions, and subjective 
perception of past clinical experiences and the opinions of ‘authorities’ which can 
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include charismatic champions of particular forms of management (Forssell and Kalso, 
2004; Tegelberg et al., 2007). Clearly, this traditional clinical practice may result in 
variable treatments of the same condition, some of which rely on subjective experience 
(experiential-based knowledge) rather than on scientific rationale (research-based 
knowledge) (Niederman and Badovinac, 1999) which means that ineffective, expensive, 
or more importantly even harmful treatments can be sometimes implemented.  
To move from tradition-based care to evidence-based care, Sackett and colleagues in the 
mid-1990s introduced the concept of Evidence-Based Medicine (EBM): “the 
conscientious, explicit and judicious use of current best evidence in making decisions 
about the care of individual patients” (Sackett et al., 1996). Apparently, the main goal 
of EBM is to support the use of the most accurate, safe, and effective intervention for 
patients in order to optimise patients’ healthcare (Haynes and Haines, 1998).  
Evidence­based medicine, or ‘dentistry’ (EBD) in our case, focuses mainly on 
determining the best research evidence relevant to a clinical problem and applying that 
evidence to resolve this problem (Haynes et al., 2002a). However, the clinician’s ability 
to make a sound clinical decision depends largely on the quality of evidence and his/her 
ability to evaluate this evidence (Gordon and Dionne, 2005). The levels of evidence for 
the effectiveness of therapeutic interventions are graded on the basis of study design 
with the highest levels of evidence coming from systematic reviews (SRs) and meta-
analyses based on high-quality randomised controlled trials (RCTs) as illustrated in 
Table 2.15 (Levels of Evidence, 2009).  
Level  Type of evidence 
1a SR (with homogeneity) of RCTs  
1b Individual RCT (with narrow Confidence Intervals)  
1c All or none study  
2a SR (with homogeneity) of cohort studies  
2b Individual cohort study (including low quality RCT; e.g., <80% follow-up) 
2c “Outcomes” Research; Ecological studies  
3a SR (with homogeneity) of case-control studies   
3b Individual Case-Control Study   
4 Case-series (and poor quality cohort and case-control studies)  
5 Expert opinion without explicit critical appraisal, or based on physiology, 
bench research or “first principles”  
Table 2.15: Levels of evidence about the effectiveness of a therapeutic intervention or 
treatment. Adapted from Levels of Evidence (2009).  
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The outcomes of systematic reviews and meta-analyses in evidence-based medicine or 
dentistry (e.g., Cochrane Collaboration) are evidence-based recommendations and 
guidelines (e.g., UK National Institute of Clinical Excellence ‘NICE’) to be applied in 
clinical practice (evidence-based practice ‘EBP’). For example, the change in the 
management of patients with impacted third molars within the UK NHS following 
NICE guidelines publication (McArdle and Renton, 2012). Clinical decision-making, 
however, cannot rely on evidence alone (Straus, 2002) because “evidence does not 
make decisions, people do” (Haynes et al., 2002b). Furthermore, dependence on 
research evidence solely by ignoring the traditional influences on clinical decisions 
(Section 2.3.3) may not depict the real clinical practice. Evidence-based decision-
making models, therefore, have emphasised that research evidence alone is not an 
adequate guide to make decisions. 
Evidence-based clinical decisions  
An evidence-based decision-making model has been proposed by Haynes and Haines 
(1998) to demonstrate a path from the generation of evidence to the application of 
evidence (Figure 2.19). This path begins with biomedical research to generate the 
evidence (the wedge shape), followed by three subsequent steps that are needed to 
implement research evidence to clinical practice (the boxes) including synthesising the 
evidence, developing clinical guidelines from research evidence, and applying the 
guidelines at the right place, time, and way. This is followed by making decisions by the 
clinicians via integrating the research evidence with the patient's clinical circumstances 
and wishes to provide the ‘evidence-based’ clinical decisions (Haynes and Haines, 
1998).  
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Figure 2.19: The path from the generation of evidence to the application of evidence.  
Reproduced from Haynes and Haines (1998) with permission from BMJ Publishing 
Group Ltd. 
The updated evidence-based clinical decision-making model described by Haynes et al. 
(2002a) demonstrates the integration of three needed key elements (Figure 2.20): 
evidence, preferences, and circumstances, but takes into consideration the central role of 
clinician’s expertise as the experience and skill that encompass and balance clinical 
state and circumstances, patients' preferences and actions, with the best research 
evidence to make evidence-based decisions. This approach can help reduce clinicians’ 
biases because it allows the clinicians to rely more on research evidence rather than 
relying ‘solely’ on their intuition and experience to make decisions (Bornstein and 
Emler, 2001). 
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Figure 2.20: Evidence-based clinical decision model. Reproduced from Haynes et al. 
(2002b) with permission from BMJ Publishing Group Ltd. 
This model, for an individual decision, can accommodate different weights for each key 
element of the decision and can be depicted visually by varying the sizes of the circles. 
In other words, for making evidence-based clinical decisions, the clinicians must apply 
their expertise (i.e., the clinicians’ basic clinical skills as well as their past experience) 
to assess the patient's clinical state and personalise the best available evidence 
(preferably from patient-centred clinical research) to fit a specific patient's 
circumstances and must also incorporate the research evidence with the individual 
patient's preferences, values, concerns, expectations, or likely actions before making a 
decision (Haynes et al., 2002a). This model has, therefore, a greater emphasis on shared 
decision-making because it incorporates the patients’ preferences and values. The 
evidence-based model, however, is rather ‘conceptual than practical’ and it is 
prescriptive rather than descriptive because it can only be used as a guidance of how 
evidence-based decisions should be made rather than how the decisions are actually 
made (Haynes et al., 2002a). In real life practice, implementation of research evidence 
has been found to be more complex than is suggested by the rational process of 
evidence-based model (Lipman et al., 2004).  
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In fact, the incorporation of evidence-based research findings and guidelines into 
clinical decision-making is not a simple straightforward process as demonstrated in 
evidence-based decision-making models because it depends on several aspects. Firstly, 
it depends largely on the availability and quality of clinical evidence itself (Turp et al., 
2004), as pointed out by Gordon and Dionne (2005) that “therapeutic decision-making 
process is highly dependent on the quality of evidence that is considered in making a 
judgment and application of that evidence to patient care”. Secondly, it requires the 
clinician to develop specific skills before being able to practice EBM/D efficiently and 
effectively and make evidence-based decisions in clinical practice. These are in brief: 
asking a clinically answerable question; searching the best available evidence to answer 
the question; critically appraising the evidence quality; integrating the evidence with 
clinical expertise and individual patient’s needs and values; evaluating performance 
(Sackett, 1997; Straus and Sackett, 1998). Thirdly, non-clinical influences on clinical 
decision-making (Table 2.14) can be a major challenge to practice EBM/D in ‘real’ 
clinical practice (Hajjaj et al., 2010). Finally, it requires frequent reviewing to each 
sequential step in the development, dissemination, implementation, and evaluation of 
guidelines to be effective (Thomson et al., 1995) and there can be several different 
factors impeding the successful implementation of research evidence into clinical 
practice ‘evidence-based practice’ (EBP). Implementation of research evidence in 
clinical practice, therefore, is not simple and may not succeed despite the availability of 
high-quality evidence. This will be discussed further in the next section (Section 2.4). 
2.3.5 Conclusion 
The clinical decision-making is an adaptive process with various factors influencing the 
clinician decision at various levels during the decision-making process. In clinical 
practice, neither prescriptive nor descriptive approaches are optimal to make a decision 
and “one approach does not fit all” (Croskerry, 2005a). Rather than being one or the 
other, the processes of decision-making may require both approaches at different stages 
of decision-making processes. Currently, the cognitive processes of decision-making are 
not yet well understood and there is always a risk of oversimplification of the clinical 
decision-making process. At the moment, clinicians’ decisions are generally related, to 
some extent, to their practical experience as well as to the degree of uncertainty and 
evidence quality. Evidence-based practice can improve clinicians’ decision-making 
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performance but there are numerous influences on decision-making process. The next 
section will discuss the implementation research of evidence in practice.
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2.4 Implementation of behaviour change interventions 
2.4.1 Introduction  
Implementation research is defined as the scientific study of methods that promote the 
uptake of research evidence in clinical practice to reduce inappropriate care (Eccles et 
al., 2007). Several reports showed that the clinicians accept the concept of ‘evidence 
base’ and agree to practice it to improve patients’ care (McColl et al., 1998). In clinical 
practice, however, many clinicians base their management of TMD patients on 
subjective experiential-based practice rather than on evidence-based knowledge 
(Durham et al., 2007).  
Implementation of evidence-based research findings into clinical practice is not a simple 
straightforward process and may occasionally fail and, therefore, may not always result 
in optimum healthcare outcomes (Haines and Donald, 1998). This ‘implementation 
failure’ is not always related to the content or quality of research evidence or guidelines 
but rather attributed to two main issues hindering implementation’s success. First, a 
failure to identify barriers and facilitators of evidence base implementation (Baker et al., 
2010). Second, a lack of theoretical basis for behavioural interventions involved in 
changing the behaviour of healthcare professionals to support evidence base 
implementation (Davis and Taylor-Vaisey, 1997; Grimshaw and Eccles, 2004; Bonetti 
et al., 2005). This section will discuss these implementation challenges and the 
development of complex behavioural interventions to facilitate implementation. 
2.4.2 Barriers and facilitators of evidence base implementation 
Implementing research evidence in clinical practice is a highly complex process that can 
be hindered by lots of barriers (Garner et al., 1998; Haines and Donald, 1998). It is 
necessary to identify these barriers in order to develop strategies to overcome them 
(Spallek et al., 2010).  
The potential barriers for dissemination and implementation of evidence-based 
guidelines in various disciplines in medicine and dentistry have been identified in 
several studies using different quantitative and qualitative research methods (Davis and 
Taylor-Vaisey, 1997; Haines and Donald, 1998; Tracy et al., 2003; Kao, 2006; Hannes 
et al., 2008; Spallek et al., 2010; Stone et al., 2014). The identified barriers are many 
and can arise at different elements of healthcare including: healthcare provider, patient, 
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practice, guidelines themselves, healthcare organisation, or wider environment. Most of 
these barriers, however, influence directly or indirectly the healthcare professionals’ 
attitude and behaviour and prevent professionals to change their decision-making 
behaviour. According to Cabana et al. (1999), most of the barriers to clinicians’ 
adherence to practice guidelines are related to professionals’ attitude and behaviour as 
demonstrated in Figure 2.21. This accentuates the necessity to develop implementation 
strategies for professionals’ behaviour change. Designing and applying behaviour 
change interventions, however, is a complex process that requires several steps (French 
et al., 2012; Porcheret et al., 2014) including:  
 Identifying the targeted clinical behaviour that needs changing.  
 Understanding the influences on the targeted behaviour.  
 Selecting the relevant techniques to change the behaviour.  
 Defining the intervention contents and active components. 
 Choosing the style or mode of intervention delivery that is likely to be effective. 
 Addressing the practical issues for implementation intervention delivery.  
All these steps are discussed below. 
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Figure 2.21: Barriers to clinicians’ implementation of practice guidelines in relation to behaviour change. Reproduced from Cabana et al. (1999) with 
permission from American Medical Association.
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2.4.3 Clinical behaviour 
Before discussing how to intervene to change behaviour it is necessary to understand 
what ‘behaviour’ means? Behaviour has been defined as “anything a person does in 
response to internal or external events. Actions may be overt (motor or verbal) and 
directly measurable, or covert (e.g., physiological responses) and only indirectly 
measurable; behaviours are physical events that occur in the body and are controlled by 
the brain” (Davis et al., 2014). Behaviour can consist of a simple, specific action or 
more complex sequences of actions (Michie and Johnston, 2012).  
To understand ‘behaviour’ further and to provide a basis for designing effective 
behaviour change interventions, a model of behaviour has been proposed by Michie et 
al. (2011b). The proposed behaviour system or ‘COM-B system’ involves three 
interacting components:  
1. Capability: “the individual’s psychological and physical capacity to engage in 
the activity concerned”.  
2. Opportunity: “all the factors that lie outside the individual that make the 
behaviour possible or prompt it”. 
3. Motivation: “all those brain processes that energise and direct behaviour, not 
just goals and conscious decision-making”.  
The three components can interact to generate behaviour that in turn can influence these 
components as depicted in Figure 2.22 (Michie et al., 2011b). 
 
Figure 2.22: The COM-B system: A framework for understanding behaviour. Modified 
from Michie et al. (2011b) with permission from BioMed Central Publisher.  
 
Capability 
 
Motivation 
 
Opportunity 
 
Behaviour 
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Implementation research involves studying what influences healthcare professionals' 
behaviour in order to enable them to use the research evidence in clinical practice 
(Eccles et al., 2007). In fact, attempting to change professionals’ behaviour is one of the 
important methods to improve the implementation of research evidence. Professionals’ 
behaviour, however, as has been shown, is likely to be influenced by a variety of 
clinical and non-clinical factors. Understanding the behaviours of healthcare 
professionals, and understanding the various factors underpinning the clinical behaviour 
to be targeted in changing clinical practice, plus understanding the theoretical basis that 
informs about the mechanisms for changing or modifying their clinical behaviour are all 
crucial steps for designing an effective implementation intervention to improve clinical 
practice towards ‘evidence-based practice’ (Grol, 2001; Eccles et al., 2007; Mazza et 
al., 2013). Changing clinical behaviour, however, is not easy and there is no “magic 
bullet” to change and improve the professionals’ clinical practice (Oxman et al., 1995). 
Nevertheless, designing behavioural change interventions that target behavioural 
determinants and is based on theoretical principles of behaviour change is more likely to 
be effective for improving healthcare (Michie et al., 2008). 
2.4.4 Behaviour change interventions 
Behaviour change interventions have been defined as “coordinated sets of activities 
designed to change specified behaviour patterns” (Michie et al., 2011b). Interventions 
for changing behaviour can be delivered at different levels: population, community, 
organisation, and individual levels (Michie, 2008). Interventions used to change 
professionals’ behaviour are typically complex and involve several interacting 
components (Craig et al., 2008b), some of which are active functioning components 
(Michie et al., 2013). Craig et al. (2008b) identified the characteristics which make an 
intervention complex. These are: the number of interacting components involved within 
the intervention; the number and level of difficulty of behaviours required by those 
delivering or receiving the intervention; the number of groups or organisational levels 
targeted by the intervention; the number and variability of outcomes; the degree of 
flexibility or tailoring of the intervention permitted. The components of behaviour 
change intervention have been described by Davidson et al. (2003) and are summarised 
in Table 2.16.  
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Intervention 
component  
Intervention question addressed  
Content/elements  
What was the content or elements of the intervention?  
How was it delivered (i.e., mode of delivery such as oral 
communication, written material, videos, interactive computer 
programs, others)? 
Provider  Who delivered it? (i.e., characteristics of intervention deliverers) 
Format  
What were the method(s) of intervention administration (e.g., 
self-help, individual, group, telephone, other)? 
Setting  
Where and when was the intervention delivered? (i.e., 
characteristics of intervention setting) 
Recipient  
To whom was the intervention delivered? Was the recipient also 
the target of the intervention? (i.e., characteristics of intervention 
recipients) 
Intensity  
How many different clinician contacts and how much total 
contact time was involved? (e.g., contact time) 
Duration  
Over what time period were intervention contacts conducted and 
how were they spaced? (e.g., number of sessions over a given 
period) 
Fidelity  
Was the intervention delivered as intended? How was this 
monitored and measured? 
Table 2.16: Minimal intervention detail to be described in research records. Adapted 
from Whitlock et al. (2002) and Davidson et al. (2003). 
Recently, the template for intervention description and replication (TIDieR) for 
behaviour change has been developed to involve all the information needed in order to 
be used as a checklist guide for better reporting and describing of behaviour change 
interventions (Table 2.17) (Hoffmann et al., 2014).  
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Item Description 
Brief name Provide the name or a phrase that describes the intervention 
Why Describe any rationale, theory, or goal of the elements essential to 
the intervention 
What Materials: Describe any physical or informational materials used in 
the intervention, including those provided to participants or used in 
intervention delivery or in training of intervention providers. 
Provide information on where the materials can be accessed (such 
as online appendix, URL) 
Procedures: Describe each of the procedures, activities, and/or 
processes used in the intervention, including any enabling or 
support activities 
Who provided For each category of intervention provider (such as psychologist, 
nursing assistant), describe their expertise, background, and any 
specific training given 
How Describe the modes of delivery (such as face to face or by some 
other mechanism, such as internet or telephone) of the intervention 
and whether it was provided individually or in a group 
Where Describe the type(s) of location(s) where the intervention occurred, 
including any necessary infrastructure or relevant features 
When and 
How Much 
Describe the number of times the intervention was delivered and 
over what period of time including the number of sessions, their 
schedule, and their duration, intensity, or dose 
Tailoring If the intervention was planned to be personalised, titrated or 
adapted, then describe what, why, when, and how 
Modifications* If the intervention was modified during the course of the study, 
describe the changes (what, why, when, and how) 
How well Planned: If intervention adherence or fidelity was assessed, 
describe how and by whom, and if any strategies were used to 
maintain or improve fidelity, describe them 
Actual*: If intervention adherence/fidelity was assessed, describe 
the extent to which the intervention was delivered as planned 
*If checklist is completed for a protocol, these items are not relevant to protocol and cannot be described 
until study is complete. 
Table 2.17: Items included in the Template for Intervention Description and Replication 
(TIDieR) checklist. Information to include when describing an intervention adapted 
from Hoffmann et al. (2014). 
As shown in Table 2.16 and Table 2.17, there are different components of behavioural 
intervention. Currently, however, a simplified consensus framework of interventions 
have been suggested by Colquhoun et al. (2014). The framework involves four key 
components as follows: 
 Active ingredients (strategies and techniques), 
 Causal mechanisms (how they function), 
 Mode of delivery (how they are delivered/applied),  
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 Intended targets (what they aim to change).  
The ‘active ingredients’ of the intervention are the key components that target the 
determinants of behaviour and have the capacity to change the targeted behaviour 
(Davidson et al., 2003; Colquhoun et al., 2014). Therefore, interventions aiming to 
change healthcare professionals’ behaviour should contain ‘active ingredients’ or 
components that effectively overcome the specific barriers encountered in relation to a 
specified ‘targeted’ behaviour (Craig et al., 2008b; Michie et al., 2013). Identifying the 
'active ingredients' responsible for behaviour change in behavioural interventions, 
therefore, is a mandatory crucial step for designing, applying, evaluating, and reporting 
behaviour change interventions.  
2.4.5 Designing and applying behaviour change interventions 
Implementation interventions are designed to change professionals’ behaviour and 
improve their uptake of evidence into practice (French et al., 2012). The UK Medical 
Research Council (MRC) established guidance for developing (Campbell et al., 2007; 
Craig et al., 2008a; Craig et al., 2008b) and evaluating (Moore et al., 2015) complex 
interventions. 
The MRC guidance is a useful generic approach to design an implementation 
intervention informed by theory. It illustrates a systematic process for developing a 
complex intervention through to its implementation in terms of four inter-related 
phases: development, feasibility and piloting, evaluation, and implementation (Figure 
2.23) (Craig et al., 2008b). In practice, however, the phases may not follow in a linear 
or even cyclical sequence. 
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Figure 2.23: Key elements of the development and evaluation process of complex 
intervention. Reproduced from Craig et al. (2008b) with permission from BMJ 
Publishing Group Ltd. 
The MRC guidance suggests the use of theoretical bases to identify influences on 
clinical behaviour as this will increase the possibility of selecting the appropriate active 
ingredients of intervention for a ‘targeted’ behaviour, thereby increasing its chances of 
success. The MRC framework, however, has been critiqued for not providing thorough 
guidance on how to use theory to progress through the early phases of the process for 
complex interventions development (Michie, 2008). Hardeman et al. (2005) proposed a 
framework to make the early phases of complex interventions development process 
more explicit. The framework involves three essential steps (Figure 2.24): Step 1, 
identifying the determinants of behaviour; Step 2, identifying the techniques of 
behaviour change; Step 3, identifying the links between the techniques of behaviour 
change and the determinants of behaviour (i.e. to identify which technique(s) need to be 
used as part of an intervention to change each ‘behavioural determinant’). The proposed 
framework indicates that the behaviour change can be achieved by targeting the 
behavioural determinants which can be identified from the theories of behaviour and 
behaviour change.  
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Figure 2.24: Proposed framework for causal modelling approaches. Each arrow 
represents a step required for the development process of intervention 
targeting/changing a specific behaviour. Modified from Hardeman et al. (2005) and 
Michie et al. (2008) with permissions from both Oxford University Press and John 
Wiley and Sons. 
Recently, French et al. (2012) issued a detailed guidance on how to progress through 
the early phases of intervention development by using a four-step systematic approach 
consisting of four guiding questions and three illustrative required tasks for each 
question to direct the selection of the most appropriate components for an 
implementation intervention. The four steps for developing a theoretically-based 
intervention designed to change clinical practice (clinician’s behaviour) are: Step 1, 
identifying the problem; Step 2, assessing the problem; Step 3, forming possible 
solutions; Step 4, evaluating the selected intervention (French et al., 2012). The steps 
for behaviour change intervention development and their relevance to the current 
project are summarised in Table 2.18.  
Step 2: Identifies 
behaviour change 
techniques 
 
Behaviour change 
techniques (BCTs) 
Behavioural 
determinants 
 
Behaviour 
Step 3: Identifies link between behaviour change 
techniques and behavioural determinants 
 
Step 1: Identifies 
behavioural 
determinants 
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Steps Tasks Relevance to current project 
Step 1:  
Who needs to 
do what, 
differently? 
• Identify the evidence-practice gap Identification of target clinical behaviours for DDwoR management.  
(Chapters 4 and 5 determined the research evidence for DDwoR management). 
• Specify the behaviour change needed to 
reduce the evidence-practice gap 
Management and/or referral of DDwoR. 
• Specify the health professional group 
whose behaviour needs changing 
Clinicians at the frontline of healthcare service. 
Step 2:  
Using a 
theoretical 
framework, 
which 
barriers and 
enablers need 
to be 
addressed? 
• From the literature, and experience of the 
development team, select which theory(ies), 
or theoretical framework(s), are likely to 
inform the pathways of change 
Given the nature of the data as well as the exploratory aims of this study, the 
theoretical domains framework of behaviour change (TDF) was utilised to inform 
data collection and analysis. 
• Use the chosen theory(ies), or framework, 
to identify the pathway(s) of change and the 
possible barriers and enablers to that 
pathway 
Theories of behaviour change informing the TDF.  
• Use qualitative and/or quantitative 
methods to identify barriers and enablers to 
behaviour change 
Qualitative TDF-informed method identified domains acting as barriers and others as 
facilitators for DDwoR management (Chapter 6).  
The core domains identified to influence clinicians’ decisions when initially presented 
with a patient having acute DDwoR at the frontline were condition-specific 
knowledge and skills. These had various inter-related effects on all other domains. 
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Steps Tasks Relevance to current project 
Step 3:  
Which 
intervention 
components 
(behaviour 
change 
techniques 
and mode(s) 
of delivery) 
could 
overcome the 
modifiable 
barriers and 
enhance the 
enablers? 
• Use the chosen theory, or framework, to 
identify potential behaviour change 
techniques to overcome the barriers and 
enhance the enablers 
As suggested for mapping the behavioural determinants to behavioural change 
techniques (BCTs) (Michie et al., 2008; Backman et al., 2015), the identified barriers 
and enablers to behaviour change of DDwoR care, as informed by the qualitative 
TDF study, can be matched to the BCTs described in the BCT-V1 taxonomy (Michie 
et al., 2013). Examples of the BCTs that may be involved to address the barriers of 
DDwoR care in a proposed future intervention are as follows:  
Shaping knowledge (BCT4.1. Instruction on how to perform the behaviour); Comparison 
of the behaviour (BCT6.1. Demonstration of the behaviour); Repetition and substitution 
(BCT8.1. Behavioural practice/rehearsal); Natural consequences (BCT5.6. Information 
about consequences); Social support (BCT3.2. Social support ‘unspecified’); Comparison 
of outcomes (BCT9.1. Credible source); Reward and threat (BCT10.6. Non-specific 
incentives); Regulation (BCT11.2. Regulate negative emotions); Self-belief (BCT15.1. 
Verbal persuasion about capability); Covert learning (BCT16.2. Imaginary reward). 
• Identify evidence to inform the selection of 
potential behaviour change techniques and 
modes of delivery 
The above BCTs could be the active ingredients that could change the determinants of 
the behaviour identified as more relevant in the qualitative study. The preferred mode 
of intervention delivery, as identified in the qualitative study, is both: face-to-face and 
electronic via eHealth platform.  
• Identify what is likely to be feasible, 
locally relevant, and acceptable and combine 
identified components into an acceptable 
intervention that can be delivered 
Not accomplished task yet  
(future work) 
Step 4:  
How can 
behaviour 
change be 
measured and 
understood? 
• Identify mediators of change to investigate 
the proposed pathways of change 
Future work 
• Select appropriate outcome measures Future work 
• Determine feasibility of outcomes to be 
measured 
Future work 
Table 2.18: Steps for developing a theory-informed implementation intervention and their relevance for the current research. Modified from French et 
al. (2012).
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The authors, however, argued that this stepped approach should be used as a 
‘conceptual aid’ rather than a ‘rigid prescription’ to guide a comprehensive intervention 
development process and it can be iteratively adjusted and refined according to contexts 
and settings (French et al., 2012). The authors also discussed the main strengths and 
potential limitations of this method. Its main strength relies in that it can guide the 
development of implementation intervention through a systematic ‘direct streamlined’ 
approach moving directly from targeting the behaviour to be changed, to identifying 
theoretical domains influencing the behaviour, to determining relevant behaviour 
change techniques, to finally implementing and evaluating a ‘complete’ intervention to 
change the ‘targeted’ behaviour. Its potential limitations, however, are related to the 
subjectivity in process of designing implementation interventions, the directness at the 
individual rather than organisational level, and the requirement for considerable time 
and resources (French et al., 2012).  
Overall, designing and applying implementation interventions informed by behaviour 
change theories and models is more likely to be effective than atheoretically-based 
interventions (Noar and Zimmerman, 2005; Abraham et al., 2009). Therefore, the use of 
behavioural theories is strongly advocated in implementation research (Eccles et al., 
2006). 
2.4.6 Psychological theories and models of behaviour change 
Theory has been defined as “a system of ideas or statements held as an explanation or 
account of a group of facts or phenomena” (Michie et al., 2005). Theories of behaviour 
change provide scientific explanations of the processes of behaviour change and 
illustrate how, when, and why change occurs. They, therefore, allow researchers to 
understand how and why interventions succeed or fail and form a basis for designing 
future behaviour change interventions (Michie and Johnston, 2012). 
Previous attempts to understand, predict, and modify the clinicians’ behaviour have 
been either atheoretical (Bero et al., 1998; Ivers et al., 2012) or based on a limited 
number of theories (Walker et al., 2003; Bonetti et al., 2006; Eccles et al., 2007) with 
varying effectiveness. In a systematic review of guideline development and 
implementation studies, only 53 of 235 reviewed studies (22.5%) were judged to have 
employed theories of behaviour or behaviour change and ten studies used individual 
constructs from theories whilst the remaining 172 studies were judged to have not 
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employed theories or constructs (Davies et al., 2010). The majority of the 53 theory-
employing studies used only one theory (42 studies) whilst only a few studies employed 
a maximum of three theories (Davies et al., 2010). Selecting one theory or few theories 
may lead to omission some of the critical theories to change the targeted behaviour 
(Francis et al., 2012). In another systematic review on the effectiveness and efficiency 
of guideline dissemination and implementation strategies (Grimshaw et al., 2004), 
considerable variation in effects of the reviewed interventions over 235 studies showing 
modest success was found. This led the authors to recommend the development of ‘a 
coherent theoretical framework’ to inform better choice of interventions for professional 
and organizational behaviour change (Grimshaw et al., 2004).  
Michie et al. (2008) advocated the use of theory in designing behaviour change 
interventions for three main reasons. Firstly, to understand and identify the causal 
determinants of behaviour and behaviour change (i.e., theoretical mechanisms of 
change) which makes the interventions more likely to be effective by targeting these 
behavioural determinants. Secondly, to test and evaluate the theory in the theoretically-
informed interventions. Thirdly, to understand and evaluate what works and not works 
in order to develop a better theory and theoretically-informed interventions across 
different contexts, populations, and behaviours. Besides these, the use of a theoretical 
basis can also be more cost-effective in developing and implementing an intervention as 
the mechanisms for its success/failure can be better understood informing the design of 
future interventions without wasting time and resources (Francis et al., 2009).  
There are, however, numerous psychological theories and models available to 
understand, predict, and change professionals’ clinical behaviour (Davis et al., 2014). 
Moreover, many of these psychological theories share overlapping theoretical constructs 
as “component parts of theories” (Michie et al., 2005). The presence of a plethora of 
psychological theories with a wide range of overlapping theoretical constructs between 
theories causes at least three problems in applying these theories and models to design 
behaviour change interventions. First, it makes the use of all the potentially relevant 
theories for behaviour change impossible increasing the risk of missing critical relevant 
theories or including irrelevant ones. Second, it causes confusion in selecting and 
applying theory to intervention design. Third, it highlights the problem of lacking the 
systematic basis for selecting the most appropriate, relevant, important, or useful 
theories for changing the targeted behaviour among all the available theories (Michie et 
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al., 2005; Francis et al., 2009; Cane et al., 2012; Francis et al., 2012). In an attempt to 
overcome these problems, Michie et al. (2005) developed the theoretical domains 
framework. 
2.4.7 Theoretical Domains Framework (TDF) 
The Theoretical Domains Framework (TDF) has been developed in 2005 by Michie and 
colleagues. The framework encompasses a broad range of psychological theories and 
constructs relevant to clinicians’ behaviour in implementing clinical evidence (Michie et 
al., 2005). It, therefore, provides the researchers a ready access to a definitive ‘full’ set 
of theoretical explanations of behaviour change and a tool to identify the relevant 
theories to particular contexts.  
The framework was accomplished through a sequential-stage systematic consensus 
method using three groups of experts: a main working group of 18 health psychology 
theorists, in collaboration with a multidisciplinary group of 16 healthcare services 
researchers including 2 dentists, and a psychological group of 30 health psychologists 
(Michie et al., 2005). The sequenced-stage consensus approach involved the following:  
 Identifying behaviour change theories and theoretical constructs, where a 
theoretical construct is “a concept specially devised to be part of a theory”.  
 Simplifying the constructs into theoretical domains, where a theoretical domain 
is “a group encompassing a set of related theoretical constructs”.  
 Evaluating the importance of the theoretical domains.  
 Conducting an interdisciplinary evaluation. 
 Validating the domain list.  
 Piloting interview questions.  
 Identifying the theoretical framework, where a framework is “a structure 
composed of parts framed together”. 
The resulting consensus identified a theoretical framework consisting of 12 theoretical 
domains from 33 theories covering 128 theoretical constructs that could help to 
understand, predict, and change the healthcare professionals’ clinical behaviour (Michie 
et al., 2005). The 12 behavioural change domains of the TDF are: 
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1. Knowledge.  
2. Skills.  
3. Social/Professional role and 
identity.  
4. Beliefs about capabilities. 
5. Beliefs about consequences.  
6. Motivation and goals. 
7. Memory, attention and decision 
processes.  
8. Environmental context and resources.  
9. Social influences.  
10. Emotions.  
11. Behavioural regulation.  
12. Nature of the behaviour. 
Each domain was associated with exemplar questions in the theoretical domains 
interview (TDI) (Michie et al., 2005) in order to allow researchers to investigate the 
domains during interviews, focus groups, or survey questionnaire.   
The TDF represents a wide range of theoretical approaches that can achieve 
comprehensive, effective, and well-rationalised intervention implementation. It has 
several strengths but it also has some weaknesses. 
TDF strengths and weaknesses  
Since its development, the TDF has been applied widely in implementation science. 
Francis et al. (2012) reviewed the TDF applications in implementation research and 
identified two major strengths in the framework: its comprehensive theoretical coverage 
of potential influences on behaviour and its capability of identifying the key mediators 
or modifiers of behaviour change (i.e., behavioural determinants that hinder or facilitate 
the intended change). An additional strength of the TDF is its capability of making links 
between theories and techniques of behaviour change (i.e., mapping behaviour change 
techniques onto behavioural determinants). Furthermore, this framework has an 
additional advantage related to its ‘flexible’ applicability because it can be applied 
‘flexibly’ in various research designs to collect qualitative (interviews or focus groups) 
or quantitative (survey questionnaires) data. For example, a generic TDF-based survey 
questionnaire has been developed recently to help the researchers in identifying factors 
influencing behaviour on a ‘representative’ sample in various contexts and settings 
(Huijg et al., 2014a; Huijg et al., 2014b). 
In fact, the TDF, as a newly applied research tool in behavioural change science, is a 
very beneficial ‘multi-functional’ tool to understand behaviour change processes and 
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potential change pathways. Figure 2.25 provides a summary of the several potential 
‘linked’ applications of TDF in implementation science.  
 
Figure 2.25: The TDF potential multi-uses in implementation research. Depicted from 
reviewing the relevant literature, mainly (Michie et al., 2005; Francis et al., 2012). 
One of the main aims of developing the TDF is to simplify and integrate a plethora of 
behaviour change psychological theories and make theory more accessible to, and 
usable by, disciplines involved in evidence base implementation other than 
psychologists; thereby, communicating the psychological constructs to an 
interdisciplinary audience (Michie et al., 2005). The cross-disciplinary implementation 
of the TDF means that it can be used to understand and change the healthcare 
professionals’ behaviour by ‘lay’ researchers other than psychologists. Obviously this is 
a major advantage for the TDF but it can be a disadvantage too if researchers applying 
the TDF have no training or experience in behavioural theory as the depth of meaning 
of the domains may not be evident to the ‘lay’ researchers with the possibility of having 
the TDF poorly or superficially applied (Francis et al., 2012). To use the framework 
thoroughly, Francis et al. (2012) advised the researchers to ‘dig deep’ beyond a 
superficial interpretation of the theoretical domains and, therefore, recommended for 
interdisciplinary research teams using the TDF for the first time to include a health 
psychologist on the team.  
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In the literature, the TDF has been used in a variety of contexts to explain 
implementation problems and to inform implementation interventions. In a review of 
TDF applying studies, Francis et al. (2012) identified 17 studies used the TDF as a basis 
for exploration the healthcare professionals’ behaviour, and the majority of these used 
semi-structured interviews’ method (Francis et al., 2012). Table 2.19 summarises some 
examples of the wide TDF applications for guidelines implementation by healthcare 
providers in a wide range of clinical settings in different parts of the world. 
Clinical setting  Study (year)* Country  
Acute lower back pain McKenzie et al. (2008) Australia 
Pediatric and new-born care Nzinga et al. (2009) Kenya 
GDPs guidelines implementation Clarkson et al. (2010) UK 
Human papillomavirus and cervical 
cancer prevention 
McSherry et al. (2012) Ireland 
Clinicians’ prescribing errors Duncan et al. (2012) UK 
Pre-operative tests for low-risk surgery  Patey et al. (2012) Canada 
Diagnostic imaging for spine disorders Bussieres et al. (2012) USA & 
Canada 
Tobacco use prevention and cessation 
counselling by dental care professionals 
Amemori et al. (2013) Finland 
Osteoarthritis patients’ self-management Porcheret et al. (2014) UK 
Application of fluoride varnish to 
children’s teeth 
Gnich et al. (2015) UK 
Neck pain management Bussieres et al. (2015) Canada 
* Studies are in chronological order. 
Table 2.19: TDF uses in various clinical contexts in different countries.  
This wide applicability of the TDF in investigating various behaviours in different 
healthcare settings provides evidence of framework success in “making psychological 
theory useful” (Michie et al., 2005) to researchers from a variety of disciplinary 
backgrounds across the world.  
The TDF, however, has also several limitations. First, it does not specify relationships 
between the domains and does not generate testable hypotheses (Francis et al., 2009) 
and, therefore, it is described as “a descriptive framework rather than a theory” (Francis 
et al., 2012). Second, despite its clarity in specifying the component constructs to each 
domain, there is some overlap between the theoretical constructs in the domains of the 
TDF making the boundaries between domains unclear and difficult to identify by the 
researchers because some constructs are related to more than one domain (Francis et al., 
2009). The last point can be especially challenging when the TDF is used as a coding 
framework for data analysis of qualitative interviews (Islam et al., 2012); nevertheless 
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there is an acknowledgement that the TDF is a proven efficient and comprehensive 
method for data analysis (Porcheret et al., 2014; Backman et al., 2015). Third, the TDF 
can generate ideas about the factors influencing behaviour but it cannot provide 
evidence about the ‘actual’ influences on clinical practice (Francis et al., 2012). That is, 
although the participants’ own views are of relevance in determining their 
perceptions/conclusion and engagement of behaviour change, the identified themes in 
TDF interviews may reflect only the participants’ own and others’ views regarding 
influences on clinical behaviours and may not necessarily reveal the ‘actual’ causes 
(Patey et al., 2012). Fourth, there is a possibility of reaching ‘premature’ data saturation 
if the selected participants for TDF interviews share similar opinions (Patey et al., 
2012). The last two points, however, related more to research methodology used (e.g., 
qualitative interviews) rather than the TDF shortcomings per se and can be overcome by 
using different research methodologies or adapting various research methods. Fifth, the 
TDF interview topic guide is criticised for being more structured, too focused, and too 
constrained leading the interviewee to discuss only the views and opinions about the 
topic that fit into the framework. One study, however, confuted this criticism by using 
randomised designs and making direct comparisons between the results of methods 
based on the TDF versus atheoretical methods, using interviews, focus groups, and a 
survey questionnaire (Dyson et al., 2011). The study found considerable overlap in the 
findings from the theoretical and atheoretical approaches. Furthermore, the data 
generated using the TDF approach also prompted the identification of beliefs that could 
not be elicited by the atheoretical approach (Dyson et al., 2011). In a recent systematic 
review of questionnaire-items used in 50 included quantitative and qualitative studies 
investigating barriers to change healthcare-related behaviour, 97% of manuscripts’ 
questionnaire-items were found to be covered by the TDF and only about 3% of items 
identified were not covered by the TDF-questionnaire which confirms the validity of 
TDF framework in assessing barriers to change (Sarmast et al., 2014). This provides 
further evidence of the comprehensive inclusive theoretical coverage of the TDF. 
Nonetheless, all the identified limitations are worth consideration and highlight the 
necessity for further refining and improving the current framework. 
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TDF refining and validation 
In a refining and validation study of the TDF, Cane et al. (2012) tested the validity of 
the original 12 domains framework developed by Michie et al. (2005) using a three-
stepped approach: Step 1, identify domains; Step 2, establish domain content; Step 3, 
finalise domain labels.  
The three-step validation process examined specifically structure, content, and labels of 
the domains by using card sort task methodology (closed and open), fuzzy cluster 
analysis, and discriminant content validation methods. The study’s results showed good 
support for the basic structure but led to two main changes of the original framework. 
First, a separation and clarification of a number of existing domains and constructs (e.g., 
44 constructs have been removed in the refined version of the 128 constructs in the 
‘original’ TDF; 3 additional domains have been added). Second, a dropout to the ‘nature 
of the behaviour’ domain with the reason being that it is a ‘dependent’ rather than an 
independent variable and related more to an understanding of the behaviour 
characteristics rather than to influences on behaviour (Cane et al., 2012). The ‘refined’ 
framework, therefore, contains 14 domains involving 84 theoretical constructs as shown 
in Table 2.20. 
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Domain  Constructs*  
1. Knowledge  Knowledge (including knowledge of 
condition/scientific rationale); procedural 
knowledge; knowledge of task environment. 
2. Skills  Skills; skills development; competence; ability; 
interpersonal skills; practice; skill assessment. 
3. Social/Professional 
role and identity 
Professional identity; professional role; social 
identity; identity; professional boundaries; 
professional confidence; group identity; leadership; 
organisational commitment. 
4. Beliefs about 
capabilities 
Self-confidence; perceived competence; self-
efficacy; perceived behavioural control; beliefs; self-
esteem; empowerment; professional confidence. 
5. Optimism Optimism; pessimism; unrealistic optimism; identity. 
6. Beliefs about 
consequences 
Beliefs; outcome expectancies; characteristics of 
outcome expectancies; anticipated regret; 
consequents. 
7. Reinforcement Rewards (proximal/distal, valued/not valued, 
probable/improbable); incentives; punishment; 
consequents; reinforcement; contingencies; 
sanctions. 
8. Intentions Stability of intentions; stages of change model; 
transtheoretical model and stages of change. 
9. Goals  Goals (distal/proximal); goal priority; goal/target 
setting; goals (autonomous/controlled); action 
planning; implementation intention. 
10. Memory, attention, 
and decision processes 
Memory; attention; attention control; decision-
making; cognitive overload/tiredness. 
11. Environmental 
context and resources 
Environmental stressors; resources/material 
resources; organisational culture/climate; salient 
events/critical incidents; person x environment 
interaction; barriers and facilitators. 
12. Social influences Social pressure; social norms; group conformity; 
social comparisons; group norms; social support; 
power; intergroup conflict; alienation; group identity; 
modelling. 
13. Emotions Fear; anxiety; affect; stress; depression; 
positive/negative affect; burn-out. 
14. Behavioural 
regulation 
Self-monitoring; breaking habit; action planning. 
* Underlined constructs are overlapped in more than one domain. 
Table 2.20: Refined theoretical domains framework. Adapted from Cane et al. (2012). 
The findings from Cane et al. (2012) have strengthened the evidence about the 
appropriateness of structure and content of the theoretical domains, thereby increasing 
the confidence in the TDF’s potential utility in implementation science. There are, 
however, some limitations of the refined-TDF, one of which is illustrated in the footnote 
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of Table 2.20, as there are still some overlaps between the theoretical constructs in the 
domains of the refined-TDF. In their study, Cane et al. (2012) discussed two possible 
limitations of the refined framework. One limitation is the weak clustering of two of the 
included domains (environmental context and resources; behavioural regulation). 
Another identified limitation is that the refined-TDF is limited to theoretical constructs 
identified early in the original-TDF, which despite their extensiveness, they do not 
cover all the available behavioural change theories (Noar and Zimmerman, 2005). 
Nevertheless, the TDF is currently the most comprehensive inclusive theoretical 
approach that can be used to identify the behavioural determinants with good reliability.   
2.4.8 Behaviour Change Techniques (BCTs) 
Behaviour change techniques (BCTs) are defined as “an observable, replicable, and 
irreducible component of an intervention designed to alter or redirect causal processes 
that regulate behaviour” (Michie et al., 2013). In other words, a BCT is proposed to be 
an active/effective ingredient within the intervention components (Michie et al., 2011a). 
BCTs can be used either alone or in combination and in a variety of formats (Michie et 
al., 2013). For example, an audit and feedback BCT has been identified as an effective 
technique for interventions to change healthcare professional’s behaviour (Ivers et al., 
2012). 
The science of behaviour change is developing quickly. The first reliable taxonomy of 
BCTs developed by Abraham and Michie (2008) included only 26 BCTs. Recently an 
extensive taxonomy of 93 BCTs has been developed by Michie et al. (2013). The ‘BCT 
taxonomy version 1’ involves 93 BCTs grouped into 16 clusters, namely:  
1. Scheduled consequences. 
2. Reward and threat. 
3. Repetition and substitution. 
4. Antecedents. 
5. Associations.  
6. Covert learning.  
7. Natural consequences. 
8. Feedback and monitoring. 
9. Goals and planning. 
10. Social support.  
11. Comparison of behaviour. 
12. Self-belief. 
13. Comparison of outcomes. 
14. Identity. 
15. Shaping knowledge. 
16. Regulation. 
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The current BCT taxonomy v1 has been described as a reliable, distinct list of clearly 
defined, non-redundant BCTs and as a ‘hierarchical’ structure (Michie et al., 2013). The 
long-term goal of the BCT Taxonomy project is to develop a comprehensive, reliable, 
and generalisable ‘core’ BCT taxonomy that: can be used as a tool for identifying, 
implementing, and evaluating behaviour change interventions, can be applied in various 
contexts and settings to different types of intervention: individual, organizational, and 
community interventions, and has international acceptance and multidisciplinary use 
(Michie et al., 2013).  
Michie et al. (2013) suggested five potential benefits that will arise from the 
development of a cross domain, internationally accepted, BCT taxonomy. Firstly, it will 
promote accurate replication of interventions. Secondly, it will facilitate correct 
implementation of ‘effective’ interventions. Thirdly, it will enable systematic reviewers 
to use a reliable method for extracting information about intervention content, thus 
identifying and synthesizing discrete, replicable, potentially active ingredients (or 
combinations of ingredients) associated with effectiveness. Fourthly, it will enable the 
intervention development to draw on a comprehensive list of BCTs to design 
interventions, and will enable well-defined, clear, and detailed reports of the 
intervention content. Finally, it will allow the investigation of possible mechanisms of 
action by linking the techniques of behaviour change with the theories of behaviour 
change.  
2.4.9 Linking behaviour change techniques to behaviour change theories 
Different behaviour change techniques can address different behavioural determinants. 
The current BCT taxonomy v1 is a methodological tool that can be used in specifying 
the detailed content (i.e., active components) of a wide range of behaviour change 
interventions but it does not, however, make links with theory (Michie et al., 2013). 
Linking the techniques of behaviour change with the theories of behaviour change is 
necessary for both developing and evaluating the theoretically-informed interventions 
(Michie and Johnston, 2012).  
Michie et al. (2008) identified three factors required for effective mapping of theoretical 
constructs to behaviour change techniques. First, examine the wide range of theoretical 
frameworks available. Second, identify the range of techniques available to change 
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behavioural determinants. Third, develop a basis for selecting and mapping relevant 
techniques to differing behavioural determinants. 
A preliminary attempt at linking BCTs with theoretical constructs of TDF (i.e. 
behavioural determinants informed by psychological theory) has been done by Michie 
et al. (2008) and found to be useful but needs further work to optimise its benefits. In 
this preliminary study, 35 BCTs were identified first and then mapped (linked or 
matched) to relevant theoretical domains and constructs by consensus of four 
independent experts. The results of this consensus mapping showed a reasonable inter-
rater agreement (71%) and identified the possible techniques that can be used for 
changing each behavioural/causal determinant in the original-TDF (Michie et al., 2008). 
The number of behavioural change techniques agreed by the experts to be useful for 
changing each domain was as follows:  
 One technique to change knowledge; environmental context and resources; 
social/professional role and identity. 
 Two techniques to change social influences; emotions.  
 Three techniques to change memory, attention, and decision processes.  
 Four techniques to change beliefs about consequences. 
 Five techniques to change action planning.  
 Nine techniques to change beliefs about capabilities; motivation and goals.  
 Ten techniques to change skills. 
This mapping process adds further evidence and support for the use of the TDF to 
identify the behavioural determinants (i.e., domains) that can be linked to appropriate 
behaviour change techniques for designing behaviour change interventions. The 
authors, however, discussed that this mapping attempt is only an illustration of what can 
be achieved further by a larger sample of experts’ consensus (Michie et al., 2008). The 
limitation of this initial mapping attempt is attributed to its subjective agreement as it 
was based on authors’ opinion (subjective experiences and knowledge) not on evidence 
of actual effectiveness of the techniques and the fact that the task was completed 
without definitions of BCTs. Nevertheless, this mapping identified several advantages. 
Firstly, there is substantial consensus in agreeing about the inappropriate technique(s) 
for changing specific determinants which could be used as evidence to avoid wasting 
resources on interventions that are likely to be unsuccessful. Secondly, there is also 
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substantial consensus in agreeing the appropriate technique(s) for changing each of the 
theoretical domains despite the uneven distribution of techniques across the causal 
determinants. Thirdly, this identification of the ‘appropriate’ techniques to change each 
behavioural determinant can be utilised as a basis for conducting intervention trials and 
undertaking systematic reviews to provide evidence about the most effective BCTs 
(Michie et al., 2008). 
2.4.10 Modes of delivery 
Various methods have been proposed in the literature to enhance the dissemination and 
implementation of evidence in clinical practice. These are many ranging from simple 
dissemination strategies enhancing accessibility to information resources such as 
mailing the clinical guidelines or educational materials to more complex 
implementation strategies using different modes of delivery, including: using opinion 
leaders or mass media campaigns; using reminder systems; educational outreach visits 
and academic detailing; developing continuing educational programmes with different 
educational strategies and educational activities such as educational meetings, courses, 
conferences, seminars, workshops, interactive group meetings and multi-professional 
collaboration; receiving audit and feedback; using computerised clinical decision 
support systems (CDSS) and tools; and combined multifaceted approaches (Oxman et 
al., 1995; Grimshaw et al., 2001; Grol and Grimshaw, 2003; Mettes et al., 2010; 
Squires et al., 2014). 
In a systematic review about the effectiveness and efficiency of guideline dissemination 
and implementation strategies (Grimshaw et al., 2004), 235 RCTs reporting 309 
comparisons were identified. Of these, 73% comparisons were multifaceted 
interventions whilst the remaining were single interventions, most commonly reminders 
(16% comparisons), educational materials (9% comparisons), and audit and feedback 
(4% comparisons) (Grimshaw et al., 2004). The review found that about 87% of the 
reviewed interventions resulted in improvements in healthcare but the majority were 
modest to moderate improvements (Grimshaw et al., 2004). Dyson et al. (2011) argued 
that the success of delivery strategies depends primarily on the type of change being 
implemented. French et al. (2012) suggested the choice of delivery mode should be 
made and guided by the ‘particular’ context and practical issues of intervention 
delivery, mainly, what is feasible according to available resources and what is 
acceptable in the relevant clinical setting to the targeted group of healthcare 
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professionals. In other words, several inter-related factors need to be taken into 
consideration when selecting the mode of delivery of an intervention such as: targeted 
behaviour, targeted population, setting, resources, as well as feasibility, practicability, 
scalability, and acceptability of the intervention itself. The choice of the appropriate 
mode or style of delivery can be informed by evidence on the effectiveness of strategies 
for changing practice from the Cochrane Effective Practice and Organisation of Care 
Group (EPOC, 2002). 
Currently, technological advances in developing computerised clinical decision support 
system (CDSS), whether via electronic computer technology (eHealth) or mobile 
technology (mHealth) platforms, may help dissemination and implementation of 
research evidence into clinical practice. The CDSS has been defined as “any computer 
program designed to help health professionals make clinical decisions” (Shortliffe, 
1987). These systems are designed to provide clinicians and patients with relevant 
clinical knowledge and patient-related information with an optimum goal to improve the 
quality of healthcare and reduce errors in practice (Davis, 2008; Vikram and Karjodkar, 
2009). They have several advantages related mainly to their practicality, feasibility, and 
economical issues (Nhavoto and Gronlund, 2014). A systematic review on the impact of 
health information technology on quality, efficiency, and costs of healthcare found three 
major benefits from using the CDSS: increasing adherence to evidence-based care, 
enhancing surveillance and monitoring, and decreasing decision-making errors 
(Chaudhry et al., 2006). According to Newman (2007), these electronic systems can 
assist clinicians in making decisions in several ways: detect potential clinical errors; 
suggest risk factors and approaches to patient differential diagnosis and management; 
suggest ‘optimal’ clinical strategies on the basis of the best available evidence and cost-
benefit and harm-benefit considerations; organise treatment plan details; gather and 
present data required to perform a treatment plan; communicate to third party payers.  
There are, however, a multitude of requirements for these electronic systems. In one 
study, ten technical elements were discussed to be required for ‘optimal’ CDSS (Bates 
et al., 2003). In addition to technical requirements of these tools, Straus (2002) 
recommended three elements that are needed to be available in the CDSS to help the 
clinicians individualising their treatment decisions and incorporating the patients’ 
values and circumstances in their decision-making process. Hence, CDSS should: 
express the risks and benefits of treatments in valid, concise, and intelligible formats to 
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patients as well as to clinicians; allow the clinicians to individualise treatment according 
to patients’ unique values and expectations; be feasible for use on busy clinical services 
(Straus, 2002). In one systematic review about these systems, four features were 
identified that should be available in CDSS to be effective in improving healthcare, 
including: provides decision support automatically as part of clinician workflow; 
delivers decision support at the time and location of decision-making; provides usable 
recommendations; and uses a computer to generate the decision support (Kawamoto et 
al., 2005). These four features share generally a common theme to make the clinicians 
easily applying and using the electronic tool with minimum efforts during the clinical 
practice.  
In addition, there are several potential challenges and concerns that may restrict the 
wide adoption of these supporting systems by clinicians. These are many but related 
mainly to users (i.e., clinicians) such as: lack of familiarity, lack of acceptability, lack of 
trust, lack of relevance, lack of time, lack of incentives, lack of functionality of 
‘cookbook’ approaches, fear of reduced autonomy or increased liability, and fear of 
legal liability. Other factors that might restrict adoption are related to systems 
themselves such as: financial considerations for development and maintenance, lack of 
knowledge maintenance and update, and lack of necessary and continuous evaluation 
(Newman, 2007; Hochadel, 2008; Vikram and Karjodkar, 2009). More importantly, 
these CDSS have theoretical limitations because most of the times they do not have a 
theory base and do not identify mechanisms of behaviour change and the BCTs 
necessary to target the behaviour. Therefore, the majority of CDSS only focus on 
motivational stages of decision-making (i.e., clinician’s knowledge). To change a 
decision-making behaviour, it is often needed to make the behaviour change 
intervention broader to encompass and address all the relevant behavioural determinants 
(e.g., clinician’s skills). Nevertheless, despite these requirements, challenges, and 
limitations, the computerised clinical decision support e-Health and m-Health systems 
seem very promising tools to improve healthcare in the future. 
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2.4.11 Conclusion  
Implementation of research evidence in practice is hindered by numerous barriers 
related mainly to healthcare professional behaviour and attitude. Changing healthcare 
professionals’ behaviour towards ‘evidence-based practice’ is difficult and challenging 
and the interventions needed to be designed to achieve this change are typically 
complex. Nevertheless, understanding the behaviours of healthcare professionals; 
identifying the influences on clinical behaviour; basing the intervention on theoretical 
principles of behaviour change; mapping the appropriate behaviour change technique to 
underlying behaviour change theory; disseminating via appropriate mode of delivery; 
and taking into consideration the practical issues of intervention delivery will more 
likely lead to effective intervention development and successful implementation. 
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2.5 Summary Conclusion  
Despite the advances in TMD research, TMD topic is still not a fully understood 
growing subject in terms of aetiology, diagnosis, and treatment. This can be challenging 
to the clinician ‘decision-maker’ due to high uncertainty levels. The clinician’s 
decisions, however, can be supported by reducing the uncertainty via research evidence 
as well as by understanding influential factors that may play a role in the clinical 
decision-making process for TMD/DDwoR management and developing appropriate 
interventional strategies to overcome these. 
The identified evidence from systematic reviews (Chapters 4 and 5) will be used with 
the identified influences on clinicians’ decisions from qualitative study (Chapter 6) to 
shape the future intervention that will be developed. This intervention will probably be 
a complex behavioural intervention to support clinicians to make a decision as well as 
to execute specific clinical behaviours. 
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Chapter 3. Aims and Objectives 
3.1 Aim 
To inform and facilitate the future development of a virtually delivered evidence-
informed behavioural intervention for clinicians at the frontline to aid them managing 
disc displacement without reduction (DDwoR) disorder. This will inform the 
development of more generic strategies with which to help improve the management of 
temporomandibular disorders (TMD) in general. 
3.2 Objectives 
1. To investigate the effects of duration of locking on the clinical outcomes of TMJ 
closed lock management and its implications for the definitions of acute and 
chronic DDwoR.  
2. To investigate the effects of conservative (non-surgical) and surgical therapeutic 
interventions used for the management of patients with DDwoR. 
3. To explore and build an understanding of professionals’ clinical decision-
making processes in the management of TMD in general and DDwoR in 
particular in order to identify factors, as informed by the TDF, influencing the 
professionals’ decisions in DDwoR management at the frontline. 
3.3 Programme of work 
The three objectives were addressed by conducting three separate consecutive studies: 
1. Systematic review of locking duration effects on timing the interventions used 
for DDwoR management. 
2. Systematic review of interventions effects on DDwoR management. 
3. Qualitative interview study with dental and medical primary and secondary care 
professionals who might be expected to be involved in DDwoR management. 
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Chapter 4. Effects of Locking Duration on Timing the Interventions in 
TMJ Closed Lock Management: A Systematic Review 
4.1 Introduction 
TMJ closed lock (CL) is a clinical term often used to describe a ‘painful locking’ 
symptom which is usually attributed to disc displacement without reduction (DDwoR) 
(Weisberg and Friedman, 1981; Okeson, 2007) or less commonly to anchored disc 
phenomenon (ADP) (Nitzan and Dolwick, 1991; Nitzan and Marmary, 1997). In this 
chapter, therefore, the ‘closed lock’ term is used to describe the clinical symptoms of 
the two clinical conditions: DDwoR and ADP. The duration of locking determines if the 
CL condition is acute or chronic (Murakami et al., 1995; Sembronio et al., 2008b).  
4.1.1 Acute and chronic closed lock duration 
The ‘acute’ and ‘chronic’ are medical terms usually used to measure the time scale of a 
disease rather than its severity. In medical dictionaries, the term ‘acute’ is often linked 
to a temporary state or condition which may/may not be severe, and the term ‘chronic’ 
is linked to a persistent or long lasting state or condition and again does not imply 
anything about severity (BMA, 2008; CCMD, 2010). In pain conditions, it is generally 
agreed that “acute pain” is a pain of recent onset with a duration of less than or equal to 
1 month (≤ 30 days) and “chronic pain” is a persistent pain with a longer duration of 
more than or equal to 3-6 months (≥ 90 days) (Carr and Goudas, 1999; Dworkin et al., 
2011). In a CL condition, the terms “acute closed lock” (ACL) and “chronic closed 
lock” (CCL) are also widely used in the literature to describe the chronicity of the 
condition according to locking duration or time since locking onset. At the moment, 
however, there is no clear indication about the chronological difference between acute 
and chronic CL; that is, how long before ‘acute’ is redefined as ‘chronic’? Intuitively, 
however, there should be a difference if the clinicians intervene in CL early versus if 
they intervene late. This is not only because of the fact that the disc may be ‘replaced’ 
back into its normal anatomic position but also because if symptomatic load is 
decreased it may be possible to avoid pain-related disability and dysfunction over the 
longer-term (Gatchel et al., 2006). 
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4.1.2 Why it is important to differentiate acute from chronic closed lock? 
The natural clinical progression of closed lock from ‘acute’ to ‘chronic’ in patient with 
DDwoR has been proposed as follows: it starts as an anteriorly displaced disc 
obstructing the translation of condyle during mouth opening. This causes restriction in 
mouth opening often associated with severe pain (acute stage). Thereafter, the repeated 
attempts to open the mouth by the patient displace the disc gradually farther forward 
anteriorly so the condyle can slide forward during mouth opening. This causes increase 
in range of mouth opening over ‘time’ often associated with reduced pain (chronic 
stage) (Haketa et al., 2010). From a clinical point of view, the progression from an acute 
to a chronic CL over time may affect the intervention effectiveness and, therefore, the 
outcome of treatment. This is in part because patients with CL may respond to a similar 
therapeutic intervention differently on the basis of locking duration, and in part because 
the assessment of the effectiveness of interventions in CL is most often based on the 
two outcomes which tend to improve over time: increased opening and decreased pain. 
In other words, locking duration may be a potential factor that can both affect treatment 
effectiveness and help predict treatment outcomes in CL management. Currently, 
however, the effects of locking duration on CL management outcome is still unknown.  
4.2 Aims and objectives 
4.2.1 Aim 
The primary aim of this systematic review was to investigate the effects of duration of 
locking on the clinical outcomes of closed lock management and its implications for the 
definitions of acute and chronic CL.  
4.2.2 Objectives 
 To investigate the effects of locking duration on the success of therapeutic 
interventions in closed lock. 
 To examine the timing definitions for acute-chronic closed lock stages. 
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4.3 Methods 
4.3.1 Study design 
Systematic review. 
4.3.2 Criteria for considering studies 
The criteria for considering studies followed the PICOS criteria which are: Participants, 
Interventions, Comparators/Control, Outcomes, and Studies.  
Types of studies   
Inclusion criteria 
As the primary aim of this review was to find the relationship between locking duration 
and CL management outcome, studies of any design that involve patients with acute or 
chronic TMJ CL (DDwoR and ADP) and investigating the effects of any form of 
conservative (non-surgical) and/or surgical interventions were considered as long as the 
duration of symptoms were reported. 
Studies involving other heterogeneous groups of TMD patients (e.g., DDwR, 
osteoarthritis, or myofacial pain) in addition to patients with CL were considered if 
separate data (e.g., locking duration and/or success rate) were provided in the study for 
CL patients, or if the sample consisted of ≥ 80% CL patients. Studies involving patients 
with a confirmed radiographic diagnosis of DDwoR/ADP associated with comorbid 
disorders were also included. 
Exclusion criteria 
Studies were excluded if they addressed diagnoses other than ‘closed lock’ (DDwoR or 
ADP). CL studies were excluded if they did not report the duration of symptoms of their 
sample or if they addressed subject matter other than CL management.  
Types of participants   
Inclusion criteria 
Patients of any age, gender, and of different stages of chronicity with clinical and/or 
radiological diagnosis of acute or chronic DDwoR as diagnosed according to: AAOP 
criteria for acute or chronic DDwoR (de Leeuw, 2008); RDC/TMD criteria (IIb or IIc) 
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for DDwoR with/without limited opening (Dworkin and LeResche, 1992); Wilkes 
early/late intermediate stages (III or IV) of internal derangement (Wilkes, 1989); or any 
other bespoke study criteria that were compatible with, or comparable to, the 
aforementioned criteria (Table 2.5) were considered as long as the duration of 
symptoms were reported. CL patients with a ‘static’ or ‘fixed’ disc (i.e., anchored disc 
‘ADP’) (Nitzan and Dolwick, 1991; Rao et al., 1993) were also included as long as the 
duration of symptoms were reported. Patients with confirmed diagnosis of 
DDwoR/ADP with comorbid disorders were also considered. 
Exclusion criteria 
CL patients with systemic diseases were excluded. 
Types of interventions   
Any form of conservative or surgical intervention was considered. The interventions 
were divided into different treatment modalities to be considered by their main 
treatment components such as: education, self-management, splint therapy, 
physiotherapy, intra-articular injection, arthrocentesis, arthroscopic and open joint 
surgery. Standardized combination of different treatments was also included. 
Types of outcome measures   
The main outcome measures considered were the success rates of the included studies in 
relation to the duration of locking of the studies’ samples. Given the lack of agreed 
valid and reliable criteria to define ‘success’ in CL management (Schiffman et al., 
2014b), the criteria for success of the reviewed intervention were based on the reported 
criteria used by each individual included study.  
As an additional measure considered, the timing definitions for acute and chronic closed 
lock stages in the studies included were also examined and retrieved. 
4.3.3 Search methods for identification of studies   
Electronic searches 
A systematic search until August 2013 was conducted in Medline database via Ovid. 
The Medline search strategy is described in Table 4.1. In addition, Google Scholar was 
also searched using ‘disc displacement without reduction’ and ‘closed lock’ keywords. 
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Ovid Medline(R) <1946 to August Week 1 2013> 
1. exp Temporomandibular Joint disorders/   
2. exp Temporomandibular Joint/ 
3. 1 or 2 
4. (lock$ adj2 (closed or jaw)).tw. 
5. ((displace$ without or dislocat$ without or unreduc$ or nonreduc$ or un-
reduc$ or non-reduc$ or derange$ without) adj6 (disc or disk or 
meniscus)).tw. 
6. 4 or 5 
7. 3 and 6 
8. limit 7 to (English language and humans)  
9. limit 8 to "review articles" 
10. 8 not 9 
Table 4.1: Medline search strategy. 
Manual searches 
To identify any additional studies, other sources were manually-searched including the 
reference lists of the included studies and the reference lists of the relevant review 
articles. 
Search limits 
English language, Peer reviewed publications.  
4.3.4 Data collection and extraction 
Selection of studies  
Eligible studies were selected by the research student according to the 
inclusion/exclusion criteria based on the title and abstract (when available) with those 
identified as clearly irrelevant from their title/abstract were excluded. The full-texts of 
all potentially eligible studies were then retrieved and examined. Throughout the 
selection process, any doubt about a study’s inclusion meant it was examined by one of 
the supervisors (JD) and the decision to include or exclude the study was made by 
discussion with the student to reach a consensus. All studies met the inclusion criteria 
then underwent data extraction and quality assessment. 
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Data extraction and management  
A standardised table was used by the student to extract and record data from the studies 
included. The information extracted from each included study involved details about the 
following: 
 Study design 
 Participant characteristics (sample size, diagnosis, age, gender, and locking 
duration)  
 Intervention 
 Follow-up period 
 Study success criteria 
 Study findings in relation to locking duration 
 Success rate 
 Timing definitions for acute and chronic closed lock stages (if stated). 
To ensure reliability, one of the supervisors (JD) crosschecked the validity of all 
extracted data. The data on duration of symptoms, follow-up period, and ACL-CCL 
timings were standardised in months and the data for the successful pain reduction 
outcome measured on 0-10 cm scale were standardised, when possible, to 0-100 mm 
scale. If not provided, the mean of the patients’ age and locking duration was calculated 
from the raw data using the Statistical Package for the Social Sciences (IBM SPSS 
statistical package v.19 for windows). 
Quality assessment of included studies   
Given the wide diversity in the design of the studies expected to be included in this 
review, the quality of included studies was assessed according to study design using the 
National Health and Medical Research Council (NHMRC) level of evidence guidelines 
for intervention trials (NHMRC, 2013) with slight modification. The studies were 
assessed independently by the student and one of the supervisors (JD) and the level of 
evidence in each study was judged by its design as: (I) highest, (II-1), (II-2), (III-1), (III-
2), (III-3), or (IV) lowest as detailed in Table 4.2. Any disagreements concerning the 
assessment were resolved by discussion to reach a consensus. All data on studies’ 
quality were summarised in the standardised table. 
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Level of 
evidence 
Study design 
I 
Evidence obtained from a systematic review of all relevant randomised 
controlled trials. 
II-1 
Evidence obtained from at least one properly-designed randomised 
controlled trial. 
II-2 
Evidence obtained from at least one poorly-designed randomised 
controlled trial. 
III-1 
Evidence obtained from well-designed pseudo-randomised controlled trials 
(alternate allocation or some other method of quasi-randomisation). 
III-2 
Evidence obtained from comparative studies (including systematic reviews 
of such studies) with concurrent controls and allocation not randomised, 
cohort studies, case-control studies, or interrupted time series with a 
control group. 
III-3 
Evidence obtained from comparative studies with historical control, two or 
more single arm studies, or interrupted time series without a parallel 
control group. 
IV Evidence obtained from case series, either post-test or pre-test/post-test. 
Table 4.2: A designation of levels of evidence. Modified from NHMRC (2013). 
Data analysis 
The included studies were grouped according to main treatment components of each 
therapeutic modality. Given the substantial heterogeneity among studies, the 
interventions’ success rates in relation to locking duration were summarised and 
tabulated by each individual study and the data were integrated in a narrative synthesis 
of the main findings from the included studies with a descriptive analysis only. 
4.4 Results  
4.4.1 Search results  
A total of 630 records were identified from electronic and manual searches (426 from 
Medline and 204 from other sources). Of these, 399 records were found potentially 
eligible and their full-texts were retrieved and examined. Ultimately, 117 studies of 126 
reports met the review inclusion criteria. The study flow diagram is demonstrated in 
Figure 4.1. 
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Figure 4.1: Study flow diagram.  Adapted from PRISMA 2009 flow diagram (Moher et 
al., 2009). 
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4.4.2 Description of included studies 
One-hundred seventeen studies of 126 reports met the review inclusion criteria 
(Appendix A). 
Characteristics of study design 
Most of the studies included in this review were non-comparative trials (37 studies), 
case series (33 studies), and case reports (20 studies) whilst only few were comparative 
trials (10 studies), and randomised clinical trials (17 studies).  
The studies were published between 1986 and 2013. Many studies included had a 
follow-up publication or an overlap published report for the conducted trial. The period 
of follow-up in the included studies varied considerably, ranging from 10 minutes only 
(Yoshida et al., 2011) to 13 years (Ozkan et al., 2012). 
Characteristics of participants 
More than 6000 participants were included in this review. The sample size of the 
included studies ranged from 1 participant in the case reports to 1506 participants in one 
retrospective study (Zhang et al., 2009a). Whilst most of the included studies involved 
participants with DDwoR, eight of the studies involved participants with ADP (N=260) 
(Nitzan et al., 1991b; Nitzan, 1994; Dimitroulis et al., 1995a; Nitzan et al., 1997; 
Casares et al., 1999; Dhaif and Ali, 2001; Sanroman, 2004; Kaneyama et al., 2007b). 
The majority of participants were females (~86%) resulting in a 6:1 female to male 
ratio. The age of the participants among all studies ranged from 11 to 77 years (mean 
patients’ age across studies ranged from 20 to 47 years). Data on duration of CL 
symptoms among all studies ranged from 1 day to 37 years (mean locking duration 
across studies ranged from 2 weeks to 5 years). 
Characteristics of interventions 
For the purpose of this systematic review, the reviewed therapeutic interventions were 
defined according to their main treatment components as follows: mandibular 
manipulation (MM), self-management (SM), physiotherapy (PT), splint therapy, 
combination conservative therapy, arthrocentesis (AC), arthroscopy (AS), and open 
surgery (OS). A detailed description of each intervention is shown in Table 4.3. 
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Intervention  Description  
Mandibular 
manipulation (MM) 
 Unlock manipulation (UM): any manual manipulation 
technique used to restore the displaced disc into its 
normal anatomical position. 
 Pumping manipulation (PM): any adjunctive technique 
used to inflate the joint space by joint space pumping 
and hydraulic pressure to assist the manipulation in 
recapturing the displaced disc. 
Self-management 
(SM) 
Any self-management programmes involving self-care 
instructions + medications (over-the-counter analgesics, 
muscle relaxants, NSAIDs) ± self-exercises. 
Physiotherapy (PT)  Any active or passive jaw stretching ‘repeated’ 
exercises. 
 Any other physiotherapies such as: ultrasound therapy, 
short wave diathermy, iontophoresis, transcutaneous 
electric nerve stimulation (TENS), pulsed 
electromagnetic fields (PEMF), or low level laser 
therapy (LLT). 
Splint therapy Any type of splint such as: stabilization splint (SS), anterior 
repositioning splint (ARS), pivot splint (PS), and soft 
splint. 
Combination therapy Any splint plus physiotherapy ± self-management. 
Arthrocentesis (AC) Any technique using needles and injections for joint 
washing and lavage inside the superior joint space. 
Arthroscopy (AS) Any technique using an arthroscope for joint hydraulic 
pumping and lavage and/or any other operative arthroscopic 
operations inside the superior joint space. 
Open surgery (OS) Any procedure using a skin incision to approach the TMJ 
such as discoplasty, discectomy, eminectomy, or 
condylectomy. 
Table 4.3: Description of reviewed interventions. 
Characteristics of outcomes 
Different objective and subjective outcome measures were assessed in the included 
studies such as pain intensity and mandibular movements and function. The majority of 
the included studies considered reduction in pain intensity, usually assessed by the 
visual analogue scale (VAS), and improvement in mouth opening, commonly measured 
using a millimetre ruler, as criteria for success of therapeutic interventions. However, 
the threshold points for the success criteria of these two outcomes differed widely 
across the studies. For pain outcome, the level of pain intensity on 0-100 scale regarded 
as ‘successful’ was: < 20, ≤ 30, ≤ 33, ≤ 40, or pain reduction ≥ 30%, ≥ 50%, or ≥ 85%. 
For mouth opening outcome, the degree of MMO in millimetres (mm) regarded as 
‘successful’ was: ≥ 30 mm, ≥ 35 mm, ≥ 36 mm, ≥ 38 mm, or ≥ 40 mm. 
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4.4.3 Quality of included studies  
The majority of the included studies had methodological weaknesses in their design. 
Specifically, most studies were either uncontrolled studies or incompletely controlled 
the other prognostic factors that might influence the outcome of treatment. Most studies, 
therefore, were assessed as poor-quality and the level of evidence was generally of a 
low grade (III-IV). 
Further details about the characteristics and quality of all the included studies are 
tabulated and summarised in Appendix A. 
4.4.4 Effects of interventions in relation to closed lock duration 
Preliminary synthesis of findings of included studies 
Multiple conservative and surgical treatment modalities were used in the included 
studies. The interventions identified were grouped according to their main treatment 
components into eight treatments: mandibular manipulation (unlocking or pumping 
MM), self-management (SM), physiotherapy (PT), splint therapy, combination therapy 
of splint + PT ± SM, arthrocentesis (AC), arthroscopy (AS), and open surgery (OS). To 
investigate the effects of these interventions in relation to locking duration, the included 
studies were tabulated and summarised in Appendix A. The success rates of 
interventions provided in Appendix A are based on the success criteria used by each 
individual study. Consequently, the definition of success was highly variable involving 
both objective and subjective outcomes with the most frequent measures of ‘success’ 
being degree of mouth opening and level of pain intensity.  
 
 
 
 
137 
 
Summary of main results 
The main findings of intervention effects in relation to locking duration are summarised 
according to the treatment components of each therapeutic modality in Table 4.4 and 
discussed further below. 
Treatment Modality 
No. of 
studies* 
Locking 
duration 
(months) 
Overall  
success rate % 
Overall  
evidence 
quality 
Mean (range) Mean (range) 
‘Unlock’ manipulation 20 9 (0.03­180)  68% (9%­100%) III­IV 
Pumping manipulation 8 7 (0.07­120)  66% (45%­100%) III­IV 
Self­management (SM) 7 ­ (0.5­25) 66% (60%­72%) III­IV 
Physiotherapy (PT) 2 weeks to years ­ II­III 
Splint therapy 12 16 (0.25­192)  60% (13%­100%) III­IV 
Combination therapy 
(Splint + PT ± SM)  
11 10 (­) 84% (71%­100%) III­IV 
Arthrocentesis (AC) 36 10 (0.03­109)  73% (22%­100%) III­IV 
Arthroscopy (AS) 32 19 (0.25­163)  79% (50%­100%) III­IV 
Open surgery (OS) 8 22 (0.5­150)  86% (70%­100%) III­IV 
* Some studies compared between different treatment modalities and, therefore, incorporated more than 
once. 
Table 4.4: Summary of findings for the effects of locking duration on the success of 
interventions used for TMJ CL management. 
Mandibular manipulation (MM) 
The studies used either manipulation only or manipulation assisted by hydraulic 
pumping to ‘unlock’ the jaw. Twenty included studies used unlock manipulation (UM) 
on DDwoR patients with a mean locking duration of 9 months (range: 0.03-180 months) 
with a variable success rate ranging from 9% to 100% (mean: 68%). Pumping 
manipulation (PM) was used in eight studies on DDwoR patients with a mean locking 
duration of 7 months (range: 0.07-120 months) with a comparable success rate (mean: 
66%) to UM.  
The included studies applied different manipulation techniques on DDwoR patients. 
The most commonly applied technique was Farrar’s manipulation (Figure 2.8) (Farrar, 
1978) and the most commonly used splint after recapturing the displaced disc was the 
anterior repositioning splint (ARS). Among all the manipulation studies included, only 
nine studies used post-manipulation imaging to assess disc recapturing with a variable 
success rate ranging from 4% to 100% (mean: 44%). 
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Self-management (SM) and physiotherapeutic (PT) interventions  
Seven studies used a self-management treatment strategy consisting of education, self-
care instructions, self-exercises, and medications on DDwoR patients with a locking 
duration ranging from 0.5 to 25 months with a mean success rate of 66% (range: 60%-
72%). Only two studies used the jaw stretching exercises by physiotherapists as the sole 
treatment on DDwoR patients with locking duration ranging from several weeks to 
several years with a ‘high’ success rate. 
Splint therapy 
Occlusal splints were either used as a sole treatment or as an adjunct to other 
interventions in DDwoR management. Twelve studies used different types of splints as 
a sole treatment with DDwoR patients. These studies’ sample had a mean locking 
duration of 16 months (range: 0.25-192) and a variable success rate ranging from 13% 
to 100% (mean: 60%). Eleven studies used splints adjunctively with other conservative 
interventions on DDwoR patients with a mean locking duration of 10 months with a 
mean success rate of 84% (range: 71%-100%).  
Arthrocentesis (AC)  
Thirty-six included studies used arthrocentesis and lavage on CL patients with a mean 
locking duration of 10 months (range: 0.03-109 months) with a mean success rate of 
73% (range: 22%-100%). The arthrocentesis success rate, however, was higher in ADP 
(91%) than DDwoR (65%) studies.  
Arthroscopy (AS) 
Arthroscopic surgery was used in thirty-two included studies on CL patients with a 
mean locking duration of 19 months (range: 0.25-163 months) with a success rate 
ranging from 50% to 100% (mean: 79%).  
Open surgery (OS) 
Eight included studies used open joint surgery on CL patients with a mean locking 
duration of 22 months (range: 0.5-150 months) with a mean success rate of 86% (range: 
70%-100%).  
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4.4.5 Acute and chronic closed lock timing definitions 
Among the included studies, only 22 studies define the acute or chronic CL stages of 
their sample. There was, however, considerable variation in the threshold that defines 
acute and chronic stages of CL among these studies ranging from 1 to 9 months. The 
variability in studies’ timing for acute and chronic CL stages according to locking 
duration is shown in Table 4.5. 
Locking 
duration 
Timing of Acute-
Chronic CL stages 
Study 
1 month 
ACL ≤ 1 mo 
CCL > 1 mo 
Yuasa et al. (2001); Sembronio et al. (2008b); 
Saitoa et al. (2010); Ghanem (2011) 
1.5-2 
months 
ACL ≤ 1.5-2 mo 
CCL > 1.5 mo 
Van Dyke and Goldman (1990); Dimitroulis 
(2002) 
2 months 
ACL < 2 mo 
CCL ≥ 2 mo 
Nadler (1988); Ozawa et al. (1996); Holmlund 
et al. (2001); Hamada et al. (2005) 
3 months CCL > 3 mo Kumagai et al. (2010)  
4 months 
ACL < 4 mo 
CCL ≥ 4 mo 
Ness (1996); Casares et al. (1999) 
3-6 months 
ACL < 3 mo,  
Sub-ACL = 3–6 mo 
CCL > 6 mo 
Stiesch-Scholz et al. (2002b) 
6 months 
ACL < 6 mo 
CCL ≥ 6 mo 
Kuwahara et al. (1990); Murakami et al. 
(1995); Hosaka et al. (1996); Emshoff and 
Rudisch (2004); Emshoff (2005); Politi et al. 
(2007); Schiffman et al. (2007) 
3-9 months 
Sub-ACL = 3–9 mo 
CCL > 9 mo 
Clark et al. (1991) 
Table 4.5: Summary of studies’ timing for acute and chronic closed lock stages 
according to duration of locking.
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4.5 Discussion  
4.5.1 Summary of main findings   
The main aim of this systematic review was to investigate the effects of locking 
duration on CL management outcome rather than to investigate the therapeutic 
effectiveness of interventions used for DDwoR management, which will be examined in 
the next chapter (Chapter 5). In this systematic review, therefore, 117 CL studies of 
different designs were included.  
The studies were grouped on the basis of main treatment modality. Despite this 
grouping, there was considerable heterogeneity among the studies included. This 
heterogeneity, however, was anticipated from the wide inclusion criteria of this 
systematic review, and was attributed to substantial variations in: study design, 
diagnostic and inclusion criteria, participants’ characteristics, interventions’ delivery, 
techniques and their combinations, outcomes measures, success criteria, and follow-up 
periods.  
Given the clinical and/or methodological heterogeneity of studies included, the main 
findings were summarised by each individual study in Appendix A. Although the 
success rates of interventions provided in Appendix A were based on the success 
criteria used by each study, most conservative and surgical interventions had 
‘acceptable’ success rates in managing acute and chronic closed lock. Nevertheless, 
there were only very few studies that used clear and robust criteria in an attempt to 
examine treatment effects in relation to duration of symptoms of their sample. 
Consequently, this permitted only the possibility to examine the ‘success’ of a wide 
variety of interventions targeting many different putative predictive factors, in which the 
locking duration constitutes only one factor amongst all the potential prognostic factors. 
In the studies included, numerous predictors other than locking duration and treatment 
type, frequency, and period were suggested, including: age, gender, level of pain, range 
of mandibular movements, parafunctional habits (clenching or bruxism), disc mobility, 
disc displacement direction and severity, joint inflammation, and stage and degree of 
intra-articular morphological and pathological changes in condyle-disc complex. 
Despite the proposed effects of these factors on CL management, it is still unclear if any 
of the suggested prognostic factors can predict the outcome of CL treatment because 
most studies had the shortcoming of not controlling the other predictors that may have 
141 
 
potential influence on treatment outcome. Amongst all the predictors suggested, only a 
few can be easily accessed via standard history and/or clinical examination such as 
patient’s age, joint pain, mouth opening, locking duration, and parafunctional habits 
whereas others require more advanced imaging (e.g., MRI) or investigations (e.g., 
arthroscopy) to be addressed such as intra-articular adhesion, joint effusion, and 
cartilage and/or osseous changes. Duration of locking is very simply estimated by self-
report, although the accuracy of patient’s report may be influenced by several factors 
including recall bias. 
In fact, it is unlikely that a single prognostic factor determines successful outcome when 
managing the CL patients. This is because many of the suggested ‘prognostic’ 
biomedical factors can interrelate or interact with each other to a greater or lesser 
degree. To give an example, the severity of intra-articular pathological changes and the 
stage of intra-articular derangement or degenerative changes may increase with the age 
of the patient and/or the duration of locking. Besides that, there are still no significant 
data on the role psychosocial factors may have in predicting outcome in CL.  
At the moment, it should be accepted that several, as yet undefined, factors probably 
influence the outcome of CL management including not only the biomedical 
characteristics of the disorder but also the patients’ psychosocial phenotype (Bernstein 
and Gatchel, 2000; Phaik, 2006; Dougall et al., 2012; Mehalick et al., 2013; Bouloux et 
al., 2015). However, until there is a better understanding of these biopsychosocial 
factors, it seems entirely reasonable, within the ethos of modern medicine and 
consistent with the recent guidance on TMD management (Greene, 2010c), to avoid 
invasive surgical interventions in the initial phases of CL management.  
Overall, one of the findings from this systematic review was that all the conservative or 
surgical interventions reviewed achieved ‘acceptable’ success rates in managing both 
acute and chronic closed lock. Amongst these interventions, mandibular manipulation 
(MM) is the simplest, quickest, least costly, and most practical and realistic approach 
that can be attempted first in every CL patient as an initial diagnostic/therapeutic 
intervention at the first point of contact. There is also some initial evidence to support 
its efficacy in ‘early’ intervention for patients with DDwoR (Chapter 5). Similarly, there 
is some evidence in the orthopaedic literature that early spinal manipulation improves 
symptoms quickly in patients with mechanical disc herniation causing acute lower back 
pain of less than 6 weeks duration (Santilli et al., 2006; Kinkade, 2007). Therefore, 
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there is no reason for not adapting this ‘early’ management approach in mechanical 
TMJ disorders such as DDwoR. However, many research questions about this 
intervention remain unanswered and need to be clarified in future research (see 
Implications for future research in Chapter 8), one of these questions is: How long the 
time period that the manipulation can be attempted to achieve ‘successful’ outcome of 
TMJ disc recapturing on post-manipulation MRI? In this review, the time-span from 
initiation of CL that allows disc ‘repositioning’, as assessed by post-manipulation TMJ 
imaging investigation, could not be determined. Nonetheless, many studies in this 
review showed that the MM can be effective in achieving the successful outcome of 
improving the clinical symptoms of DDwoR patients (i.e., increasing opening and 
decreasing pain) without necessarily recapturing the displaced disc. Similarly, spinal 
manipulation has been shown to improve patients’ symptoms even when disc position 
appears unchanged at follow-up (Santilli et al., 2006). In fact, TMJ manipulation as a 
treatment modality can aid both diagnosis and treatment and is unlikely to have adverse 
effects. There are, therefore, few significant contraindications to justify postponement 
of attempting to treat TMJ DDwoR initially through this simple approach. 
Another interesting finding in this review was the considerable controversy in the 
definition of acute and chronic CL stages in relation to locking duration. This 
controversy may be attributed to variations in effectiveness of treatments and authors’ 
findings in their studies due to varying levels of chronicity in their sample. In other 
words, the progression from ACL to CCL is probably one of the potential reasons for 
confusing outcomes reported in the literature around CL management. In this review, 
some of the clinical trials involving patients with DDwoR defined their samples into 
ACL and CCL based on the chronicity of DDwoR (i.e., locking duration or time since 
DDwoR onset). The most reliable diagnostic criteria for DDwoR (Dworkin and 
LeResche, 1992; Schiffman et al., 2014a), however, depend mainly on the patients’ 
signs and symptoms rather than the duration of symptoms in order to classify acute 
versus chronic DDwoR. Actually, a more appropriate clinical classification of acute and 
chronic DDwoR can be based on the time-scale for the possibility of recapturing the 
displaced disc into its normal anatomical position (i.e., from DDwoR to DDwR) with a 
non-invasive intervention. In this review, however, the transition point from acute to 
chronic CL stage and its implications on ‘early’ management could not be identified and 
needs further investigation. Similarly, the effects of locking duration on CL treatment 
outcomes remain unproven and need to be investigated in future research. 
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4.5.2 Overall completeness and applicability of evidence   
The majority of studies included in this review were uncontrolled and did not examine 
the potential effect of placebo and/or the possible resolution of CL symptoms over time 
(Greene et al., 2009; Yura, 2012). More importantly, only very few studies attempted, 
with adequate statistical power, to analyse the treatment effects according to duration of 
symptoms on a large sample size. Similarly, very few studies took in consideration the 
other potential prognostic factors, whether biomedical or psychosocial, that can 
influence the treatment outcome. All these shortcomings made it difficult to establish 
the ‘real’ effect of locking duration on CL treatment outcome. In this review, therefore, 
the evidence for the effects of locking duration on treatment outcome was contradictory 
and inconsistent. This may suggest that the degree of intra-articular pathological 
changes is more influential than the locking duration on CL treatment outcome but this, 
currently, cannot be established.  
4.5.3 Quality of the evidence   
The level of evidence in this review was of a low grade (III-IV) because the included 
studies were too heterogeneous and most were uncontrolled poor-quality studies. This 
suggests the need for better quality evidence to understand the effects of locking 
duration on closed lock management outcomes.  
In this review, however, the quality assessment of the included studies was based solely 
on study design. Despite this was a suitable way to summarise the studies according to 
their designs (NHMRC, 2013), it did not totally illustrate the strength of the evidence as 
the study design is only one of numerous components contributing to evidence strength.  
4.5.4 Potential biases in the review process   
This review, to the best of the research team’s knowledge, is the first comprehensive 
and systematic review that has investigated the effects of locking duration on CL 
treatment outcome. There were, however, some limitations in the review process related 
mainly to the review’s wide inclusion criteria and possibility of publications and 
language biases.  
The decision to include all the CL studies reporting the locking duration in their sample 
was made because the main aim of this systematic review was to investigate if there is 
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any relationship between locking duration and CL treatment outcome. To achieve this 
aim, however, a systematic search was conducted in only one database for English 
language publications. Searching multiple databases without language restrictions 
would help in the future to overcome these potential biases. Furthermore, there were a 
large number of CL studies that were initially identified but they did not report the 
duration of symptoms in their study sample and, therefore, were excluded. Similarly, 
many surgical trials included CL patients’ not-responding to conservative interventions 
for several months (i.e., CCL) but they did not specify the exact duration of symptoms 
in their study sample and were also excluded. In addition, it should also be taken into 
consideration that the duration of locking data extracted from studies included may not 
be precise because they rely on the accuracy of the data reported by the patients with 
potential recall bias. Nevertheless, the large number of studies included in this review 
lessens the effects of these biases as the studies encompassed different treatment 
modalities representing a wide variety of interventions used for acute and chronic CL 
management.  
4.6 Conclusions  
The objectives of this systematic review were to assess the effects of duration of locking 
on the success of therapeutic interventions used in closed lock and to define the acute 
and chronic CL stages. In this review, all the reviewed interventions, whether 
conservative or surgical, achieved ‘acceptable’ success rates in managing both acute and 
chronic closed lock. Therefore, neither the transition point from acute to chronic CL 
stage nor the effects of locking duration on treatment outcome/success could be 
determined in this review and, hence, remained controversial. The studies included, 
however, were too heterogeneous and most were of poor-quality suggesting the need for 
better quality studies to understand the effects of locking duration on closed lock 
management outcomes. Until having a better understanding, management of patients 
with closed lock should be started initially with the simplest, cheapest, quickest, and 
most practical first diagnostic and treatment approach for this condition at the earliest 
given opportunity in the patient’s healthcare journey. This intervention based on current 
evidence would seem to be mandibular manipulation. 
The evidence from this review, however, was generally of a low grade because it was 
based mostly on uncontrolled studies. To identify the best available evidence for the 
clinical effectiveness of therapeutic interventions used for DDwoR management, a 
145 
 
systematic review on randomised controlled trials for DDwoR management is needed. 
This will be explored in the next chapter (Chapter 5). 
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Chapter 5. Effects of Therapeutic Interventions for the Management of 
TMJ Disc Displacement without Reduction: A Systematic Review 
5.1 Introduction 
Disc displacement without reduction (DDwoR) disorder as an advanced intra-articular 
biomechanical disorder is often associated with significant ‘painful locking’ symptoms 
(Okeson, 2007). In clinical practice, therefore, a wide variety of conservative and 
surgical treatment options have been suggested and used in an attempt to alleviate 
symptoms of patients with DDwoR. The necessity to identify the true effects of these 
interventions is crucial since to-date there is insufficient evidence to justify the use of 
many of them.  
5.1.1 Contradictory confusing evidence of therapeutic interventions effects 
In the literature, a plethora of studies have investigated the therapeutic effects of various 
conservative and surgical interventions for DDwoR but most, if not all, claim ‘success’. 
This may have led to the multitude of conflicting opinions among authorities on how 
and when to manage DDwoR: conservatively, because it has a natural remitting course 
and, therefore, may need only to enhance the adaptive/healing process (de Leeuw et al., 
1994; Look et al., 2014), or surgically because it is intuitively a mechanical problem, 
and, therefore, may need to intervene early by a manipulative/surgical ‘mechanistic’ 
solution to improve symptoms ‘quickly’ (Sembronio et al., 2008b; Murakami, 2014). 
The contradictions in the evidence base for DDwoR management also occur within each 
group of conservative and surgical interventions with opinions divided over the role of 
physiotherapy (Nitzan et al., 1997; Kurita et al., 1999; Nicolakis et al., 2001; Yuasa et 
al., 2001; Stiesch-Scholz et al., 2002a; Haketa et al., 2010; Craane et al., 2012b), splint 
therapy (Lundh et al., 1992; Linde et al., 1995; Sato et al., 1995; Stiesch-Scholz et al., 
2002b; Minakuchi et al., 2004; Stiesch-Scholz et al., 2005), or use of adjunctive 
medication in arthrocentesis or arthroscopy (Alpaslan and Alpaslan, 2001; Aktas et al., 
2010a; Sipahi et al., 2015). When treating patients with DDwoR, however, the 
mechanism of natural improvement in DDwoR signs and symptoms (Chapter 2, Section 
2.2.5) must always be taken in consideration before evaluating the actual therapeutic 
effect of a particular intervention. 
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5.1.2 Why it is important to identify the therapeutic effects of these interventions? 
In terms of clinical decision-making in the management of DDwoR, the competing 
concepts and diverse opinions in the literature may increase the degree of uncertainty in 
the therapeutic decision-making process among clinicians. This therapeutic decision-
making is dependent on evidence quality (Gordon and Dionne, 2005). The lack of 
evidence on the most appropriate treatment for DDwoR may lead the management to be 
based more on experience than evidence (Durham et al., 2007). In clinical practice, the 
variation in the management of DDwoR, may result in subjective decisions which may 
decrease the probability of making optimal therapeutic risk-benefit and/or cost-benefit 
decisions. As a consequence, patients may receive unnecessary investigations which 
delays their active management or may not receive the most appropriate treatment with 
the possibility of receiving unnecessary or even harmful treatment not supported by 
scientific evidence being applied. 
One solution to overcome this problematic controversial issue is by applying the 
concept of ‘evidence-based management’. Conti et al. (2003) stated that “the concept of 
Evidence Based Dentistry (EBD) must always guide clinical procedures, especially in a 
field where invasive and irreversible procedures with poor scientific evidence 
historically comprised standard management strategies”. As seen in the previous 
chapter, different interventions of varying levels of invasiveness have been used for 
managing patients with DDwoR. Their clinical effectiveness, however, remains unclear. 
From the previous chapter (Chapter 4), there are some indications for the need to 
intervene initially by non-invasive conservative interventions. However, the most 
efficacious/effective approach is still unclear and needs to be clarified based on up-to-
date best available evidence in order to optimise patients’ healthcare and avoid any 
harmful or unnecessary treatment. 
5.2 Aim 
The aim of this systematic review was to investigate the effects of different conservative 
(non-surgical) and surgical therapeutic interventions used for the management of 
patients with DDwoR. 
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5.3 Methods 
5.3.1 Study design 
Systematic review. 
5.3.2 Protocol and registration 
This systematic review was conducted in accordance with the guidance of Cochrane 
Collaboration (Higgins and Green, 2011) and Centre for Reviews and Dissemination 
(CRD) (Akers et al., 2009), and is reported according to the Preferred Reporting Items 
for Systematic Reviews and Meta-Analyses (PRISMA) statement (Moher et al., 2009). 
The student was trained by attending a course in Cochrane systematic review methods. 
The review protocol was peer-reviewed by two TMD experts and registered at the 
international Prospective Register of Systematic Reviews (PROSPERO) database and, 
therefore, all the methods of inclusion/exclusion criteria and data collection/analysis 
were pre-specified and documented in advance. The protocol is available in Appendix B 
(Al-Baghdadi et al., 2012). 
5.3.3 Criteria for considering studies 
The criteria for considering studies followed the PICOS criteria. A summary table for 
the inclusion/exclusion criteria is available in Appendix C. 
Types of studies   
Inclusion criteria 
Randomised clinical trials (RCTs) involving patients with TMJ DDwoR and comparing 
any form of conservative or surgical interventions against each other, placebo or no 
treatment were considered. Quasi-randomised clinical trials (qRCTs), such as those 
allocated patients by using alternate days of the week, birth date, or consecutive 
attendance were considered only if the baseline demographic details (e.g., severity of 
condition) of each comparable group were approximately similar. 
Studies involving other heterogeneous groups of TMD patients (e.g., DDwR, 
osteoarthritis, and myofascial pain) in addition to patients with DDwoR were 
considered if separate data for DDwoR patients were provided in the study. If separate 
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data were not provided but the percent of DDwoR patients in the study sample was 
more than 70%, the study was examined to be included. 
Exclusion criteria 
Studies comparing different types or techniques of the same treatment modality were 
excluded such as trials comparing different techniques of arthroscopy, different 
techniques of arthrocentesis, or those comparing different types of occlusal splints. In 
addition, studies evaluating interventions after an initial surgical modality such as trials 
evaluating different medications or splints after arthroscopy or arthrocentesis were also 
excluded. 
Types of participants   
Inclusion criteria 
Patients of any age, gender, and of all degree of severity with clinical and/or 
radiological diagnosis of DDwoR as diagnosed according to: AAOP criteria for acute or 
chronic DDwoR (de Leeuw, 2008); RDC/TMD (IIb or IIc) criteria for DDwoR 
with/without limited opening (Dworkin and LeResche, 1992); Wilkes early/late 
intermediate stages (III or IV) of internal derangement (Wilkes, 1989); or any other 
compatible criteria for DDwoR diagnosis (Table 2.5) were considered. Confirming the 
disc position by soft tissue imaging was not a prerequisite to include the study. 
Studies which involve participants with confirmed diagnosis of DDwoR disorder with 
comorbid disorders were also considered. 
Exclusion criteria 
DDwoR patients with systemic diseases were excluded. 
Types of interventions   
Inclusion criteria 
Different forms of conservative or surgical therapeutic interventions for DDwoR were 
considered. The control was any alternative intervention, placebo, or no treatment.  
The interventions were divided into different treatment modalities to be considered by 
their main treatment components such as: education, self-management, splint therapy, 
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physiotherapy, intra-articular injections, arthrocentesis, arthroscopic and open joint 
surgery. Studies that evaluate these groups of therapeutic interventions against each 
other, placebo or no treatment were included. Standardized combination of different 
treatments was also included.  
Types of outcome measures   
The main outcome measures considered were reduction in pain intensity and 
improvement of mouth opening. The outcomes were evaluated over short-term (≤ 3 
months) and long-term (> 3 months) follow-up periods according to the International 
Association for the Study of Pain’s definition of ‘chronic pain’ (Merskey and Bogduk, 
1994; Dworkin et al., 2011). 
 Primary outcomes 
The primary outcomes focus on the main clinical symptoms of DDwoR: 
 Pain (associated with the TMJs): patient assessed using any recognized validated 
pain scale (e.g., visual analogue scale ‘VAS’, numerical rating scale ‘NRS’, or 
multi-dimensional pain scale) either at rest or during jaw function (e.g., 
chewing). For this review, TMJ pain intensity during jaw function was 
considered as a primary outcome. 
 Maximum mouth opening (MMO): this is the inter-incisal distance on maximum 
mouth opening (preferably including vertical incisal overbite), which could be 
assessed using any suitable instrument such as ruler, caliper, kinesiograph either 
actively (the patients open their jaw themselves) or passively (the clinician 
opens the jaw of the patient). For this review, the quantitative measurement for 
active/unassisted maximum mouth opening (aMMO) outcome was considered as 
a primary outcome. 
 Secondary outcomes 
 Other mandibular movements: these include passive/assisted maximum mouth 
opening (pMMO), comfortable/painless maximum mouth opening (cMMO), 
laterusion, and protrusion, which could be assessed using any suitable 
instrument such as ruler, caliper, kinesiograph. 
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 Any self-assessed patient’s satisfaction, quality of life, or mandibular function 
evaluated with a validated questionnaire such as OHIP-TMD or mandibular 
function impairment questionnaire (MFIQ). 
 Operation/admission duration in studies involving surgical interventions: the 
operating time was recorded in minutes/hours and the duration of hospital 
admission was recorded in hours/days. 
 Costs of therapy: the currency was recorded in £ or $. 
 Adverse events: Any complications that happened during the therapy or 
thereafter were considered and their severity were examined. Some examples 
include: hypersensitivity or other adverse reactions to medications; post-
treatment complications of occlusal interventions; post-surgical complications. 
5.3.4 Search methods for identification of studies   
Electronic searches   
Four bibliographic databases were electronically-searched up to 1st November 2013: 
 Cochrane Central Register of Controlled Trials (CENTRAL) (via the Cochrane 
Library, November 2013 issue) 
 Medline via Ovid (1966-November 2013) 
 Embase via Ovid (1980-November 2013) 
 Scopus via SciVerse (1966-November 2013). 
Detailed search strategies were developed for each database in order to identify the 
studies to be included or considered for this review. The search strategies were 
developed primarily for the Medline and then revised appropriately for each database to 
take into account the differences in controlled vocabulary and syntax rules. A detailed 
description of Medline search strategy is shown in Table 5.1. 
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Ovid Medline (R) <1966 to October Week 4 2013> 
1. exp Temporomandibular Joint disorders/ 
2. exp Temporomandibular Joint/ 
3. 1 or 2 
4. (temporomandibular joint or tmj).tw. 
5. (derangement adj6 (disorder$ or condition$)).tw. 
6. (derangement adj2 internal).tw. 
7. (lock$ adj2 (closed or jaw)).tw. 
8. ((displace$ or dislocat$ or unreduc$ or nonreduc$ or un-reduc$ or non-reduc$ 
or derange$) adj6 (disc or disk or meniscus)).tw. 
9. or/4-8 
10. 3 and 9 
The above subject search was linked to the Cochrane Highly Sensitive Search 
Strategy (CHSSS) for identifying randomised controlled trials (RCTs) in MEDLINE: 
sensitivity maximising version (2008 revision) as referenced in Chapter 6.4.11.1 and 
detailed in box 6.4.c of the Cochrane Handbook for Systematic Reviews of 
Interventions version 5.1.0 (updated March 2011) (Lefebvre et al., 2011): 
1. randomized controlled trial.pt. 
2. controlled clinical trial.pt. 
3. randomized.ab. 
4. placebo.ab. 
5. drug therapy.fs. 
6. randomly.ab. 
7. trial.ab. 
8. groups.ab. 
9. or/1-8 
10. exp animals/ not humans.sh. 
11. 9 not 10 
Table 5.1: Medline search strategy. 
Manual searches 
Other sources were manually-searched to identify any additional studies including: 
citation search of included studies, reference lists of included studies, along with the 
reference lists of relevant review articles and textbooks’ chapters. In addition, the 
following journals were identified as being potentially important to be hand-searched 
for this review as they were highly likely journals to contain relevant studies to the 
review topic: 
1. Journal of Oral and Maxillofacial Surgery (from 2010 to October 2012). 
2. Cranio: Journal of Craniomandibular Practise, currently Journal of 
Craniomandibular & Sleep Practice (from 1996 to October 2012). 
3. Journal of Prosthetic Dentistry (from 1999 to September 2012). 
4. Journal of Oral Rehabilitation (from 2004 to October 2012). 
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5. Journal of Orofacial Pain, currently Journal of Oral & Facial Pain and Headache 
(from 1987 to December 2012). 
6. Oral Surgery, Oral Medicine, Oral Pathology, and Oral Radiology (from 2004 to 
February 2012). 
7. International Journal of Oral & Maxillofacial Surgery (from 2003 to October 
2012). 
The tables of contents in these journals, including the journals’ list of future 
publications, were hand-searched by the student to identify eligible studies from their 
title/abstract. All the journals were hand-searched according to dates not already have 
been hand-searched as part of the Cochrane worldwide hand-searching programme (i.e., 
according to Master List of journals completed search by the Cochrane Oral Health 
Group up to October 2012). 
Personal contact 
All the authors of eligible studies were contacted by electronic mail and asked for 
clarification and missing data as necessary. 
Search limits 
English language, Peer reviewed publications. Conference proceedings and abstracts 
were not included in this review. 
5.3.5 Data collection and analysis   
Data collection and analysis was performed in accordance with the Cochrane 
Collaboration guidelines using the review manager software (V. 5.2) (RevMan, 2012). 
Selection of studies   
Eligible studies were selected by the student according to the inclusion/exclusion 
criteria based on the title and abstract (when available) of all reports identified through 
the electronic and manual searches. Clearly irrelevant reports were identified by their 
title/abstract and were excluded by the student. If it is unclear whether a study should be 
included the full-text was consulted. The full-texts of all potentially eligible studies 
were then retrieved and independently examined in-duplicate by the student and one of 
the supervisors (JD) to establish eligibility. To ensure reliability, blinding procedures 
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were used for the supervisor (JD) regarding the author’s names, institutions, and/or 
journal. Disagreements about inclusion/exclusion between the two were resolved 
through discussion to reach consensus or, when necessary, by discussion with another 
supervisor (JS) to reach consensus. All studies that met the inclusion criteria were then 
underwent quality assessment and data extraction. Studies excluded at this stage or 
subsequent stages were identified and the reasons for exclusion were recorded in the 
“characteristics of excluded studies” table. 
Data extraction and management   
Data extraction was informed by the standard extraction strategies set out in the 
Cochrane Handbook for Systematic Reviews of Interventions and study details were 
entered into the “characteristics of included studies table”. A standardised, pre-piloted 
form based on Cochrane recommendations was used to extract data from the included 
studies. The extraction form is available in Appendix D. In brief, the information 
extracted from each included study involved details about the following: 
 Trial methods 
 Participant characteristics 
 Interventions 
 Control 
 Outcomes 
 Results 
 Authors’ conclusions 
 Sources of funding and conflicts of interest (if stated). 
The data were extracted by the student and their validity was crosschecked by one of the 
supervisors (JD ‘blinded’). Any disagreements between the two were resolved through 
discussion to reach consensus or, when necessary, by discussion with another supervisor 
(JS) to reach consensus. Authors of the studies included were contacted via e-mail to 
clarify study design and/or request missing data as required.  
Assessment of risk of bias in included studies   
Before data analysis, the methodological quality of all studies included was appraised 
and assessed independently and in-duplicate by the student and one of the supervisors 
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(JD ‘blinded’) using the Cochrane risk of bias tool (Higgins et al., 2011a): random 
sequence, allocation concealment, blinding, incomplete data, selective reporting, and 
other potential sources of bias. Each domain in the tool was allocated one of the 
following judgments: low risk of bias, unclear risk of bias, or high risk of bias. 
Disagreements over the risk of bias in particular studies were resolved by discussion 
between the two to reach consensus or, when necessary, by discussion with another 
supervisor (JS) to reach consensus. All data on quality were tabulated and summarised 
appropriately. Sample size calculation for statistical power was also examined using 
G*3 Power statistical package (v. 3.1.7). 
Data analysis 
The main data analysis for this review was performed according to the Cochrane 
statistical guidelines (Higgins and Green, 2011) using Review Manager software (V. 
5.2) (RevMan, 2012) comparing between the effects of different interventions (i.e., 
between-group statistical differences). P value < 0.05 for between-group difference was 
considered statistically significant. 
Measures of treatment effect   
The estimates of effect of an intervention were expressed as risk ratios (RR) with 95% 
confidence intervals (CI) for dichotomous data, and as mean differences (MD) with 
95% CI for continuous data. 
Unit of analysis issues   
The units of primary outcomes (pain and MMO) were measured in millimetres. For 
uniformity, data were analysed and presented for pain intensity by rescaling the 0-10 cm 
VAS or NRS to 0-100 mm scale. 
Dealing with missing data   
The authors of the included studies were contacted to request missing data whenever 
possible. If the data were unobtainable, attempts were made (using SPSS ‘v. 22’ or 
Excel spread sheets ‘v. 14’) to calculate the missing data from the available reported 
data as suggested by the Cochrane handbook for dealing with missing data (Higgins et 
al., 2011b). The analyses involved the available/obtainable data but no statistical 
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methods were used to impute for missing continuous data related to withdrawals or 
drop-outs (i.e., attrition). 
Assessment of heterogeneity   
Clinical and statistical heterogeneities were assessed across the studies prior to pooling. 
Clinical heterogeneity was determined by examining the clinical characteristics of the 
included studies. This includes examining any clinical diversity or variation in: types of 
interventions (e.g., dosage, technique, and mode of delivery), severity/chronicity of 
condition (i.e., acute vs. chronic), and treatment outcomes (e.g., pain, MMO) in each 
study as these may have an effect on the intervention effect-size. Statistical 
heterogeneity was examined by Chi2 and I2 statistics (Higgins and Thompson, 2002). 
Substantial heterogeneity was considered to be present when there was a significant p 
value < 0.05 for Chi2 test and an I2 statistic > 50% (Deeks et al., 2011). 
Data synthesis and investigation of heterogeneity   
The included studies were grouped according to type of therapeutic interventions. 
Pooling of clinically and statistically homogeneous trials to provide estimates of the 
effects of the interventions was attempted. If there were two trials pooled, a fixed-effect 
model was used; but if there were more than two trials, a random-effects model was 
used. Meta-analysis was not undertaken when there was substantial heterogeneity 
among studies; instead, the review data were integrated in a narrative synthesis of the 
findings from the included studies structured around types of interventions with a 
descriptive analysis only. The available results for the outcomes of interest were 
tabulated if they could not be included in a proper meta-analysis. 
Assessment of reporting biases   
A test for funnel plot asymmetry to assess publication bias (Egger et al., 1997) was 
planned to be performed only if a sufficient number of included studies suitable for 
inclusion in a meta-analysis were identified. However, it was not performed due to 
insufficient numbers of studies pooled in the meta-analyses. 
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Subgroup analysis  
A subgroup analysis based on chronicity of closed lock condition (acute or chronic) was 
conducted when possible. The time-span from onset of DDwoR that allows disc 
‘recapture’ is probably the most suitable way for determination the transition time-point 
from acute to chronic closed lock. Although this was undetermined in the previous 
systematic review (Chapter 4), in this review, the threshold of acute DDwoR was 
estimated at a cut-off point of 1 month duration of locking as suggested in many 
previous studies (Sembronio et al., 2008b; Saitoa et al., 2010; Ghanem, 2011). This 
estimated period was also based on the ‘assumption’ that the disc may be less likely 
‘recapture’ after 1 month as suggested in the available literature (Farrar, 1978); although 
this requires further investigation to be proven. 
Sensitivity analysis   
A sensitivity analysis was performed, when appropriate, to demonstrate if there was any 
effect of the wide diagnostic inclusion criteria decision on primary outcomes in the 
meta-analyses. This was performed by excluding the trials that did not radiographically 
confirm DDwoR clinical diagnosis by soft tissue imaging. 
Additional analysis 
A supplementary data analysis was also performed by examining the change from 
baseline in primary outcomes for each individual intervention at short- and long-term 
follow-up periods (i.e., within-group statistical difference from baseline). If mean 
change and standard deviation (SD) for mean change was not reported in the studies, 
differences in means and SD for differences were calculated according to guidance in 
the literature (Cohen, 1988; Markiewicz et al., 2008; Fritz et al., 2012; Katsnelson et 
al., 2012) using an Excel sheet (v. 14). If within-group statistical difference (p value < 
0.05) from baseline was not reported in the studies, it was calculated by the paired t test 
for summarised data (mean differences) using the Minitab statistical package (v. 16). 
This separate analysis was performed to help better understand and interpret the 
potential clinical significance of improvement from baseline for the primary outcomes 
of each intervention. 
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5.4 Results 
5.4.1 Search results 
A total of 3333 records were identified from all databases. The search strategy identified 
3307 records from electronic searches (477 CENTRAL, 1347 Medline, 689 Embase, 
and 794 Scopus) which after removal of duplicates resulted in 2288 records. After the 
initial screening of the titles and abstracts of these records, 2116 records were excluded 
as irrelevant to the topic of this review. Full-text copies of potentially eligible papers 
were then retrieved and 26 additional reports were obtained through hand-searching 
other sources resulted in a total of 172 full-texts being reviewed. Of these, 86 were 
eliminated and excluded from further assessment for two main reasons: non-randomised 
trials or trials’ participants received no specific TMD diagnosis or other diagnosis than 
DDwoR. This left 86 potentially relevant studies which their full-text copies were re-
examined carefully and after close reading, 52 further studies (of 62 reports) were 
excluded for different reasons summarised in the characteristics of excluded studies’ 
table. Finally, 24 reports represented 20 studies met the review inclusion criteria. Figure 
5.1 illustrates the screening process.  
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Figure 5.1: Study flow diagram. Adapted from PRISMA 2009 flow diagram (Moher et 
al., 2009). 
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160 
 
5.4.2 Description of studies 
Included studies   
Twenty studies (of 24 reports) fulfilled the review inclusion criteria (Lundh et al., 1992; 
Petersson et al., 1994; Linde et al., 1995; Fridrich et al., 1996; Schiffman et al., 1996; 
Goudot et al., 2000; Holmlund et al., 2001; Minakuchi et al., 2001; Yuasa et al., 2001; 
Maloney et al., 2002; Yuasa et al., 2003; Minakuchi et al., 2004; Peroz et al., 2004; 
Yoshida et al., 2005a; Ismail et al., 2007; Politi et al., 2007; Schiffman et al., 2007; 
Diracoglu et al., 2009; Haketa et al., 2010; Yoshida et al., 2011; Craane et al., 2012a; 
Sahlstrom et al., 2013; Yoshida et al., 2013; Schiffman et al., 2014b). The 
characteristics of included studies are described below and summarised in the 
characteristics of included studies’ table available in Appendix E. 
Characteristics of trial design and setting 
Of the 20 trials, 19 had a randomised study design whilst one trial had a quasi-random 
study design (Diracoglu et al., 2009). Of the included trials, one trial had 4 parallel arms 
(Schiffman et al., 2007), four trials had 3 parallel arms (Schiffman et al., 1996; 
Minakuchi et al., 2001; Maloney et al., 2002), whilst the remaining trials had 2 parallel 
arms. Blinding was attempted in 11 trials at least in one step (Petersson et al., 1994; 
Schiffman et al., 1996; Minakuchi et al., 2001; Yuasa et al., 2001; Peroz et al., 2004; 
Schiffman et al., 2007; Diracoglu et al., 2009; Haketa et al., 2010; Craane et al., 2012a; 
Sahlstrom et al., 2013). 
Of the 20 included trials, five trials were conducted in Japan (Minakuchi et al., 2001; 
Yuasa et al., 2001; Yoshida et al., 2005a; Haketa et al., 2010; Yoshida et al., 2011), five 
in Sweden (Lundh et al., 1992; Petersson et al., 1994; Linde et al., 1995; Holmlund et 
al., 2001; Sahlstrom et al., 2013), four in the USA (Fridrich et al., 1996; Schiffman et 
al., 1996; Maloney et al., 2002; Schiffman et al., 2007), two trials in Germany (Peroz et 
al., 2004; Ismail et al., 2007), and one trial conducted each of Belgium (Craane et al., 
2012a), France (Goudot et al., 2000), Turkey (Diracoglu et al., 2009), and Italy (Politi 
et al., 2007). 
The included trials were published between 1992 and 2013, with 16 trials were 
published from 2000 onward. Four trials had a follow-up publication for the conducted 
trial (Yuasa et al., 2003; Minakuchi et al., 2004; Yoshida et al., 2013; Schiffman et al., 
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2014b). Eight of the trials received funding (Lundh et al., 1992; Petersson et al., 1994; 
Schiffman et al., 1996; Minakuchi et al., 2001; Maloney et al., 2002; Peroz et al., 2004; 
Schiffman et al., 2007; Haketa et al., 2010) and two trials did not (Craane et al., 2012a; 
Sahlstrom et al., 2013), whilst the remaining 10 trials did not report about funding. 
The period of follow-up in the included trials were ranged from 1 day to 5 years with 
just one trial conducted follow-up for 5 years (Schiffman et al., 2007). Twelve trials had 
withdrawals or loss to follow up (Petersson et al., 1994; Linde et al., 1995; Fridrich et 
al., 1996; Holmlund et al., 2001; Minakuchi et al., 2001; Yuasa et al., 2001; Peroz et 
al., 2004; Schiffman et al., 2007; Diracoglu et al., 2009; Haketa et al., 2010; Craane et 
al., 2012a; Sahlstrom et al., 2013), whilst 7 trials had no dropouts (Lundh et al., 1992; 
Schiffman et al., 1996; Goudot et al., 2000; Maloney et al., 2002; Politi et al., 2007; 
Yoshida et al., 2011), and one trial had unclear follow-up period and dropouts (Yoshida 
et al., 2005a). 
Characteristics of participants 
A total of 1305 participants were included in this review, of which, 1288 had a DDwoR 
diagnosis. The sample size of the included trials varied widely. The smallest trial had 19 
participants (N = 15 DDwoR) (Fridrich et al., 1996) and the largest had 305 participants 
(Yoshida et al., 2005a). While most of the included trials were conducted using a 
homogenous sample of DDwoR diagnosis, five of the included trials had heterogeneous 
samples. Of these 5 trials, separate data for DDwoR subgroup were obtained and/or 
extracted from 2 trials (Maloney et al., 2002; Peroz et al., 2004), whilst the other 3 trials 
had more than 70% DDwoR patients in their sample and, therefore, were included 
(Fridrich et al., 1996; Goudot et al., 2000; Ismail et al., 2007). 
The majority of participants were females (~86%) resulting in a 6:1 female to male 
ratio. The age of the participants ranged from 14 to 81 years (mean = 35 years). Data on 
duration of DDwoR symptoms were not always reported, but ranged from 1 day to 16 
years in the fifteen trials reporting data on duration of symptoms. According to 
‘estimated’ 1 month duration of locking cut-off point for acute-chronic DDwoR, six 
trials included patients with chronic DDwoR (Goudot et al., 2000; Holmlund et al., 
2001; Minakuchi et al., 2001; Peroz et al., 2004; Politi et al., 2007; Sahlstrom et al., 
2013), eight trials included acute-chronic mixed DDwoR patients (Linde et al., 1995; 
Yuasa et al., 2001; Yoshida et al., 2005a; Ismail et al., 2007; Schiffman et al., 2007; 
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Haketa et al., 2010; Yoshida et al., 2011; Craane et al., 2012a), whilst only one trial 
included exclusively acute DDwoR patients (Diracoglu et al., 2009). 
Five of the included trials reported using the RDC/TMD (Maloney et al., 2002; Peroz et 
al., 2004; Ismail et al., 2007; Craane et al., 2012a; Sahlstrom et al., 2013) whilst the 
remaining 15 trials recruited patients using criteria compatible with the RDC/TMD 
diagnosis for DDwoR. Of the included trials, 15 trials confirmed DDwoR clinical 
diagnosis by soft tissue imaging, specifically: 11 trials by MRI (Fridrich et al., 1996; 
Goudot et al., 2000; Minakuchi et al., 2001; Yuasa et al., 2001; Maloney et al., 2002; 
Ismail et al., 2007; Politi et al., 2007; Schiffman et al., 2007; Diracoglu et al., 2009; 
Haketa et al., 2010; Sahlstrom et al., 2013), 2 trials by MRI in some patients (Peroz et 
al., 2004; Craane et al., 2012a), and 2 trials by arthrography (Lundh et al., 1992; 
Petersson et al., 1994). 
Characteristics of interventions 
It was anticipated in advance in the review protocol (Appendix B) that a wide variety of 
interventions were being used for DDwoR management. Grouping the interventions to 
summarise the main findings related to each treatment modality used for DDwoR was 
necessary but it was difficult decision to make due to different combinations of 
interventions used, which differed sometimes from the pre-specified treatment grouping 
in the protocol. Nevertheless, for the purpose of this review, the treatment strategies of 
reviewed therapeutic interventions were classified into three levels of invasiveness 
involving different treatment modalities considered by their main treatment components 
as demonstrated in Table 5.2. 
Accordingly, twenty-one comparisons were made between different interventions as 
follows: 12 comparisons among non-invasive conservative interventions; 3 comparisons 
between minimally-invasive surgical interventions and non-invasive conservative 
interventions; 4 comparisons between invasive surgical interventions and non-invasive 
conservative interventions; 1 comparison between minimally-invasive and invasive 
surgical interventions; and 1 comparison among invasive surgical interventions. 
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Intervention Description  
1. Non-invasive Involves any conservative (non-surgical) interventions. 
 Patient education Includes information, explanation, and reassurance only. 
 Self-management Includes self-care instructions and advice plus 
pharmacotherapy (any topical or oral medication such as: 
over-the-counter analgesic, NSAIDS, muscle relaxants) ± 
self-exercises (home exercise programmes). 
 Splint therapy Includes different types of occlusal splints such as: 
stabilisation splints, repositioning splints, or soft splints. 
 Physiotherapy Includes different approaches of physical therapy such as: 
- Mandibular manipulation (MM): a ‘singular’ manual 
mandibular manipulation technique to ‘unlock’ the jaw 
and recapture the displaced disc (disc repositioning).   
- Jaw exercises: ‘repeated’ jaw ‘stretching’ exercises 
applied either by the patients themselves (home exercise 
programme ‘self-exercises’) or by clinicians (professional 
exercise therapy ‘active or passive jaw exercises’). 
- Other physiotherapeutic modalities: ultrasound therapy, 
short wave diathermy, iontophoresis, transcutaneous 
electric nerve stimulation (TENS), pulsed 
electromagnetic fields (PEMF), or low level laser therapy 
(LLT). 
 Combination 
therapy 
Includes splints plus jaw exercises ± (self-
care/medication/ education ± psychosocial ‘cognitive 
behavioural’ therapy ‘CBT’). 
2. Minimally-invasive Involves any intra-articular intervention by needles only. 
 Arthrocentesis A technique using needles and injections for joint 
hydraulic pumping and lavage inside the superior joint 
space. 
3. Invasive Involves any surgical interventions. 
 Arthroscopic 
surgery 
A technique using an arthroscope for joint hydraulic 
pumping and lavage and/or any other operative 
arthroscopic operations inside the superior joint space. 
 Open joint surgery A technique using a skin incision to approach the 
temporomandibular joint such as discoplasty, discectomy, 
eminectomy, or condylectomy. 
Table 5.2: Description of interventions. 
Characteristics of outcomes 
All bar one trial (Yoshida et al., 2011) considered pain intensity of the TMJ as an 
outcome and all bar two trials (Lundh et al., 1992; Schiffman et al., 2007) 
assessed/reported the mouth opening outcome whilst only 11 trials assessed the daily 
activity interference and/or jaw functional limitation (Fridrich et al., 1996; Schiffman et 
al., 1996; Holmlund et al., 2001; Minakuchi et al., 2001; Yuasa et al., 2001; Peroz et 
al., 2004; Politi et al., 2007; Schiffman et al., 2007; Haketa et al., 2010; Craane et al., 
2012a; Sahlstrom et al., 2013).  
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In the included trials, the objective ‘clinician-measured’ outcomes of mandibular 
movements such as mouth opening, protrusive, and laterusive movements were usually 
measured by a ruler and expressed in millimetres. The subjective ‘patient-reported’ 
outcomes of pain intensity and functional limitation, however, were measured using 
different tools and scales. For pain intensity, the visual analogue scale (VAS) was the 
most frequently used scale to assess pain intensity in 17 trials, but it was sometimes 
calibrated differently, either 0-10 cm or 0-100 mm, across different studies. Other 
alternative or additional tools were also used to assess pain including: numerical rating 
scale (NRS) (Maloney et al., 2002); McGill pain questionnaire (MPQ), total pain rating 
index (PRI), and total number of words chosen (NWCtotal) (Craane et al., 2012a); 
characteristic pain index (CPI) and graded chronic pain scale (GCPS) (Sahlstrom et al., 
2013); symptoms severity index (SSI) (Schiffman et al., 1996; Schiffman et al., 2007). 
For functional limitation, different tools were also used by the 11 trials including: 
mandibular function impairment questionnaire (MFIQ) (Holmlund et al., 2001; Politi et 
al., 2007; Craane et al., 2012a); jaw functional limitation scale (JFLS) (Sahlstrom et al., 
2013); restriction of daily life activities (by VAS) (Peroz et al., 2004); interference with 
daily life (by VAS) (Yuasa et al., 2001); daily activity limitation (DAL) (Minakuchi et 
al., 2001), limitation of daily functions (LDF) (Haketa et al., 2010); jaw mobility and 
dietary alterations (Fridrich et al., 1996); craniomandibular index (CMI) (Schiffman et 
al., 1996; Schiffman et al., 2007). 
The operative/admission duration was reported in two surgical trials (Holmlund et al., 
2001; Politi et al., 2007) and the cost of interventions was reported in a follow-up report 
of one trial (Schiffman et al., 2014b). 
Adverse effects of interventions were observed and reported in 6 trials (Linde et al., 
1995; Schiffman et al., 1996; Goudot et al., 2000; Holmlund et al., 2001; Politi et al., 
2007; Schiffman et al., 2007), whilst no adverse events were observed in 4 trials 
(Petersson et al., 1994; Fridrich et al., 1996; Yuasa et al., 2001; Haketa et al., 2010). 
The remaining 10 trials did not report about adverse events. 
Excluded studies   
All 52 studies (of 62 reports) which did not meet the inclusion criteria of this review 
were excluded and the reasons for their exclusion are detailed in the characteristics of 
excluded studies’ table available in Appendix F. The main reasons for exclusion of 
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many of these studies were related to the characteristics of the enrolled participants, the 
comparative interventions, and/or study design:       
 Other TMD than DDwoR or no specific DDwoR diagnosis (Gray et al., 1991; 
Gray et al., 1994b; Carmeli et al., 2001; Nguyen et al., 2001; Wahlund et al., 
2003; Sanroman, 2004; Nunez et al., 2006; Oliveras-Moreno et al., 2008; 
Ziegler et al., 2010). 
 Mixed TMD sample with no separate data reported/obtained for patients with 
DDwoR and the percent of DDwoR patients in the study sample was less than 
70% to include the whole trial (Bertolami et al., 1993; Stegenga et al., 1993b; 
Reid et al., 1994; McNamara et al., 1996; Ekberg et al., 1998; Kulekcioglu et 
al., 2003; Nilsson et al., 2009; Marini et al., 2010; Nascimento et al., 2013; 
Katyayan et al., 2014). Three of these excluded studies (Bertolami et al., 1993; 
Reid et al., 1994; Marini et al., 2010) were originally included but after further 
assessment, no numerical data were obtained for DDwoR subgroup and the 
number of patients with DDwoR was less than 70% in the trial sample size and 
were eventually excluded. 
 Similar treatment modality of the comparable groups (Miyamoto et al., 1999; 
Schmitter et al., 2005b; Stiesch-Scholz et al., 2005; Long et al., 2009; 
Matsumoto et al., 2011). 
 Similar initial surgical treatment modality of the comparable groups (McCain et 
al., 1989; Bryant et al., 1999; Alpaslan and Alpaslan, 2001; Furst et al., 2001; 
Prager et al., 2007; Zuniga et al., 2007; Alpaslan et al., 2008; Arinci et al., 2009; 
Aktas et al., 2010b; Aktas et al., 2010a; Morey-Mas et al., 2010; Ghanem, 2011; 
Hamed, 2012; Elsholkamy et al., 2013; Emes et al., 2013; Hammuda et al., 
2013). 
 Study design not eligible for this review (non-randomised trials) (Murakami et 
al., 1995; Sato et al., 1997b; Sato et al., 2001a; Stiesch-Scholz et al., 2002a; 
Hall et al., 2005b; Sato and Kawamura, 2008; Machon et al., 2012; Yucel et al., 
2014). 
 Not a treatment study (Kaplan et al., 1989). 
 Outcomes not relevant (Gu et al., 1998; Hirota, 1998). 
 Poor quality and protocol violation (Bertolucci and Grey, 1995b). 
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5.4.3 Risk of bias in included studies   
The authors of all included studies were contacted for clarification about study design 
and/or missing data by electronic mail. Useful information and further clarification of 
study design were obtained on six of the included trials (Petersson et al., 1994; 
Schiffman et al., 1996; Holmlund et al., 2001; Yuasa et al., 2001; Schiffman et al., 
2007). The individual domain risk of bias assessment for each study is shown in Figure 
5.2 and the risk of bias judgements for the included studies are detailed below. 
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Figure 5.2: The individual domain risk of bias for each study. Symbols: + Low risk of 
bias, ? Unclear risk of bias, - High risk of bias. 
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 Allocation (selection bias)   
Sequence generation 
Of the included trials, only 10 had adequate sequence generation and were assessed as 
being at low risk of bias for this domain. Of these 10 trials, three trials used random 
number tables (Schiffman et al., 1996; Haketa et al., 2010; Sahlstrom et al., 2013), and 
each one of the remaining 7 trials used either third party randomisation (Schiffman et 
al., 2007), shuffling envelopes (Peroz et al., 2004), computer-generated-random-
number (Minakuchi et al., 2001), lottery system (Petersson et al., 1994), truncated 
binomial design (Yoshida et al., 2011), electronically generated blocks (Craane et al., 
2012a), or stratified block randomisation (Yuasa et al., 2001). Apart from the others, 
one trial had inadequate sequence generation by alternate allocation (Diracoglu et al., 
2009) and assessed as being at high risk of bias for this domain, whilst the remaining 10 
trials provided insufficient details about the method of sequence generation and were 
assessed as being at unclear risk of bias for this domain. 
Allocation concealment 
Six trials described adequate allocation sequence concealment and were assessed as 
being at low risk of bias for this domain (Schiffman et al., 1996; Peroz et al., 2004; 
Schiffman et al., 2007; Haketa et al., 2010; Craane et al., 2012a; Sahlstrom et al., 
2013). Two trials had no concealed allocation and assessed as being at high risk of bias 
for this domain (Linde et al., 1995; Diracoglu et al., 2009). For the remaining 12 trials 
allocation concealment was not reported or described in enough detail and these studies 
were assessed as being at unclear risk of bias for this domain. 
Blinding (performance bias and detection bias)   
It is notable that due to the nature of most of the interventions being studied, blinding 
was not feasible for participants or healthcare providers except in 2 double-blinded 
studies. Furthermore, blinding of outcome assessors was not always possible for patient-
reported outcomes. Therefore, the overall risk of bias in blinding of participants, 
personal, outcome assessors, and data analysts for all outcomes was evaluated under a 
single domain. 
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Two trials were double-blinded (Schiffman et al., 1996; Peroz et al., 2004), and 8 trials 
were single-blinded (Petersson et al., 1994; Minakuchi et al., 2001; Yuasa et al., 2001; 
Schiffman et al., 2007; Diracoglu et al., 2009; Haketa et al., 2010; Craane et al., 2012a; 
Sahlstrom et al., 2013). Consequently, 10 of the included trials were assessed as being 
at low risk of performance and detection bias. Only one trial was assessed as being at 
unclear risk of bias for this domain due to unfeasible blinding for the patients-reported 
outcomes (Lundh et al., 1992). The remaining 9 trials did not provide any information 
about the blinding which is assumed to be not attempted and were assessed as being at 
high risk of bias for this domain. 
Incomplete outcome data (attrition bias)   
Ten of the 20 included trials were assessed as being at low risk of bias with regard to 
incomplete outcome data. In these 10 trials, seven trials had no dropouts (Lundh et al., 
1992; Schiffman et al., 1996; Goudot et al., 2000; Maloney et al., 2002; Ismail et al., 
2007; Politi et al., 2007; Yoshida et al., 2011), and the other 3 trials had dropouts but 
adequately applied the intention-to-treat (ITT) analysis (Minakuchi et al., 2001; 
Schiffman et al., 2007; Craane et al., 2012a). Six of the included trials were assessed as 
being at unclear risk of bias for this domain due to two main reasons: too few patients 
(one or two) dropped-out and excluded from analysis without reporting the reason for 
withdrawals in 3 trials (Petersson et al., 1994; Linde et al., 1995; Peroz et al., 2004); or 
the ITT principle was either partially or inadequately applied in 3 trials (Yuasa et al., 
2001; Haketa et al., 2010; Sahlstrom et al., 2013). The remaining 4 trials were assessed 
as being at high risk of bias for this domain due to patient withdrawals related to the 
interventions’ adverse effects and/or high or unclear dropouts without applying ITT 
analysis (Fridrich et al., 1996; Holmlund et al., 2001; Yoshida et al., 2005a; Diracoglu 
et al., 2009). 
Selective reporting (reporting bias)   
It was difficult to assess a trial’s selective reporting in the absence of its protocol. 
Nevertheless, the assessment for this domain was based largely on two main issues: 
First, whether all the pre-specified outcomes described in the methods section of the 
published report were addressed in the results section of the report. Second, whether the 
planned assessed outcomes in the trial would reasonably be expected in such a clinical 
trial for DDwoR management. 
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Half of the included trials (10/20) were judged as free of selective reporting bias, as they 
reported and/or provided all the expected, clinically important outcomes pre-specified in 
their methods sections and were consequently assessed as being at low risk of reporting 
bias (Schiffman et al., 1996; Minakuchi et al., 2001; Maloney et al., 2002; Peroz et al., 
2004; Ismail et al., 2007; Schiffman et al., 2007; Diracoglu et al., 2009; Haketa et al., 
2010; Craane et al., 2012a; Sahlstrom et al., 2013). In another 4 trials, there was 
insufficient information to make a clear judgment and they were assessed as being at 
unclear risk of reporting bias (Linde et al., 1995; Goudot et al., 2000; Yuasa et al., 
2001; Politi et al., 2007). The remaining 6 trials either did not report the data of planned 
outcomes adequately or did not report/assess an expected, clinically important outcome 
and were assessed as being at high risk of bias for this domain. 
Other potential sources of bias   
This domain represents any other apparent bias in the trial design or conduct other than 
the already-assessed biases in the risk of bias tool (i.e., selection, performance and 
detection, attrition, and reporting biases). It involves any concerns about bias in the 
included studies, such as: baseline imbalance, blocked randomization in unblinded 
trials, or effects of funding sources or conflicts of interest. 
Five of the included trials were considered to be free of other sources of bias and were 
assessed as being at low risk of bias for this domain (Goudot et al., 2000; Minakuchi et 
al., 2001; Yuasa et al., 2001; Peroz et al., 2004; Haketa et al., 2010). For 7 trials, the 
other sources of bias were unclear (Petersson et al., 1994; Linde et al., 1995; Fridrich et 
al., 1996; Schiffman et al., 1996; Schiffman et al., 2007; Craane et al., 2012a; 
Sahlstrom et al., 2013). The remaining 8 trials were suspected to have other potential 
sources of bias and were assessed as being at high risk of bias with regard to this 
domain. 
Overall risk of bias 
None of the studies included in this review were assessed as at low risk of bias across 
all domains. Eight studies were assessed as being at unclear overall risk of bias because 
there was either insufficient information in the trial report and/or available from the 
authors or because it was not possible to make a definite judgement to determine risk of 
bias in at least one domain of the bias assessment tool (Schiffman et al., 1996; 
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Minakuchi et al., 2001; Yuasa et al., 2001; Peroz et al., 2004; Schiffman et al., 2007; 
Haketa et al., 2010; Craane et al., 2012a; Sahlstrom et al., 2013). The remaining 12 
studies were assessed as being at high overall risk of bias because each of these studies 
was at high risk of bias in one or more domains (Lundh et al., 1992; Petersson et al., 
1994; Linde et al., 1995; Fridrich et al., 1996; Goudot et al., 2000; Holmlund et al., 
2001; Maloney et al., 2002; Yoshida et al., 2005a; Ismail et al., 2007; Politi et al., 2007; 
Diracoglu et al., 2009; Yoshida et al., 2011). The summary assessment for the overall 
risk of bias is shown in Figure 5.3.  
 
Figure 5.3: Summary assessment for the overall risk of bias.  
Additional considerations 
 All the authors of the included studies were contacted, and more than half of 
them replied (12/19 ‘same first author in 2 trials’ 63%).  
 Of the twenty studies included, seven presented a priori sample-size calculation 
whilst thirteen did not report/perform a priori sample-size calculation. Of the 
examined thirteen studies, five had adequate statistical power (≥ 80%) whilst 
eight had inadequate statistical power (< 80%) (Appendix E). 
 The main criticism was the lack of homogenous comparable groups which made 
it difficult to pool the results. 
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5.4.4 Effects of interventions   
Preliminary synthesis of findings of included studies 
All the included studies except one study (Yoshida et al., 2005a) had extractable 
numerical data for statistical analysis. For uniformity across the studies included, data 
were analysed and presented by rescaling pain VAS or NRS on 0-10 cm to a 0-100 mm 
scale in five studies (Goudot et al., 2000; Holmlund et al., 2001; Maloney et al., 2002; 
Politi et al., 2007; Diracoglu et al., 2009). 
The reviewed interventions varied widely in invasiveness. For the purpose of this 
review, the interventions were grouped according to their level of invasiveness into 
three groups: non-invasive, minimally-invasive, and invasive interventions (Table 5.2). 
The data are presented by grouping the interventions to compare between non-invasive, 
minimally-invasive, and invasive treatment modalities. As a result, twenty-one 
comparisons among interventions were made. Data for between-group statistical 
analyses of the 21 comparisons for the primary outcomes (pain at jaw function, 
active/unassisted aMMO) are presented at short- and long-term follow-up time-points 
for each comparison in the summary of findings table (Table 5.3). The summary of 
findings for all secondary outcomes is available in Appendix G. Data for within-group 
statistical analyses of differences from baseline for the two primary outcomes at short- 
and long-term follow-up time-points are tabulated and summarised in Appendix H to 
help in assessment of the potential clinical significance of differences. 
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Comparison 
(Study) 
Primary 
outcome 
Follow-up 
(short/long-
term) 
No. of 
Patients 
(Trials) 
Relative effect (95%CI) a 
p value for between-
group difference b 
Overall 
Risk of 
Bias 
Outcome 
measuring 
tool/scale c 
1. MM vs. No treatment 
(Yoshida et al., 2011) 
MMO 
10 min  
(ST) 
148 
(1 RCT) 
RR 16.67 (5.44 to 51.06) p< 0.0001 favours MM High MMO>38mm 
2. Jaw exercises vs. 
Education only 
(Craane et al., 2012a) 
Pain d 
3 mo 
(ST) 
42 
(1RCT) 
MD 3.81 (-6.15 to 13.77) NS Unclear VAS (0-100) 
Pain d 
13 mo 
(LT) 
42 
(1 RCT) 
MD 0.62 (-5.46 to 6.70) NS Unclear VAS (0-100) 
MMO 
3 mo 
(ST) 
45 
(1 RCT) 
MD -3.10 (-6.96 to 0.76) NS Unclear aMMO (mm) 
MMO 
13 mo 
(LT) 
42 
(1 RCT) 
MD -3.80 (-7.68 to 0.08) 
NS (p= 0.05 towards 
Educ) 
Unclear aMMO (mm) 
3. Self-management vs. 
Education only 
(Minakuchi et al., 2001) 
Pain 
2 mo 
(ST) 
44 
(1 RCT) 
MD -4.40 (-19.54 to 10.74) NS Unclear 
VAS (0-100) 
on chewing 
MMO 
2 mo 
(ST) 
44 
(1 RCT) 
MD -1.40 (-6.90 to 4.10) NS Unclear aMMO (mm) 
4. Self-management vs. No 
treatment 
(Yuasa et al., 2001) 
Pain & 
MMO 
1 mo 
(ST) 
60 
(1 RCT) 
RR 1.80 (1.00 to 3.23) NS (p= 0.05 towards SM) 
Unclear 
No. improved 
patients for: 
VAS pain & 
MMO 
Subgroup 
analysis 
1 mo 
(ST) 
15 Acute RR 1.05 (0.57 to 1.94) NS 
45 Chronic RR 2.51 (1.06 to 5.95) p< 0.05 favours SM 
5. Self-management vs. 
Splint 
(Haketa et al., 2010) 
Pain 
2 mo 
(ST) 
44 
(1 RCT) 
MD -15.20 (-31.55 to 1.15) NS (p= 0.07 towards SM) Unclear VAS (0-100) 
MMO 
2 mo 
(ST) 
44 
(1 RCT) 
MD 6.00 (2.67 to 9.33) p< 0.001 favours SM Unclear 
MMO with 
pain (mm) 
6. Splint vs. Control 
(Lundh et al., 1992) 
Pain 
12 mo 
(LT) 
51 
(1 RCT) 
RR 0.49 (0.26 to 0.92) p< 0.05 favour Control High 
No. reduced 
pain 
7. Splint vs. TENS 
(Linde et al., 1995) 
Pain 
6 wk 
(ST) 
31 
(1 RCT) 
RR 8.53 (1.21 to 60.33) p< 0.05 favours Splint High 
Reduction in 
pain≥50% 
MMO 
6 wk 
(ST) 
31 
(1 RCT) 
MD -0.16 (-4.07 to 3.75) NS High 
Change from 
baseline mm 
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Comparison 
(Study) 
Primary 
outcome 
Follow-up 
(short/long-
term) 
No. of 
Patients 
(Trials) 
Relative effect (95%CI) a 
p value for between-
group difference b 
Overall 
Risk of 
Bias 
Outcome 
measuring 
tool/scale c 
8. Combination therapy e 
vs. Education only 
(Minakuchi et al., 2001) 
Pain 
2 mo 
(ST) 
46 
(1 RCT) 
MD -2.80 (-16.12 to 10.52) NS Unclear 
VAS (0-100) 
on chewing 
MMO 
2 mo 
(ST) 
46 
(1 RCT) 
MD 1.40 (-3.94 to 6.74) NS Unclear aMMO (mm) 
9. Combination therapy 
vs. Self-management 
(Minakuchi et al., 2001; 
Schiffman et al., 2007) 
Pain 2-3 mo (ST) 
97 
(2 RCTs) 
SMD 0.22 (-0.19 to 0.62) NS Unclear VAS & SSI 
Pain 
60 mo 
(LT) 
50 
(1 RCT) 
MD 0.00 (-0.13 to 0.13) NS Unclear SSI (0-1) 
MMO 
2 mo 
(ST) 
48 
(1 RCT) 
MD 2.80 (-2.95 to 8.55) NS Unclear aMMO (mm) 
10. Jaw exercise + splint vs. 
Splint f 
(Maloney et al., 2002; 
Ismail et al., 2007) 
Pain 
1-3 mo  
(ST) 
50 
(2 RCTs) 
MD 0.90 (-12.28 to 14.07) NS High 
VAS & NRS 
(0-100) 
MMO 
1-3 mo  
(ST) 
50 
(2 RCTs) 
MD 4.67 (1.80 to 7.55) p< 0.01 favours Exr+Sp High aMMO (mm) 
11. Active PEMF vs.  
Placebo PEMF 
(Peroz et al., 2004) 
Pain d 
6 wk 
(ST) 
31 
(1 mRCT) 
MD 0.23 (-17.96 to 18.42) NS Low VAS (0-100) 
Pain d 
4 mo 
(LT) 
30 
(1 mRCT) 
MD 19.49 (0.97 to 38.01) p< 0.05 favour placebo Unclear VAS (0-100) 
MMO d 
6 wk 
(ST) 
31 
(1 mRCT) 
MD -2.47 (-8.23 to 3.29) NS Low aMMO (mm) 
MMO 
4 mo 
(LT) 
30 
(1 mRCT) 
MD -1.00 (-6.09 to 4.09) NS Unclear aMMO (mm) 
12. Active iontophoresis vs. 
Placebo iontophoresis g 
(Schiffman et al., 1996) 
Pain 
1 wk 
(ST) 
18 
(1 RCT) 
MD -0.03 (-0.21 to 0.15) NS Unclear SSI (0-1) 
MMO 
1 wk 
(ST) 
18 
(1 RCT) 
MD 1.90 (-5.70 to 9.50) NS Unclear aMMO (mm) 
13. Arthrocentesis vs. 
Arthrography only 
(Petersson et al., 1994) 
Pain h 
2 mo 
(ST) 
33 
(1 RCT) 
MD -16.02 (-34.79 to 2.75) NS (p= 0.09 towards AC) High 
VAS (0-100) 
after chewing 
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Comparison 
(Study) 
Primary 
outcome 
Follow-up 
(short/long-
term) 
No. of 
Patients 
(Trials) 
Relative effect (95%CI) a 
p value for between-
group difference b 
Overall 
Risk of 
Bias 
Outcome 
measuring 
tool/scale c 
Arthrocentesis vs. 
Arthrography only 
MMO 
2 mo 
(ST) 
33 
(1 RCT) 
MD -3.00 (-9.54 to 3.54) NS High mm 
14. Arthrocentesis vs.   ATN 
LA block 
(Sahlstrom et al., 2013) 
Pain d 
(no ITT) 
3 mo 
(ST) 
37 
(1 RCT) 
MD 24.60 (6.06 to 43.14) p< 0.01 favours LA Unclear 
VAS (0-100) 
at movements 
Pain 
(ITT) 
3 mo 
(ST) 
45 
(1 RCT) 
RR 0.72 (0.46 to 1.14) NS Unclear 
Reduced 
pain≥30% 
MMO d 
3 mo 
(ST) 
37 
(1 RCT) 
MD -4.90 (-10.00 to 0.20) NS (p= 0.06 towards LA) Unclear aMMO (mm) 
15. Arthrocentesis vs. 
Combination therapy 
(Diracoglu et al., 2009) 
Pain 
3 mo 
(ST) 
110 
(1 qRCT) 
MD -19.3 (-28.54 to -10.06) p< 0.0001 favours AC High VAS (0-100) 
Pain 
6 mo 
(LT) 
110 
(1 qRCT) 
MD -28.80 (-36.56 to -21.04) p< 0.0001 favours AC High VAS (0-100) 
MMO 
3 mo 
(ST) 
110 
(1 qRCT) 
MD 1.93 (-0.75 to 4.61) NS High mm 
MMO 
6 mo 
(LT) 
110 
(1 qRCT) 
MD 2.35 (-0.07 to 4.77) NS (p= 0.06 towards AC) High mm 
16. Arthroscopy vs.          
Self-management 
(Schiffman et al., 2007) 
Pain 
3 mo 
(ST) 
50 
(1 RCT) 
MD 0.01 (-0.12 to 0.14) NS Unclear SSI (0-1) 
Pain 
60 mo 
(LT) 
51 
(1 RCT) 
MD 0.03 (-0.09 to 0.15) NS Unclear SSI (0-1) 
17. Arthroscopy vs. 
Combination therapy 
(Schiffman et al., 2007) 
Pain 
3 mo 
(ST) 
43 
(1 RCT) 
MD -0.08 (-0.24 to 0.08) NS Unclear SSI (0-1) 
Pain 
60 mo 
(LT) 
47 
(1 RCT) 
MD 0.03 (-0.09 to 0.15) NS Unclear SSI (0-1) 
18. Open surgery vs.        
Self-management 
(Schiffman et al., 2007) 
Pain 
 
3 mo 
(ST) 
 
48 
(1 RCT) 
MD -0.07 (-0.20 to 0.06) NS Unclear SSI (0-1) 
Pain 
60 mo  
(LT) 
50  
(1 RCT) 
MD 0.05 (-0.09 to 0.19) NS Unclear SSI (0-1) 
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Comparison 
(Study) 
Primary 
outcome 
Follow-up 
(short/long-
term) 
No. of 
Patients 
(Trials) 
Relative effect (95%CI) a 
p value for between-
group difference b 
Overall 
Risk of 
Bias 
Outcome 
measuring 
tool/scale c 
19. Open surgery vs. 
Combination therapy 
(Schiffman et al., 2007) 
Pain 
3 mo 
(ST) 
41 
(1 RCT) 
MD -0.16 (-0.32 to -0.00) p< 0.05 favours OS Unclear SSI (0-1) 
Pain 
60 mo 
(LT) 
46 
(1 RCT) 
MD 0.05 (-0.09 to 0.19) NS Unclear SSI (0-1) 
20. Arthroscopy vs. 
Arthrocentesis 
(Fridrich et al., 1996; 
Goudot et al., 2000) 
Pain 
12 mo 
(LT) 
62 
(1 RCT) 
MD 10.00 (-1.20 to 21.20) NS (p= 0.08 towards AC) High VAS (0-100) 
MMO 
6-24 mo 
(LT) 
81 
(2 RCTs) 
MD 5.28 (3.46 to 7.10) p< 0.0001 favours AS High mm 
21. Open surgery vs. 
Arthroscopy 
(Holmlund et al., 2001; 
Politi et al., 2007; 
Schiffman et al., 2007) 
Pain 
3 mo 
(ST) 
42 
(1 RCT) 
MD -0.08 (-0.23 to 0.07) NS Unclear SSI (0-1) 
Pain 
12 mo 
(LT) 
81 
(3 RCTs) 
SMD -0.50 (-0.95 to -0.06) p< 0.05 favours OS High VAS & SSI 
Sensitivity 
analysis 
12 mo 
(LT) 
61 
(2 RCTs) 
SMD -0.43 (-0.93 to 0.08) NS High VAS & SSI 
MMO 
12 mo 
(LT) 
40 
(2 RCTs) 
RR 1.07 (0.76 to 1.49) NS High MMO>35mm 
Abbreviations: AC: arthrocentesis, aMMO: active (unassisted) maximum mouth opening, AS: arthroscopy, ATN LA block: auriculotemporal nerve local anaesthesia block, CI: 
confidence interval, Educ: education, Exr+Sp: exercises plus splint, ITT: intention-to-treat analysis, LT: long-term, MD: mean difference, min: minutes, MM: mandibular 
manipulation, mm: millimetres, MMO: maximum mouth opening, mo: months, mRCT: multi-centre randomised clinical trial, No.: number of patients, NRS: numerical rating scale, 
NS: non-significant, OS: open surgery, PEMF: pulsed electromagnetic fields, qRCT: quasi-randomised clinical trial, RCT: randomised clinical trial, RR: risk ratio, SM: self-
management, SMD: standardised mean difference, SSI: symptoms severity index, ST: short-term, TENS: transcutaneous electric nerve stimulation, VAS: visual analogue scale, wk: 
weeks.  
a The risk ratio (RR) is the ratio of the chance of experiencing a particular event that occurs with use of the intervention to that occurs with the use of control. The mean difference 
(MD) is the difference in means values between two groups in a clinical trial. It estimates the amount by which an intervention changes the outcome on average compared with the 
control. It can be used as a summary statistic in meta-analysis when outcome measurements in all studies are made on the same scale. The standardized mean difference (SMD) is 
used as a summary statistic in meta-analysis when the studies all assess the same outcome but measure it on different scales. It expresses the size of the intervention effect in each 
study relative to its variance (SD). Further details about the statistical analysis used to measure the relative effects of interventions in clinical trials are available in the Cochrane 
handbook for systematic reviews of interventions (Higgins and Green, 2011) which is accessible online.  
b Statistical significance (p-value<0.05) for between-group statistical differences. 
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c For uniformity, data were analysed and presented by rescaling pain scales (VAS and NRS) on 0-10 cm (Goudot et al., 2000; Holmlund et al., 2001; Maloney et al., 2002; Politi et 
al., 2007; Diracoglu et al., 2009) to a 0-100 mm scale.  
d Unpublished statistical data provided by the contacted authors (personal e-mail communication). 
e Combination therapy of splint plus jaw exercises (± self-care/education/medication ± cognitive behavioural therapy ‘CBT’) conservative interventions. 
f In Maloney et al. (2002), Therabite devise + splint group and wooden tongue depressors + splint group were merged as one group: jaw exercises plus splint. 
g In Schiffman et al. (1996), three groups were compared (active iontophoresis by dexamethasone + lidocaine, control iontophoresis by lidocaine only, and placebo iontophoresis by 
normal saline). In this table, however, only the comparison between active and placebo iontophoresis was considered and reported. 
h Estimated from figure 2 in the published trial. 
Table 5.3: Summary of findings for the primary outcomes (pain at jaw function and unassisted/active maximum mouth opening). 
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In the following section, data for primary outcomes and adverse effects of interventions 
over short-term (≤ 3 months) and longest-term (> 3 months) are presented first for each 
comparison and then summarised on the basis of each treatment modality. All data for 
secondary outcomes are summarised in Appendix G. 
Comparisons of non-invasive interventions 
 Mandibular manipulation (MM) versus control (Table 5.3, comparison 1) 
Two studies by the same authors compared the short-term effectiveness of single 
mandibular manipulation (MM) against control with the key difference being the 
delivery of manipulation: by clinicians (Yoshida et al., 2005a) or by patients themselves 
(Yoshida et al., 2011).  
In Yoshida et al. (2005a), the effects of MM (by clinician) in combination with a single 
dose of NSAID were compared against a single dose medication (NSAID) (control 
group) on a total of 305 patients randomised by 2:1 ratio into two groups. No 
extractable data were available from the published report (no variance reported) but the 
authors reported that 172/204 (84%) patients in the MM group showed decreased pain 
and increased opening at 1week. Of 172 improvers, 170 had 'acute' (≤ 1 month) and 2 
had 'chronic' (> 1 month) DDwoR. 
In Yoshida et al. (2011), the authors compared the immediate effectiveness of self-MM 
(by patient) with no treatment (control) 10 minutes after the intervention on a total of 
148 patients randomised equally to either group. This study evaluated only the 
mandibular movements as outcomes. The number of patients with MMO > 38mm was 
significantly greater 10 minutes after self-MM than no treatment (risk ratio (RR) = 
16.67; 95%CI: 5.44 to 51.06; p < 0.00001). In a follow-up report of the trial (Yoshida et 
al., 2013), analysis for the self-MM group showed that the ‘improvers’ (50/74) had a 
shorter duration of locking (mostly 'acute' DDwoR: mean = 35 days), whilst the non-
improved patients (24/74) had a longer duration of locking (mostly 'chronic' DDwoR: 
mean = 88 days).  
 Jaw exercises versus education (Table 5.3, comparison 2) 
Craane et al. (2012a) compared active jaw manipulation by physiotherapists to patients’ 
education only (control) for 13 months on a total of 49 patients (completers N = 42) 
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with DDwoR with and without limited mouth opening. In this study, there was no 
statistically significant difference between the effect of jaw exercises and patients’ 
education on VAS pain at 3 months (MD = 3.81mm; 95%CI: -6.15 to 13.77; p = 0.45) 
or 13 months (MD = 0.62mm; 95%CI: -5.46 to 6.70; p = 0.84). Similarly, there was no 
statistically significant difference between the effect of jaw exercises and patients’ 
education on active MMO at 3 months (MD = -3.10mm; 95%CI: -6.96 to 0.76; p = 
0.12) or 13 months (MD = -3.80mm; 95%CI: -7.68 to 0.08; p = 0.05).  
 Self-management versus control (Table 5.3, comparisons 3 & 4) 
Two studies compared self-management (self-exercises + self-care/medication) to no 
active treatment (control) for 1 to 2 months on a total of 104 patients (Minakuchi et al., 
2001; Yuasa et al., 2001).  
Minakuchi et al. (2001) compared self-management against patient education only. In 
this study, there was no statistically significant difference between the effect of self-
management and education on VAS pain during chewing (MD = -4.40mm; 95%CI: -
19.54 to 10.74; p = 0.57) at 2 months. Similarly, there was also no statistically 
significant difference between the comparative groups on active MMO (MD = -
1.40mm; 95%CI: -6.90 to 4.10; p = 0.62) at 2 months. 
Yuasa et al. (2001) compared self-management against no treatment. In the published 
study, all the outcomes were reported as median only with slight favour for the self-
management over control. The study’s authors combined the measured outcomes VAS 
and MMO to assess the TMJ dysfunction. By counting the number of ‘improved’ 
patients, a greater number of patients experienced decreased pain and increased opening 
in the self-management group than non-treatment group at 1 month, but the difference 
was not statistically significant (RR = 1.80; 95%CI: 1.00 to 3.23; p = 0.05). In a 
subgroup-analysis, however, self-management demonstrated a statistically significant 
difference in effects over no treatment with 'chronic' (> 1 month) DDwoR (RR = 2.51; 
95%CI: 1.06 to 5.95; p = 0.04), but no statistically significant difference in effects on 
'acute' (≤ 1 month) DDwoR (RR = 1.05; 95%CI: 0.57 to 1.94; p = 0.88).  
 Self-management versus splint (Table 5.3, comparison 5) 
Haketa et al. (2010) compared self-management involving self-exercises (+ self-
care/NSAIDs) to splint (+ self-care/NSAIDs) for 2 months on a total of 52 patients 
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(completers N = 44). In this study, although there was greater reduction in pain intensity 
in the self-management group than splint group at 2 months, the difference was not 
statistically significant (MD = -15.20mm; 95%CI: -31.55 to 1.15; p = 0.07). For mouth 
opening, however, there was a statistically significant difference in favour of self-
management over splint on MMO with pain (MD = 6.00mm; 95%CI: 2.67 to 9.33; p = 
0.0004) at 2 months. In this study, no signs of adverse events were observed from the 
two interventions. 
 Splint versus control (Table 5.3, comparison 6) 
Lundh et al. (1992) evaluated the long-term effects of splints against no treatment 
(control) for 12 months on a total of 51 patients diagnosed by arthrography and given 
information and pain medication as needed. This study evaluated only patients’ pain as 
an outcome. The number of patients with no pain or reduced pain was significantly 
greater in untreated patients than those treated with splints at 12 months (RR = 0.47; 
95%CI: 0.25 to 0.88; p = 0.02). 
 Splint versus transcutaneous electric nerve stimulation (TENS) (Table 5.3, 
comparison 7) 
Linde et al. (1995) compared splints versus TENS for 6 weeks on a total of 33 
participants (completers N = 31). In this study, the number of patients with reduction in 
pain intensity (at rest, chewing, and at opening) by ≥50% was significantly greater in 
the splint group than TENS group at 6 weeks (RR = 8.53; 95%CI: 1.21 to 60.33; p = 
0.03). In contrast, there was no statistically significant difference between the effect of 
the two interventions neither on the number of patients with MMO >40mm (RR = 1.28; 
95%CI: 0.49 to 3.33; p = 0.61) nor on the MMO change from baseline (MD = -0.16mm; 
95%CI: -4.07 to 3.75; p = 0.94) at 6 weeks. In this study, TENS reported to cause mild 
hypersensitivity skin reaction especially in the TMJ area. It was, however, unclear how 
many patients in the TENS group this sensitivity reaction was observed. 
 Combination therapy versus education (Table 5.3, comparison 8) 
Minakuchi et al. (2001) compared the short-term effects of combined splint plus 
exercises (+ self-care/medication/education) treatment strategy to education only 
(control) on 46 participants for 2 months. In this study, there was no statistically 
significant difference between the effects of combination therapy and education only 
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neither on VAS pain on chewing (MD = -2.80mm; 95%CI: -16.12 to 10.52; p = 0.68), 
nor on active MMO (MD = 1.40mm; 95%CI: -3.94 to 6.74; p = 0.61) at 2 months. 
 Combination therapy versus self-management (Table 5.3, comparison 9) 
The comparison between combination therapy including splint plus jaw exercises (+ 
self-care/medication/education  ± CBT) versus self-management (self-
care/medication/education ± self-exercises) was conducted by two studies (Minakuchi 
et al., 2001; Schiffman et al., 2007) on a total of 102 patients (completers N = 98) for 2 
months and 60 months respectively. For pain intensity, pooling the results of the two 
studies showed no statistically significant differences between the effects of combined 
treatment strategy over self-management strategy on pain intensity over the short-term 
(2-3 months) (standardized mean differences (SMD) = 0.22; 95%CI: -0.19 to 0.62; p = 
0.29) (meta-analysis 1, Figure 5.4). Similarly, in one study (Schiffman et al., 2007), 
there was no statistically significant difference between the effects of the two treatment 
strategies on SSI for pain at 60 months (MD = 0.00; 95%CI: -0.13 to 0.13; p = 1.00). 
For mouth opening, there was also no statistically significant difference between the 
effect of comparative groups on active MMO (MD = 2.80mm; 95%CI: -2.95 to 8.55; p 
= 0.34) at 2 months in one study (Minakuchi et al., 2001). In Schiffman et al. (2007), no 
adverse events were observed from the two interventions. 
 
Figure 5.4: Forest plot of pooled data regarding pain outcome for combination therapy 
vs. self-management.  
 Combination of splint plus jaw exercises versus splint (Table 5.3, comparison 
10) 
This comparison was conducted by two studies (Maloney et al., 2002; Ismail et al., 
2007) on a total of 50 patients (45 patients with DDwoR) for 1 and 3 months follow-up 
respectively with the key difference being the delivery of jaw exercises: by clinicians 
(Ismail et al., 2007) or by patients themselves using either a mechanical device 
(Therabite) or wooden tongue depressors (WTDs) (Maloney et al., 2002). For pain 
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intensity, pooling the results of the two studies showed no statistically significant 
difference in effects of combined treatment over splint alone on pain intensity over the 
short-term (1-3 months) (MD = 0.90; 95%CI: -12.28 to 14.07; p = 0.89). For mouth 
opening, however, pooling the results of the studies showed a statistically significant 
difference in favour of the combined treatment over splint alone on MMO over the 
short-term (1-3 months) (MD = 4.67mm; 95%CI: 1.80 to 7.55; p = 0.001) (meta-
analysis 2, Figure 5.5).  
 
Figure 5.5: Forest plot of pooled data regarding pain and mandibular movements 
outcomes for combination of splint plus jaw exercises vs. splint only. 
 Active pulsed electromagnetic fields (PEMF) versus placebo PEMF (Table 5.3, 
comparison 11) 
Peroz et al. (2004) compared active PEMF versus placebo PEMF for 4 months on 31 
patients in DDwoR subgroup (completers N = 30). In this multi-centre RCT, there was 
no statistically significant difference in effects of active and placebo PEMF on VAS 
pain intensity at 6 weeks (MD = 0.23mm; 95%CI: -17.96 to 18.42; p = 0.98), but the 
difference was statistically significant in favour of placebo PEMF at 4 months (MD = 
14.49mm; 95%CI: 0.97 to 38.01; p = 0.04). For mouth opening outcome, there was no 
statistically significant difference in effects of active and placebo PEMF on active 
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(unassisted) MMO at 6 weeks (MD = -2.47mm; 95%CI: -8.23 to 3.29; p = 0.40) and 4 
months (MD = -1.00mm; 95%CI: -6.09 to 4.09; p = 0.70). 
 Active iontophoresis versus placebo iontophoresis (Table 5.3, comparison 12) 
Schiffman et al. (1996) compared active iontophoresis (dexamethasone and lidocaine) 
versus control iontophoresis (lidocaine only) versus placebo iontophoresis (normal 
saline) for 1 week on a total of 27 patients. In this study, iontophoresis by lidocaine with 
or without dexamethasone demonstrated greater short-term effects over placebo 
iontophoresis by normal saline on all measured outcomes but the differences were not 
statistically significant. For pain, there was no statistically significant difference in 
effects neither between active and placebo iontophoresis (MD = -0.03; 95%CI: -0.21 to 
0.15; p = 0.75) nor between control and placebo iontophoresis (MD = -0.10; 95%CI: -
0.25 to 0.05; p = 0.18) on total symptoms severity index (SSI) for pain at 1 week. 
Similarly, for mouth opening, there was no statistically significant difference in effects 
neither between active and placebo iontophoresis (MD = 1.90; 95%CI: -5.70 to 9.50; p 
= 0.62) nor between control and placebo iontophoresis (MD = 2.00; 95%CI: -3.22 to 
7.22; p = 0.45) on active MMO at 1 week. In this study, two types of mild transient 
adverse effects of iontophoresis were reported: skin erythema and dizziness. Skin 
erythema resolved within 8 hours and dizziness resolved when the power source was 
turned off. The study’s authors, however, did not report how many patients experienced 
these adverse events and in which group these events occurred. 
Comparisons of minimally-invasive versus non-invasive interventions 
 Arthrocentesis versus control (Table 5.3, comparisons 13 & 14) 
Two studies evaluated the short-term effects of arthrocentesis and lavage to a control 
group: a diagnostic arthrography (Petersson et al., 1994), or an auriculotemporal nerve 
(ATN) block as sham treatment (Sahlstrom et al., 2013) on a total of 79 patients 
(completers N = 70) for 2 to 3 months respectively. For pain intensity, the VAS pain 
was reported as median (range) in Petersson et al. (1994). From Figure 2 in the 
published trial, the individual VAS pain after chewing could be estimated for each 
individual patient in both groups. Accordingly, the ‘estimated’ mean and standard 
deviation for each comparative group was calculated by SPSS. There was slight favour 
for arthrocentesis over diagnostic arthrography on reducing the pain after chewing at 2 
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months but the difference in effects was not statistically significant (MD = -16.34mm; 
95%CI: -35.00 to 2.32; p = 0.09). In the study conducted by Sahlstrom et al. (2013), 
there was a statistically significant difference in effect in favour of local anaesthesia 
(LA) group on VAS pain at jaw movements at 3 months (MD = 24.60mm; 95%CI: 6.06 
to 43.14; p = 0.009). By applying the ITT principle by the study’s authors, no 
statistically significant difference between the effect of the two interventions was 
demonstrated for the reduction of pain intensity ≥ 30% (RR = 0.72; 95%CI: 0.46 to 
1.14; p = 0.16) or ≥ 50 % (RR = 0.78; 95%CI: 0.46 to 1.32; p = 0.36). For mouth 
opening, there was no statistically significant difference in effects of arthrocentesis and 
arthrography on MMO (MD = -3.00 mm; 95%CI: -9.54 to 3.54; p = 0.37) at 2 months in 
Petersson et al. (1994). Similarly, in Sahlstrom et al. (2013), there was also no 
statistically significant difference in effects of arthrocentesis and LA alone on 
unassisted (active) MMO with pain (MD = -4.90mm; 95%CI: -10.00 to 0.20; p = 0.06) 
at 3 months. Pooling the data from both studies to evaluate the overall effect of 
arthrocentesis against control was not possible due to clinical (unmatched ‘control’ 
groups) and statistical (chi2 < 0.05; I2 > 50%) heterogeneity. No signs of adverse events 
were observed from the interventions by Petersson et al. (1994). 
 Arthrocentesis versus combination therapy (Table 5.3, comparison 15) 
Diracoglu et al. (2009) compared arthrocentesis to a combination of splint plus self-
care/self-exercises conservative treatment for 6 months on 120 patients with 'acute' 
DDwoR (≤ 1 month) (completers N = 110) allocated by consecutive patients’ 
attendance one to each group. In this quasi-randomised trial, arthrocentesis 
demonstrated a highly significant statistical difference in effects over combination 
therapy on VAS pain at 3 months (MD = -19.3mm; 95%CI: -28.54 to -10.06; p < 
0.0001) and 6 months (MD = -28.80mm; 95%CI: -36.56 to -21.04; p < 0.00001). 
Although arthrocentesis exerted greater effects on MMO, the difference in effects 
between the two interventions were not statistically significant at 3 months (MD = 
1.93mm; 95%CI: -0.75 to 4.61; p = 0.16) and at 6 months (MD = 2.35mm; 95%CI: -
0.07 to 4.77; p = 0.06).  
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Comparisons of invasive versus non-invasive interventions 
 Arthroscopy versus conservative treatments (Table 5.3, comparisons 16 & 17) 
Schiffman et al. (2007) compared arthroscopic surgery to two conservative treatment 
strategies: self-management (self-care/medication/education); combination of splint plus 
exercises (+ self-care/medication/education plus CBT). The comparison of arthroscopy 
versus self-management was conducted on 55 patients (completers N = 51) and the 
comparison of arthroscopy versus combination therapy was conducted on 51 patients 
(completers N = 47) for 60 months. For pain, there was no statistically significant 
difference in effects of arthroscopy and self-management on SSI at 3 months (MD = 
0.01; 95%CI: -0.12 to 0.14; p = 0.88) and at 60 months (MD = 0.03; 95%CI: -0.09 to 
0.15; p = 0.63). There was also no statistically significant difference in effects of 
arthroscopy and combination therapy on SSI at 3 months (MD = -0.08; 95%CI: -0.24 to 
0.08; p = 0.31) and at 60 months (MD = 0.03; 95%CI: -0.09 to 0.15; p = 0.63). In this 
study, no signs of adverse events were observed from these interventions. 
 Open surgery versus conservative treatments (Table 5.3, comparison 18 & 19) 
Schiffman et al. (2007) also compared open surgery with the same conservative 
interventions: self-management and combination therapy. The comparison of open 
surgery versus self-management was conducted on 55 patients (completers N = 51) and 
the comparison of open surgery versus combination therapy was conducted on 51 
patients (completers N = 47) for 60 months. Again, there was no statistically significant 
difference in effects of open surgery and self-management on SSI at 3 months (MD = -
0.07; 95%CI: -0.20 to 0.06; p = 0.30) and at 60 months (MD = 0.05; 95%CI: -0.09 to 
0.19; p = 0.48). However, open surgery demonstrated a statistically significant 
difference in effects over combination therapy on SSI at 3 months (MD = -0.16; 95%CI: 
-0.32 to -0.00; p = 0.04) but not at 60 months (MD = 0.05; 95%CI: -0.09 to 0.19; p = 
0.48). In this study, open surgery caused moderate transient motor nerve injury in one 
patient. 
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Comparison of invasive versus minimally-invasive interventions 
 Arthroscopy versus arthrocentesis (Table 5.3, comparison 20) 
Two studies made this comparison (Fridrich et al., 1996; Goudot et al., 2000) on a total 
of 81 patients with disc displacement with and without reduction (69 patients had 
DDwoR) for 6 to 24 months. For pain intensity, although the reduction in pain was 
greater in arthrocentesis group than in arthroscopy group in Goudot et al. (2000), the 
difference in effects between the two interventions on VAS pain intensity at 12 months 
was not statistically significant (MD = 1.00; 95%CI: -0.12 to 2.12; p = 0.08). In Fridrich 
et al. (1996), the VAS for pain intensity was reported as effect estimate for both 
interventions over the longest follow-up (range from 6 to 24 months) but no variance 
was reported. Therefore, pooling the data for this outcome could not be performed. For 
mouth opening, pooling the data from both studies resulted in a statistically significant 
difference in effects of arthroscopy and arthrocentesis on MMO in favour of 
arthroscopy over the long-term (6-24 months) (MD = 5.28mm; 95%CI: 3.46 to 7.10; p < 
0.00001) (meta-analysis 3, Figure 5.6). No adverse events were observed by Fridrich et 
al. (1996), while four surgical complications were reported by Goudot et al. (2000), two 
in each group. In the arthroscopy group, one patient had moderate transient facial palsy 
for 3 months duration, and the other patient had severe cervico-facial oedema required 
prolonged intubation for 12 hours. In arthrocentesis group, two patients had severe 
bradycardias [vagal reactions] (one asystole). The asystole recovered after Isoprenalin 
injection and the other recovered spontaneously when lavage stopped. The risk ratio of 
adverse events between the two interventions were non-significant (RR = 0.88; 95%CI: 
0.13 to 5.85; p = 0.89) but the trial authors reported that the observed adverse effects of 
arthrocentesis were more serious than the arthroscopic adverse effects. 
 
Figure 5.6: Forest plot of pooled data regarding maximum mouth opening outcome for 
arthroscopy vs. arthrocentesis. 
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Comparison of invasive interventions 
 Open surgery versus arthroscopy (Table 5.3, comparison 21) 
Three studies made this comparison on a total of 94 patients (completers N = 88) for a 
follow-up period ranging from 1 to 5 years (Holmlund et al., 2001; Politi et al., 2007; 
Schiffman et al., 2007). In terms of the outcome of pain, there was no statistically 
significant difference in effects of the two surgeries on pain intensity over the longest 
follow-up in each of the 3 trials. Nevertheless, pooling the data from the three studies 
showed a statistically significant overall effect for open surgery over arthroscopy on 
reducing the pain intensity at 12 months (SMD = -0.50; 95%CI: -0.95 to -0.06; p = 
0.03). However, by excluding the study not confirming the DDwoR clinical diagnosis 
by MRI (Holmlund et al., 2001), the sensitivity-analysis showed no statistically 
significant difference in effects of the two surgical procedures (SMD = -0.43; 95%CI: -
0.93 to 0.08; p = 0.10). In relation to mouth opening, pooling the data from two studies 
(Holmlund et al., 2001; Politi et al., 2007) showed no statistically significant difference 
between the effects of open joint and arthroscopic surgeries on number of patients with 
MMO >35mm (RR = 1.07; 95%CI: 0.76 to 1.49; p = 0.71) at 12 months (meta-analysis 
4, Figure 5.7). Surgical complications were reported in all the three trials. In Holmlund 
et al. (2001), a small region of hyposensitivity close to the incision was observed in 
open surgery group. Similarly, mild transient hyposensitivity in the preauricular area 
was observed by Politi et al. (2007) but in both groups. In Schiffman et al. (2007), one 
arthroplasty patient experienced moderate transient motor nerve injury that resolved 
completely.  
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Figure 5.7: Forest plot of pooled data regarding pain, mandibular movements, and 
function outcomes for open joint surgery vs. arthroscopic surgery. 
Summary of therapeutic intervention effects 
The treatment modalities used for DDwoR management are summarised according to 
main treatment components in each therapeutic modality as follows: 
Patient education (2 studies) 
The effects of patient education and reassurance only as a control group without any 
active intervention were compared against active therapeutic interventions in two of the 
included trials (Minakuchi et al., 2001; Craane et al., 2012a) with no additional effects 
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of active therapeutic interventions over education alone on all the measured outcomes 
over the short- and long-term. 
Self-management (4 studies) 
The effects of self-management programmes involving self-care plus medication and 
education plus/minus self-exercises were compared against other treatment modalities 
in four trials (Minakuchi et al., 2001; Yuasa et al., 2001; Schiffman et al., 2007; Haketa 
et al., 2010) with no additional effects of other interventions over self-management on 
all measured outcomes over both short- and long-term. No adverse effects for this 
treatment modality were observed in two trials (Schiffman et al., 2007; Haketa et al., 
2010) whilst the remaining 2 trials did not report about adverse events. 
Splint therapy (5 studies) 
Occlusal splint as a solitary treatment modality was evaluated against no treatment or 
other interventions in five trials (Lundh et al., 1992; Linde et al., 1995; Maloney et al., 
2002; Ismail et al., 2007; Haketa et al., 2010). Overall, the splint therapy as a sole 
treatment approach did not have additional effects over no treatment or other active 
interventions over the short- or long-term. The adverse effects of splints were not 
reported in any of the 5 trials. 
Physiotherapy (7 studies) 
Various physiotherapeutic modalities were evaluated against no treatment or other 
interventions in six trials (Linde et al., 1995; Schiffman et al., 1996; Peroz et al., 2004; 
Yoshida et al., 2005a; Yoshida et al., 2011; Craane et al., 2012a). In two trials (Yoshida 
et al., 2005a; Yoshida et al., 2011), early mandibular manipulation by patients or by 
clinicians demonstrated initial beneficial effect in decreasing pain and increasing mouth 
opening over the short-term in patients with ‘acute’ closed lock resulting from DDwoR 
of short duration of onset. In another trial (Craane et al., 2012a), however, active jaw 
exercises by physiotherapists on patients with DDwoR with/without limited opening 
showed no additional effects over patients’ education alone on all measured outcomes 
over the short- or long-term. No adverse events were reported in these 3 trials. In the 
other three trials (Linde et al., 1995; Schiffman et al., 1996; Peroz et al., 2004), 
miscellaneous of electro-physiotherapeutic modalities (TENS, PEMF, Iontophoresis) 
were evaluated but all demonstrated no additional effects over placebo treatment or 
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splint therapy on all measured outcomes over the short- and long-term. Electro-physical 
treatment by TENS and iontophoresis were reported to cause mild adverse events in two 
trials (Linde et al., 1995; Schiffman et al., 1996), whilst the other trial (Peroz et al., 
2004) did not report about adverse effects of PEMF. 
Combination therapy (5 studies)  
The effects of combination of splint plus physiotherapy (plus/minus any of medication 
and education or CBT) treatment strategy against other treatments modalities were 
evaluated in five trials (Minakuchi et al., 2001; Maloney et al., 2002; Ismail et al., 
2007; Schiffman et al., 2007; Diracoglu et al., 2009). When compared with the ‘less’ 
invasive and more conservative interventions (i.e., patients’ education or self-
management), the combined treatment strategy had no additional effects on all 
measured outcomes over the short- or long-term. When compared with the ‘more’ 
invasive surgical interventions (i.e., arthrocentesis, arthroscopy, open surgery), the 
combination therapy improved mandibular movements and function as much as the 
surgical interventions over the short- and long-term but it was less effective in reducing 
the pain intensity than arthrocentesis over the short- and longer-term, and open surgery 
over the short-term. No adverse effects of combination therapy were observed by 
Schiffman et al. (2007), whilst the remaining 4 trials did not report about adverse 
events. 
Arthrocentesis (5 studies) 
The effects of arthrocentesis and lavage under LA ± IV sedation were evaluated against 
sham treatment or other interventions in five trials (Petersson et al., 1994; Fridrich et 
al., 1996; Goudot et al., 2000; Diracoglu et al., 2009; Sahlstrom et al., 2013). When 
compared against sham or placebo treatments (control groups) (Petersson et al., 1994; 
Sahlstrom et al., 2013), arthrocentesis demonstrated no additional effects on all 
measured outcomes over the short-term. When compared to combination therapy 
(Diracoglu et al., 2009), however, arthrocentesis had greater effects in reducing the pain 
intensity but had comparable effects in improving the mandibular movements over both 
short- and long-term. Nevertheless, when compared to arthroscopy (Fridrich et al., 
1996; Goudot et al., 2000), arthrocentesis had less effects than arthroscopy on 
improving mouth opening but it had comparable effects to arthroscopy on reducing the 
pain intensity over the long-term. Adverse effects of arthrocentesis were not observed in 
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two trials (Petersson et al., 1994; Fridrich et al., 1996), and not reported in another two 
trials (Diracoglu et al., 2009; Sahlstrom et al., 2013), whilst two severe intra-operative 
adverse events during the lavage procedure were observed in one trial (Goudot et al., 
2000). 
Arthroscopy (5 studies) 
The effects of arthroscopic surgery under GA or LA + IV sedation were evaluated 
against other surgical and conservative interventions in five trials (Fridrich et al., 1996; 
Goudot et al., 2000; Holmlund et al., 2001; Politi et al., 2007; Schiffman et al., 2007). 
When compared with the non-surgical conservative treatment strategies (self-
management or combination therapy) (Schiffman et al., 2007), arthroscopy did not have 
any additional effects on all measured outcomes over the short- or long-term. When 
compared with arthrocentesis (Fridrich et al., 1996; Goudot et al., 2000), however, 
arthroscopic surgery under LA or GA was more effective than arthrocentesis under LA 
on improving the mouth opening but it had equivocal effects on reducing the pain 
intensity over the long-term. However, when compared with open surgery (Holmlund et 
al., 2001; Politi et al., 2007; Schiffman et al., 2007), arthroscopic surgery was less 
effective than open surgery on reducing the pain intensity but had similar effects on 
mandibular movements over the long-term. No adverse effects of arthroscopic surgery 
were observed in three trials (Fridrich et al., 1996; Holmlund et al., 2001; Schiffman et 
al., 2007), whilst three kinds of post-arthroscopic complications were observed in the 
other two trials (Goudot et al., 2000; Politi et al., 2007). 
Open surgery (3 studies) 
The effects of open joint surgery versus other therapeutic interventions were evaluated 
in three trials (Holmlund et al., 2001; Politi et al., 2007; Schiffman et al., 2007). When 
compared with the non-surgical conservative interventions, open surgery had no 
additional effects over self-management on all measured outcomes over the short- and 
long-term. Open surgery, however, demonstrated greater effects on reducing the pain 
intensity more quickly than the combination therapy over the short-term but had no 
additional effects over the long-term, and had also no additional effects on improving 
the mandibular function over both short- and long-term. When compared with closed 
surgery (arthroscopy) (Holmlund et al., 2001; Politi et al., 2007; Schiffman et al., 
2007), open joint surgery demonstrated greater overall effects over arthroscopic surgery 
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on reducing the pain intensity over the long-term but it had no additional effects on 
improving the mandibular movements and function over the short- and long-term. 
Surgical complications of transient sensory or motor nerve injuries from the open joint 
surgical procedures were observed in all the three surgical trials. 
5.5 Discussion 
5.5.1 Summary of main findings   
The wide range of therapeutic options used in clinical practice for alleviating symptoms 
of patients with DDwoR is reflected in this systematic review in which 20 trials were 
included, providing data for 21 comparisons between and among interventions of 
varying levels of invasiveness. 
The main findings from each intervention reviewed will be discussed narratively to help 
in summarising the evidence behind the effectiveness of each of eight treatment 
modalities used for DDwoR management. In this review, the analysis for the primary 
outcomes was conducted both between- and within-group.  
When the interventions were compared with each other (between-group), the least 
invasive conservative intervention by patient education and/or self-management exerted 
comparable effects to more ‘active’ (combined splint plus physiotherapy) or ‘invasive’ 
(TMJ surgery) treatment approaches over both short- and long-term. This indicates that 
educating the patients with DDwoR about this disorder with reassurance about its 
favourable natural course together with self-care instructions had an important role and 
a beneficial effect during the primary management of DDwoR.  
Amongst the physiotherapeutic interventions, early mandibular manipulation by a 
clinician or by the patient exerted an immediate effect by increasing mouth opening in 
patients with ‘acute’ DDwoR over the short-term. These promising results, however, are 
unstable and the long-term effects of manipulation are questionable due to inadequate 
follow-up periods. Jaw ‘stretching’ exercises, whether alone or in combination with 
others, also increased mouth opening but their short- and long-term effects were varying 
and inconsistent among studies. Electro-physiotherapeutic modalities, on the other 
hand, had generally no additional effects over placebo or splint therapy over short- or 
long-term and could cause mild transient adverse effects.  
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Splint therapy as a sole treatment had no additional effects over other interventions or 
no treatment over the short- and long-term; although their use as an adjunct to other 
interventions helped to alleviate symptoms. This combination of splint plus 
physiotherapy plus/minus other conservative interventions had comparable effects to 
both: ‘less’ invasive and more conservative interventions of education and self-
management, and ‘more’ invasive surgical interventions of arthrocentesis, arthroscopy, 
or open surgery over the short- and long-term. This combination therapy, however, was 
less effective in reducing the pain intensity than: arthrocentesis over the short- and 
longer-term, and open joint surgery over the short-term. 
The minimally-invasive surgical intervention of arthrocentesis and lavage had no 
additional effects over sham treatments or arthroscopic surgery over the short- or long-
term. Arthrocentesis, however, reduced pain intensity more than non-invasive 
conservative combination therapy in 'acute' DDwoR over both short- and long-term in 
one study (Diracoglu et al., 2009). This study, however, was quasi-randomised based on 
alternate allocation to intervention groups and, therefore, if excluded from this review, 
arthrocentesis’ effect remains questionable and unproven. Although arthrocentesis is 
often regarded as simple and relatively ‘less’ invasive in comparison with other surgical 
interventions, it could be also associated with rare but severe surgical complications. In 
one study (Goudot et al., 2000), arthrocentesis caused severe bradycardias in two 
patients during the lavage procedure, one of which was of a refractory nature and 
caused a reversible asystole. The study’s authors did not explain the mechanism for this 
presumably lavage-induced bradycardia. Possible factors leading to reflex bradycardia 
and asystole may be related to trigeminal nerve stimulation resulting in a trigeminal-
derived vagal reflex (trigeminocardiac or trigeminovagal reflex bradycardia) (Roberts et 
al., 1999).  
The invasive arthroscopic and open joint surgical interventions generally had no 
additional effects over non-invasive conservative interventions over the short- and long-
term; although open surgery decreased pain intensity significantly more than 
combination therapy over the short-term only. When surgical procedures where 
compared with each other, arthroscopic surgery increased mouth opening significantly 
more than arthrocentesis over the long-term. Open surgery also decreased pain intensity 
significantly more than arthroscopic surgery over the long-term. However, a sensitivity-
analysis did not confirm the significant difference between arthroscopic and open joint 
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surgery in reducing the pain intensity thereby suggesting this result is unstable and the 
evidence is not robust. In the former comparison between arthroscopy and 
arthrocentesis, the significant increase in mouth opening in arthroscopy as compared to 
arthrocentesis may be due to the fact that arthrocentesis was done under LA whilst 
arthroscopy was done in most patients under GA. This use of different anaesthetic 
approaches (LA, IV sedation, GA) in the surgical trials made the circumstances 
incomparable. Any direct comparison between the different surgical procedures, 
therefore, is questionable because the magnitude and/or force for manipulating the jaw 
during the procedure has been proven to vary with the type of anaesthetic approach and 
is not always easy to control in unconscious versus conscious patients (Mehra and Arya, 
2015). Consequently, this might have direct influence on an objective-measured clinical 
outcome such as mouth opening. In the latter comparison between arthroscopic and 
open joint surgeries, the significant decrease in pain intensity in open surgery as 
compared to other interventions may be due to complete disruption of sensory afferent 
pain pathways in the local TMJ area which probably leads to a decrease in pain. This 
sensory disruption is less likely to occur in non-surgical conservative therapy or other 
less invasive closed joint surgical procedures when compared to more invasive open 
joint surgery. The more invasive nature of open surgery also has the potential to further 
stimulate and potentiate any central and peripheral sensitisation as opposed to 
arthroscopic surgery, which due to less tissue damage, may less likely be stimulatory to 
peripheral and central nociceptive processes. Another explanation for this significant 
difference may be simply attributed to the fact that the pain intensity is a subjective self-
measured outcome and patients receiving more invasive intervention may self-report a 
greater reduction in pain (patient mind bias). Arthroscopic and open joint surgical 
procedures could also be associated with surgical complications, most commonly 
moderate transient motor and/or sensory facial or trigeminal nerve injuries.  
Overall, the between-group analysis showed no statistically significant differences in 
effects between and among the majority of reviewed interventions. In contrast, the 
within-group analysis for difference from baseline caused by each individual 
intervention revealed that the majority of reviewed interventions resulted in a 
statistically significant improvement from baseline in both primary outcomes over the 
short- and long-term (Appendix H). These findings indicate that most analysed 
interventions were effective, to a greater or a lesser degree, in alleviating DDwoR 
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symptoms, specifically decreasing pain and increasing opening. These findings, 
however, highlight also four important issues: 
Firstly, the improvement in patients’ symptoms regardless of treatment-specific effects 
could be explained by placebo effect of interventions (Greene and Laskin, 1972; Laskin 
and Greene, 1972; Moseley et al., 2002; Dimitroulis, 2015) or TMJ adaptation and 
possible symptomatic resolution during the ‘favourable’ natural course of the disorder 
(Sato et al., 1997a; Kurita et al., 1998b; Yura, 2012). In this review, many included 
studies did not examine intervention against a 'true' untreated control group. This made 
it difficult to determine the ‘real’ effect of reviewed interventions. Therefore, the 
estimate of the interventions’ effect-size should be interpreted with caution because it 
may be simply due to placebo effects and/or TMJ adaptation over time.  
Secondly, the non-specific effects of the reviewed interventions mean that there were 
potential powerful therapeutic effects of placebo among all interventions reviewed. This 
raises the question: Is harnessing the power of the placebo effect by any of these 
interventions for treating patients with symptomatic DDwoR is ethical or unethical? 
Actually the answer to this question is complicated and controversial (Finniss et al., 
2010). According to American Pain Society (APS) position paper, the use of placebo 
treatment in clinical practice is ‘unethical’ and should be avoided, but its use is only 
ethical for clinical research purposes (Sullivan et al., 2005) even for surgical trials 
(Horng and Miller, 2002). In the TMD field, however, where robust evidence about 
most treatments is lacking, harnessing the power of the placebo effect seems practical 
and suggested to be ‘ethical’ in clinical practice (Greene et al., 2009). In fact, it seems 
reasonable to harness the power of the placebo effect in TMD patients’ management 
given that the treatment is safe, cheap, reversible, non-invasive, and can enhance the 
natural healing process.  
Thirdly, many studies included in this review were identified to be underpowered for 
detecting statistically significant differences between the compared interventions. 
Mostly, this insufficient power indicates ‘poor’ methodological quality; for example, 
Petersson et al. (1994) would have needed a reasonable sample size (~48 patients in 
each group) to achieve adequate power. This insufficient power, however, can also 
confirm the review’s finding of the minimal therapeutic differences between the 
interventions’ effects; for example, Holmlund et al. (2001) would have needed a very 
large, and unrealistic, sample size (~132 patients in each group) to achieve adequate 
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power. This enormous sample size would have been highly impractical and improbable 
in a single-centre RCT given the low incidence of DDwoR and the difficulty in 
recruiting patients with DDwoR which may take several years (Schiffman et al., 2007; 
Sahlstrom et al., 2013). 
Finally, although there was an absence of statistically significant differences between 
interventions, the majority of reviewed interventions resulted in a statistically 
significant improvement from baseline. This raises the question: is this improvement 
from baseline clinically meaningful or not? To answer such a question, the clinically 
important difference (CID) for the primary outcomes of this review must be determined 
and identified from the patient’s perspective (Copay et al., 2007). For pain outcome, the 
CID was identified in previous studies to be a reduction from baseline of approximately 
one third (~30%), specifically: 20 mm on a 100 mm VAS (Jensen et al., 2003), or 2 
points on an 11-point NRS (Farrar et al., 2001). In the studies included, however, pain 
intensity was measured via different instruments (tools/scales), which were not always 
directly comparable (Williamson and Hoggart, 2005). For mouth opening outcome, an 
increase of at least 9 mm was suggested in a previous study (Kropmans et al., 2000) to 
demonstrate a statistically and clinically improvement in MMO. Kropmans et al.’s 
study, however, had several methodological flaws and the threshold of 9 mm was 
determined on the basis of the smallest detectable difference in measurements for 
assisted/passive MMO in patients with “painfully restricted TMJ disorders” receiving 
no treatment. This is as opposed to a CID in MMO that requires an assessment from the 
patient’s perspective after receiving a therapeutic intervention (Dworkin et al., 2008). 
Currently, there is no agreed CID for MMO. Further studies on biopsychosocially 
representative samples of patients with DDwoR are required in order to address CID for 
MMO. Nonetheless, if the 9 mm for assisted/passive MMO improvement is considered 
as perhaps indicative of CID, it could be estimated that an increase from baseline of 
about 6.5 mm or more would represent the CID for unassisted/active MMO. This is 
because there is about 2.5 mm difference between unassisted and assisted MMO for 
DDwoR patients (Hesse et al., 1996) due to joint laxity and passive stretch force. These 
suggested numerical values can be used as an approximate to help interpret the clinical 
significance of change from baseline reported in Appendix H. 
Notwithstanding the limitations of this review, one issue has become apparent from the 
review’s findings: most interventions appear to alleviate symptoms of DDwoR with no 
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significant differences between non-invasive conservative interventions and minimally-
invasive or invasive surgical interventions. Given the paucity of current evidence and 
the difficulty in interpreting the clinically important difference, it makes intuitive sense 
from this finding to suggest a stepped ‘timely-management’ approach to treat patients 
with symptomatic DDwoR initially with the most minimal, least invasive, least 
expensive, and simplest intervention: education and self-management with ‘early’ 
manipulation and escalate to more expensive and more active or invasive treatment only 
if needed (see Implications for clinical practice Section 8.1). This recommendation, 
however, should be interpreted in the context of a review based mostly on single studies 
of unclear to high risk of bias. Future well-conducted research may change or confirm 
this. 
5.5.2 Overall completeness and applicability of evidence 
The participants included in this review had an average age of 35 years and were mainly 
females (~86%) thereby mirroring other closed lock reviews (Al-Belasy and Dolwick, 
2007; Monje-Gil et al., 2012). The participants, however, represented a heterogeneous 
patients’ sample and had some limitations. Firstly, the patients were mostly recruited 
from specialised university clinics and hospitals; that is they were most likely referred 
patients. Other first-point contact clinical settings such as general practice or emergency 
departments were not used but would provide patients with early DDwoR onset and 
probably different therapeutic responsiveness. Secondly, the participants differed 
considerably in the duration of DDwoR symptoms’ onset ranging from one day to 
several years. This clinical point is quite important for DDwoR as the magnitude of 
treatment effect may differ depending on the chronicity of DDwoR (acute versus 
chronic) (Chapter 4). Thirdly, the participants differed also in the presence/absence of 
comorbid disorders which may affect the therapeutic responsiveness. All these factors 
may have affected the magnitude of treatment effect due to possible variation in the 
level of pathological changes in the intra-articular tissues amongst other variables. To 
investigate the effect of one of these variables, a cut-off point of one month locking 
duration was estimated for acute-chronic DDwoR subgroup analysis. Nevertheless, only 
very few analyses could be conducted using this threshold and the influence of locking 
duration on interventions’ effectiveness again could not be established. 
Another consideration for the participants’ characteristics in this review is related to 
their recruitment or acceptance to participate in the trials included. In a follow-up report 
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by Yuasa et al. (2003), the authors examined the DDwoR patients who refused to 
participate in their trial (Yuasa et al., 2001). The individuals who refused were found to 
have more severe symptoms than those accepted the enrolment in the trial. This may 
make the generalisation of any of the findings from any RCT of DDwoR patients 
questionable. 
5.5.3 Quality of the evidence   
This systematic review included studies of various levels of quality but most were 
identified to have various methodological weaknesses and/or incomplete reporting. For 
example, some trials had incomplete reporting of their randomisation process; others 
had incomplete reporting of follow-up results or did not report useful extractable data 
such as point estimate and/or variance; and some trials had small sample size and were 
underpowered to detect any statistical significant differences between the interventions. 
In addition to these, given the subjective nature of the outcomes assessed within the 
included trials, blinding was not always feasible in all trials to protect against bias in 
patient-reported outcomes.  
Different therapeutic interventions of varying levels of invasiveness were being used in 
the studies included. Unsurprisingly, therefore, there was high degree of clinical 
heterogeneity among the studies. Although the interventions were grouped on the basis 
of their main treatment components, the combination of different interventions and the 
variations in techniques used and/or the delivery of interventions varied considerably 
among the studies. This was not only for the conservative non-surgical interventions but 
also for surgical interventions because, despite their perceived similarity, the surgical 
procedures also suffered from clinical heterogeneity in applied techniques and important 
differences were observed in the following: arthrocentesis lavage fluid volumes (50-150 
ml), sometimes less than the recommended ideal therapeutic lavage volume (100-400 
ml) (Zardeneta et al., 1997; Kaneyama et al., 2004); arthroscopic techniques - lysis and 
lavage only or operative arthroscopy; open joint surgical procedures – condylectomy, 
disc repositioning, or disc removal; anaesthetic approaches - local anaesthesia, 
intravenous sedation, or general anaesthesia; use of intra-articular medications injected - 
no medication, sodium hyaluronate, or corticosteroids; intra- and/or post-operative jaw 
manipulation. All these differences made the circumstances incomparable and any 
direct comparison difficult. In this review, therefore, the majority of comparisons 
involved only one trial and only four comparisons involved trials having homogenous 
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comparable groups eligible for pooling, thereby, allowing only four meta-analyses to be 
performed. However, even within the pooled studies in each comparison, there was 
some heterogeneity whereby studies did not exactly use the same combination of 
interventions, or used dissimilar scales/tools to measure the outcomes, or sometimes 
assessed the measured outcomes at differing time points. The strength of evidence for 
the reviewed interventions, therefore, could not be clearly established and any 
conclusion should be interpreted with caution.  
Another important limitation in this review is related to variation in outcome variables 
in the studies included. Regarding the two primary outcomes considered in this review, 
some studies had wide inclusion criteria and included some patients who did not have 
limited opening or pain at the baseline. This may bias the results as it affects the effect 
size of the reviewed interventions. Furthermore, there were also variations in outcome 
assessments in the studies included which made comparison across trials problematic. 
In this review, the most common outcomes assessed for DDwoR were: pain intensity, 
mandibular movements, and functional limitation measures. The objective outcomes of 
mandibular movements were measured by a ruler and expressed in millimetre, but the 
subjective outcomes of patient’s reported pain intensity and functional limitation were 
assessed using different tools and scales. For pain intensity, the most widely used scale 
was the VAS, but it was also calibrated differently, either 0-10 cm or 0-100 mm across 
studies. For patients’ functional limitation, different tools were used across the studies 
such as: MFIQ, JFLS, DAL, and many others. Furthermore, some of the outcomes were 
measured by composite variables such as SSI for pain and CMI for jaw dysfunction that 
made it unclear which symptom or clinical sign was changing. All these variations in 
measuring the outcomes caused a problem with the comparison of the effects of 
interventions across various studies because the reported effect-size of the intervention 
may vary with the type and scale of tool used. In addition, the included trials had 
generally a narrow focus on certain elements such as the functional limitations on 
everyday living activities which probably do not encompass all the aspects of quality of 
life (QoL). None of them captured the broad multidimensional nature of patients' QoL 
by involving the various subtle psychosocial aspects discussed by Locker (Locker, 
1988; Locker and Allen, 2007) which may affect patients with 'chronic' disorders such 
as TMD. Besides this, only one trial evaluated the cost of therapies used (Schiffman et 
al., 2014b). Future trials need to address these outcomes and should follow the Initiative 
on Methods, Measurement, and Pain Assessment in Clinical Trials (IMMPACT) 
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(Dworkin et al., 2005; Dworkin et al., 2008) and Consolidated Standards of Reporting 
Trials (CONSORT) (Schulz et al., 2011).  
Another noticeable limitation is the application of intention-to-treat principle. Although 
this was reported to be undertaken by six of the included trials that reported incomplete 
follow-up, only one study (Minakuchi et al., 2001) used and presented this analysis 
appropriately by including all the randomised participants (i.e., including all the 
dropouts according to the last available observation) regardless of receiving the 
interventions or not in the published report statistical analysis. In the other five trials, 
the ITT principle was applied and/or presented in different ways, none of which 
reported the data appropriately according to ITT basis. In Schiffman et al. (2007), the 
randomised participants who refused the treatment were excluded from study analysis 
and only 8 of 10 dropped-out patients were available at the 5 years evaluation and were 
re-included in the final analysis. In Haketa et al. (2010), only the patients dropped-out 
after 1 month were re-included in the final analysis (6 out of 14 dropped-out patients). 
In Yuasa et al. (2001), the trial authors used the last observation carried forward 
(LOCF) for the dropped-out patients, but assuming them to be improved in the final 
analysis of dichotomous data. In Craane et al. (2012a), the ITT analysis was only 
presented in the linear-mixed-model statistical analysis in the published trial. In 
Sahlstrom et al. (2013), ITT analysis was applied for only one outcome ‘pain’ (the 
primary outcome for the trial). These variations may reflect difficulty in applying ‘full’ 
ITT analysis or misunderstanding of the definition of ITT analysis and how the trial 
authors believe it should be implemented (Hollis and Campbell, 1999).  
Despite these methodological flaws and clinical variations among the studies, there 
were also some positive findings from this review. For example, there was increasing in 
methodological quality in the recently published trials than the earlier trials. Two 
recently published trials (Craane et al., 2012a; Sahlstrom et al., 2013) followed the 
CONSORT statement. Another positive finding was that despite the low incidence of 
DDwoR amongst TMD and difficulty in recruiting patients into trials, more than half of 
the included trials involved more than 20 participants in each comparative arm group in 
their sample size. This may reflect the need for patients with symptomatic DDwoR to 
treatment. 
All the aforementioned considerations weaken the validity of the review findings. 
Overall, the quality of evidence is still weak due to insufficient studies for each 
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comparison and unclear or high risk of bias amongst the majority of studies included. 
More high-quality studies are needed to strengthen the emerging evidence for the 
interventions used for DDwoR management. 
5.5.4 Potential biases in the review process   
Multiple decisions were made by the research student and the supervisory team during 
the construction of the review protocol and thereafter during the conduction of this 
systematic review. These related mainly to setting out the review inclusion/exclusion 
criteria and other review methods, as follows: 
First, one of the main concerns before establishing the review protocol was the 
diagnostic accuracy of DDwoR and the possible differences in the diagnostic criteria 
used for DDwoR diagnosis in clinical trials. This made it difficult to set out the review 
inclusion criteria for different reasons. The inclusion of participants with a generic 
diagnosis (e.g., painful limited opening) might reduce the validity of the review results 
regarding the targeted condition ‘DDwoR’. Depending on just the RDC/TMD as 
reliable criteria for DDwoR diagnosis (Dworkin and LeResche, 1992), despite its 
comprehensiveness and wide use in TMD research, may not be representative since it 
may not have been widely used in the ‘closed lock’ trials. In fact, neither depending on 
multiple diagnostic systems nor depending on just one system is precise. Including 
different clinical diagnostic approaches for DDwoR may be problematic but more 
practical as it would include all relevant DDwoR trials so that the concluded evidence 
will be representative to miscellaneous therapeutic interventions used in clinical practice 
for DDwoR patients. In this review, therefore, considerations were made for inclusion 
the most widely used diagnostic criteria for DDwoR in clinical trials such as 
RDC/TMD, AAOP, and Wilkes staging or any other compatible criteria for DDwoR 
diagnosis. TMJ soft tissue imaging may be used as an ‘optional’ adjunct to confirm disc 
position in patients with DDwoR; however, including such a strict criterion may again 
lead to exclude some of the relevant DDwoR cases and the evidence will be probably 
not representative and, consequently, not generalisable. Nevertheless, studies not 
confirming DDwoR by soft tissue imaging were identified and subjected to a sensitivity 
analysis (where applicable) to highlight the effect of this wide inclusion decision on the 
concluded evidence for primary outcomes. 
202 
 
Second, another consideration in the review inclusion criteria was the possibility of 
including different stages of DDwoR chronicity in the included participants. In fact, 
there are difficulties in defining the transition point from acute to chronic DDwoR both 
in terms of the duration of complaint (Chapter 4) and the level of restriction in mouth 
opening because there may be a gradual resolution of limited mouth opening with the 
passage of the time. This was taken in consideration by performing subgroup analysis 
(where possible) for acute-chronic DDwoR stages based on the estimated ‘1 month’ cut-
off point for the reported duration of locking in the included trials. 
Third, another concern is there were a number of studies that included, in addition to 
DDwoR patients, other TMD patients in their sample. The decision to exclude them was 
easy to make but was inappropriate because it may weaken the external validity of the 
review findings for such a low incidence condition. Two strategies, therefore, were 
employed to avoid excluding those studies. Firstly, the trials were included if more than 
‘70%’ of their sample size diagnosed with DDwoR. Such a decision may introduce bias 
in the systematic review process and to lessen such a bias, it was made early in the 
review protocol before reviewing the studies and after consultation with an experienced 
Cochrane reviewer and a subsequent discussion between the student and the supervisory 
team to reach a consensus. Given the low incidence of DDwoR amongst TMD, the 
percentage of DDwoR in the sample must be reasonable and practical. The choice of 
percent was arbitrary and subjective and, therefore to further minimize the bias, the final 
decision about the contamination percent (70%) was made by one of the supervisors 
(VA) who had no prior knowledge in the TMD field and had no idea about any of 
DDwoR trials. By this set at 70%, three more trials were included in the review 
(Fridrich et al., 1996; Goudot et al., 2000; Ismail et al., 2007). Secondly, the trials were 
included if the separate data for DDwoR subgroup were available or obtainable. 
Therefore, if the identified trials had a DDwoR subgroup in their study sample and 
separate data for patients with DDwoR were provided in the published report, the trials 
were included. However, if the trials did not provide separate data for DDwoR subgroup 
and the percent for patients with DDwoR was less than 70%, the trials’ authors were 
contacted by the student to ascertain if they could provide the separate statistical data 
for DDwoR in order to include the study. By this method, two more trials were included 
in the review (Maloney et al., 2002; Peroz et al., 2004).  
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Fourth, one of the review exclusion criteria was the randomised trials that compared 
similar therapeutic treatment modality or those compared different kinds of medications 
or splints after surgical interventions for DDwoR patients. The decision to not include 
such RCTs related to research team belief that including such trials will not answer the 
systematic review question about which of the different treatment modalities used in 
clinical practice have more beneficial effects and less harmful adverse effects to be 
more appropriate for use in DDwoR management. To give an example, it is more 
important for patients, clinicians, and policy makers to know first whether 
arthrocentesis and lavage, a widely used treatment modality for DDwoR management, 
is an appropriate and more effective treatment modality than conservative interventions 
rather than knowing which medication or splint should be used ‘after’ arthrocentesis. 
This may be only needed to be known if there is robust evidence supporting the use of 
arthrocentesis for DDwoR management which is currently lacking. 
Fifth, an additional consideration in this review was the incomplete reporting in some of 
the trials’ publications. In order to minimise this shortcoming, the student contacted all 
the authors of the included studies for clarification regarding unclear aspects in study 
design and/or missing data. This strategy was generally successful as more than half of 
the authors replied (63%) and most of them were able to provide useful data; although 
one author could not adequately provide the requested information due to English 
language barrier. Therefore, some domains in the risk of bias tool remained unclear to 
make a definite judgment. 
Finally, although searching several databases with wide range of synonyms as well as 
hand-searching relevant journals was employed in an attempt to include all eligible 
studies, the language bias could not be minimised by including non-English language 
RCTs due to resources limits. Nonetheless, the large number of included trials is most 
likely represented the various interventions used for DDwoR management. 
Furthermore, one non-English language RCT was identified from its abstract (Yuasa et 
al., 1997) for possible translation and inclusion/exclusion if this review needs to be 
updated. In addition to this, three recently published RCTs (El-Sayed, 2014; Alajbeg et 
al., 2015; Nagata et al., 2015) and one follow-up report (Baker et al., 2015) are 
currently available for inclusion/exclusion if this review needs to be updated in the 
future. This update, however, seems currently unnecessary as the findings from all the 
five published reports coincide with the concluded evidence from this review. 
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5.5.5 Agreements and disagreements with other systematic reviews   
In this chapter, the criteria used to include the studies and the methods applied to 
appraise and analyse the studies included differed from those applied in the previous 
chapter. This is primarily due to difference in main aim of the two systematic reviews as 
the aim of the first systematic review (Chapter 4) was to investigate the effects of 
locking duration on DDwoR management outcome whilst the aim of the second 
systematic review (Chapter 5) was to investigate the effects of interventions used for 
DDwoR management.  
The findings from the current review had extrapolated the results of more than two 
decades ago review about DDwoR management (Kropmans et al., 1999). Despite its 
limitations, Kropmans’s review concluded that all the reviewed interventions were 
effective with little or no significant differences in effects on pain intensity, maximum 
mouth opening, or mandibular function impairment between splint, physiotherapy, 
arthrocentesis, and arthroscopy. The results of the current review did not differ in that 
all the therapeutic interventions seem to be effective with little or no differences in 
effects between the comparable groups.  
The current review’s findings concurred also with the previous Cochrane reviews for 
arthrocentesis (Guo et al., 2009) or arthroscopy (Rigon et al., 2011) in that: non-
invasive conservative interventions should be applied first, there is insufficient evidence 
to support or refute using the minimally-invasive and invasive surgical interventions, 
and there is a need for more high-quality RCTs. The current review, however, differed 
in some aspects from the published Cochrane reviews about TMJ disorders 
management. Given the low incidence of DDwoR amongst TMD, it was quite an 
interesting and positive finding to include 20 trials in this review in comparison to a 
recently published Cochrane review about the interventions used for the management of 
TMJ osteoarthritis (OA) which included a restricted number of trials (only 3 RCTs) (de 
Souza et al., 2012). The number of studies included in other Cochrane reviews 
investigating only one treatment modality for TMJ disorders was not dissimilar and 
ranged from two to seven RCTs (Shi et al., 2003; Guo et al., 2009; Rigon et al., 2011), 
some of these trials did not meet the present review inclusion criteria. 
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5.6 Conclusions   
The aim of this review was to assess the effectiveness of therapeutic interventions used 
for DDwoR management. Many of the interventions analysed in this review are 
commonly used in clinical practice for patients with DDwoR. The main finding from 
this systematic review suggests that non-invasive conservative interventions were 
equally effective as minimally-invasive and invasive surgical interventions with no 
significant differences in therapeutic effects between interventions, but that the most 
minimal interventions attained their beneficial effects at lower costs and lower risks in 
comparison to more active or invasive interventions. Evidence levels, however, are 
currently insufficient for definitive conclusions, because the included studies were too 
heterogeneous and at an unclear to high risk of bias. The comparable therapeutic effects 
of reviewed interventions, paucity of high-quality evidence, and the greater risks and 
costs associated with more complex interventions, suggest the use of the simplest, least 
costly, and least invasive interventions to initially manage patients with DDwoR. Of the 
variety of non-invasive conservative interventions reviewed, patient education and self-
management with early mandibular manipulation were the least expensive and least 
risky interventions having the optimum cost-benefit and risk-benefit values to DDwoR 
patients. Currently, there is insufficient evidence to support or refute the use of 
minimally-invasive and invasive surgical interventions for DDwoR. There may well be, 
however, specific clinical cases where a surgical intervention may help, but the body of 
evidence does not give a clear indication of when this may be. 
The evidence identified in Chapters 4 and 5 should be implemented in practice for 
evidence-based DDwoR management. The clinicians, however, may not implement the 
available evidence in clinical practice due to several influences on their decisions. The 
next chapter will explore the clinicians’ decision-making processes.  
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Chapter 6. Professionals’ Clinical Decision-Making Processes in the 
Management of TMD/DDwoR: A Qualitative Study 
6.1 Introduction  
6.1.1 Qualitative research in healthcare 
In recent years, qualitative research has become increasingly important in studying 
healthcare by introducing new methods to understand the complexity of the system 
from the point of view of patients and providers (Nicholls, 2009b). The main aim of 
qualitative research is to develop concepts that can help people to understand a 
particular phenomenon in a natural rather than an experimental setting (Pope and Mays, 
1995). Qualitative research seeks to explore, explain, and understand the phenomenon 
under study by focusing on the individual experiences, values, attitudes, behaviours, and 
interactions (Nicholls, 2009a). Therefore, it has become an extremely useful research 
method for examining the clinical decision-making process by exploring and 
understanding both the explicit and the implicit clinicians’ decisions (Jette et al., 2003; 
McGinnis et al., 2009). 
Qualitative research is more appropriate to answer exploratory questions such as 
“what?”, “how?”, and “why?” rather than quantifiable questions such as “how many?” 
or “how frequently?” (Pope and Mays, 1995; Greenhalgh and Taylor, 1997). For 
example, the clinicians may advise the patients with DDwoR to perform jaw-stretching 
exercises at home to improve their mouth opening. Quantitative research is suitable to 
assess the effectiveness of the self-exercise treatment and to determine the frequency of 
patients’ compliance with treatment and the proportion of comply/not comply patients, 
whilst qualitative research is more appropriate to examine and explain why some 
patients do not comply with the self-exercise regimen. 
Patients with DDwoR, as for the whole TMD, may present to different dental and 
medical specialities in clinical practice. Acute DDwoR, however, is one of the most 
startling and objective presentations of all the TMD presenting often without any 
warning and causing severe limitation in mandibular movements and moderate to severe 
levels of pain (Okeson, 2007). It may, therefore, be shocking to the patients who, 
understandably, often immediately attend their primary care clinician or local 
emergency service. In the previous chapters, the evidence suggests that patients with 
DDwoR can be improved by intervening early with simple minimal non-invasive 
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conservative interventions. There is, however, a lack of understanding in relation to how 
frontline clinicians behave when they are confronted with such an acute TMD and what 
clinical decisions they may make. Such questions need answering using a qualitative 
rather than quantitative study design. 
6.2 Aims and Objectives  
6.2.1 Aim 
The aim of this qualitative study was to explore and build an understanding of 
professionals’ clinical decision-making processes in the management3 of TMD in 
general and DDwoR in particular in order to identify influences on professionals’ 
decisions. 
6.2.2 Objectives 
 To examine the clinicians’ decision-making processes in the management of 
TMD, specifically examining the clinicians’ decisions in diagnosing, treating, or 
referring DDwoR.  
 To identify the factors, as informed by the TDF, influencing clinicians’ decision-
making in the management of TMD, specifically determining the influences on 
clinicians’ decisions in diagnosing, treating, or referring DDwoR. 
6.3 Methods 
6.3.1 Study design 
Qualitative study. 
6.3.2 Philosophical assumptions of qualitative methodologies 
In qualitative research, it is crucial to identify the philosophical assumptions or stance 
of the qualitative researcher to produce rigorous meaningful research due to intimate 
bond between philosophy (philosophical assumptions: the ideas and beliefs that inform 
research), methodology (a theory of how research will proceed), and methods (the way 
the research study is conducted) (Nicholls, 2009b; Creswell, 2013).  
                                                 
3 In this chapter, the term ‘management’ is used broadly to cover diagnosis and treatment and/or referral 
of patients during the professionals’ clinical decision-making processes. 
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The researchers’ philosophical assumptions of qualitative methodologies depend on 
how they view reality (ontology) and truth (epistemology).  
Ontology is the nature of reality (Denzin and Lincoln, 2011; Creswell, 2013). It has two 
extreme stances: realism and idealism. Realism is the belief that the reality is entirely 
independent of the researcher perception and of the research process with no 
interconnection between them. Idealism is the belief that the reality is only dependent 
on the researcher perception and it cannot be separated from the researcher or the 
research process. In between these two stances, there are numerous ontological stances 
one of which is subtle realism which attempts to represent reality rather than to 
reproduce it (Mays and Pope, 2000). In other words, subtle realists believe in the social 
world’s reality but they accept that there is no manner in which the researcher can claim 
to have absolute isolation from the social world studying it.  
Epistemology is the theory of knowledge that deals with the nature and status of 
knowledge (how we know what we know) (Pope and Mays, 1995; Creswell, 2013). It 
has also two extremes: positivism and interpretivism. Positivism is the belief in single 
objective reality; that is, reality exists without human involvement and that objects have 
their own real ‘essence’ or ‘entity’ regardless of individual experience or social 
conventions which is the philosophical basis of the quantitative research (Nicholls, 
2009b). Interpretivism is the belief in multiple realities; that is, reality related to 
individual ‘unique’ experience and personal and social relations which is one of the 
philosophical bases of the qualitative research (Van Manen, 1990).  
In this qualitative study, my ontological stance is subtle realism and my epistemological 
stance is interpretivism; by that I mean: I accept the fact that I am a clinician and a 
researcher with broad knowledge in the field and this may impact on my interpretation 
of the study data to some extent; however, by recognising and reflecting my position, I 
realised the potential bias that may bring to the data interpretation and, therefore, every 
attempt was made to minimise it. 
6.3.3 Ethics 
Ethical approval was obtained to conduct this study from the Newcastle University-
Faculty of Medical Sciences Ethics Committee (FMS: EC 00632/2013; Appendix I) and 
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from each NHS Trust’s Research and Development department (R&D) as appropriate to 
each individual participant’s employment. 
6.3.4 Qualitative sampling 
Qualitative research assumes that every person is unique. It is, therefore, concerned with 
a sample that can ‘represent’ a breadth of human experiences and that can provide 
appropriate and meaningful insights into the studied phenomenon (i.e., purposive non-
probability sampling) rather than a sample that ‘represents’ the background population 
(i.e., probability sampling in quantitative research) (Nicholls, 2009a).  
Several different qualitative sampling strategies are described in the literature which 
aim to recruit participants into the study who can add both depth and breadth to 
understand the studied phenomenon (Coyne, 1997; Patton, 2002). Sampling strategies, 
however, are determined by the research aim and each strategy serves a particular 
purpose (Patton, 2002). In this study, the strategy used to identify healthcare 
professionals for interviews was purposive, criterion-based, maximum variation 
sampling. 
Purposive sampling was used in order to gain a depth and breadth of viewpoints from 
differing groups of healthcare providers who might be expected to hold differing 
experiences, attitudes, beliefs, and opinions to understand the phenomenon under study 
‘DDwoR’. Criterion sampling of five years or more of length of time since graduation 
(i.e., experience post-qualification) was predetermined as an indication of clinical 
expertise4 acquisition according to Benner (Benner, 1982; Dreyfus and Dreyfus, 2009) 
and was used to stratify the primary care dental practitioners into new GDPs (< 5 years) 
and experienced GDPs (≥ 5 years). Maximum variation sampling was aimed to reflect 
diversity in practice settings (urgent care, usual care, and specialist care) and involved 
clinicians with differing levels (years) of experiences, grades, training, qualifications, 
and specialties (accident and emergency ‘A&E’, oral surgery and oral and maxillofacial 
surgery ‘OMFS’, and medical and dental ‘non-specialist’ community services) in 
different geographical regions of the North of Tyne in the UK as detailed in Table 6.1.  
                                                 
4 The practitioner’s clinical expertise is defined as “the proficiency and judgment that each clinician 
acquires through clinical experience and practice” (Straus and Sackett, 1998, p.339). 
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The clinicians in the OMFS specialist service were selected among other secondary care 
specialities because they are likely involved in managing patients with limited mouth 
opening conditions including patients presenting with TMJ closed lock (i.e., acute 
DDwoR) (Field et al., 2013; DeAngelis et al., 2014) and, therefore, may have 
experienced the studied phenomenon ‘DDwoR’, thereby being able to provide insight 
on the DDwoR care pathway. It was also aimed at including clinicians in OMFS 
specialist service to compare their decision-making processes in DDwoR management 
with the processes of clinicians at the frontline in emergency and non-specialist 
community services. 
Sampling inclusion criteria 
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 Primary care clinicians registered with the General Dental Council (GDC): 
new and experienced general dental practitioners (GDP). 
 Primary care clinicians registered with the General Medical Council 
(GMC): general medical practitioners (GMP). 
 Emergency on-call dentists registered with the community dental service 
(CDS) or work in the dental emergency clinic (DEC). 
 Accident and emergency (A&E) junior, middle grade, and senior medical 
staff: foundation trainee F1 and F2, senior house officers (SHO), speciality 
registrar doctors (StR), staff grade specialty (StG) or Trust doctors, 
associate specialists (AsSp), and specialists/consultants (Cons). 
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 Oral surgery and oral and maxillofacial surgery (OMFS) junior, middle 
grade, and senior team members: foundation trainee F1 and F2, senior 
house officers (SHO), speciality registrar doctors (StR), staff grade 
specialty (StG) or Trust doctors, associate specialists (AsSp), and 
specialists/consultants (Cons). 
Sampling exclusion criteria 
  Clinicians unable to give informed consent to participate in the study. 
Table 6.1: Study sample inclusion and exclusion criteria. 
Sample identification 
Practitioners were identified from the relevant professional registrar and the practice or 
hospital department and were contacted, either directly or via their gatekeepers. The 
clinicians were invited to take part in the study by a standard posted or e-mailed letter 
involving general invitation statement about the ‘temporomandibular joint disorders’ 
rather than the specific ‘disc displacement without reduction’ disorder in order to avoid 
any possibility of ‘biased knowledge’ gain prior to interviews. The letter also contained 
a standardized participant information sheet and a consent form and all are available in 
Appendix J. 
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The invited clinicians were left to reflect on whether or not they would like to 
participate for two weeks. If no reply was received within two weeks a reminder e-mail 
or telephone call was made. If they were interested in being involved they were 
contacted by the research student and a mutually convenient time was made to interview 
them either face-to-face or via telephone. If a practitioner declined the invitation or did 
not respond, the next individual fitting the study sampling criteria on the registrar/in the 
department was contacted. Informed written consent was signed and obtained from all 
participants before their individual interview, but the topic guide was not given to any 
participant prior to their interview.   
Study sample (Participants) 
Sampling in qualitative research often continues until data ‘saturation’ is achieved; that 
is, when no new concepts are likely to emerge with further data collection (Ellett and 
Beausang, 2002). Data saturation in previous qualitative studies in the dental field has 
been seen to occur prior to thirty interviews with healthcare professionals (Durham et 
al., 2007; Cope et al., 2014; Stone et al., 2014; Vernazza et al., 2015). In this study, 
saturation across the theoretical domains was achieved following 21 interviews.  
The professionals participated in this study were from primary and secondary 
(emergency and specialist) care Trusts across North East of England. The study sample 
involved 12 males and 9 females. Sixteen were frontline clinicians who might be the 
first-point of contact by DDwoR patients and 5 OMFS clinicians who might be mostly 
involved in their management. Ten primary care dental practitioners participated in this 
study. Of the ten, 3 were new GDPs and 7 were experienced GDPs. This stratification 
was planned for the primary care medical practitioners but not used for two reasons: 
First, it was difficult to achieve because most of the contacted medical practitioners did 
not respond or declined to participate in this study. Second, with further data collection 
and analysis it was proven unnecessary due to similarity of knowledge among all the 6 
interviewed medically-qualified practitioners (3 GMPs and 3 A&E). The detailed and 
summary characteristics of interviewed participants are displayed in Table 6.2 and 
Table 6.3 respectively and can be cross-referenced to the references in parentheses 
following each quotation in the data and discussion section. Emboldened acronyms 
from Table 6.3 will be used throughout Section 6.4. 
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Participants’ characteristics 
Primary care  
service 
Secondary care 
service 
Primary care  
clinicians 
Secondary care 
clinicians 
Frontline clinicians  
(GDP, GMP, A&E) 
Surgeons 
Identification 
number 
Range of 
years of 
experience 
Urgent  
Care 
Usual  
Care 
Urgent 
care 
Specialist 
care 
Emergency 
dentists 
GDP GMP A&E OMFS 
1 21-30        
2 11-20        
3 5-10        
4 < 5       
5 < 5       
6 < 5       
7 11-20       
8 11-20       
9 5-10       
10 21-30       
11 11-20       
12 11-20       
13 > 30        
14 < 5       
15 < 5       
16 5-10       
17 21-30        
18 5-10       
19 11-20       
20 11-20       
21 > 30       
Totals 1 to > 30 years 3 10 4 3 6 
Table 6.2: Detailed characteristics of the qualitative study’s sample. 
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Healthcare service setting   
Background 
qualification 
Type of practitioner Number 
Primary 
care (PC) 
Usual access 
Dentally-
qualified 
New General Dental 
Practitioner (< 5 years) 
(NGDP) 
3 
Usual access 
Dentally-
qualified 
Experienced General 
Dental Practitioner (≥ 5 
years) (EGDP) 
4 
Emergency access 
Dentally-
qualified 
Emergency General 
Dental Practitioner 
(EMGDP) 
3 
Usual access 
Medically-
qualified 
General Medical 
Practitioner (GMP) 
3 
Primary care clinicians Total  13 
Secondary 
care (SC) 
Emergency access 
represented by 
accident and 
emergency 
departments 
(A&E) 
Medically-
qualified 
A range of professional 
grades such as: senior 
house officers, middle 
grades (service and 
training), or consultants 
3 
Frontline (A&E, GMPs, and GDPs) clinicians Total 16 
Specialist access 
represented by 
oral surgery and 
maxillofacial 
surgery 
departments 
(OMFS) 
Dentally- ± 
Medically-
qualified 
A range of professional 
grades such as: senior 
house officers, middle 
grades (service and 
training), or consultants 
5 
OMFS clinicians Total  5 
Secondary care clinicians Total  8 
Cumulative Total  21 
Table 6.3: Summary characteristics of the qualitative study’s sample. 
6.3.5 Qualitative data collection 
The three methods commonly used for data gathering in qualitative healthcare research 
are: observation, focus groups, and interviews. In this study, the interview method was 
chosen because this type of data collection method allows the exploration of individual 
participant’s own ideologies, perceptions, experiences, and rationale in-detail 
(Fitzpatrick and Boulton, 1994). 
Qualitative interviews are of three main types: structured, semi-structured, and in-depth 
(Britten, 1995). In this study, semi-structured interviews were used to collect the data. 
Semi-structured interviews are based on a pre-defined set of loosely structured broad 
themes that define the area to be explored initially using open ended questions and from 
214 
 
which the interviewer or interviewee may diverge in order to chase an idea or thought in 
more detail using prompts and probes (Britten, 1995; Nicholls, 2009a). Probes are the 
researcher’s responsive questions used to find out more about issues brought up by the 
interviewee. Prompts are the researcher’s directional questions used to raise other issues 
that might interest the researcher and have not been raised during the course of the 
interview (Kwortnik, 2003). 
Interview questions  
An interview topic guide structured around the TDF (Michie et al., 2005; Cane et al., 
2012) was used. The topic guide was developed by the student and its content validity 
was assessed by two of the supervisors: theoretically by a specialist in health 
psychology (VA) and clinically by a topic expert and experienced qualitative researcher 
(JD), thereby ensuring that the questions accurately represented the theoretical domains 
and adequately covered the TMD and DDwoR management topic.  
This study was an inductive and iterative piece of research in that as interviews 
progressed, the topic guide was evolving according to data gathered and analysed. The 
final version of the interview topic guide is available in Appendix K.   
The interviews followed a standard protocol to ensure consistency. Before the 
interviews, the clinicians were advised that the interview’s aim was not to critique their 
practice or test their knowledge, but to help enhance understanding the problems they 
may face in relation to managing TMD in order to allow participants to talk freely and 
give honest frank answers. Furthermore, all the interviewed clinicians did not have 
professional or personal relationships with the interviewer. During the interviews, the 
participating professionals described first their qualifications, years of experience, and 
discipline or practice setting. After that, the participants were asked about their 
perspectives on chronic orofacial pain (COFP) to facilitate communication and to 
understand how they conceive COFP and its composing conditions. After this, TMD in 
general was discussed, and then focus was turned to DDwoR comparing it at the end of 
the interviews with TMJ dislocation. Prompts were used to change the topic (e.g., 
COFP, TMD, DDwoR, or dislocation) and probes were used, when necessary, for 
further clarification. 
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Interview procedures 
All the interviews were undertaken by the research student. The student was trained by 
attending a number of courses in qualitative research. Furthermore, the first interview 
conducted by the student was monitored by one of the supervisors (JD), an experienced 
qualitative researcher, to assess and develop further the student’s interview skills. 
Most interviews (N = 18) were conducted face-to-face in one of the rooms in Newcastle 
Dental Hospital and three interviews were accomplished via telephone. The telephone 
interviews were conducted for clinicians’ convenience, either because they were 
reluctant to participate in a face-to-face interview or because they were unable to attend 
the Dental Hospital. 
The mean duration of the interviews was 45.22 (± SD 14.86) minutes. All the interviews 
were recorded (with permission from the participants) using a digital voice recorder 
(Olympus DS-660) and the audio files were anonymised using study numbers and 
transcribed verbatim by a professional company who had no links with the clinicians 
involved in the study and with whom we had a confidentiality agreement. Subsequently, 
each anonymised transcript was cross-checked with the original recording by the 
interviewer to ensure the accuracy of transcription and then the audio recording was 
securely deleted. The British Dental Association’s guild remuneration rate (£77/hour) 
was provided from the student’s bench fees to the participating clinicians to compensate 
for their time. 
6.3.6 Qualitative data analysis 
The data analysis in quantitative research begins after completion of the ‘numerical’ 
data collection, whilst the conceptual analytical process in qualitative research begins 
during the ‘textual’ data collection (Nicholls, 2009c). Such ‘within data collection’ 
continuous analysis in qualitative research has the advantage of allowing the researcher 
to go back and make sense of the data, refine questions, develop hypotheses, and follow 
emerging paths of inquiry in more depth throughout the data collection period. It also 
enables the researcher to look for deviant cases (i.e., the ‘outliers’ that contradict the 
emerging propositions or hypotheses) that can be used to refine the emerging concept 
(Pope et al., 2000). 
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There are two distinct forms of reasoning to an idea: inductive and deductive reasoning. 
Quantitative research is concerned with the deductive process of theory testing, whilst 
qualitative research is largely involved in the inductive process of theory building 
(theory developing, production, formation, or generation) (Nicholls, 2009b). Inductive 
reasoning is an iterative process of examining and re-examining the theoretical ideas 
within the data to develop hypotheses (Bloor, 1978). In other words, it tries to construct 
a theoretical meaning and understanding of a problem or a phenomenon as a result of 
exploration (Thomas, 2006). Its ultimate aim is to generate/build theory that explains 
the problem or the phenomenon under study (Nicholls, 2009b). Qualitative research, 
however, does not always use an inductive analytical approach. The themes used to 
describe and explain the phenomenon may be derived inductively (obtained gradually 
from the data to generate a hypothesis) or used deductively (either at the beginning or 
during the data collection/analysis) (Pope et al., 2000).  
In this study, I used both inductive and deductive iterative approaches in various stages 
of data analysis. This is because I, the interviewer, am also a clinician; as a result it 
would be extremely difficult to isolate myself totally from the data. However, given my 
experience in the field as a researcher and a clinician, I attempted to avoid bias in data 
analysis by approaching the relevant literature about the factors (barriers) that might 
influence the clinicians’ decisions in TMD/DDwoR management only after the 
preliminary findings had emerged. Furthermore, I tried to present the data from two 
points of view: as a researcher and as a clinician.   
To analyse the qualitative data, several approaches are available (Rapley, 2011). In this 
study, the inductive/deductive analysis of healthcare professionals’ decision-making 
processes was conducted following the framework analysis approach (Ritchie and 
Spencer, 1994) but it was informed by the Theoretical Domains Framework (TDF) of 
behaviour change (Michie et al., 2005). 
The ‘framework analysis’ approach used in this study is a method developed by Ritchie 
and Spencer (1994) for applied qualitative research. It involves five analytical stages: 
familiarization; identifying a thematic framework; indexing; charting; mapping and 
interpretation. Ritchie et al. (2003) pointed out that this framework approach has several 
advantages: it is grounded and generative, dynamic, systematic, and comprehensive; 
enables easy original text retrieval; allows within-case and between-case analysis; is 
accessible to people other than the primary analyst; and can be appropriate to research 
217 
 
that has specific questions, a limited time period, a predetermined sample (e.g., 
professional participants), and a specific priori issues (e.g., policy issues).  
The TDF was employed in this study as an a priori analysis framework to examine and 
understand the influences on professionals’ decision-making processes and to unpick 
and identify the determinants of professionals’ clinical behaviour. The identified 
‘behavioural determinants’ can then be used to help inform the design of a behaviour 
change intervention based on theoretical framework; such ‘behavioural determinants’ 
cannot be completely identified if an atheoretical approach was used.  
In summary, the TDF was utilised as a coding framework and the framework approach 
was used to help organise the data and the analysis.  
The interview transcripts were analysed in seven stages as follows: 
Stage 1- Familiarisation  
The first three transcripts were read and re-read several times and their audiotapes were 
listened to by the student to obtain a general sense of the information provided and for 
familiarisation with the raw data.  
Stage 2- Coding interview transcripts 
This is regarded as the first ‘formal’ step in data analysis in which all the interview 
transcripts were coded by the student using line-by-line coding, which is the most 
intensive and productive manner to code the data (Strauss and Corbin, 1990). It was 
suggested that one of the potential limitations of using the TDF as a coding framework 
for data analysis is the possibility of preventing themes from emerging ‘naturally’ if 
they did not ‘fit’ the ‘pre-defined’ theoretical domains (McCluskey and Middleton, 
2010; McSherry et al., 2012). To overcome this limitation, the codes were generated 
initially ‘freely’ without using the ‘pre-defined’ domains and then mapped to the 
theoretical domains and their relevant constructs.  
The first three coded interviews were reviewed independently by one of the supervisors 
(RG), an experienced qualitative clinical researcher, to crosscheck the validity of the 
used codes. Thereafter, the student coded all the interviews guided by the theoretical 
framework for subsequent analyses. 
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Stage 3- Mapping codes into theoretical domains 
An a priori theoretical framework based on the TDF was used to facilitate data analysis. 
Excel spreadsheets (v. 14, Microsoft office professional plus 2010, USA) were used to 
facilitate the organization of the data into relevant theoretical domains and constructs 
from the TDF thereby allowing immediate comparison of data.  
The coded data and their representative quotes were mapped to the relevant constructs 
within the theoretical domain of the TDF by the student. Codes that initially seemed to 
be irrelevant to the theoretical domains were placed into a separate ‘additional’ theme 
for further analysis. After further analysis, however, the codes in the additional theme 
were merged with the theoretical domains. To avoid data misrepresentation, the student 
referred back to the psychological definitions of the domains and constructs and also to 
the theoretical domains interview (TDI) questions. This process helped to generate the 
working definitions to describe each theoretical domain for this study as detailed in 
Table 6.4. 
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    Domain a  ‘Psychological’ definition b  Working definitions c (domain description) 
1. Knowledge  An awareness of the existence of something.  This domain describes the professionals’ clinical knowledge about TMD/DDwoR 
disorders and their procedural knowledge to diagnose and treat these disorders. It 
also describes the professionals’ knowledge about the scientific evidence and 
guidelines for TMD/DDwoR management. 
1.1 Experiential 
knowledge 
A ‘conscious event’ that is lived through, or 
undergone, that stimulates the acquisition of 
knowledge (knowledge acquisition from experience). 
This is a construct of ‘knowledge’ domain. It describes the professionals’ acquired 
knowledge through practice on TMD/DDwoR patients. 
2. Skills  An ability or proficiency acquired through practice. This domain describes the professionals’ skills and competencies to diagnose and 
treat TMD/DDwoR. 
2.1 Experiential 
learning 
A ‘conscious event’ that is lived through, or 
undergone, and that stimulates expertise learning to 
take place by actively performing and participating in 
an activity (i.e., learning from experience). 
This is a construct of ‘skills’ domain. It describes the professionals’ previous 
experience and learning through practice in intervening with TMD/DDwoR patients. 
3. Social/ 
Professional 
role and 
identity 
A coherent set of behaviours and displayed personal 
qualities of an individual in a social or work setting. 
This domain describes the professionals’ perceived role and identity as well as their 
perceived responsibility in managing patients with TMD/DDwoR. It also describes 
the professionals’ boundaries in TMD/DDwoR management. 
4. Beliefs about 
capabilities 
Acceptance of the truth, reality, or validity about an 
ability, talent, or facility that a person can put to 
constructive use. 
This domain describes professionals’ perceived self-confidence and beliefs about 
their abilities in TMD/DDwoR management. 
5. Beliefs about 
consequences  
Acceptance of the truth, reality, or validity about 
outcomes of a behaviour in a given situation. 
This domain describes the professionals’ beliefs about consequences which are 
broadly divided into clinicians’ expectancy about the disorder progress and their 
beliefs about potential consequences of certain clinical decisions. 
6. Optimism The confidence that things will happen for the best or 
that desired goals will be attained. 
This domain describes the professionals’ optimism/pessimism about TMD/DDwoR 
management. 
7. Reinforcement Increasing the probability of a response by arranging a 
dependent relationship, or contingency, between the 
response and a given stimulus. 
This domain describes perceived professional incentives or rewards, whether self-
reward, social reward, material reward or health-system reward (e.g., CPD hours), 
associated with managing patients with TMD/DDwoR. 
8. Intentions A conscious decision to perform a behaviour or a 
resolve to act in a certain way. 
This domain describes the professionals’ intentions to manage TMD/DDwoR 
patients and their intrinsic motivation to improve their knowledge and skills in order 
to implement their intentions. 
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    Domain a  ‘Psychological’ definition b  Working definitions c (domain description) 
9. Goals  Mental representations of outcomes or end states that 
an individual wants to achieve. 
This domain describes the professionals’ goal setting and action planning for 
TMD/DDwoR management. This is associated with the priority or importance 
ranking of a certain behaviour or sets of behaviours for TMD/DDwoR management.  
10. Memory, 
attention, and 
decision 
processes 
The ability to retain information, focus selectively on 
aspects of the environment and choose between two or 
more alternatives. 
This domain describes the professionals’ memory for (e.g., forgetting), and attention 
to (e.g., focussing) TMD/DDwoR disorders as well as to their memory for the 
disorders’ management guidelines. It also refers to specific decision-making 
relevant to TMD/DDwoR management. 
11. Environmental 
context and 
resources 
Any circumstance of a person's situation or 
environment that discourages or encourages the 
development of skills and abilities, independence, 
social competence, and adaptive behaviour. 
This domain describes the availability, accessibility, and functionality of resources 
as well as the environmental barriers and facilitators for TMD/DDwoR 
management. 
12. Social 
influences 
Those interpersonal processes that can cause 
individuals to change their thoughts, feelings, or 
behaviours. 
This domain describes social influences from other clinicians, patients, as well as 
healthcare organisations on professionals’ decisions for TMD/DDwoR management. 
Any of these people or systems could cause social support or social pressure and 
thereby encourage or discourage the management.  
13. Emotions  A complex reaction pattern, involving experiential, 
behavioural, and physiological elements, by which the 
individual attempts to deal with a personally 
significant matter or event. 
This domain describes professionals’ emotional responses (positive or negative), 
stress, fear, or burnout that could be caused by managing patients with TMD or 
DDwoR.  
14. Behavioural 
regulation 
Anything aimed at managing or changing objectively 
observed or measured actions. 
This domain describes the professionals’ self-regulatory processes that aim to 
change their behaviour as a result of specific behaviour change techniques (e.g., 
self-monitoring, feedback, breaking habit, action planning, and coping planning) 
and that could lead to change in order to improve TMD/DDwoR management.  
15. Nature of 
behaviour 
The nature of the aggregate of all responses made by 
an individual in any situation. 
This domain describes the nature of professionals’ behaviour in TMD/DDwoR 
management.  
a Data representing the theoretical domains are available in Table 6.9. 
b All domain definitions, except for the definition of the domain ‘Nature of the behaviour’ (from Huijg et al. (2014b)) and the constructs ‘Experiential knowledge’ and ‘Experiential 
learning’, were based on definitions from the American Psychological Associations’ Dictionary of Psychology (APA, 2007) and as defined and used in the TDF (Michie et al., 2005; 
Cane et al., 2012). 
c Our study-specific domain description. 
Table 6.4: Theoretical domains and their psychological and working definitions. Adapted from Michie et al. (2005) and Cane et al. (2012).
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Stage 4- Generating the theoretical framework 
The student generated the initial framework guided by the TDF. To ensure the 
reliability of the generated framework, two supervisors (VA & JD) crosschecked 
independently the consistency in coding the representative quotations within and across 
domains. Thereafter, the student refined the theoretical framework for subsequent 
analyses. The completed framework was examined then by one supervisor (VA), a 
specialist in health psychology, to ensure that the coded data were allocated 
appropriately into the constructs within the relevant domains. Consensus on framework 
and its representative data was achieved by successive meetings and discussion with the 
supervisory team. The finalised framework involved 15 theoretical domains and their 
relevant constructs adapted from the original and revised TDF (Michie et al., 2005; 
Cane et al., 2012), with some additions, as depicted in Figure 6.1.
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Figure 6.1: Study’s theoretical domains and their relevant constructs. 
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Stage 5- Identifying relevant theoretical domains 
The domains having greater clinical significance and reporting were considered likely to 
be relevant for changing the professionals’ behaviour. The relevance of the domains 
were identified through consensus discussion between the student and one of the 
supervisors (JD), a topic expert, to interpret the importance of the domain from a 
clinical perspective and then confirmed by another supervisor (VA), a specialist in 
health psychology. 
Stage 6- Mapping the clinical decision-making processes of participants  
As a separate analysis, the pattern of clinical decision-making process for each 
practitioner was identified, analysed, and then depicted in a graphical map representing 
the management pathway of individual clinician.  
This additional step of data analysis served three purposes: First, it enabled the 
researcher to understand more thoroughly the clinical decision-making process for each 
individual practitioner (a worked example for one clinician is available in Appendix L). 
Second, it allowed the researcher to identify the commonalities and differences between 
clinicians’ decision-making processes and combining those processes that shared 
similar patterns in a singular assembled map representing each group of practitioners 
(Appendix M). Third, it helped the development process of a generic map of decision-
making processes for all clinicians (Figure 6.6). 
Stage 7- Data interpretation 
This is the final step in data analysis in which the data were summarised and the 
findings were reported. Representative data from the transcripts were used to support 
the discussed findings. 
All the data in this chapter were independently examined by three of the supervisors 
(JD, VA, & RG) at various stages of data analysis and the analysis findings were 
reviewed, discussed, revised, and agreed.  
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6.4 Data and Discussion 
6.4.1 Introduction 
As is usual practice in qualitative research, the qualitative data are often presented and 
discussed simultaneously (Mays and Pope, 1995). Throughout this section, therefore, 
the findings from the qualitative analysis will be discussed jointly with presenting 
quotations to support the discussed data. The presented quotes are representative of the 
qualitative data. The quotes are edited sometimes by adding additional words in squared 
brackets to aid clarity and meaning but no substantial changes have been made to the 
original meaning by interviewee. At the end of each quotation, acronyms in parenthesis 
are used referring to practitioner’s type and practice setting as well as participant’s 
reference number as clarified in the below example. Table 6.3 gives further details 
regarding the meanings of acronyms used in this section. 
(OMFS4) 
Practitioner’s type and practice setting            Participant study identification number 
The findings from the qualitative analysis will be discussed in four main subsections:  
 Subsection 6.4.2: Generic and detailed section describing the professionals’ 
clinical decision-making processes in TMD/DDwoR management. 
 Subsection 6.4.3: Brief and focused section summarising the influences on 
the professionals’ decisions in TMD/DDwoR management building upon 
data presented in Section 6.4.2. 
 Subsection 6.4.4: Summary section of main findings from Sections 6.4.2 and 
6.4.3.  
 Subsection 6.4.5: Strengths and limitations section of the qualitative study. 
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6.4.2 Professionals’ clinical decision-making process in the management of 
temporomandibular disorders 
The clinical decision-making process is known to be a complex non-sequenced process 
influenced usually by numerous factors at different phases of process (Mezher et al., 
1998; Hajjaj et al., 2010). For the purposes of discussing the qualitative data and clarity 
for the reader, however, this section will consider the following: 
First, any similarities and differences in decision-making process between different 
groups of practitioners are highlighted wherever possible. As it will become clear later 
from the presented data in this section, the clinicians’ processes were based mainly on 
their professionals’ background (dentally- or medically-qualified) and practice setting 
(primary or secondary care, emergency or community non-specialist or specialist 
services). Therefore, the healthcare professionals are grouped as follows: 
 Frontline clinicians: include GMPs, GDPs, and A&E clinicians. 
 Primary care clinicians: include GMPs and GDPs.  
 Secondary care clinicians: include A&E and OMFS clinicians.  
 Dentally-qualified clinicians: include GDPs and OMFS clinicians5.  
 Medically-qualified clinicians: include GMPs and A&E clinicians. 
Second, the factors, as informed by the TDF, that emerged from the data throughout this 
section that reportedly implicitly or explicitly influenced the clinicians’ decisions are 
emboldened in brackets after each quotation and related back to Table 6.4 which 
explains the domains of the decision-making taxonomy used. The main findings from 
each of these emerging themes, however, will be summarised separately in Section 
6.4.3 on factors influencing the clinicians’ decisions. 
Third, although in clinical practice multiple decisions are often made concurrently by 
the clinicians during the decision-making process and each decision made may provide 
feedback for others (Zeleny, 1982; Bornstein and Emler, 2001), for the purposes of this 
section, the clinicians’ decision-making process is discussed in a chronological event 
                                                 
5 Some interviewed clinicians are dually qualified (i.e., they hold a medical degree in addition to dental 
degree). 
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order. This is started from patients’ presentation till their referral and clinicians’ 
suggestions to avoid referral. This section, therefore, includes five separate, but 
sequential, steps as follows:  
 Step 1: Patients’ presentation to clinician’s practice. 
 Step 2: Clinicians’ diagnostic decisions (patients’ diagnosis). 
 Step 3: Clinicians’ treatment decisions (patients’ treatment6). 
 Step 4: Clinicians’ referral decisions (patients’ referral). 
 Step 5: Clinicians’ suggestions to support their own decisions. 
Fourth, in each step, the data are reported sequentially. Firstly COFP and TMD in 
general are discussed, followed by the more specific diagnoses of DDwoR and TMJ 
dislocation. 
Step 1: Presentation  
The clinicians varied in their knowledge and experience of managing patients’ 
presenting with the discussed clinical conditions (COFP, TMD, DDwoR, and TMJ 
dislocation). This seemed to be related, in addition to their qualification, to their clinical 
work context. 
Work context influence on clinicians’ knowledge and experience 
The work context of clinicians seemed to determine the type and frequency of contact 
with patients having acute or chronic conditions. This, in turn, appeared to influence the 
clinicians’ knowledge and experience about the discussed clinical conditions. 
The literature suggests that patients suffering from painful conditions in the head and 
neck region can present to clinicians of any medical or dental speciality in primary or 
secondary care (Madland and Feinmann, 2001; Beecroft et al., 2013; Israel and Davila, 
2014). However, due to the structure of the UK National Health Service (NHS), patients 
with COFP often seek care first from their general medical or dental practitioners in 
                                                 
6 Although the term ‘management’ may be more accurate than ‘treatment’ for a non-curable condition 
such as TMD (Mercuri, 2013), it was used in this chapter to differentiate it from the broad ‘management’ 
term  (see Footnote 3). 
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primary care (community, often non-specialist, based care) (Newton-John et al., 2001; 
Bell et al., 2008; Durham et al., 2011). The study sample confirmed this and offered 
reasons for it:  
1. Primary care clinicians as gatekeepers to secondary care. 
2. Patients’ ease of access. 
“I guess these people they’ve perhaps put up with such [chronic] pain…and so 
with the access to GPs [being] easier than specialists you’re going to be seeing 
them a lot” (GMP9) (Environmental context and resources). 
Some of the clinicians in primary care, however, seemed to have limited knowledge 
about the main conditions causing chronic pain in the orofacial region. The most 
frequently acknowledged or mentioned condition was TMD, perhaps as a result of the 
fact that they knew they were being interviewed about this, or possibly because it is the 
most common COFP condition that the clinicians frequently encounter with in their 
clinical practice (Wirz et al., 2010; Yazdi et al., 2012). 
“Q7: What do you know about other [COFP] conditions apart from the TMD?  
 R8: I suppose there’s the salivary glands could cause problems. And, you know, 
there’s [are] other things related like the ears and the head, ears related to it I 
suppose could be nothing to do with the teeth or the TMD” (EGDP18) 
(Knowledge). 
In contrast, the secondary care clinicians working in hospital-based specialist services 
such as the oral surgery and maxillofacial surgery departments (OMFS) appeared more 
familiar with the diagnosis and treatment of patients presenting with conditions causing 
chronic pain in the head and neck region (Beecroft et al., 2013) and, subsequently, 
seemed to have higher levels of knowledge and greater experience of COFP. 
“I suppose immediately I’d think of a shortlist of things [COFP conditions] but 
the things that spring to mind would be temporomandibular joint pain disorder 
[dys]function, TMJPDS [previously used acronym for TMD] – atypical facial 
pain, trigeminal neuralgia, I’d also think about burning mouth syndrome. There 
are other causes of chronic pain…chronic neuropathic pain following cancer 
surgery, …chronic pain because…[of] bisphosphonate necrosis or osteomyelitis 
or osteoradionecrosis” (OMFS11) (Knowledge). 
                                                 
7 Interviewer Question 
8 Interviewee Response  
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The clinicians working in hospital-based emergency (urgent care) services such as the 
accident and emergency departments (A&E) were “not really exposed to this kind of 
thing [COFP] very often at all and especially in A&E” (A&E6). The A&E clinicians 
appeared to have a very basic knowledge about COFP and the conditions that comprise 
it but they seemed to be more aware about the acute presentations of COFP conditions 
(Durham, 2012) they might encounter in A&E.  
“We probably don’t see very much of that [COFP] where I work. It tends to be 
more er the obviously trauma, acute infections and things like that...but I imagine 
the sort of the things you’ll be getting [in A&E], er things like the neuralgias, so 
facial neuralgias and like I say disc disorders of the TMJ joint and bits and pieces 
like that but again it’s not something that we see very much of” (A&E16) 
(Knowledge ‘experience’). 
TMD is the most common non-odontogenic pain in the orofacial region. In the UK, it 
was suggested that approximately 3-4% of population suffering from TMD attend 
clinical practice for consultation and ⁄or management (Gray et al., 1994a). In primary 
care, the dental practitioners suggested TMD was quite a common problem and they 
probably saw such patients on a weekly to monthly basis: “I probably see on average I 
would say 2, 3 [TMD] patients a week” (EGDP12), whilst the medical practitioners 
explained that TMD patients presented less frequently to their surgeries, probably on a 
monthly or yearly basis: “new patients [with TMD] I would think er probably one a 
month” (A&E/GMP17). In secondary care, the OMFS clinicians reported seeing 
referred TMD patients “probably, on a weekly basis” (OMFS20). The A&E clinicians, 
however, reported being rarely confronted with any of the common TMD problems but 
they reported their experience of acute presentations: “I’ve had someone come in with 
trigeminal neuralgia but I haven’t had someone come in with temporomandibular joint 
dysfunction. I’ve had someone come in with a jaw dislocation…. It really isn’t 
something [TMD] that we commonly see” (A&E6). This suggests that the dentally-
qualified clinicians in the study sample had generally more experience with TMD than 
the medically-qualified clinicians. In addition to their limited experience, the medically-
qualified clinicians in the study sample (GMPs and A&E) acknowledged their 
insufficient knowledge about TMD topic because it was not covered sufficiently neither 
in their undergraduate educational courses: “we weren’t taught very much about it” 
(A&E6) nor in their postgraduate training programmes.  
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“I think it’s probably not something [TMD] that, you know, is done at 
undergraduate much. Obviously most GPs go through various rotations and, you 
know, the ones that you most do is something like paediatrics, gyne.., psychiatry. 
These are the kind of mandatory ones and obviously none of those really cover 
TMJ problems and then people may choose to do extra things like say ENT but 
then that’s not a mandatory one so I think that people just pick it up from their GP 
training as opposed to having a special orthopaedic or erm ENT or, you know, 
any specific rotation or specific pathway” (GMP8) (Knowledge; Skills). 
The professionals’ knowledge of the aetiological factors causing TMD varied widely 
among clinicians, which reflects the uncertainty in the literature (Luther, 2007), but it 
seemed to depend, to some extent, on their reported experiences with patients attending 
treatment to their practices. The literature suggests that general practitioners more 
commonly encounter simpler TMD cases whilst the specialists are more likely 
encountering more complex TMD cases (Steenks, 2007; De Boever et al., 2008; 
Beecroft et al., 2013). This seems to be reflected in the study data when aetiological 
factors were discussed. In primary care, most clinicians focused purely on the pivotal 
role of stress as the main aetiological factor in common TMD. This is in contrast to 
OMFS clinicians in secondary care who seemed to be more knowledgeable about the 
complex 'biopsychosocial' aetiology of TMD (Dougall et al., 2012). This is probably 
related to their knowledge and experience of managing patients with the chronic 
refractory TMD who are often referred to secondary care. 
“I think the majority [of TMD] I see are due to parafunction and er sort of 
bruxism and that kind of thing. Very rarely have I seen any associations with 
trauma but erm it’s sort of mainly parafunction and I think stress has got a 
massive part to play in all of that and often you see patients where they have a 
very stressful life event going on and, you know, they’re on top of everything else, 
now they’ve got this pain and they’re not sleeping and they can’t make sense of 
it” (EGDP12) (Knowledge ‘experience’). 
“I think there’s clearly an exacerbation or a precipitation by psychosocial factors 
which interact very strongly with whatever mechanical and functional problems 
are going on and I think it’s quite complex… I think you have to judge each case 
on its merits and I think you have to try and pick out for that patient how much of 
this is caused by sort of tissue damage or...and how much of it is related to the 
psychosocial components, and I think that varies from person to person, but I 
believe quite firmly that all the patients that we see have got a combination of all 
of these factors…” (OMFS11) (Knowledge ‘experience’). 
Given their experience in chronic refractory cases, some OMFS clinicians exemplified 
the interaction between the patient’s biomechanical and psychosocial factors as a 
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‘vicious cycle’: “it’s the chicken and the egg situation is it, they’ve had the problem 
with the jaw, they’ve had the pain, they’re sick of the pain, now they’re depressed, the 
depression is making the jaw problem worse… it is a circle and everything’s got one 
thing has an effect on the other” (OMFS20) (Knowledge ‘experience’). 
Some of the clinicians in OMFS departments were also able to discuss the possible 
aetiological factors behind the genesis of disc displacement in patients with advanced 
disc derangement disorders they might encounter in specialist service, such as the disc 
could be displaced due to: “acute trauma to the jaw…a whiplash to the jaw…crash 
intubation… [or] chronic causes of it [DDwoR] as well where just sort of click, click, 
click and eventually it just goes” (OMFS21), or because “the articular 
disc…attached… anteriorly by the superior head of the lateral pterygoids” (OMFS4). 
The causes they discussed, however, are considered only as possible risk factors in the 
multifactorial aetiology of disc displacement (Manfredini, 2009).  
These views differ from those in A&E departments who seemed to have a more limited 
knowledge regarding the aetiology of acute presentations of TMD they might encounter 
in emergency service. 
“I know that certain patients are more prone to er to getting things like the 
dislocations because they have sort of a laxity of the ligaments or and it’s sort of 
like a shallower angle between the articulating bits of the joint. Erm…sometimes 
it’s almost a trauma to an area can make them more prone to it…” (A&E16) 
(Knowledge).  
In general, the respondents reported diverse experiences with TMD but suggested that 
the TMD patients who seek treatment with them are often middle-aged or younger 
patients, mostly females, during periods of stress. This finding is in line with the 
majority of the TMD literature (de Kanter et al., 1993; Wahlund, 2003). Although, in 
contrast, OPPERA studies suggested that the first-onset TMD is not predominantly a 
condition of females in early adulthood (Slade et al., 2013a).  
“In general practice it tends to be erm I’d see mainly women late thirties or 
forties they seem to have problems with TMD because they might be going 
through a lot of stress in their personal lives erm so that’s something that, you 
know, can be picked up on” (NGDP15) (Knowledge ‘experience’; Skills). 
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In primary care, the clinicians reported they most commonly saw patients with either 
asymptomatic clicking or mild TMD pain whilst they saw patients with severe TMD 
pain less commonly. This is again consistent with the incidence of TMD subgroups 
because the most common forms of TMD are low grade myofascial pain and disc 
displacement with reduction (DDwR) whilst acute TMD problems are, relatively, less 
common (Manfredini et al., 2012). 
“Usually the patients I come across come in with pain and clicking and I’d say 9 
times out of 10 they do grind their teeth through the night and they’re aware of 
that or their partner is, they wake up in the morning with pain… so I’d say that’s 
the usual kind of patients we see” (EGDP18) (Knowledge ‘experience’). 
“There will be certain conditions like the acute TMD cases which can be 
challenging because the patient is in extreme pain…but that’s very low” 
(EMGDP1) (Knowledge ‘experience’; Beliefs about capabilities). 
Unsurprisingly, therefore, the primary care clinicians reported more experience with the 
more common TMD subtypes and considered these to be usually a mild, self-limiting 
but a chronic, recurrent problem: “often it is a chronic condition and a recurring 
condition” (EGDP13) and “most cases are probably not so severe” (NGDP5). This is 
as opposed to acute DDwoR (i.e., closed lock9) which the primary care clinicians 
apparently saw as a very different condition: acute, severe, uncommon problem that 
they do not encounter frequently in their daily general practice describing their 
experiences with such an acute DDwoR patient’s presentation as “the odd time” 
(EMGDP3). 
“I mean generally the TMD problems that you do see in practice is [are] due to 
grinding, stress, you know, the bog standard sort of things. You haven’t got the 
locking jaws or with this lady [referring to a DDwoR patient] it was just I hadn’t 
seen it before” (EMGDP2) (Knowledge ‘experience’). 
The clinicians usually remember their personal experience with the conditions they have 
encountered in the past: “we tend to remember patients we’ve seen and conditions we’ve 
treated” (A&E/GMP17). This is especially true for recognition and recall of salient 
event/critical incident such as patients presenting with acute severe symptoms (Arkin 
                                                 
9 During the interviews, the terms ‘closed lock’ and ‘DDwoR’ were used colloquially indistinguishably 
but the clinical condition was explained to the interviewee as the symptomatic acute DDwoR associated 
with TMJ pain and limited mouth opening. 
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and Duval, 1975; Light et al., 1979; Cioffi, 2001). Patients with DDwoR, especially in 
early/acute phase, can be presented with quite severe complaints of TMJ pain and 
limited opening symptoms impacting their functional capabilities and quality of life 
(Anastassaki and Magnusson, 2004; Silva Machado et al., 2012; Fotedar et al., 2015), 
as demonstrated in this quote: “she was clearly in acute pain and hadn’t slept…she had 
quite severe trismus as well” (EMGDP3). Some clinicians in primary care, therefore, 
could easily retrieve their previous experience with this type of patient’s presentation: 
“there was a gentleman, this is quite a long time ago, who had a very...limited opening 
and he erm just couldn’t get any opening at all really, …it was one of the worst ones 
I’ve ever seen” (EGDP12). The ease of retrieval of these particular DDwoR cases from 
the participants’ memory is probably related to their salience and, therefore, they were 
intensively and dominantly held in participants’ memory (Arkin and Duval, 1975). The 
clinicians, however, found it difficult to remember the characteristic signs and 
symptoms of DDwoR if they had not encountered such a case frequently in clinical 
practice. 
“The anatomical malalignment as they [DDwoR patients] open their mouth erm 
would make me think this is significant, I need to do something about this. Now 
whether I would remember which side it [jaw] deviated to or not that I couldn’t 
tell you” (A&E/GMP17) (Knowledge; Beliefs about consequences; Memory, 
attention, and decision processes). 
Patients with DDwoR can be presented to any clinician at the frontline. In a survey-
based study of patients’ choices conducted in the UK, the majority of patients chose to 
consult first a medical (84%) rather than a dental (16%) practitioner if they would have 
a restricted mouth opening symptom (Bell et al., 2008). In the data, however, the 
majority of clinicians at the frontline, whether dentally- or medically- qualified, seemed 
unfamiliar with this type of patient’s presentation. 
“I think genuinely it would strike me as being such an unusual presentation 
[DDwoR] that actually, you know, a differential list of things that it may or may 
not be would be even less and I fear to say would be beyond my understanding of 
the situation such that I’d be saying ‘listen I don’t know what it is, what’s the plan 
to somebody in secondary care’. So it’s less missing diagnosis, it’s more not 
having any idea what it is” (GMP7) (Knowledge; Beliefs about capabilities). 
Many of frontline clinicians (A&E, GMPs, & GDPs) in the study sample reported they 
had not been confronted with a patient having painful limited opening symptom of 
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‘DDwoR’ (12 out of 16 clinicians). That said, some clinicians might have seen such a 
patient but uncertain about the specific ‘DDwoR’ diagnosis. 
“If it’s either painful for them or they can’t seem to open their mouth very wide 
then erm, and I have come across those patients which haven’t given it that name 
[DDwoR], and I would erm, you know, I would refer those patients early” 
(GMP8) (Knowledge; Skills; Memory, attention, and decision processes; 
Nature of behaviour). 
The low incidence of DDwoR amongst TMD patients (Manfredini et al., 2011) is 
probably one of the main reasons for the lack of knowledge and experience with 
DDwoR disorder specifically amongst the majority of frontline clinicians in the sample: 
“I’m not sure if I know much about that [DDwoR] at all” (NGDP14). Perhaps not 
unexpectedly, the clinicians’ experience with patients having DDwoR, as any other 
sudden-onset uncommon condition, did not depend on the number of years the 
practitioners worked in clinical practice: “I haven’t come across it in my how many 
years of practice and I did used to work full-time” (EGDP10); it depended, however, on 
their previous exposure, probably by chance, to such acute DDwoR in the out-of-hours 
emergency service, as demonstrated in the below quote:  
“…when I was on-call I had this poor lady [referring to a DDwoR patient] who’d 
come in…for this one-to-one system …, she’d been told to go to her GP. She’d 
gone to the walk-in centre and because we’re right opposite the walk-in centre 
she’d stumbled across us erm so I managed just to see her” (EMGDP2) 
(Environmental context and resources).  
In the data, the majority of frontline clinicians appeared ‘unfamiliar’ with the nature of 
DDwoR “I’m not familiar with that at all” (EGDP18). Therefore, they expressed 
several worries and concerns if confronted with patients displaying symptoms of 
DDwoR: 
“Actually my first worry would be that they’ll be [DDwoR patients] in a lot of 
discomfort and a lot of pain, affect their eating and, you know, general day to day 
things. So I guess that will be my first concern is that they’ll be going through a 
lot of pain really” (EGDP18) (Beliefs about consequences; Emotions). 
On the contrary, apart from one clinician unfamiliar with the condition: “I’ve not 
encountered it myself” (OMFS20), all OMFS clinicians, regardless of their working 
experience, reported that they had encountered patients having DDwoR in secondary 
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care and being familiar with this type of patient’s presentation: “that’s a fairly frequent 
[presentation]” (OMFS11). Therefore, they were relatively, “not particularly 
[worried]” (OMFS11) if confronted with an acute DDwoR.  
The uncertainty over the DDwoR diagnosis in primary care and the early referral of the 
‘undiagnosed’ patients from primary to secondary care for such a low incidence 
disorder could explain why the OMFS clinicians saw DDwoR patients more frequently 
in secondary care setting and, therefore, had more experience than the primary care 
clinicians. Another finding relating to the referral process was that of the referral 
waiting time was sometimes seen as being too long: “it usually takes a few 
months...about 2 to 3 months” (EGDP18), and by this time the DDwoR patients may 
have resolution of the acute symptoms (Yura, 2012). Therefore, if there is a delay in 
patient’s presentation, the secondary care clinicians might be confronted more often 
with the chronic rather than the acute DDwoR; although this could not be verified in the 
data. 
The low incidence of DDwoR, however, cannot be rationalised as the sole reason for the 
lack of knowledge about DDwoR among the frontline clinicians. The incidence of acute 
TMJ dislocation amongst TMD is not determined yet but it seems to be comparable to 
that of DDwoR (Luz and Oliveira, 1994; Dahlstrom, 1998). In the data, many frontline 
clinicians reported that they had also never been confronted with an acute TMJ 
dislocation (9 out of 1510 clinicians) but despite that, many of them had seemingly 
sufficient knowledge about the condition presentation and its management.   
“Q: If we talk about another condition which is the TMJ dislocation, have you 
been confronted with such a patient?  
 R: No but I know about the management of it… you have to put your thumbs on 
the occlusal surface of the lower molars and then manipulate the mandible 
backwards into place” (EMGDP3) (‘procedural’ Knowledge). 
In summary, the clinicians’ knowledge and experiences seemed to vary according to 
their work context which determines the type and frequency of patients’ presentation to 
their practices. The GDPs appeared to have higher levels of knowledge and experience 
with TMD than the GMPs but, all the dental and medical primary care clinicians 
                                                 
10 The first interviewee (EMGDP1) was not asked about TMJ dislocation.  
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seemed to be familiar with TMD patient’s presentation and considered TMD as a mild 
self-limiting problem. The repetitive frequent exposure to more common TMD 
problems in primary care probably increases the professionals’ knowledge and skills in 
diagnosing and treating such ‘mild’ conditions over the years. In contrast, given the low 
incidence and infrequent exposure to uncommon severe TMD problems, all the 
clinicians at the frontline, whether dentally- or medically- qualified, seemed unfamiliar 
with acute DDwoR patient’s presentation and had limited knowledge and experience 
with DDwoR specifically. Clearly, these variations have impacts on the clinicians’ 
diagnostic, treatment, and referral decisions. 
Step 2: Diagnosis 
The clinicians seemed to have differing levels of diagnostic uncertainty and ability to 
make a diagnosis for the discussed clinical conditions.  
Value of terminology used for conditions’ diagnosis 
When the clinicians asked first about chronic orofacial pain (COFP), most, if not all, 
primary and secondary care clinicians considered it a vague generic terminology. The 
clinicians often described COFP as an “umbrella” (OMFS4), “undifferentiated” 
(GMP7), or “very broad” (OMFS11) term “covering a wide umbrella of different 
problems” (EGDP10), and “could mean any number of things” (EMGDP3). This 
supports the view that the term ‘COFP’ should not be used for diagnosis, instead it is 
necessary to sub-classify it in order to establish an accurate diagnosis (Benoliel and 
Sharav, 2010). The definition of the reference period for ‘chronic’ pain differed from 
clinician to clinician in secondary care as either “longer than three months” (OMFS19) 
or “more than about 6 months” (OMFS11). This reflects the debate around the 
definition of duration of ‘chronic’ pain in the literature (Von Korff et al., 1992; 
Merskey and Bogduk, 1994; Palla, 2006; Dworkin et al., 2011). 
Similarly to the ‘COFP’ term, the term ‘TMD’ was also described by some clinicians as 
“an umbrella term” (EMGDP3) involving “a wide variety of disorders” (EGDP10). In 
the recently expanded TMD taxonomy, 56 different conditions were initially considered 
and 37 disorders were included (Peck et al., 2014), which indicates that the use of TMD 
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as a diagnostic term is of limited value (Benoliel and Sharav, 2010). There is some 
evidence that the use of generic all-inclusive ‘TMD’ diagnosis in clinical practice and 
scientific research can be one of the reasons for the clinicians’ lack of ability to 
differentiate between subtypes of temporomandibular disorders. Two recently published 
studies have shown that only a small percentage (10-24%) of referred TMD patients had 
a formal ‘TMD’ subgroup diagnosis defined (Beecroft et al., 2013; Kraus, 2014). In the 
current study, many clinicians at the frontline (A&E, GMPs, & GDPs) found difficulty 
to remember the TMD subgroups or appeared uncertain about them: “certainly I don’t 
know the difference between erm the subgroups of TMD so maybe that would be 
something and maybe how to treat each one slightly differently” (NGDP14). 
Furthermore, the data indicated that most frontline clinicians revealed vague knowledge 
about DDwoR/closed lock terms and confused these with other terms (e.g., DDwR and 
DDwoR; closed lock and open lock) or expressed lack of understanding of ‘DDwoR’ 
terminology: “I don’t understand what that term [DDwoR] is. I don’t have insight into 
what that is and why that would be a subgroup of TMJ disorder” (GMP7) 
(Knowledge). 
Clearly, labelling patients with different disorders as ‘TMD’ patients hinders the 
development of knowledge about different TMD subtypes’ diagnoses and treatments. 
This has led some experts to suggest the use of TMD as a ‘diagnostic label’ should be 
discarded altogether (Laskin, 2008; Benoliel, 2010). However, this is a debatable issue 
with some experts arguing for simplicity by grouping all patients with common TMD 
problems together and treating them all using ‘similar’ conservative management 
approach in the first instance. They suggest this will be of benefit to frontline clinicians 
in that they will be more likely to easily remember the simple things to do in practice 
(Greene, 2010b). Others, however, argue for detailed management by differentiating 
between the different disorders of TMD and providing targeted treatments to each 
disorder specifically in order to avoid a “blunderbuss” type approach to treatment of all 
TMD patients (Okeson, 2007). There is, in fact, a need to understand both the 
specificity of each temporomandibular disorder’s pathophysiology and the effectiveness 
of each associated specific treatment for each individual disorder (Okeson, 1997a). For 
example, the effectiveness of the ‘unlock’ mandibular manipulation when used as a 
treatment specifically for DDwoR management. 
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Diagnostic uncertainty 
The general approach often reported by the clinicians when confronted with a clinical 
condition was trying to identify the source of the problem: “very often we seek for the 
cause of the pain” (A&E/GMP17). In biopsychosocial COFP conditions, however, 
there could be no obvious ‘biomedical’ cause to explain the chronic pain to make a 
diagnosis (Madland et al., 2001). The clinicians in primary care, therefore, generally 
reflected upon COFP repeatedly as “a long standing history of pain without an obvious 
cause or certainly one that’s undiagnosed” (GMP9) (Knowledge).  
In a national survey conducted in the UK, Aggarwal et al. (2012) explored GDPs’ 
diagnosis, treatment and referral patterns of COFP conditions using 4 case-scenario 
questionnaires. The study found that most GDPs could correctly diagnose the TMD 
(87%) and burning mouth syndrome (92%) scenarios but they were less successful in 
diagnosing the other two ‘atypical’ orofacial pain conditions. In a national survey of the 
UK final year dental students, about 36% of respondents showed reduced confidence in 
the differentiation between pain of odontogenic and non-odontogenic origin (Macluskey 
et al., 2012). Recently, a qualitative study conducted in the UK reported that all the 
sampled primary and secondary care medical and dental practitioners felt uncertain 
about diagnosing COFP patients (Peters et al., 2015). Similarly, in this study, the 
majority of primary and secondary care clinicians generally acknowledged difficulty in 
diagnosing COFP conditions and often reported trying to ‘pick-up’ the diagnosis by “a 
process of eliminating the causes” (OMFS20). Many dental practitioners, however, 
indicated that they could recognise patients having a TMD problem: “I pick it up quite 
straightaway when they [patients] start giving a history. Straightaway I’m thinking I 
don’t think this is teeth, what it is: is TMD” (EMGDP2). Nevertheless, most clinicians 
also pointed out that the TMD diagnostic process may not always be simple and “can 
be very difficult” (OMFS19) sometimes because it can be “quite difficult to find the 
exact cause [of pain]” (EGDP18) or to differentiate the TMD pain from other sources 
of pain.  
“I think some cases are very plain and obvious that, you know, that is a 
temporomandibular disorder case, some I find tricky erm when the patient is 
coming in with a dental pain that I don’t agree is of dental origin, you know. I 
find that those cases are a bit tricky to diagnose and is it this tooth that’s maybe 
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sort of causing the pain or is it a different condition to sort of a facial pain or a 
TMD” (NGDP5) (Skills). 
Misdiagnosis of TMD in general practice is not uncommon (Renton and McGurk, 
1999). The clinicians’ diagnostic uncertainty about TMD was highlighted in previous 
qualitative studies (Durham et al., 2007; Durham et al., 2010). In the data, the clinicians 
attributed their diagnostic uncertainty about TMD to several factors including: TMD 
being a clinical diagnosis without any definitive investigations available currently to 
identify its causes, non-specific TMD symptoms may overlap with other conditions or 
fluctuate over time, TMD symptoms are usually subjective and, therefore, the patients 
may find difficulty explaining their subjective 'pain' symptoms and clinicians may also 
find difficulty eliciting a meaningful response from the patient. 
“I think it’s not easy [to diagnose TMD] because of the potential for quite a lot of 
uncertainty and also my appreciation of it suggests that it’s largely a sort of 
clinical diagnosis therefore there’s always a degree of uncertainty and I think a 
lot of it is about, you know, excluding the possibility of mass lesion or whatever, 
depends on the age of the patient, is probably on my mind first and then I would 
always suggest it to the patient openly that it’s a working diagnosis really and not 
that I have the necessarily all of the answers but this is something we’re going to 
try and, you know, we do see this, let’s give it a try with that level of 
certainty…[because] there’s no absolute way of proving or disproving it, you 
know, …there’s not a definitive investigation which proves it or disproves is a 
dangerous thing” (GMP7) (Skills; Beliefs about capabilities; Beliefs about 
consequences). 
Some clinicians reported that they “offer a trial of treatment” (GMP9) to the TMD 
patients and measure the patients’ treatment response as a kind of diagnostic measure: 
“I think it’s often diagnosis by providing a splint and seeing if the problem goes away” 
(EGDP10). This strategy clearly shows the clinicians’ diagnostic uncertainty as well as 
unpredictability about the outcomes of the provided treatment. 
When asked if a patient having TMJ pain and limited opening presented to their 
practices, the majority of clinicians at the frontline (A&E, GMPs, & GDPs) felt 
“uncomfortable” (EGDP10) and expressed high degree of diagnostic uncertainty. 
“Well you want to rule out, I guess erm...well you want to check their [DDwoR 
patients] background, their systemic history, you want to make sure they’ve not 
got something like quinsy or something. If that’s ruled out and it does seem like 
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TMJ and they can’t open their mouth I’d be quite uncertain actually” (GMP9) 
(Knowledge; Skills; Beliefs about capabilities; Beliefs about consequences).  
In actual practice situations, some frontline clinicians recalled their past experiences of 
confronting patients with TMJ pain and limited opening symptoms which potentially 
are suggestive of a ‘DDwoR’ disorder. Most of them, however, were either uncertain 
about the specific ‘DDwoR’ diagnosis: “the one patient I did see, I wasn’t really sure if 
they had reduced or not. They [She] had quite bad trismus and restricted movement so I 
wasn’t sure whether it was [disc displacement] without reduction or with reduction” 
(EMGDP3), or concerned regarding a misdiagnosis: “I’ve had one patient who couldn’t 
open their mouth for some months and I’m worried about a dislocation of the TMJ” 
(GMP9) (Knowledge; Skills; Beliefs about capabilities; Beliefs about 
consequences). 
This study indicates that diagnostic uncertainty about DDwoR among frontline 
clinicians is mostly attributed to their limited knowledge and experience with the type 
of acute DDwoR that presents as a severely painful sudden-onset condition with an 
‘extra’ symptom of limited mouth opening. Consequently, most, if not all, clinicians at 
the frontline reported their lack of confidence in diagnosing the ‘DDwoR’. 
“I wouldn’t feel very confident. Erm I’d probably sort of describe the situation 
and describe my examination finding to someone but reaching sort of the actual 
[DDwoR] diagnosis I think I would probably struggle with that because I don’t 
see very much of it” (A&E16) (Knowledge; Skills; Beliefs about capabilities). 
The uncertainty in DDwoR diagnosis among the frontline clinicians could be also due to 
the fact that DDwoR may be ‘lost’ through the general, and colloquial, use of the 
catchall ‘TMD’ term (Laskin, 1998). As mentioned, this may result in lack of ability to 
differentiate DDwoR from other temporomandibular disorders as shown in the below 
quote:  
“Q: When you try to diagnose such a [DDwoR] patient how confident do you 
feel?  
  R: Erm not 100 percent. I’m not sure what the subgroups are all called. I know 
that it all falls under the one umbrella of TMD but I’m not sure which subtype to 
put it under. So to diagnose TMD I’d be fairly confident erm but to put it into a 
subcategory I’d be less confident, yeah” (NGDP14) (Knowledge; Beliefs about 
capabilities). 
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The last point is confirmed in recent studies which found that the majority of referred 
patients with TMD signs and symptoms have not been given a specific descriptive 
subtype diagnosis or given only a generic ‘TMD’ diagnosis (Beecroft et al., 2013; 
Kraus, 2014). In this study, most frontline clinicians seemingly were able to just simply 
categorise a patient presented with painful/limited opening as a patient having a 
‘significant’ problem and refer the ‘undiagnosed’ patient early rather than being able to 
specifically diagnose ‘DDwoR’. 
“I think a lot of general practices knowing what’s normal and knowing what’s not 
normal but I think if I was examining that patient I would think that okay this is 
not normal mouth opening, you know, there’s something going on here that needs 
looking at more so, like I say, I wouldn’t necessarily give it that [DDwoR] 
diagnosis but I would refer on for a diagnosis” (GMP8) (Knowledge; Skills; 
Beliefs about capabilities; Beliefs about consequences; Memory, attention, 
and decision processes). 
Clearly, the high diagnostic uncertainty of frontline clinicians could have a negative 
impact on patients who might be referred without being given a specific diagnostic 
‘label’ and subsequently not having any information, explanation, or reassurance about 
their condition at the first-point of contact (Durham et al., 2010). 
“I saw him [a potential DDwoR patient] on sort of an acute basis obviously but 
then it took a while for the referral to come through and that gentleman sadly 
always had, he never regained full movement of his joint after that, that occasion. 
Erm he was very accepting of it and, you know, it made it potentially quite 
difficult erm but, you know, for that gentleman it wasn’t a positive outcome...there 
was a permanent problem and they never resolved…. We never really did get to 
the bottom of why that occurred” (EGDP12) (Skills; Beliefs about capabilities; 
Beliefs about consequences). 
In contrast to frontline clinicians, all OMFS clinicians, apart from one: “I wouldn’t feel 
particularly confident” (OMFS20), felt able to make at least the clinical diagnosis of 
DDwoR, but reported using magnetic resonance imaging (MRI) in order to investigate 
the disc position and increase their confidence through confirmation of their 
‘provisional’ DDwoR clinical diagnosis.  
“I tend to usually carry out an MRI before I feel really confident [in DDwoR 
diagnosis] but I feel erm yeah that there are significant amounts of patients that I 
think that’s what’s happening, or I’m pretty sure that’s what’s happening, yeah” 
(OMFS19) (Knowledge; Skills; Beliefs about capabilities; Environmental 
context and resources).   
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Diagnosis process 
History and clinical examination 
TMD diagnosis is based largely on a detailed patient history and thorough clinical 
examination (Greene, 2010b). In a recent survey-based study, most GDPs reported that 
they primarily diagnose TMD on the basis of history (37%) or examination (30%) 
(Aldrigue et al., 2015). In this study, the majority of primary and secondary care 
clinicians paid specific attention to key findings in patient history, specifically social 
history, and/or clinical examination. The dentally-qualified clinicians, however, focused 
their attention more on characteristic signs and symptoms of TMD and, therefore, 
appeared more confidently able to diagnose TMD clinically than the medically-qualified 
clinicians.  
“I find it quite easy [to diagnose TMD]. Erm often they’ve come to the practice a 
few times that I often notice, because I always do my full checks of everything, 
doing my extra-oral examinations, so I pick up on erm people that are quite 
stressed” (NGDP15) (Knowledge; Skills; Beliefs about capabilities).  
“It’s difficult so it might not be someone [TMD patient] who you automatically 
straightaway diagnose it” (GMP8) (Knowledge; Skills; Beliefs about 
capabilities).  
The difference between dental and medical practitioners’ ability to diagnose TMD could 
be attributed to limited knowledge, experience, and expertise in TMD among medical 
practitioners as one dental practitioner articulated: “[The] general medical 
practitioners…very much feel, or seem to feel, that the mouth is a dentist’s remit and 
don’t have quite so much expertise” (OMFS19). The medical practitioners confirmed 
this assertion by giving that as a reason to signpost their patients to GDPs: “I have a 
healthy regard for my lack of understanding about what goes on in the mouth and er 
our dental colleagues are experts in that area” (GMP7) (Knowledge; Skills). 
As previously stated, TMD is a group of different disorders and clinicians might, 
therefore, expectedly encounter various types of TMD problems in their clinical 
practice. This was seen to add difficulty with the diagnosis process as demonstrated in 
the below quote: 
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“It’s [TMD] just so varied. That’s part of the difficulty that it’s trying to make a 
clear diagnosis about how serious the condition is based on their symptoms 
because it can be acute or they can become chronic” (EGDP12) (Skills; Beliefs 
about capabilities). 
In the initial step of the TMD diagnosis process, therefore, some dental practitioners 
reported that they split-up the TMD into different subgroups, mainly muscular- and 
joint-related disorders. 
“Well in my mind and from my training I tend to divide it [TMD] up into 
myofascial problems so muscular, joints, specifically joint related problems and 
then TMD as a manifestation of any chronic systemic disorder such as arthritis or 
things like that” (EMGDP3) (Knowledge; Skills). 
The most reliable criteria that can help clinicians differentiate between subgroups of 
TMD are the research diagnostic criteria (RDC/TMD) (Dworkin and LeResche, 1992). 
The use of the RDC/TMD in clinical practice, however, has been shown to be hindered 
by lots of barriers: lack of clinicians’ familiarity; clinicians’ perceptions of the tool as 
overly complex, time-consuming, and designed specifically for research purposes; the 
similarity of conservative treatments utilised for most TMD patients regardless of their 
specific diagnosis; the presence of sub-clinical symptoms with respect to the RDC/TMD 
in some TMD patients (Durham et al., 2007; Beecroft et al., 2013). In this study, one 
GDP highlighted the difficulty of applying ‘extensive’ criteria to diagnose different 
subgroups of TMD due to time constraints in NHS primary care: 
“I think clinicians just need to be taught better understanding of TMD conditions 
just generally and then a bit more specifically about…diagnosing the different 
conditions but I think the NHS contract doesn’t allow time for clinicians to spend 
time doing all the different criteria that they do in a hospital” (NGDP15) 
(Knowledge; Skills; Environmental context and resources). 
In fact, the ‘original’ RDC/TMD has been criticised for being only appropriate for 
research purposes (Dimitroulis, 2013). An adapted, more practical, shortened version 
has been established and disseminated (Hasanain et al., 2009) but it seems to be not 
widely used in clinical practice. Hopefully, the newly developed diagnostic criteria 
(DC/TMD) (Schiffman et al., 2014a) may overcome this problem but their claimed 
clinical utility and practicality seems doubtful and needs to be proven. To give an 
example, one of the criteria for DDwoR diagnosis in the ‘original’ RDC/TMD is the 
absence of clicking sound. Interestingly, most OMFS clinicians in the study sample 
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reported their reliance on this criterion to make the ‘DDwoR’ diagnosis: “usually these 
patients have…a long standing history of a clicking jaw and then one day it doesn’t 
click, it just locks” (OMFS11). Unfortunately, to increase the sensitivity and specificity 
scores of DDwoR diagnosis, this criterion has been omitted from the newly 
‘recommended’ DC/TMD (Table 2.6), perhaps because it cannot always be 
confirmatory for DDwoR diagnosis (Miller et al., 1985; Widmalm et al., 1992). This 
finding gives some indication that the new criteria for DDwoR may be impractical for 
use. This study shows that most of the clinicians sampled found difficulty recalling 
different TMD subtypes and specifically were unfamiliar with the diagnosis of DDwoR. 
The clinicians, it would seem, are in need of a user friendly tool focusing on particular 
pathognomonic signs and symptoms which will allow them to make better diagnostic 
decisions and, for DDwoR specifically, avoid the potentially serious consequences of 
misdiagnosis (Beddis et al., 2014). At the moment, it is difficult to prove if the new 
DC/TMD has the claimed clinical utility (Vilanova et al., 2015) and if it can aid the 
clinicians to differentiate the DDwoR from other conditions with similar ‘trismus’ 
symptom (Table 2.7).  
The existence of numerous conditions which may present with symptoms mimic to 
DDwoR, such as limited opening, is one of the diagnostic difficulties that clinicians 
may encounter when diagnosing a DDwoR patient, making the differential diagnosis of 
DDwoR challenging. Nevertheless, there are specific key findings that should make the 
clinician able to distinguish the DDwoR disorder from other conditions causing 
‘trismus’ and most OMFS clinicians were seemingly aware of these. 
It has been suggested that the practice of decision-making improves the clinicians’ 
performance over time (Benner, 1982; Botti and Reeve, 2003; Croskerry, 2005a) and, 
therefore, “experienced clinicians perform better than novices” (Croskerry, 2005a). This 
seems to be reflected in this study as it was noticed that there was an important disparity 
in the initial phase of diagnostic decision-making processes for DDwoR between 
clinicians at the frontline (A&E, GMPs, & GDPs) and those at the specialist (OMFS) 
service. Most OMFS clinicians focused their attention to pathognomonic signs and 
symptoms of DDwoR:  
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“Well there may be clues in what they tell you that they may have had problems 
for a number of years, they may have had a clicking joint initially and then it 
stopped clicking and then they started to have problems opening. They might have 
a completely closed down in the morning, they might get much more sort of stiff as 
the day goes on but yeah, generally kind of pain and mobility issues and I suppose 
on examination you might notice…they wouldn’t have a click, they might have 
trismus, they might deviate to their abnormal site,… They might be very tender as 
well, the muscles of mastication” (OMFS19) (Knowledge; Skills; Memory, 
attention, and decision processes). 
In contrary, most frontline clinicians did not pay specific attention to such signs and 
symptoms. This is apparently related to lack of knowledge and experience with DDwoR 
disorder specifically among the frontline clinicians rather than forgetting to mention the 
details of the decision-making process pertaining diagnosis, as illustrated in the below 
quote: 
“I try and do a physical examination first so I try and work out how the joint is 
actually working by literally just asking patients to open and close. Find out if the 
joint’s rotating and translating properly, if there’s a click present, erm if there’s 
any deviation of the lower jaw whilst the patient’s opening or closing and if 
there’s any pain associated with any of those movements and then I would just 
record that. I’m not terribly confident in interpreting that and saying exactly 
what’s going on within the joint but if there was something significant, erm 
particularly the patient couldn’t translate to something like that that with the 
limited opening those would be the ones I would be most concerned about, the 
ones I would need to refer more quickly” (EGDP12) (Knowledge; Skills; Beliefs 
about capabilities; Beliefs about consequences; Memory, attention, and 
decision processes; Nature of behaviour).  
The two groups of clinicians seemingly utilised completely different approaches in 
decision-making. The ‘experienced’ OMFS clinicians seemingly could recognise the 
pattern of DDwoR early and target particular information to diagnose ‘DDwoR’ by the 
pattern recognition decision-making approach (Manias et al., 2004; Banning, 2008). 
This is illustrated in the below quote:  
“I suppose it’s a matter of er if something that the patient might say might trigger 
you into thinking oh maybe it’s this and I’ll ask a few more questions about this 
erm, you know, some of them might say ‘I initially had a click and now I don’t 
have a click anymore’ and so that might make you feel that, you know, they’ve got 
disc displacement without reduction now” (OMFS19) (Knowledge; Skills; 
Memory, attention, and decision processes). 
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In contrast, given their high diagnostic uncertainty, the ‘inexperienced’ frontline 
clinicians faced with DDwoR might try to use all the available resources in order to 
ascertain a diagnosis by an exhaustive decision-making approach (Croskerry, 2002). 
This is demonstrated in the below quote: 
“I think you’d think about getting x-rays erm because it will be a case of wanting 
to see if there is either er injury to the jaw, a dislocation so you think about your 
OPG and your mandible, again your OPG would show if there’s something that’s 
sort of a tooth abscess or something that could be causing infection so it would 
help with the diagnosis. Erm again you’d probably think about doing blood tests if 
you were thinking of it as something like an acute infection or to check things like 
erm sort of calcium levels and bits and pieces in case, rather than it being a jaw 
that was locked, it was like a trismus erm or anything and you don’t really sort of 
see it or you only see it rarely with things like sort of tetanus” (A&E16) 
(Knowledge; Skills; Beliefs about consequences; Environmental context and 
resources). 
Many clinicians, however, seemed to approach clinical decision-making by firstly 
ruling out the worst-case scenario (Croskerry, 2002) when they encountered patient 
with ‘unusual’ presentation, such as DDwoR. This approach not only reflects the 
clinicians’ diagnostic uncertainty but also their concerns/worries about missing serious 
pathology. 
“I think one thing that would be quite important to pick up with it and one reason 
why you may do an MRI scan is people who present with trismus, ...it can 
sometimes be caused by temporal fossa tumours so you do an MRI scan to 
investigate for that because often sort of women over 30 or 40 would start to 
get...you start to sort of think could it be something odd, you know, just some 
facial pain you can’t quite understand that it doesn’t fit with anything classic” 
(OMFS4) (Knowledge; Beliefs about consequences; Memory, attention, and 
decision processes; Environmental context and resources). 
The clinicians’ concerns/worries about misdiagnosis and the consequences of missing 
serious pathology ‘in their mind’ and their expectations of ‘worst case scenarios’ 
probably led the ‘inexperienced’ clinicians at the frontline to directly refer possible 
DDwoR patients to the specialists. This ‘rule of thumb’ approach of referring the 
undiagnosed potentially ‘significant’ condition early before establishing a definitive 
‘DDwoR’ diagnosis is a simple heuristic decision-making but it might not be the best 
decision and often prone to bias in conditions of uncertainty (Gigerenzer et al., 1999; 
Hutchinson and Gigerenzer, 2005). 
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In the data, some clinicians pointed out the importance they placed on identifying that 
“there are no red flags that concern” (A&E/GMP17; Emotions) them in the initial 
stage of the diagnostic process. The necessity to educate clinicians to enhance their 
knowledge about the red flags’ signs and symptoms (Table 2.9) when diagnosing 
patients with painful conditions in order to avoid potential serious consequences of 
delayed diagnosis/treatment has been emphasised in the literature (Huntley and 
Wiesenfeld, 1994; Al-Jamali et al., 2013; Beddis et al., 2014). This point was also 
highlighted in this study by one OMFS clinician as a result of discussion with peers: 
“I think that as a whole professionals maybe should be more aware of the 
worrying signs to look out for, like I went and had a chat with [surgeon name], 
…and said well you’re forgetting a patient’s kind of got this sudden boring type 
pain around the TMJ region and they’re kind of over 50, you’ve got to be thinking 
about things like acoustic neuromas, also if you’re getting bilateral pain up here 
thinking things of giant cell arteritis or be aware of the broader picture. Erm and 
it’s something that doesn’t always come to the forefront. I suppose if I saw an 
elderly patient and they were getting this pain for the first time, they’ve not had it 
before, I’d be more concerned just because of their age, erm but I don’t think 
everybody’s particularly aware of that” (OMFS20) (Knowledge; Beliefs about 
consequences; Memory, attention, and decision processes; Emotions; Social 
influences). 
Radiographic investigations 
In addition to patient history and clinical examination, many clinicians discussed the 
role of various diagnostic investigations, mostly TMJ radiographic investigations. In the 
literature, TMJ imaging such as orthopantomograph (OPG), computed tomography 
(CT) scan, or MRI have been found to be routinely and repeatedly used for patients with 
TMD (Beecroft et al., 2013; Kraus, 2014). In a survey-based study, about half of the 
GDPs sampled reported their frequent use of radiological investigations to diagnose 
TMD (Wirz et al., 2005). In this study, most primary care clinicians reported that 
panoramic radiographs are unnecessary for the majority of TMD patients but they might 
order OPG for DDwoR case scenario to rule-out other pathologies: “I might take an 
OPG just to rule out any pathology around the joints” (NGDP15). The absence of OPG 
machine in some primary care practices was, sometimes, given as an additional reason 
to refer patients to secondary care: “we have no erm OPG machine erm so we have no 
availability to do that so that would be another reason why I would need to refer if I 
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thought the joint did need to be looked at” (EGDP12) (Knowledge; Memory, 
attention, and decision processes; Environmental context and resources).  
The OMFS clinicians also reported that they might request an OPG or even a CT scan 
for joint-related disorders to rule-out pathologies and they might order a MRI for 
DDwoR to identify the disc position. The clinicians, however, differed in their 
perspectives regarding the necessity of imaging the joint: “I’m not entirely convinced 
about the usefulness of the MR scan for imaging the jaw joint mechanism” (OMFS11). 
They also expressed contradictory opinions about the usefulness of MRI findings for 
DDwoR treatment planning, for example with this clinician saying:  “sometimes you 
might confirm that there is a problem with the disc but you might still not do anything 
about it anyway” (OMFS19), as opposed to this clinician who stated: “it does influence 
my decision to actually be more aggressive in the treatment” (OMFS21). These 
opposing views reflect the considerable debate in the literature around the role of 
imaging in TMJ disorders management in general and its appropriateness for DDwoR 
patients in particular. Many authors advocated minimising their use to avoid 
unnecessary risk of ionising radiation and waste resources without beneficial outcome 
(Kraus, 2014; Ekberg et al., 2015), whilst others supported their use to aid diagnostic 
decision-making process and avoid risk of missing a serious pathology (White and 
Pullinger, 1995; Al-Jamali et al., 2013; Beddis et al., 2014).  
In fact, with detailed history and thorough clinical examination, it is often possible to 
diagnose patients with ‘acute’ DDwoR with limited opening clinically without the need 
for any imaging to the joint (Manfredini and Guarda-Nardini, 2008). Nevertheless, this 
study indicated that most of the OMFS clinicians sampled might order MRI for DDwoR 
patients despite its controversial role and effect on management decision. The rationale 
given for ordering MRI varied between clinicians, but in summary the reasons given 
included: 
1. Rule-out serious pathologies such as tumours and reassure the clinician’s 
concerns: 
“Erm you may do an MRI scan just to reassure yourself that there’s nothing 
abnormal there” (OMFS4) (Beliefs about consequences). 
2. Confirm DDwoR clinical diagnosis: 
  
248 
 
 
“I think that the only way you can absolutely confidently diagnose that 
[DDwoR] is to have an MRI which is actually being reported by an experienced 
radiologists or you have a look at it yourself” (OMFS21) (Beliefs about 
capabilities). 
3. Used to find a biomedical cause of the problem thereby increasing the 
professional’s confidence about the diagnosis of the condition and explaining it 
to the patient. It is also used as a back-up for the clinician (potentially for 
medico-legal purposes):  
“I like to do it [MRI]. I think erm I don’t know if that’s the nature of someone 
that’s involved in surgery. You just like to see a picture of something clearly. 
Because…sometimes it doesn’t necessarily manage and it doesn’t really 
necessarily change what you end up doing, but I suppose then you can more 
confidently explain to the patient, it’s like a backup at the very least. So I like to 
do them” (OMFS19) (Professional role and identity; Beliefs about 
capabilities; Beliefs about consequences). 
4. Planning for joint surgery before intervening: 
“If it [DDwoR] comes to surgery a lot of the time I would arrange an MRI” 
(OMFS21) (Beliefs about consequences).  
In summary, the clinicians vary in their diagnostic decision-making processes and 
abilities to diagnose TMD and DDwoR. The dental practitioners appeared more 
confidently able to diagnose TMD clinically than the medical practitioners, but all the 
clinicians at the frontline, whether dentally- or medically- qualified, were uncertain 
about DDwoR disorder specifically to make a diagnosis. These variations clearly have 
impacts on their treatment/referral decisions. 
Step 3: Treatment  
The clinicians seemingly vary in their perceived role, abilities, and plans to treat the 
discussed clinical conditions.  
Clinicians’ perceptions of the conditions and their perceived role in treatment process 
Several published reports emphasise the important role the general medical and dental 
practitioners should play in early diagnosis and treatment of COFP/TMD conditions in a 
primary care setting (Okeson and de Kanter, 1996; Dimitroulis, 1998; Newton-John et 
al., 2001; Steenks, 2007; Durham et al., 2011; Klasser and Gremillion, 2013). This is 
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primarily to avoid potential psychosocial consequences of delayed diagnosis and 
treatment (Gatchel et al., 2006; Durham et al., 2010). In the study data, however, the 
primary care clinicians often reported their negative perceptions about COFP patients’ 
response to treatment and prognosis: “I think that will be, without referring them 
[COFP patients], I think it will be a case of seeing them all the time and without moving 
forward” (GMP9). The perceived role of the majority of primary care clinicians, 
therefore, was to try and identify the cause of the problem or source of pain, rule-out 
serious pathology and ‘pick-up’ a diagnosis, and then refer patients with chronic pain 
early to secondary care rather than treating them in primary care. In a recent qualitative 
study conducted in the UK, Peters et al. (2015) explored the experience and 
understanding of COFP by patients and primary and secondary care medical and dental 
practitioners. The study found that all participants share negative experience of COFP 
as difficult and frustrating to understand and manage (Peters et al., 2015). Other studies 
also found that the primary care clinicians have difficulties in managing COFP patients 
and often prefer to refer early without initiating a treatment (Aggarwal et al., 2012; 
Beecroft et al., 2013). This could be interpreted as a type of disposal of ‘deviant’ 
patients as described by Jeffery (1979) and Freidson (1984). 
“My role in chronic conditions would be, as a general practitioner in a primary 
care setting, would be to 1) exclude er easily treatable dental conditions, say 
dental caries, periodontal disease, pulpitic teeth, erm that sort of thing to er look 
for obvious occlusal problems, erm say loss of posterior support and treating that 
sort of thing. 2) I would erm be involved in simple treatment of TMJ dysfunction 
erm and referral for the other conditions like if I made a diagnosis of trigeminal 
neuralgia I would refer erm for treatment erm and more complex erm occlusal 
problems I would refer” (EGDP13) (Professional role and identity; Beliefs 
about capabilities; Memory, attention, and decision processes). 
Some GMPs, however, felt that they have a role to treat chronic pain patients in primary 
care. This may be in part due to their broad medical background and experience in 
treating chronic conditions such as diabetes and rheumatoid arthritis (Weel, 1996) and 
in part due to differences in the nature and type of clinicians’ practices; that is: the 
dental practitioners are usually more orientated to intervene ‘physically’ to treat the 
patients’ dentoalveolar diseases rather than to wait and see (Brennan and Spencer, 2006) 
whilst the medical practitioners are generally more orientated to listen to patients’ 
complaints and prescribe medications (Bell et al., 2008) as one participant highlighted: 
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“I think that my role almost begins and ends with listening to the patient and certainly 
that’s 99 percent of the job that I do day in day as a GP” (GMP7) (Professional role 
and identity). 
In secondary care, the difference in the nature of the services provided by A&E and 
OMFS clinicians and how patients access them for care seemed to be reflected in 
clinicians’ perceived roles (Ismail et al., 2013). The A&E clinicians seemed to feel that 
patient attendance with chronic problems to A&E is ‘inappropriate’. They stated that in 
the context of urgent access services they cannot prescribe long-term medications, 
review or follow-up these patients, refer them to other services or receive feedback from 
these services. Therefore, they felt that they do not have a role to treat COFP patients 
and prefer to signpost those patients directly to a more ‘appropriate’ clinician: “if 
people do come in with chronic problems your main role is to try and signpost them to 
someone more appropriate or unless there’s something more serious going on” 
(A&E6). The OMFS clinicians, however, are usually involved in treating referred 
COFP patients (Beecroft et al., 2013). In the data, apart from one OMFS clinician: “if it 
doesn’t involve surgery, I don’t think it’s my role” (OMFS21), all felt they have a role 
to treat the COFP patients.     
“I think my first role is to rule out any serious pathology and then …try and pick 
out what is wrong with that patient, what is the major contributing factor to their 
symptoms and then try to work out what’s going to benefit them most in terms of 
reducing their symptoms, and this is where it gets quite difficult” (OMFS11) 
(Professional role and identity; Beliefs about consequences; Beliefs about 
capabilities; Memory, attention, and decision processes). 
Similarly to clinicians’ negative perceptions about COFP patients, the primary and 
secondary care clinicians also reported negative perceptions about TMD patients: “often 
when you talk to colleagues about patients everyone kind of gets that heart sink when 
there’s a TMD patient” (OMFS20). The so-called ‘heart sink’ feeling (O'Dowd, 1988; 
Bligh, 1999) about TMD patients among clinicians is probably related to their 
awareness about the complex biopsychosocial nature of TMD and the possible 
challenges when managing those patients which can potentially be attributed to multiple 
reasons. 
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One of the reasons for this may be a previously expressed view that the TMD patients 
can be ‘needy’ patients (Durham, 2007) because they “take a lot more time” (GMP8) 
and require longer successive appointments. In the data, most clinicians highlighted that 
they “need [a] longer [appointment time]…with TMD patients” (OMFS20) than other 
conditions to take history, examine, diagnose, and treat, or even to review them on 
regular follow-up appointments. In one study, an initial comprehensive consultation of 
about 45-60 minutes was suggested to be needed for complex COFP condition in order 
to achieve patient’s satisfaction (Napenas et al., 2011). Time constraints, therefore, were 
repeatedly mentioned by the primary and secondary care clinicians for TMD 
management: “often you need a lot of time spent just listening to them and often a GP 
doesn’t have that time” (NGDP14) (Beliefs about consequences; Environmental 
context and resources).  
Another reason for the perceived difficulty is related to clinicians’ perceptions of 
unpredictability of outcomes of provided treatments for TMD that achieves optimal 
outcomes: “often it’s a case of trying something and seeing how that particular 
individual responds to that” (EGDP12). This is again attributed to the biopsychosocial 
nature of TMD which may require management at the individual level as emphasised by 
many participants: “it’s a case of managing the individual rather than the case itself” 
(EMGDP1) because “no two patients are the same” (OMFS19), this is, “because you 
might have [TMD] patient(s) with the same sort of symptoms and they respond 
differently to the same treatment” (OMFS20) (Knowledge; Beliefs about 
consequences).  
The individualised management of the biopsychosocial TMD may require the need for a 
tailored intervention personalised to each individual TMD patient needs (Litt and Porto, 
2013). This approach, however, can be problematic if we want to apply the evidence-
based practice for ‘optimum’ TMD care. This is because the ‘evidence-base’ concept is 
based largely on findings from high-quality, methodologically robust, randomised 
controlled trials (RCTs) which form the basis for high-grade evidence from systematic 
reviews and meta-analyses (Rosner, 2012). Currently, however, the vast majority of 
RCTs about TMD management are conducted by recruiting, grouping, and randomising 
the patients based on their biomedical rather than their psychosocial factors. Although 
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the findings from such RCTs may provide some indications of evidence for TMD 
management, they may provide insufficient basis for tailoring effective interventions 
and can be difficult to generalise (Reissmann et al., 2008). Subsequently, this may 
indicate that the current application of ‘evidence-base’ concept in TMD management is 
questionable. This is certainly true in ‘non-mechanical’ biopsychosocial disorders such 
as myofascial pain as opposed to more biomechanical disorders such as TMJ DDwoR or 
ankylosis. This coupled with the fact that the TMD is a group of heterogeneous 
disorders rather than a singular disorder (Peck et al., 2014), which adds further 
difficulty to TMD management. Unfortunately, in addition, several published 
systematic reviews such as Cochrane reviews investigated the effects of a specific 
therapeutic intervention on general ‘TMD’ rather than on specific subtype of TMD (Shi 
et al., 2003; Guo et al., 2009; Luther et al., 2010; Mujakperuo et al., 2010; Rigon et al., 
2011), which adds further confusion to the field. All these points could explain why it is 
always difficult to find high-quality robust evidence and guidelines for TMD 
management despite the presence of numerous RCTs and systematic reviews about 
TMD management (Chapter 2, Section 2.2.7). Perhaps for future work, the axis 2 of 
DC/TMD (Dworkin et al., 2002) should be used together with an adaptation of the 
template for behavioural change intervention description and replication criteria 
(TIDieR) (Hoffmann et al., 2014) for conducting person-centred RCTs of tailored 
interventions for TMD management.  
At the moment, the absence of high-quality robust evidence for TMD management and 
the presence of differing management ideologies and contradictory opinions among 
experts (Jenkins, 2014) can cause confusion for the clinicians managing the TMD 
patients, especially at the frontline. 
“In terms of further education erm there’s [are] so many courses on occlusion 
and different splints and this that and the other and a lot of them are really trying 
to help with TMJ [TMD]. It is quite confusing and it’s difficult to know really 
which is one person saying a splint’s rubbish, another person will say this splint’s 
brilliant and this one won’t work in that and then you’ll hear somebody else 
saying something completely the opposite again and I’m just very sceptical about 
the whole thing” (EGDP12) (Knowledge). 
There are, however, some published guidelines that could help the general practitioners 
to initially manage TMD/DDwoR patients such as: the National Institute for Health and 
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Care Excellence-Clinical Knowledge Summaries for TMJ disorders (NICE CKS, 2010), 
the European Academy of Craniomandibular Disorders (EACD) guidelines for GDPs 
(De Boever et al., 2008), and the recent TMD management guidelines for primary care 
from the UK Specialist Interest Group in Orofacial pain and TMD (USOT) (Durham et 
al., 2013). Studies, however, have shown that the clinicians often do not follow 
guidelines for COFP/TMD management and prefer to manage their patients by 
experiential-based practice (Durham et al., 2007; Reissmann et al., 2015). Similarly, 
most clinicians in this study reported that they do not use any specific guidelines in their 
practices neither for TMD management: “no I wouldn’t say I use any specific guidelines 
[for TMD management] at the moment” (NGDP5), nor for DDwoR management: “I 
haven’t read anything for GDPs specifically on the sort of first line management of the 
closed lock” (EMGDP3). The clinicians seemingly depended on their experiences about 
the treatments that “seem to work” (NGDP14), their clinical training, and the 
management ideologies of teaching staff which are often influenced by personal 
perspectives (Durham et al., 2007; Klasser and Greene, 2007). 
“I don’t have any written guidelines [to use for TMD management]. What I’ve 
read, what I’ve done as a practitioner that seems to work. And what I know, what 
I’ve been taught” (EGDP10) (Knowledge; Skills).  
In the absence of use of management guidelines, the professionals’ clinical decision-
making processes are, expectedly, subjective. In the data, there was some subjectivity 
and variability in decision-making processes among clinicians but it was clear that the 
decision processes for TMD management were relatively similar among each group of 
practitioners. 
In primary care, the GMPs as ‘generalists’ who “see everything of everybody’s 
specialist area” (GMP7) perceived the TMD as a more ‘dental’ topic: “I guess it’s a 
problem that sometimes people just associate it with seeing your dentist” (GMP9). The 
GMPs reported that they had “a role [in TMD management] but it’s very early on 
because erm there’s only so much we can do in primary care” (GMP9). One of the 
reasons for this perceived minor role in TMD management is discussed in the literature 
(Okeson and de Kanter, 1996; Field et al., 2013) and highlighted by one dental 
practitioner: “a doctor can’t be expected to take an impression to make a splint fit but 
they could suggest that they went to the dentist and had that” (OMFS19). The GMPs 
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confirmed this statement: “I’ve often signposted people to their community dentist 
because as I understand it they sometimes consider fitting them with certain devices to 
wear particularly overnight” (GMP7) and reported that they could treat TMD patients 
by medications only. One GMP, however, reported the ‘additional’ prescription of over-
the-counter mouth guards due to suggestion by a dentist who was a relative of theirs. 
These ‘non-fitting’ appliances, however, can cause serious adverse events including 
choking hazards, tissue damage, and irreversible occlusal changes (Wassell et al., 
2014).  
The GDPs, on the other hand, perceived their role included the initial management of 
TMD: “I think my role is to try and erm sort of diagnose, you know, try and do the 
simple things that I can do in a practice setting before I refer” (EGDP18). They 
reported that they can largely treat the more common and usually mild pain TMD cases 
related to ‘stress’, by providing the ‘simple or basic’ conservative treatments including: 
education, reassurance, self-care instructions and advice, analgesic and/or anti-
inflammatory medications, and jaw exercises, massages, and hot/cold packs; then the 
next step is the provision of soft splints and occasionally the hard splints. This initial 
conservative treatment, up to the stage of provision of splints, was described as “the 
first-line of defence” (EMGDP2) for the GDP, possibly due to clinician’s perceived 
limits in providing further treatment options to TMD patients. 
The GDPs seemingly perceived the provision of splints as the only physical action they 
could do to TMD patients in primary care: “the only treatment you do would be kind of 
stage 2 as I would call it, so first stage would be conservative [self-management], stage 
2 would be the splint, stage 3 would be referral to hospital” (NGDP14). Some studies 
have shown that the most widely used splint type by GDPs for TMD was the hard 
(stabilisation) splint (35%-45%) whilst the soft splint was used less frequently (6%-
26%) (Ommerborn et al., 2010; Aldrigue et al., 2015). In another study, however, the 
GDPs applied the soft splints more frequently to treat TMD (Gnauck et al., 2012). In 
this study, all the GDPs reported their ability to provide soft splints but only a few 
reported they had additional training to provide the hard (stabilisation) splints. When 
compared with the hard splints, the soft splints seemed to be more preferred by GDPs 
because they are easier to make, relatively cheaper, and not require specific skills (e.g., 
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restorative course training (Wassell et al., 2004)); in addition, the evidence shows that 
both types seem to be effective (Pettengill et al., 1998; Alencar and Becker, 2009). 
“Probably early in my career I used hard acrylic splints quite often, bite raising 
appliances, I’ve used erm soft splints latterly erm which are effective in some 
cases but not in every case but easy to make and those have been inexpensive to 
make” (EGDP13) (Skills; Beliefs about capabilities; Environmental context 
and resources). 
In NHS primary care, the provision of splints is the only financial incentive to GDPs for 
TMD management because they “are very well remunerated for providing an occlusal 
splint” (EGDP10; Reinforcement) according to price per units of dental activity 
(splint= 12 UDAs) in the current NHS dental contract (Milsom et al., 2008; DOH, 
2013). However, the expensive cost of splint, in primary dental care NHS specifically 
(band 3) (DOH, 2014), is a financial barrier to TMD patients because it makes the 
patients refuse this treatment modality to what they think it is just a ‘gum shield’ and 
the clinicians cannot guarantee its effectiveness.  
“I’d offer them [TMD patients] the splint, soft splint. Erm but in general practice 
patients often don’t want to pay so what we do in our practice is erm if they’re 
exempt it don’t matter, that’s their problem but often patients don’t want to pay 
for a splint so we often offer them privately so say to them ‘look we can get the lab 
to make you one for £70 instead of paying £214 because that’s how much it would 
be on the NHS’. So that’s the way we – well at the time persuade them to have this 
but often patients don’t want to pay £70 for what they think is a gum shield” 
(NGDP14) (Environmental context and resources). 
This financial barrier for TMD patients and lack of remuneration for GDPs (Tickle et 
al., 2011) to compensate for the time required to manage TMD was also highlighted in a 
previous qualitative study (Durham et al., 2007) suggesting the need to revise the NHS 
dental contract in the UK. Recently, there is a prospect for ‘reforming’ the current 
‘UDA-based system’ dental contract by introducing a new system of payment 
incorporating a combination of activity, capitation (“paying dentists related to the 
number of patients under their care rather than the numbers of courses of treatment they 
provide”), registration (“encouraging a partnership between patient and dentist to 
facilitate health improvement over time”), and quality payments (DOH, 2010a; DOH, 
2015; Holmes et al., 2015). If implemented in the future, the national dental contract 
reform programme (DOH, 2015) together with ‘smart’ NHS dental services 
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commissioning (NHS Commissioning Board, 2013) may have the potential to influence 
clinical practice and improve quality of primary care for TMD patients. 
In secondary care, the A&E clinicians perceived their role to provide urgent treatments 
to patients attending with more acute nature of TMD problems. Consequently, they 
reported providing only simple pain medications and advice if encountered TMD 
patients in addition to signposting them to a more ‘appropriate’ clinician. The OMFS 
clinicians, on the other hand, felt they were responsible to treat the ‘referred’ TMD 
patients from primary care: “I am in a position where people refer to me for advice 
about what to do” (OMFS4; Professional role and identity), but they often started 
with similar conservative treatment that may have been provided initially in primary 
care; although they also reported that they can provide further treatment options to 
patients following initial conservative treatment such as providing: further explanations 
using diagrams, skulls, and/or TMJ imaging, long-term pain medications such as anti-
depressants, and/or surgical management.  
The OMFS clinicians, however, vary in their perceived responsibility to treat TMD. For 
example, this clinician stated: “I’m not sure I want to see a patient, a clinic that was 
only TMJ patients because I think I’d find that quite difficult, but equally I think seeing 
patients with facial pain disorders is part of my practice and it provides balance to my 
practice and I don’t have a problem with that” (OMFS11), as opposed to this clinician 
who stated: “as a surgeon I feel it’s my role…to actually help those [TMD] patients that 
require the surgery rather than deal with the other people that don’t” (OMFS21) 
(Professional role and identity; Beliefs about capabilities). 
It is worth noting that the study sample did not include clinicians sampled from 
different specialties in secondary care such as restorative dentistry or oral medicine 
specialists who may have different management ideologies. Despite that, it becomes 
quite noticeable from the current data, as well as from previous published qualitative 
data (Durham et al., 2007), that the management ideologies of TMD appear to depend 
largely on the professionals’ background, qualifications, interests, and practice.  
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“I think that erm I’m well aware of the fact that probably I’m I would say more 
dismissive than maybe I should be of things like occlusal rehabilitation. Erm I 
suppose that if some people get referred to a restorative department with TM joint 
dysfunction they’ll be treated in a far different way than if they go to an oral 
surgery department because the interests are different and it’s interesting to see 
how the treatment would [be] different and I’m sure it does differ. You probably 
get fancy splints, a bit of occlusal grinding, all that sort of thing” (OMFS21) 
(Knowledge; Skills; Professional role and identity). 
When the clinicians were specifically asked about their possible treatment plan for a 
patient who presents with painful/limited opening, most clinicians at the frontline 
(A&E, GMPs, & GDPs) showed lack of confidence in their abilities to treat the DDwoR 
case scenario: “I don’t feel confident that I’d know what I’m doing” (EGDP10), giving 
the reasons of limited knowledge and lack of prior experience and/or proper training to 
treat such an acute condition: “quite difficult [to manage DDwoR] I would say, based 
on what training I have and knowledge” (EMGDP3) (Knowledge; Skills; Beliefs 
about capabilities).  
The data demonstrated that most GDPs felt they have sufficient training to diagnose and 
treat mild TMD problems but they felt they have insufficient training to diagnose and 
treat acute TMD problems such as DDwoR: “To manage…[TMD] due to teeth 
grinding…, I think we have enough training. I think the basics are there for that. It’s 
when it starts becoming a bit more complicated…. So I think that’s [DDwoR] where we 
can and do need a bit more training” (EMGDP2). Consequently, some GDPs felt their 
current role to manage mild TMD rather than severe TMD such as DDwoR: “The role I 
have in terms of making sure that they make, you know, the right choices on a daily 
basis about how to manage that [TMD] condition and to understand it. Erm exercises, 
pain relief, avoidance of habits, that kind of thing. Erm but there are certain things that 
I feel are kind of out of my remit and if things aren’t responding or for example if a 
patient had a limited opening or severe pain or whatever then I think that’s when I 
would choose to refer” (EGDP12) (Skills; Professional role and identity; Beliefs 
about capabilities; Memory, attention, and decision processes; Nature of 
behaviour). 
The perceived difficulty in DDwoR treatment amongst frontline clinicians is attributed 
in part to clinicians’ uncertainty in identifying the cause of pain and/or limited opening 
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and in part to the fact that those patients often presented with acute severe symptoms of 
pain and restricted opening hindering the clinicians’ ability to manage the patient. 
“I think it’s difficult [to manage such a patient with painful limited mouth 
opening] if it’s not an obvious cause such as an infection and then give it tooth 
relating if it is an infection then there’s a cause and you could treat the cause erm 
but I think if it didn’t, you know, if it wasn’t any of those things and you’ve 
eliminated everything else then actually it’s very difficult to treat” (EGDP18) 
(Knowledge; Skills; Beliefs about capabilities). 
“I mean obviously if they’ve got painful mouth opening and like an affected 
ability to eat and erm make the pain worse...it would probably make me want to 
refer them earlier than just someone with TMJ pain but with normal mouth 
opening… Erm just because I feel that I can offer something to TMJ, you know, in 
terms of pain relief and so on whereas this is sort of pain as well as not being able 
to open their mouth so I just feel that I can’t offer anything so, you know, then I 
would refer earlier” (GMP8) (Knowledge; Skills; Beliefs about capabilities; 
Memory, attention, and decision processes; Nature of behaviour). 
In real practice situations, the frontline clinicians reported their inability to manage 
DDwoR patient: “I was a bit lost on exactly what to do” (EMGDP2) and felt helpless to 
intervene and help when encountered a DDwoR patient: “I did feel a little bit helpless 
but there was very little I could actually do to physically help him [a possible DDwoR 
patient] at the time that that happened” (EGDP12). This “bad experience” (EGDP12) 
caused an emotional impact on the clinicians who regretted not being able to relieve the 
acute patients’ symptoms and could not perform any ‘physical’ act to stop the patients’ 
suffering at the first-point of contact. Noticeably, this past experience was also a 
motivational factor for those clinicians to improve their clinical knowledge and develop 
additional skills to manage DDwoR in the future. 
“It was just I was quite lost when she was locked. I was quite lost exactly what to 
do because she was in so much pain erm and I just felt, you know, that’s why I 
rang up the SHO Maxfax because obviously it was a Sunday evening and it was 
just for any other dental pain that comes in, abscesses and stuff I can get you out 
of pain, you know, I can numb you up, I can do something, I can sort you and I 
kind of felt a little bit lost that she came in and then when she walked out in the 
same pain that she came in because I couldn’t physically do anything for her. I 
obviously told her what she had to do, instructions what to follow, and I had an 
appointment for her for a couple of days time but I did feel a bit lost that I 
couldn’t take her pain away” (EMGDP2) (Beliefs about capabilities; Beliefs 
about consequences; Emotions; Memory, attention, and decision processes). 
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In contrast, the majority of OMFS clinicians reported that they were able to treat 
DDwoR patients at least initially. 
“Generally I don’t tend to find them [DDwoR patients] difficult to manage 
because I do have a sort of a set erm, you know, set of measures that generally 
help people so I think when they first attend it’s fairly straightforward to manage 
them because they often haven’t tried all of these measures and once you’ve 
started them then things improve. It becomes more difficult later on when they’re 
not improving” (OMFS4) (Knowledge; Skills; Beliefs about capabilities). 
In the data, all OMFS clinicians reported that it is the responsibility of primary care 
clinicians, primarily GDPs and to a lesser extent GMPs, to provide the initial 
management for TMD patients: “I think it’s well within the scope of the general dental 
practitioner to manage these [TMD] cases. I think if a general medical practitioner 
wants to develop this they need to get some further training” (OMFS11). This is 
consistent with the views in the literature (Okeson and de Kanter, 1996; Dworkin, 2001; 
Steenks, 2007; De Boever et al., 2008) and broadly agreed with the primary care 
clinicians’ perceived role and beliefs about their abilities to manage the TMD patients 
conservatively initially: “surely we can do that [conservative TMD management] as 
general practitioners” (NGDP14). 
For DDwoR management, however, the OMFS clinicians had contradictory opinions 
regarding the primary care clinicians’ responsibility to manage patients with DDwoR. 
Some reported that “it should be managed at primary care” (OMFS4) and it is 
appropriate for GDPs to manage the DDwoR patients initially in primary care prior to 
referral to secondary care and, therefore, “in terms of closed lock…there’s still a role 
for primary care” (OMFS11). However, others felt that it is a specialised area and often 
requires knowledge, experience, and expertise to be treated and, therefore, “that’s a 
condition that’s justifiable to, for sure, to come to secondary care” (OMFS19). This 
disparity in specialists’ opinions was also found in the literature (Gray et al., 1994a; 
Durham et al., 2013; Field et al., 2013; DeAngelis et al., 2014) and in the data reported 
by the frontline clinicians regarding their perceptions and opinions in their ability and 
responsibility to manage DDwoR. Most clinicians at the frontline felt that they do not 
have the ability to manage patients with DDwoR and “wouldn’t institute any treatment” 
(EGDP13). They perceived their role as ‘generalists’ and as such felt comfortable to 
treat the general most common mild pain in TMD patients but stated that an acute 
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severe DDwoR “seems a very specialist thing which perhaps is beyond the scope of the 
general practitioner” (EGDP10) and “it’s a sort of specialist area which would need 
access to specialist investigations…and specialist treatments and so not the primary 
care” (EGDP13). Therefore, the data indicate that those clinicians prefer to refer 
DDwoR to be treated in secondary care rather than treating it in primary care. 
Conversely, few frontline clinicians, might try to “do all the conservative stuff” 
(NGDP14) for the initial management of DDwoR to relieve the patients’ acute 
symptoms prior to referral to secondary care despite also acknowledging that “the 
management is difficult for a primary care dental practitioner” (NGDP5). They 
perceived their role as ‘first-line clinicians’ to relieve the patients’ acute symptoms 
firstly in primary care prior to referral to secondary care.  
“Yes [it’s important to manage DDwoR in primary care] because I think, even 
though I haven’t seen it in my day to day job, you know, I think we are going to 
get people coming to us as their first port of call and I think we should be able to 
do something to them, be able to help them” (EMGDP2) (Professional role and 
identity; Beliefs about capabilities; Goals). 
This ‘first-line’ professional identity led one GDP to suggest a guideline for early 
management of DDwoR patient in primary care prior to referral to secondary care: 
“maybe… there should be a system where the patient has to have had some early 
intervention by a clinician and they can only be referred after so long” (NGDP15) 
(Professional role and identity). 
Actually, the majority of primary and secondary care clinicians seemingly had the 
perspective that early management is better for DDwoR patients. The clinicians, 
however, expressed different opinions about the pathophysiology of DDwoR in relation 
to the necessity to intervene early, as these participants stated: “[to avoid] any risk of it 
progressing to the chronic closed lock” (EMGDP3), “the earlier it is er receiving 
definitive treatment the less disability will be in the long-term” (A&E/GMP17), “if it’s 
just recently happened it’s probably easier to correct than if they wait for perhaps a few 
hours” (OMFS20), “the longer you leave the meniscus all bunched up at the front of 
the joint the more likely it is to become deformed or and it’s more likely to not be 
successful [the treatment]” (OMFS21), or “[the patient may] benefit from an earlier 
surgical intervention”  (OMFS11) (Knowledge; Beliefs about consequences; Goals). 
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Most of these beliefs, however, are not necessarily well supported in the literature 
(Chapter 2, Section 2.2.4). 
Overall, the perspective of many clinicians in primary care is that, although it is 
perceived as being important, they do not feel, at present, it is possible to manage 
DDwoR patients in primary care without guidance from secondary care, or appropriate 
further training. In the data, many primary care clinicians appeared to favour a role of 
providing the continuation of care after resolution of acute DDwoR symptoms in 
secondary care.  
“I think it’s important that we then pick up the kind of [DDwoR] patient 
afterwards so obviously like with any area when you refer a patient they still come 
back to you on the practice isn’t it, so we still need to understand it and reinforce 
whatever the specialist may say but as far as I’m aware I don’t know anything 
specific that you could do in primary care but certainly like with any conditions 
we would then sort of review the patients afterwards and just see, you know, how 
they are managing” (GMP8) (Professional role and identity; Beliefs about 
capabilities).   
In summary, it is important to diagnose/reassure the DDwoR patients’ initially at the 
first-point of contact (Durham et al., 2010). It is also not infeasible, with further 
education and training, to treat this type of patient, at least initially, in primary care. 
However, given the limited knowledge and skills of primary care clinicians at the 
moment, it may be more appropriate for them to just review the DDwoR patients after 
they discharged back from secondary care for continuity of care. 
Treatment options 
Various treatment options were discussed in the literature for DDwoR management 
most commonly, manipulation therapy, splint therapy, and TMJ surgery (Murakami et 
al., 1995). Nevertheless, the majority of clinicians at the frontline (A&E, GMPs, & 
GDPs) either had no idea about possible therapeutic interventions or suggested/guessed 
some conservative or surgical interventions that could be used in secondary care for 
patients with DDwoR: “I don’t know what the treatment is” (EGDP10), or “I would be 
guessing” (EGDP12). In secondary care, however, the OMFS clinicians reported that 
they manage DDwoR initially conservatively in a similar way to any other TMD 
conditions: “it’s managed in the same way as er disc displacement with reduction” 
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(OMFS4), but some clinicians focused on certain treatment options for DDwoR 
disorder specifically such as: reassurance about DDwoR natural course, explanation the 
role of disc and mechanism of the condyle-disc complex to the patient, early jaw 
manipulation and exercises, topical analgesic/anti-inflammatory medications over the 
affected joint/muscle, in addition to provision of or - referral for - more invasive 
treatment options such as intra-articular joint injections and/or surgical management 
depending on the clinician’s surgical skills.  
One of the conservative treatment options suggested in the literature more than four 
decades ago to specifically manage patients with DDwoR initially is the ‘unlock’ 
mandibular manipulation (Farrar, 1971). The data demonstrate, however, that only a 
few of the surgeons reported having the skills “I tried to learn it” (OMFS19) and/or the 
procedural knowledge “I’ve kind of read about it rather than having to do it in 
practice” (OMFS20) about the technique. Furthermore, all the other participant groups 
in primary and secondary care lacked any procedural knowledge about it. Nevertheless, 
some A&E clinicians suggested the manipulation therapy as a possible treatment 
approach to increase mouth opening in patients with DDwoR, possibly due to their 
knowledge in TMJ anatomy or may be due to their preference to achieve quick remedy 
in A&E (Maull et al., 2009).  
“I think it is manipulation of the jaw is what needs to be done [for DDwoR]. I 
suspect it’s done in a very similar way for an anterior [TMJ] dislocation but I 
would say it’s more difficult because of the reduced mouth opening and but again 
that’s speculation. Erm that’s just from what I know of the condition and the 
anatomy” (A&E16) (Knowledge; Beliefs about capabilities). 
In comparison with the manual manipulation for ‘unlocking’ a locked jaw in patients 
with DDwoR, most GDPs reported evidence of procedural knowledge about the manual 
manipulation for ‘relocating’ a dislocated jaw. This was despite the fact, as previously 
mentioned, that the majority of those GDPs’ interviewed had never been confronted 
with a TMJ dislocation case. The GMP group, however, also lacked the procedural 
knowledge about the ‘relocation’ technique but some assumed it would be a 
manipulation therapy, perhaps by lay knowledge and ‘common-sense’ thinking (Popay 
and Williams, 1996). 
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The identified differences in professionals’ knowledge about the manipulation 
techniques for TMJ dislocation and DDwoR management give some possible 
indications that the curriculum for the UK dental schools may involve more focused 
teaching for dental students about TMJ dislocation than DDwoR, as one participant 
highlighted: “I don’t think we have been taught well [about DDwoR] but I think…if 
you’re talking about the jaw locking there’s always a lot of focus on the fact that oh it’s 
most likely if it’s kind of a really wide open lock then it’s most likely to have been a 
dislocation” (OMFS20). The differences in knowledge regarding TMJ dislocation 
management between the dentally- and medically- qualified clinicians may also indicate 
that the curriculum for the UK medical schools may not involve teaching the medical 
students about TMJ dislocation. 
Learning the ‘unlock’ manual manipulation technique is one of the required skills for 
the early management of DDwoR and could be a ‘life-saving’ manoeuvre in critical 
situations (Redick, 1987; Aiello and Metcalf, 1992; Akasapu et al., 2015). Although the 
manipulation therapy is often regarded in the literature as a simple treatment approach 
and easy to apply (Mongini et al., 1996; Spencer, 2005), some clinicians in this study 
felt the opposite. One OMFS clinician described this manipulation as “quite technique 
sensitive” (OMFS19) requiring highly skilled hands to ‘recapture’ the displaced disc. 
When suggested as a potential treatment option, most frontline clinicians also felt that 
this treatment approach requires a level of acquired skill and is challenging to apply by 
them to DDwoR patient due to pain and limited opening symptoms. Some of them 
expressed their fears from manipulation consequences if they would try to manage the 
patient but some clinicians also expressed their intentions to learn and implement it in 
the future. 
“I have, you know, dislocated jaws before erm [while] extracting teeth and I have 
been able to re-manipulate them but to do that on a patient that was already in 
pain erm I don’t know. I would be very worried about making something worse. 
But maybe more information and I would feel more confident, I don’t know” 
(EGDP12) (Skills; Beliefs about capabilities; Beliefs about consequences; 
Emotions). 
The discrepancy between the literature and clinicians’ perceptions regarding the manual 
manipulation simplicity and applicability highlights the problem that sometimes a 
treatment seen to be easy to ‘experienced’ clinicians may not be so to ‘inexperienced’ 
  
264 
 
 
clinicians. This is discussed in the literature regarding TMJ dislocation management 
(Parker, 2012) and highlighted in the data by one participant regarding DDwoR 
management:  
“It’s [DDwoR management] probably easier than I would think but then that’s 
the expert would say this was easy and I would say well I’ve no idea because I’ve 
never done it so it’s not easy for me” (A&E/GMP17) (Beliefs about 
capabilities).  
Another conservative treatment option suggested extensively in the literature for 
DDwoR management is the splint therapy (Chung and Kim, 1993; Stiesch-Scholz et al., 
2002b). In several quantitative studies, the splint therapy was found to be the most 
widely chosen/used treatment option by GDPs to routinely manage TMD patients  
(Pierce et al., 1995; Tegelberg et al., 2001; Ommerborn et al., 2010; Kraus, 2014; 
Aldrigue et al., 2015; Reissmann et al., 2015). The GDPs in this study were broadly 
consistent with this aspect of the professionals practice’s pattern identified in these 
quantitative studies. They shared the experience that the splints can help the majority of 
TMD patients and have relatively low risks and, therefore, all GDPs reported that they 
provide splints routinely to lots of TMD patients. For DDwoR management, however, 
most GDPs expressed uncertainty if occlusal splints can be used at all due to limited 
opening symptom.  
“With a closed lock I don’t know whether a splint would be advisable 
straightaway. I think they might find that it’s erm a bit too restrictive to put a 
splint in there where there’s not enough movement anyway” (NGDP14) 
(Knowledge; Skills; Beliefs about capabilities). 
The ‘extra’ symptom of mouth opening limitation may make the routine decision to take 
impression to construct a full-coverage splint challenging and sometimes impossible for 
the GDPs; although making an emergency partial-coverage splint is still possible 
(Stapelmann and Turp, 2008). Some OMFS clinicians, on the other hand, were able to 
discuss the possible role of splint in recapturing the displaced disc. 
Surgical interventions, mostly arthrocentesis, are also suggested widely in the literature 
for DDwoR management (Al-Belasy and Dolwick, 2007). However, apart from very 
small number of GDPs suggesting arthrocentesis as a possible treatment option for 
DDwoR, the majority of frontline clinicians seemingly had vague knowledge about the 
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role of TMJ surgery in TMD/DDwoR management. Although it is not their professional 
role to provide TMJ surgical management, it is imperative for them to be aware about 
the role of TMJ surgery to clarify and explain its risks and benefits to the TMD patients 
(Dimitroulis, 2011). 
Unsurprisingly, the OMFS clinicians reported higher levels of knowledge about the 
TMJ surgical procedures, their mechanisms of actions, and their risks but they had 
differing opinions regarding their beneficial effects. This reflects the lack of evidence to 
support or refute the use of TMJ surgical interventions (Chapter 5). The OMFS 
clinicians also expressed their concerns about the consequences of TMJ surgical 
management and, therefore, often reported that they tried to avoid TMJ surgery, instead 
informing them about the possible intra- and post- operative surgical complications 
alongside the message that TMJ surgery cannot guarantee success.  
“I think…you have to make people aware of the fact that it’s erm not really an 
ultimate success having this sort of surgery. You have to make sure that they’re 
very well aware of the pitfalls and the possible complications and they’ve got to 
go in with their eyes open” (OMFS21) (Knowledge; Beliefs about 
consequences).   
In fact, several therapeutic options of various degrees of invasiveness are available for 
the clinicians for TMD/DDwoR management but the evidence from the literature 
suggests that the clinicians should try the minimal non-invasive conservative options 
first (Al-Baghdadi et al., 2014a; Al-Baghdadi et al., 2014b). Reassuringly, all the 
clinicians, including the surgeons, in the current study sample applied generally the 
same first principle to their management of TMD/DDwoR, that being: “do the patient 
no harm and [do not] make the problem worse” (OMFS20). In practice this meant 
starting ordinarily with the non-invasive reversible conservative treatment options: “I 
still think that you should start simple. I always think that, and you should start non-
surgical” (OMFS21), and putting the invasive irreversible surgical treatment option “at 
the end of the management scale” (EMGDP3). The participants shared the common 
attitude that “the absolute last resort is jaw surgery” (NGDP14) because the majority 
of TMD patients would improve with the conservative therapy and only a minority may 
require surgery which also increases their confidence and optimism in TMD 
conservative management. 
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“I think I’ve always had the view that a majority of patients with TMJ disorders 
can be managed conservatively but there will always be a minority that may 
require some surgical treatment and I think that basic philosophy has always 
underpinned my attitude towards it” (OMFS11) (Knowledge; Beliefs about 
consequences).  
In comparison with the other TMD, however, the biomechanical DDwoR disorder can 
be sometimes more resistant to conservative treatment (Yamaoka et al., 1997) requiring 
frequent visits to complete treatment (Dahlstrom, 1998; Anastassaki and Magnusson, 
2004) and may occasionally need surgery (Castro et al., 2009). This is mirrored in the 
data as a few OMFS clinicians reported that in their experience the DDwoR patient 
might not always improve early with the conservative management and may end-up 
requiring surgery. These experiences seemingly lessened the clinicians’ confidence and 
optimism in DDwoR conservative management.  
“I think I will probably in the explanation make more reference to the disc and to 
what might be going on…and I would usually say that ‘I think that we try this sort 
of conservative management first and we’ll see it may be that we’ll need to do 
some further treatment following it’ whereas I think I’d try and be a bit more 
optimistic with the other [TMD] patients. I’m not sure if I’d do anything else at 
that initial stage of treatment planning but I guess I might have a lower 
expectation of improvement maybe myself… Just that [because] they’ve kind of 
got a definite physical problem [DDwoR] that can be difficult, very difficult to 
sort out” (OMFS19) (Knowledge; Skills; Beliefs about capabilities; Beliefs 
about consequences; Optimism). 
Overall, the data in this study suggest that the participants’ management pathway at 
different levels of TMD/DDwoR patients care pathway (primary, secondary, and 
tertiary care) can be “a ladder” (OMFS4) management “beginning from advice going 
all the way up to TM joint replacement” (OMFS21) as depicted in Figure 6.2. 
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Figure 6.2: TMD/DDwoR Ladder Management. 
Treatment plan time scale and rationale 
In the data, all the clinicians, as mentioned, do not use any specific guidelines in their 
practices for TMD/DDwoR management. Interestingly, however, the majority of 
primary and secondary care clinicians seemed to have clear plan regarding the time-
frame for the initial conservative step and for reviewing the patients before 
contemplating alternative treatment approach or referring them for further management.  
“Well with any treatment plan the idea is to make sure that they’re [patients] 
getting better so if they’re not getting better within a certain time-frame then you 
might try a different type of treatment” (GMP9) (Goals; Memory, attention, and 
decision processes; Behavioural regulation). 
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The set ‘time-frame’, however, differed widely between clinicians in primary and 
secondary care from as early as couple of weeks to several months or even years. In 
primary care, most clinicians demonstrated a low threshold for reviewing TMD patients 
over and over again without progressing and they tended to refer their patients early, 
mostly within 1 month, if not responded to initial conservative treatment: “I normally 
review them [TMD patients] after 2 weeks and then another 2 weeks and if things aren’t 
getting any better after 4 weeks I will refer” (NGDP15); although few clinicians tended 
to review their patients for longer periods of times, mostly 2, 3 or even 6 months. In 
secondary care, however, the clinicians in OMFS departments tended to follow-up the 
referred TMD patients for longer periods of time, ranging from 6 months to 2 years or 
even longer: “I would anticipate having the majority of TMJ patients under follow-up 
for maybe 1 to 2 years but I’d anticipate there would be a small percentage who go on 
to be, you know, almost on long-term follow-up” (OMFS11). This difference is 
probably due to OMFS clinicians’ higher levels of knowledge about TMD chronicity 
plus their responsibility to provide the definitive management. Similarly, the OMFS 
clinicians seemingly had also a treatment plan for managing patients with DDwoR 
conservatively for several months before referring or escalating towards the surgical 
management.  
“Q: For how long do you usually follow-up those [DDwoR] patients or wait for 
the conservative management before escalating to surg…?  
 R: Probably not long. It very much depends. I’ll normally review them, as I say, 
after sort of two months then maybe four months and if things aren’t really getting 
much better maybe after sort of six months I’d probably say let’s do something 
else” (OMFS21) (Goals; Memory, attention, and decision processes; 
Behavioural regulation). 
In general, the majority of primary and secondary care clinicians rationalised their plans 
of time-frame periods based on their expectations of patient’s response to treatment. 
The allocated time-frame by most primary care clinicians, however, was often too short: 
“I think 4 weeks is adequate if somebody is wearing a soft splint, doing the exercises, 
soft diet and I think if things aren’t getting any improvement we should refer at that 
stage” (NGDP15). The time-frame for ‘chronic’ pain of more than three months 
(Dworkin et al., 2011) can probably be used to advise the primary care clinicians to 
follow-up/review the TMD patients before referral to secondary care unless there are 
‘red flags’ (Table 2.9). This three-month review period probably avoids patient’s 
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disability and allows sufficient time to assess a clinically important change in TMD 
treatment outcomes (Moufti, 2007). However, the data suggest that such an advice can 
be challenging for a variety of reasons summarised in Table 6.5. 
Reasons for TMD patients’ follow-up difficulty by primary care clinicians  
 Primary care clinicians need reassurance that the TMD patients have nothing 
else more serious (Beliefs about consequences). 
 Patients themselves need reassurance and may request further treatment by 
secondary care clinicians (Social influences). 
 Increase in patients suffering time if they do not respond to treatment provided 
in primary care (Beliefs about consequences; Emotions). 
 Lengthy referral waiting time (sometimes 2-3 months or longer) which can 
further increase patient suffering (Beliefs about consequences). 
 Lack of primary care clinicians’ incentives/remuneration to manage those 
patients plus time constraints for TMD management and follow-up reviews in 
NHS primary care (financial and time restraints barriers) (Reinforcement; 
Environmental context and resources). 
 Lack of interest in TMD (Knowledge; Professional role and identity). 
 Table 6.5: Reasons for TMD patients’ follow-up difficulty in primary care. 
Treatment outcomes, goals, and success 
When managing TMD patients, the clinicians should have three basic goals to achieve 
from the provision of the treatments: reducing pain, restoring function, and optimising 
patients’ quality of life (de Leeuw and Klasser, 2013). The majority of primary and 
secondary care clinicians, however, reported that they do not set ‘formal’ goals for 
TMD management, but a common goal of symptoms management was mentioned 
repeatedly throughout the interviews: “to get the patient out of pain is my kind of goal” 
(EMGDP2) (Goals). 
One of the important reasons for not setting ‘formal’ goals for TMD management can 
be attributed to unpredictable outcomes of treatments provided. The uncertainty over the 
TMD management outcomes seemingly led the clinicians to avoid setting goals due to 
the fear of not meeting these goals causing disappointment to both patient and clinician, 
as articulated by one participant: 
“I don’t [set goals], no, because I think it’s difficult. I think if you then set goals 
then it’s – I think it’s probably out of fear of maybe failing to meet those goals…, 
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but I don’t think it will be unreasonable for there to be some goals, but I think if 
you set a goal it’s whether you keep that goal to yourself or you shout it at the 
patient. I think if you shout at the patient the risk then of causing disappointment 
and I don’t think you can say by then I would hope that you have less clicking and 
improved jaw movement and less pain” (OMFS20) (Beliefs about consequences; 
Emotions). 
In order to determine the ‘clinical success’, some clinicians reported depending mainly 
on subjective questioning relating to patients satisfaction with their level of 
improvement.  
“Well I don’t actually have a sort of any scales [to measure clinical success]. It’s 
usually on direct questioning with the patients and if they’ve come along with 
pain, trismus, click they’re the specific things that I ask them about, and if some 
people come along and say yeah that’s fine,… So I don’t really get too bothered if 
they’ve got reasonable function without absolutely wide opening as long as 
they’re pain free and they’re click free. So they’re the three things that I ask and I 
would look upon, I suppose, absolute success if I’ve got somebody who is free of 
pain, erm can eat what they like, can open as wide as they want and don’t have a 
click. I suppose that’s it in simplistic terms” (OMFS21) (Goals). 
Patients’ satisfaction as an outcome measure is clearly subjective and varies inter-
individually and may not reflect the patients’ needs (Durham et al., 2007). For future 
research, there is a need for standardised criteria for measuring clinical success and 
treatment outcomes (not just relying on satisfaction) in TMD/DDwoR management 
which are currently lacking (Durham et al., 2007; Schiffman et al., 2014b).  
In summary, the clinicians varied in their perceived roles, abilities, and plans to treat 
TMD and DDwoR. The primary care dental practitioners appeared more able to treat 
TMD initially when compared to the primary care medical practitioners, but all the 
clinicians at the frontline, whether dentally- or medically- qualified, seemed unable to 
treat DDwoR. These variations clearly have impacts on their referral decisions. 
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Step 4: Referral 
The clinicians seemingly varied in their perceived limitations to manage the discussed 
clinical conditions and, therefore, their referral decisions and pattern were varied.  
Referral decisions and reasons 
Referral of TMD patients from primary to secondary care are often reported to be of a 
high rate in the literature (Beecroft et al., 2013; Villa et al., 2015). In a recent survey-
based study, the frequency of clinicians’ referrals of TMD patients to specialists was 
about 22.5% (Reissmann et al., 2015). Studies indicate that most TMD patients referred 
to secondary care are from dental practitioners (56%-85%) and to a lesser degree from 
medical practitioners (15%-28%) (Anastassaki and Magnusson, 2004; Vallon and 
Nilner, 2009). In this study, the GMPs reported that they often signposted the TMD 
patients to primary care dental practitioners or sometimes referred them to secondary 
care setting. This referral decision was mostly made because of their perceived limits in 
providing further treatment options other than the medical management.  
“I think we should be able to diagnose classic temporomandibular joint disorder 
and erm initiate basic treatment which what we can do in primary care… I don’t 
think we should be thinking about how to fit erm mouth guards to the patients erm 
or whether we should decide if they should have an x-ray or CT or an MRI or 
whatever” (GMP9) (Skills; Professional role and identity; Beliefs about 
capabilities). 
The GDPs, on the other hand, reported that they often referred the non-responding TMD 
patients to secondary dental care, specifically to local dental hospitals and, mostly to 
restorative departments. This referral decision was mostly made when the TMD patients 
failed initial conservative treatment and related to the GDPs’ beliefs about their own 
limits in providing further treatment options. 
“We’ve got the basic facilities in primary care that we can provide on the 
education side of things. Erm certain stabilisation splints can be provided erm but 
following on from that er I wouldn’t be prescribing any long-term medications or 
anything along those lines so that would be sort of probably the limitation there is 
I would say we’ve got that basic management that we can try but if it’s persisting 
longer than that or if the symptoms are severe then I think that’s quite a difficult 
case to manage in primary care. I think that would be the sort of stage where I 
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would be referring onwards” (NGDP5) (Skills; Professional role and identity; 
Beliefs about capabilities; Memory, attention, and decision processes). 
Within the interviews of those working in primary care, there were sporadic references 
to unrealistic expectations for the outcome of the referral and management by secondary 
care: “positive [side of patient’s referral] I think...I’m going to get this solved, you 
know. [The] dental hospital are [is] going to wave a magic wand and be able to cure 
this and sort this out” (EMGDP2; Optimism). This unrealistic optimistic view about 
the specialists’ ability to ‘cure’ chronic pain patients was also expressed by a few GDPs 
in a previous quantitative study (Dahlstrom et al., 1997). Despite the fact that these 
references presented sporadically in our data, they could potentially have a significant 
impact, not only on the referred patients’ expectations, but also on the clinicians’ 
referral patterns. Nevertheless, there is also a constant pressure on clinicians in NHS 
primary care to undertake management themselves and reduce referrals to secondary 
care (Faulkner et al., 2003; Akbari et al., 2008). In the data, some primary care 
clinicians highlighted different kinds of pressure to decrease referrals such as: referral 
rates monitoring, referral costs, and referral back from secondary care.  
“We also have constant downward pressure on our external referrals to 
secondary care so and this might be an area where erm if we do things better, if 
we know more we might reduce some referrals into secondary care which then 
our CCG [Clinical Commissioning Group11] would be happy about” (GMP7) 
(Professional role and identity; Environmental context and resources; Social 
influences). 
All the clinicians also highlighted the necessity of receiving feedback about their 
referred patients: “Yes [I think it’s important to receive a feedback]…Because they’re 
ultimately our patients, they’re going to be coming back to us for management and we 
need to know clearly what is expected in terms of monitoring that patient. Also we could 
learn…for the future” (EGDP10). This ‘ownership feeling’ about their patients is one of 
the several reasons given for feedback importance. The most common reported reason, 
however, was attributed to professionals’ future own-learning or self-education about 
the patient they were confronted with but diagnosed and/or treated by someone else in 
order to continue patients’ care afterwards or avoid these referrals in the future. At the 
                                                 
11 Clinical commissioning groups (CCGs) are NHS organisations recently developed by the Health and 
Social Care Act 2012 in order to organise the delivery of NHS services in England instead of the Primary 
Care Trusts (PCTs) (UK legislation, 2012). 
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moment, however, many clinicians at the frontline reported that they did not get 
‘formal’ feedback letters which may not always be possible especially if the clinicians 
are working in emergency single-point access services. Therefore, enhancing the 
feedback process between the healthcare services can be beneficial.  
“I think if it’s possible [to get the feedback] yeah [it’s important]. Both for my 
own education so I can remember next time to refer earlier, later, try something 
else first, but also just in terms of continuity of care, to know what the patient’s 
being told and those sorts of things” (A&E/GMP17) (Behavioural regulation). 
In secondary care, as previously mentioned, the A&E clinicians reported that they 
preferred to signpost the TMD patients to a more ‘appropriate’ clinician or service due 
to their perception that their role did not include treating patients with chronic 
conditions. On the contrary, the OMFS clinicians reported a responsibility to treat the 
referred TMD patients but they too reported limits, suggesting that they refer the 
refractory TMD patients to physiotherapy or other departments in the hospital including 
chronic pain management clinics (tertiary care). Some OMFS clinicians, however, 
reported problems with such referrals, including: poor communication with the 
physiotherapy team: “I’ve never really been able to find an actual physiotherapist to 
speak to about their management, directly one on one” (OMFS19); limited “access to 
support services” (OMFS20); and lack of psychological support service linked to their 
departments: “we don’t have a psychologist whose time is devoted to helping with facial 
pain issues” (OMFS11) (Environmental context and resources; Social influences). 
Different reasons for TMD patients’ referral to secondary or tertiary care services have 
been discussed in the literature (Vallon and Nilner, 2009; Kraus, 2014). In the data, the 
explicit reason for professionals’ referral decisions for TMD patients was generally the 
patients’ non-response to treatment provided. There were, however, other inferred 
‘implicit’ reasons for clinicians’ referral decisions for TMD patients which are 
summarised in Table 6.6. 
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TMD referral decision reasons 
- Limited knowledge and experience for primary care clinicians especially the 
medical practitioners (Knowledge; Skills). 
- Acute TMD with severe signs and symptoms: early referral for difficult cases out 
of the remit of primary care clinician such as severe joint-related disorders or 
acute pain conditions and trauma-related disorders (Professional role and 
identity; Beliefs about capabilities; Beliefs about consequences). 
- Signpost TMD patients to a more appropriate clinician (e.g., referral to 
restorative dentists if suspecting an occlusal problem) (Professional role and 
identity). 
- For a diagnosis or to confirm diagnosis (Skills). 
- For extra- or alternative- therapy by other clinicians (Skills). 
- To avoid misdiagnosis and to make sure not missing something else (rule-out 
other pathologies, reassuring the patient that there is nothing more serious) 
(Beliefs about consequences). 
- To avoid patient suffering and go untreated (Beliefs about consequences). 
- For a second opinion: more reassurance for both clinician as well as the patient 
by having the advice from two clinicians: generalist and specialist (Beliefs about 
capabilities; Beliefs about consequences). 
- Anxious/distressed/emotional patient wants early referral for specialist opinion 
and may not listen to generalist or may not want to try the treatment options 
suggested by the primary care clinician perceiving them as too simple and not 
effective (Emotions; Social influences).  
- The clinician’s own emotion and work stress/load/pressure may make the 
clinicians refer a patient not usually referred in normal circumstances (Emotions; 
Environmental context and resources). 
- Therapy cost (e.g., splint cost) (Environmental context and resources). 
- For further assessments and investigations such as joint imaging 
(Environmental context and resources). 
- Patients need more time to treat and review (Environmental context and 
resources). 
- To avoid patient spending a lot of money to get treated in primary dental care 
private practice (Beliefs about consequences; Environmental context and 
resources). 
- Lack of financial incentives/remuneration (Reinforcement). 
- Before a surgical intervention to the TMJ being considered (Beliefs about 
consequences). 
Table 6.6: Clinicians’ referral reasons for TMD patients.  
When discussing approaching management of the DDwoR case scenario, all the 
clinicians at the frontline (A&E, GMPs, & GDPs) reported that they preferred to seek 
advice/support directly over the phone from an experienced clinician in secondary care 
and/or make an early referral decision to secondary care setting, usually to oral and 
maxillofacial surgery and occasionally to restorative dentistry departments.  
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In real decision-making situations, the frontline clinicians reported seeking phone 
advice and referring early when encountered DDwoR patient for the first time.  
“I managed just to see her [a DDwoR patient] and with her I had to actually ring 
up the SHO on-call for Maxfax to ask their advice because I was a bit lost on 
exactly what to do. But again they would just say, you know, quite reinforce, 
reassure her the soft diet, the ibuprofen, the hot-cold erm compresses and they 
actually booked her in for a consultant clinic about two days later to be 
reviewed” (EMGDP2) (Skills; Beliefs about capabilities; Memory, attention, 
and decision processes; Social influences; Nature of behaviour). 
The advice over the phone should come normally from either the on-call senior house 
officers (SHO) in OMFS or ENT services in general hospitals or from the specialists in 
local dental hospitals: “if it’s during the day I’d ring the dental hospital. Obviously 
when it’s out of hours I just ring the SHO on-call for Maxfax and find that” (EMGDP2). 
The given advice and referral priority, however, may vary depending largely on call-
handler experience and qualification, as highlighted by one participant:  
“I think the problems are, at the outset, who answers the phone in the first place if 
it’s somebody who is a dentist whose qualified they may be more likely to say 
yeah send them [DDwoR patients] over, we’ll have a look to see what’s going on 
and see what we can do. Erm if they get a receptionist or a nurse might say oh 
well you’ll just have to fax the referral over and we’ll prioritise it, so they may not 
highlight that it’s something that maybe needed to be seen urgently” (OMFS20) 
(Environmental context and resources; Social influences). 
The phone advice was described as easy, quick, and accessible to frontline clinicians: 
“it’s reasonably easy to get advice from the hospital. I found it very easy” (EGDP10). 
The advice over the phone seems to be a very useful tool to reduce clinicians’ 
uncertainty and increase their confidence in DDwoR management. This is because some 
frontline clinicians reported that they feel more confident to diagnose the DDwoR 
patient under guidance from experienced clinicians and were also more willing to 
commit to the advice given over the phone regarding the treatment plan and/or 
treatment/referral options.  
“[I] need to be confident on the [DDwoR] diagnosis and that again can be 
discussed on the telephone…[and] if I’m given clear instructions I will do what 
I’m told to do and if it works that’s great and if it doesn’t then I’ll send them in” 
(A&E/GMP17) (Beliefs about capabilities; Memory, attention, and decision 
processes; Intentions; Social influences). 
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In the literature, studies have reported a proportionally large number of DDwoR 
patients’ referrals (11%-22%) among all the referred TMD patients, which is mostly 
related to the fact that patients with DDwoR are more often complain of severe 
symptoms (Dahlstrom, 1998; Anastassaki and Magnusson, 2004; Vallon and Nilner, 
2009; Kraus, 2014). The severity of acute DDwoR symptoms may be what is leading 
the frontline clinicians in the study sample to seek advice and refer DDwoR early in 
comparison with the other temporomandibular disorders, “because the other [TMD] 
conditions people are in pain but they’re not in as much pain. Generally on a scale 
they’re on a scale of about five out of ten as a kind of pain, the ones we see in practice 
but this lady [referring to a DDwoR patient] she was ten out of ten, she was an absolute 
agony” (EMGDP2; Nature of behaviour). In addition to symptoms’ severity, however, 
there were other inter-related reasons for frontline clinicians’ early referral decision to 
DDwoR patients which are summarised in Table 6.7.  
DDwoR early referral decision reasons: 
- Professionals’ lack of knowledge, training, and experience with DDwoR 
(Knowledge; Skills). 
- Professionals’ beliefs that the DDwoR is a specific area require specialist 
investigations and treatments (Professional role and identity). 
- For definitive diagnosis (Skills; Beliefs about capabilities). 
- To avoid misdiagnosis (Beliefs about consequences). 
- For further investigations such as joint imaging (Environmental context and 
resources). 
- To avoid inappropriate treatment, mismanagement, or making the problem worse, 
or not providing the proper treatment at the appropriate time (Beliefs about 
consequences). 
- For patient’s reassurance via inter-disciplinary care in secondary care (Beliefs 
about consequences). 
- To avoid patients’ suffering from severe symptoms and their impact on patients’ 
quality of life (Beliefs about consequences; Emotions). 
- To avoid chronic patients’ disability due to lengthy referral process (Beliefs about 
consequences; Emotions). 
Table 6.7: Frontline clinicians’ early referral decision inter-related reasons for DDwoR 
patients. 
Although DDwoR is not a life-threating condition, all the frontline clinicians 
highlighted the need for referral ‘urgency’ for patients with acute DDwoR to be seen 
and treated ‘quicker’. This urgent referral perception is probably related to clinicians’ 
worries and concerns over the severity of acute DDwoR symptoms, patient suffering, 
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and the negative impact on patient's functional capability and quality of life. This 
perception is probably intensified by the clinicians’ awareness about the potential 
negative consequences their referral decision could cause in patients in terms of 
patients’ inconvenience and their continued worries and suffering due to lengthy referral 
process. This process may prolong due to environmental circumstances as demonstrated 
in this quote: “she [a possible DDwoR patient] was already on referral to secondary 
care erm but she couldn’t be seen at the hospital…at that time because it was the 
summer holidays” (EMGDP3). The clinicians, therefore, often warned patients about 
the referral waiting time: “I normally warn patients it could be 2 to 3 months and I 
would hope that during that time that they would at least see an appointment but I know 
sometimes it has been longer” (EGDP12). The clinicians in secondary care also felt this 
long waiting time is an issue: “I think waiting times for patients to get here to start with 
[is a problem]” (OMFS20) (Beliefs about consequences; Emotions; Environmental 
context and resources). 
Overall, the frontline clinicians expressed several worries and concerns if confronted 
with the acute DDwoR patient’s ‘unusual’ presentation, and this was seen to be related 
mainly to clinicians’ limited knowledge and experience with it. The expressed worries 
and concerns led the frontline clinicians to make an early or urgent referral decision for 
DDwoR to secondary care as depicted in Figure 6.3. 
In secondary care, however, the OMFS clinicians reported that they also make the 
decision to refer the DDwoR patients if they not respond to their initial conservative 
measures. The clinicians reported that they refer DDwoR patients firstly to 
physiotherapy service. If the patient fails to improve following physiotherapy, the 
OMFS clinicians suggested they refer to colleagues with a sub-specialist interest in the 
surgical management of TMD (tertiary care). They preferred to leave the decision on 
appropriateness of surgery to the sub-specialist because of their perceived ‘difficulty’ of 
making this surgical decision.  
“I think once you’re getting down to the delivery of erm surgical therapy, be that 
minimally invasive in the form of arthroscopy or arthrocentesis or even joint 
replacement, I think it needs to be sort of 1 or 2 er individuals who have 
developed that as a special interest within their practice who manage it and it’s 
for them to make the ultimate decisions if they think that’s appropriate and erm to 
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deliver that treatment. I think it’s better that it’s someone with a sub-specialist 
interest that does that” (OMFS11) (Skills; Professional role and identity; 
Beliefs about capabilities; Memory, attention, and decision processes).   
The surgical decision for TMD/DDwoR patients is usually a difficult decision to make 
(Moore, 2006) but its difficulty could be increased further by patients’ requesting 
surgery; although it was accepted that this only really occurs in those with severe 
persistent symptoms: “most of the time people are pushing me to have something more 
done because they’re fed up of it” (OMFS21). 
“A lot of people though will find that with really particularly bad TM joints 
symptoms they can’t go out for a meal, they can’t, you know, their social 
interactions are affected and all those things and often people, by the time they 
come to having more major things done, they’re really at their wits end and those 
would almost said that they’ll have anything done if it will help” (OMFS21) 
(Social influences).
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Figure 6.3: Map representing the frontline clinicians’ early referral decision process and its reasons. 
Acute Closed Lock 
patient’s presentation 
at the frontline 
Clinicians unfamiliar 
with DDwoR and 
uncertain about it 
Decision to:  
Get quick advice 
and/or  
Early referral 
Clinicians’ worry/concern about: 
- Presentation: unusual condition, severity of CL 
symptoms (TMJ Pain & LMO) and its impact on 
patient's QoL (jaw functioning, speaking, eating, 
working ...etc.) and its associated negative 
psychosocial consequences and also worried about 
its recurrence. 
- Diagnosis: diagnostic uncertainty and possibility 
of misdiagnosing serious pathology. 
- Treatment: management uncertainty and 
inability to treat and alleviate patients' symptoms 
and mismanagement consequences. 
- Referral: Lengthy referral waiting time 
increasing patient's suffering. 
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Referral pathway 
The referral pathway for patients should progress logically from primary through to 
secondary to tertiary care services; although from the perspective of those interviewed, 
there is no obvious and ‘straightforward’ current referral pathway for the TMD patients. 
The lack of formal referral path for COFP/TMD patients was also highlighted in 
previous studies (Durham et al., 2011; Peters et al., 2015). In the study data, TMD 
patients’ referral path could depend on multiple factors, one of which is the availability 
of a practitioner with a special interest in TMD in a particular region. This preference to 
refer TMD patients to TMD specialists was also expressed by the majority of GDPs in 
previous quantitative studies (Tegelberg et al., 2001; Aggarwal et al., 2012). 
“There’s not a clean cut kind of pathway for it [TMD] so depending on what area 
you are or you might know colleagues that are quite good or sensitive in treating 
that condition” (GMP8) (Environmental context and resources; Social 
influences). 
Some GMPs, however, expressed ‘referral uncertainty’ about where to refer their TMD 
patients: “it tends to be a referral which can be quite hard because you don’t know 
often is it maxfax, is it dental, is it ENT, is it chronic pain clinic as it’s quite hard to 
sometimes get these [TMD] patients to the right place” (GMP8). This is perhaps due to 
lack of TMD speciality in the UK and the “huge overlap between other specialties 
and…overlap of conditions it can be” (GMP8) (Knowledge). 
There is also a possibility for multiplicity of referrals for patients having chronic 
refractory TMD pain. Such ‘chronic’ patients can see multiple clinicians and receive 
various diagnoses/treatments in different services in their care pathways (Durham et al., 
2011; Beecroft et al., 2013; Kraus, 2014). In this study, a few clinicians mentioned 
some chronic patients not-responding to treatments with this participant stating: 
“they’ve seen numerous dentists and they’ve been referred to numerous people and 
nobody can quite figure out what’s going on” (NGDP14). Evidently, such multiple 
‘cyclic’ re-referrals of TMD patients can have negative psychosocial impacts on the 
patients (Durham et al., 2011). The possible referral pathways reported in the data for 
TMD patients are depicted in Figure 6.4.
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Figure 6.4: TMD patients’ possible referral pathway.
Community non-specialist service (primary care)   Specialist service (secondary care)   Support or sub-specialist service (tertiary care) 
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Dental Practices 
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management 
Refer to:  
- Dental Hospital (oral 
surgery or restorative 
departments)   
Or to: 
- General Hospitals 
(OMFS or ENT 
departments) 
Refer to: 
physiotherapy 
service 
Refer to: 
Chronic pain 
management clinic 
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In comparison with the TMD patients’ referral pathways, the referral pathways for 
DDwoR patients in the reported data seemed to be less complicated. On the contrary to 
routine ‘ordinary’ TMD cases, none of the GMPs in the study sample preferred to 
signpost the DDwoR patients to their GDPs. This is possibly due to the nature of 
DDwoR patient’s presentation and their perceptions for the necessity of ‘urgent’ 
management and their preference to get advice from a more experienced practitioner if 
confronted with such an acute condition. 
“I’d probably have a very low threshold about phoning for some advice on 
somebody with that situation [DDwoR] which is clearly quite different from erm 
perhaps the kind of patients I had in mind when we were talking before [TMD] so 
and I think probably my port of call in that situation would be somebody from the 
maxillofacial team on the phone saying what do I do with this” (GMP7) (Beliefs 
about consequences; Memory, attention, and decision processes; Nature of 
behaviour). 
The on-call senior house officers in general hospitals or the specialists in local dental 
hospitals were often the first point in DDwoR referral pathway (secondary care) whilst 
the surgeons with special interest in TMJ surgical management were seemingly the final 
step in the DDwoR management/referral pathway (tertiary care): “I find that most of 
them are coming from almost tertiary referrals,…they’ve probably been seen by the 
general practitioner in the first instance then somebody else, then me” (OMFS21). 
DDwoR patients with failed surgical management, however, may be referred further to 
chronic pain management clinics (Moody and Clark, 1995; Edwards et al., 2014); 
although this is not explicitly revealed in the data. The potential referral pattern and 
multi-level care pathway for patients with DDwoR is demonstrated in Figure 6.5. 
In summary, the clinicians varied in their perceived limitations to manage 
TMD/DDwoR. The primary dental and medical care clinicians appeared to refer TMD 
after providing, at least initially, some conservative treatments, but all the clinicians at 
the frontline, whether dentally- or medically- qualified, preferred to seek advice directly 
and/or refer DDwoR early. The participants, therefore, suggested various factors that 
can help them to change and improve their current clinical practice and avoid referrals.
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Figure 6.5: DDwoR patients’ possible referral pathway.
Potential waiting time 1 day to 3 months or longer 
Non-response to treatment 
Emergency access: 
Primary care: 
Frontline clinicians’ 
early referral 
decision (Figure 6.3) 
Frontline (usual or urgent care) service             Specialist service (secondary care)             Support or sub-specialist service (tertiary 
care)                                                      
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Step 5: Clinicians’ suggestions to support their own decisions 
During the interviews, the participants suggested different future strategies to improve 
their current clinical practice, mostly related to enhancing their clinical knowledge and 
skills. One of the most frequently mentioned strategies given by the majority of primary 
and secondary care clinicians was the availability of evidence-based guidelines for 
TMD management: “well as usual I suppose any evidence-based erm findings erm is 
always the best way to change a practice” (OMFS19) (Behavioural regulation).  
There is, clearly, a need for all practitioners to have access to high-quality evidence-
based guidelines detailing: when to treat, when to review, and when to refer the 
TMD/DDwoR patients which is currently lacking. However, the literature suggests that 
even if such guidelines did exist, there could be numerous barriers for dissemination 
and implementation of guidelines (Cabana et al., 1999; Miller and Kearney, 2004; Stone 
et al., 2014). In this study, several barriers to accessing and using guidelines were 
identified by some participants such as: their preference to read ‘simple’ rather than 
‘complicated’ journals; their clinical experience can contradict and overrule the 
available evidence; they may not frequently examine the large number of available 
guidelines and may find difficulty to recall them in general practice. The last point can 
be specifically true for uncommon conditions such as DDwoR. This is because recalling 
a specific guideline among the numerous available guidelines in general practice can be 
challenging for the general practitioners and they seem to remember only the guidelines 
for the most commonly encountered cases. Therefore, even if guidelines about 
uncommon conditions such as DDwoR exist, the clinicians may not be aware of them or 
not remember to use them because they do not encounter such patients frequently. 
“I think its possible new guidelines might [change my current practice] but 
guidelines for conditions which we don’t see that often are often sort of filed in 
the cupboard really rather than online somewhere and they’re not looked at 
again” (GMP7) (Memory, attention, and decision processes; Behavioural 
regulation). 
One of the possible ways to overcome this problem and to support the clinicians’ 
decision-making in relation to management of their patients is the use of electronic tools 
(e-tools) (Johnston et al., 2004; Vikram and Karjodkar, 2009). In a cross-over 
randomised trial comparing internet-based TMJ tutorial with traditional seminars, the e-
learning was perceived well by the dental student participants and no differences were 
found between the e-learning and usual teaching modes at delivering information to 
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students (Al-Riyami et al., 2010). In the data, the e-tools were described as “easily 
accessible mediums of education” (OMFS19) and the majority of primary and 
secondary care clinicians thought that such an e-tool for DDwoR management can be 
useful because the clinicians are usually familiar with the e-learning, online induction, 
and continuing professional development (CPD) online learning (Leggate and Russell, 
2002; Bullock et al., 2003; Browne et al., 2004; Stone et al., 2014).  
“Yeah definitely [a virtually delivered tool or intervention can help to manage 
DDwoR]. I think internet, if there’s something online I mean that’s the most useful 
easiest way of accessing even more than a study day really because I mean I do a 
lot of my CPD online so I think that’s the best way really” (EGDP18) 
(Environmental context and resources). 
Useful suggestions for the electronic intervention were given by the clinicians including 
the incorporation of patient educational leaflets and appropriate self-care videos to 
educate and teach the patients how to care themselves for their ‘own’ condition. 
Similarly, the e-tool was suggested to be eye catching, easily accessible, and attractive 
to use by rewarding the clinicians with CPD hours/points. It was suggested also to be 
simple and practical that can to be used easily within a short time and containing brief e-
learning videos that can be easier to recall by the general practitioners. 
“In GP we’re bombarded with all sorts of stuff all the time and trying to work out 
what’s useful and what’s not can be very difficult. So, you know, if you can 
provide an eye catching simple and very brief erm information bite, sound bite, or 
something to general practitioners to say you can do this by doing this then that 
will be helpful” (A&E/GMP17) (Environmental context and resources; 
Behavioural regulation). 
There are still, however, some barriers for using such an e-tool by frontline clinicians. 
Some clinicians expressed their concerns about the possibility of DDwoR misdiagnosis 
and mismanagement without hands-on ‘formal’ training courses. 
“I think if there was a tool to help recognise the [DDwoR] condition that would 
help. If the treatment is manipulation then I’m not sure...that I would be able to do 
that without proper formal training. I think it would be quite difficult” (GMP9) 
(Beliefs about capabilities; Beliefs about consequences).  
“The only concern I would have is that if I had misdiagnosed that patient and 
then I tried to manipulate the joint that I could make things worse and that’s only 
the experience of hands-on actually achieving that and achieving a result with 
that” (EGDP12) (Beliefs about consequences).  
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The mode of intervention delivery could be via electronic health (eHealth) or mobile 
health (mHealth) media (Eysenbach and Group, 2011; Free et al., 2013). In this study, 
some clinicians stated that they would prefer an intervention to be on desktop computer 
screen (eHealth) because these are better visualised by both patient and clinician in 
comparison with the smart phone (mHealth). However, although the latter might be 
more difficult to visualise and it is often regarded as a personal tool, phone applications 
(smartphone Apps) are easier and quicker to access (Akter and Ray, 2010).  
“You don’t need to do it on a phone because people like that are going to present 
to the surgery and you can look at YouTube like that. Looking on a phone, you 
know, it’s a bit more difficult” (A&E/GMP17) (Environmental context and 
resources). 
In relation to the content of the proposed virtual intervention, participants put forward, 
explicitly, several ideas they felt should be included in a proposed virtual intervention to 
help them diagnose and treat DDwoR. There were, however, some other components 
that emerged ‘implicitly’ from the interviews in terms of theoretical domains that could 
be also a part of an intervention tool. All these components are summarised in Table 
6.8. 
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Suggested intervention’s components: 
An electronic tool (App) involves the following: 
- Simple diagnostic guide (easy, clear, concise, quick and practical) to help recognise 
closed lock condition and diagnose DDwoR (Knowledge; Skills; Environmental 
context and resources).  
- Patient information leaflet include self-care instructions that can be printed out and 
provided to patients (Knowledge; Skills; Environmental context and resources). 
- Virtual online videos attached for e-learning/training demonstration (certified videos 
rather than usual YouTube videos) about (Knowledge; Skills):  
1) How to examine the closed lock patient and make the DDwoR diagnosis. 
2) Simple explanation about TMJ anatomy, mechanism of the disc, and DDwoR 
condition to both patients and professionals in addition to self-care instructions 
to patients. 
3) How to perform the practical manoeuvre of 'unlock' manual mandibular 
manipulation technique for acute DDwoR and also probably the relocation 
manipulation technique for acute TMJ dislocation. 
Educational lectures:  
-   A brief bulletin or brief lecture series that can be delivered to all general practices or 
professionals’ organisations or departments (Knowledge). 
Training courses:  
- Hands-on formal training courses or study days about TMD/DDwoR diagnosis and 
treatment (Knowledge; Skills). 
- All the above need to be attractive to use/attend by rewarding the professionals with 
CPD hours/points (Reinforcement ‘reward’). 
Emerged intervention’s components: 
In terms of theoretical domains:  
- Knowledge: Tutorials about normal/abnormal TMJ and condyle-disc complex 
mechanism. 
- Skills ‘experience’: Simulation web-based or ‘real’ practical courses. 
- Social/Professional role and identity: Increase responsibility perception of first-
line clinicians. Emphasise the importance of early diagnosis/treatment and negative 
sequelae of delayed diagnosis/treatment.   
- Beliefs about capabilities: Increase self-efficacy. Set graded practice/tasks under 
supervised/supported conditions. Use modelling (brief videos). Increase awareness 
about the disorder natural course and good response to conservative treatments. 
- Beliefs about consequences: Dealing with outcome expectations on consequences 
of misdiagnosis, mismanagement and referral. Increase awareness about the 
disorder natural course and the red flags signs and symptoms. 
- Memory, attention, and decision processes: Electronic easily accessible tool to 
resolve memory and attention problems and to assist clinicians in their decision 
processes. 
- Emotions: Dealing with patients’ emotions and with own emotions. Increase 
awareness about the acute TMD conditions and the red flags signs and symptoms. 
- Social influences: Advice over the phone from secondary care. 
- Behavioural regulation: Feedback about professionals’ performance. It may also 
involve a questionnaire for evaluation of the e-tool. 
Table 6.8: Components for a proposed intervention for DDwoR management.  
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Summary of professionals’ decision-making processes 
It becomes clear from the presented data in this section that the clinical decision-making 
processes of healthcare professionals for managing TMD generally and DDwoR 
particularly were varied between the clinicians but based mainly on professionals’ 
background and their practice setting. These processes have been depicted in maps 
(diagrams) representing the management pathways for each group of practitioners 
(GDPs, GMPs, A&E, & OMFS) and are available, with their representative quotations, 
in Appendix M. A generic map summarising the TMD and DDwoR management 
pathways for all clinicians is shown in Figure 6.6.
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Figure 6.6: Generic map summarising the clinicians’ decision-making processes for TMD and DDwoR management.
        Review within 3 to 6 months 
        No review (direct referral) 
OMFS clinicians 
Frontline clinicians 
(A&E, GMPs, & GDPs) 
Secondary care  
OMFS clinicians 
Review within 3 to 24 months 
Review vary from as early as 2 weeks to about 6 months 
Primary care clinicians 
(GMPs & GDPs) 
Patient’s presentation Diagnosis Treatment              Referral 
 
TMD  
(Mild signs & 
symptoms) 
If not-responding to treatment: 
GMPs: signpost to GDPs or 
refer to secondary dental or 
medical care. 
GDPs: refer to secondary dental 
care. 
- History and clinical examination. 
- GDPs: PAs & OPG ‘if needed & 
available’ to rule-out dentoalveolar cause 
of pain and other pathologies. 
General ‘TMD’ diagnosis 
(mostly myofacial pain and/or DDwR) 
Acute DDwoR 
(Closed Lock) 
(Severe TMJ pain 
& limited opening) 
Initial conservative management: 
GMPs: mostly medical management and sometimes over-the-
counter mouth guards. 
GDPs:  
- 1st step conservative management of education, medications, self-
management, and physiotherapeutic measures.  
- 2nd step splint therapy (mostly soft splint and occasionally 
stabilization hard splint). 
 
- History and clinical examination. 
- OPG/CT/MRI ‘if needed’ to rule-out 
other pathologies and confirm clinical 
diagnosis. 
Specific ‘TMD’ diagnosis 
(muscular or joint-related 
derangement/degenerative disorders). 
 
Initial conservative (non-surgical) management: 
- 1st step: conservative management of education, medications, 
self-management, and physiotherapeutic measures.  
- 2nd step: splint therapy (soft or hard splints). 
- 3rd step (if not-improved): re-check differential diagnosis, change 
medications, long-term anti-depressant medications. 
If not-responding to treatment: 
- Referral to physiotherapy 
service. 
If still not-responding: 
- Referral to a TMJ surgeon. 
- Referral to chronic pain 
management clinic. 
Initial non-surgical conservative management, similar to 
other TMD ‘above’ but more focus on: natural course of the 
disorder, role of the disc, topical medications, and sometimes 
manipulation therapy. 
Surgical management by a consultant surgeon. 
  
- History and clinical examination. 
Difficult to examine intra-orally due to 
limited opening. 
- Rarely OPG ‘if needed/available’ to 
rule-out other pathologies or causes of 
pain/limited opening symptoms. 
Diagnostic uncertainty 
Mostly no treatment or rarely may start initial conservative self-
management and medications to relief acute symptoms. 
 
Seek quick advice via phone or 
refer early to secondary dental 
care. 
- History and clinical examination.  
Provisional clinical diagnosis 
- Rarely OPG /CT to rule-out other 
pathologies or causes of pain/limited 
opening symptoms. 
- Sometimes ordering MRI to confirm 
‘DDwoR’ clinical diagnosis. 
If not-responding to treatment: 
- Referral to physiotherapy 
service. 
If still not-responding: 
- Referral to a consultant 
surgeon with sub-specialist 
interest for surgical 
management. 
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6.4.3 Factors influencing the professionals’ clinical decision-making process: A 
summary of TDF-informed analysis  
In the previous section (Section 6.4.2), the influences on clinicians’ decision-making 
processes were presented under the generic recurrent themes, as informed by the TDF, 
which emerged from the interviews. These were represented by including emboldened 
references to the theoretical domains in parentheses following relevant data. This 
section (Section 6.4.3), therefore, is going to briefly outline and summarise the main 
findings of data relevant to each domain. 
The possible factors from the TDF that influence the frontline clinicians’ decision-
making process in DDwoR management are summarised domain by domain in the text 
below and their relevant data are tabulated in Table 6.9. This table is a matrix 
representing the fifteen theoretical domains’ representative data (vertical) against the 
three phases of clinical decision-making process: diagnosis, treatment, and referral 
decisions (horizontal).  
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Theoretical 
Domains 
Quotes representing the influences (theoretical domains) on clinicians’ decisions in DDwoR management 
Clinical decision-making process 
Diagnosis decisions  Treatment decisions Referral decisions 
1. Knowledge “I feel quite vague on it. I don’t feel very 
knowledgeable on closed lock specifically” 
(EMGDP3). 
 
“I think again it’s just the knowledge of it 
[DDwoR]. Erm I think the main difficulties 
clinicians face is just they don’t really know 
what treatment to provide for the different 
[TMD] conditions” (NGDP15). 
“I really don’t know about this condition” 
(GMP9). 
2. Skills “I don’t know if it’s happening because of 
muscle spasm or because there is an internal 
derangement. That’s where I’m not sure” 
(EGDP12). 
“I just feel we haven’t really – I haven’t been to 
any training that would, you know, that instantly 
tells me what to do if a patient had that 
[DDwoR]” (EGDP18). 
“This is [DDwoR] out of my area of expertise. I 
would refer them” (A&E/GMP17). 
 
 Experience “I’ve worked here [general practice] for 10 
years and we haven’t come across anyone with 
that problem [DDwoR]” (EGDP18). 
“It’s probably one of those ones like say I 
haven’t come across a case like that [DDwoR] 
so erm my experience of it is limited and I would 
imagine even if you have come across a case like 
that in your career it’s going to be one or two 
sort of cases as extreme as you’ve described 
there so there’s probably not going to be a 
whole lot of experience in it [to manage]” 
(NGDP5).   
“From my point of view I’ve never seen it 
[DDwoR] so it’s, you know, it’s difficult to then 
say oh this is what we do and rather than to 
start with we can box it sometimes speaking to 
an experienced practitioner or maxillo..and 
either send them in” (EMGDP1). 
3. Professional 
role and 
identity 
“Well because you’re the first, because you’re 
in primary care, I think it is important that the 
[DDwoR] patient is aware of what’s going on, 
that you’re reassuring them that there’s nothing 
serious wrong…. So yeah I do think it’s 
important to get that knowledge to the patient 
first of all” (NGDP14).  
 
“I think for that patient who walks in with the 
limited opening or worse still the dislocated jaw 
it would be wrong not to be able to provide them 
with something, some advice” (EGDP10). 
“I think if the [DDwoR] patient has been seen in 
secondary care and has been diagnosed and 
then needs further management, depending on 
what that would be, you know, if it’s just a case 
of knowing that the patient has somewhere to go, 
just to free up the secondary care if nothing else, 
then that’s the role of somebody in primary care 
I think” (EGDP12). 
“I think it [DDwoR] is a specialised area and 
we don’t see it often so we need to send on, to 
someone who treat to ultimate, maybe even, you 
know, someone who’s seen a lot of it so they can 
manage it and understand it” (GMP8).  
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Theoretical 
Domains 
Quotes representing the influences (theoretical domains) on clinicians’ decisions in DDwoR management 
Clinical decision-making process 
Diagnosis decisions  Treatment decisions Referral decisions 
4. Beliefs about 
capabilities  
“Maybe [I’ll] not be able to just sort of diagnose 
the specific condition [DDwoR]” (NGDP5). 
“A majority of [TMD] patients that I have 
managed I would term that, you know, for me as 
successful. Erm it’s only been the difficult 
patients [DDwoR] that I feel that I’ve been 
unable to manage in practice so it’s the only 
ones I’m least confident with that I’ve not really 
done enough maybe about improving my skills” 
(EGDP12). 
“Q: Why do you think you start earlier referral 
for such a [DDwoR] condition while you may 
try to manage other [TMD] conditions before 
referral? R: I think it’s because we don’t know 
much about it, erm and it’s a limited experience 
in treating it. Erm so I guess it’s the lack of 
confidence treating it really” (EGDP18). 
5. Beliefs about 
consequences 
“I was concerned that there was something 
seriously deranged in the joints, that was my 
biggest fear and that’s why I wanted him [a 
possible DDwoR patient] to be seen erm 
because his joint was not moving, you know, as 
it should have been” (EGDP12).   
 
“The amount of pain killer I gave I would be 
very wary about. Again like I said with the 
patient with the jaw dislocation that had a 
reaction to the morphine… I’d be very worried 
about doing something like that with the patient 
with reduced mouth opening because of the 
difficulty there with intervention erm if they had 
issues” (A&E16). 
“I think it’s probably important [to manage 
DDwoR in primary care]… because if they’re 
going to be in an acute situation coming to me 
with limitation of opening and I’m going to be 
sending them away saying ‘I’m not really sure 
what’s going on here’ and then they’re going to 
have that huge 3-month wait to be seen, 2 to 3 
month it is” (EGDP10). 
6. Optimism  “Obviously if somebody comes in with a locked 
jaw or erm, you know, really acute pain and 
sever trismus it can be very difficult. There’s no 
magic quick fix that you can suddenly give them 
to improve that” (EGDP12). 
 
7. Reinforcement “If I was working in a general practice I 
certainly want to be paid for it. Not that money’s 
the be all and end all but when you’ve got UDA 
[Units of Dental Activity] targets to meet I think 
a lot of GPs are very guilty of ‘I’ve only got 10 
minutes to talk about this at the end’, or not 
even, at the end of an examination because 
they’re not going to really bring that – I 
mean…realistically a general practitioner isn’t 
going to bring that patient back for a review” 
(NGDP14). 
“If you were a practitioner working in the NHS 
there is no funding, you will be doing charity 
work if you got involved in these cases. It will be 
of no benefit. In fact it would be detrimental 
financially to a practitioner to treat such cases” 
(EGDP13). 
“There’s no particular incentive. It’s just I 
would want to treat them as I would any other 
patient. The incentive, I mean I do prefer not 
having to refer a patient so and obviously it’s 
much better for the patient as well if we can 
manage them here [at the general practice] and 
they don’t have to, you know, go through a long 
waiting list, so yeah I mean there’s a lot of 
incentives, you know, that you don’t have to 
refer a patient and you can treat them at the 
practice” (EGDP18). 
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Theoretical 
Domains 
Quotes representing the influences (theoretical domains) on clinicians’ decisions in DDwoR management 
Clinical decision-making process 
Diagnosis decisions  Treatment decisions Referral decisions 
8. Intentions “I think if I had a patient with the condition you 
mentioned earlier, disc displacement without 
reduction, I think if I saw more patients like that 
then that would influence me to increase my 
knowledge myself and try to manage them 
better” (NGDP15). 
“I like doing practical manoeuvres. If it works 
for the patient the patient thinks it’s wonderful, 
the doctor’s a magician, he just did this and I 
was better, you know, and so learning practical 
manoeuvres that could help are very helpful” 
(A&E/GMP17).  
“I mean I would quite prefer a bit more 
experience… I guess we should be trained on it 
a bit more and it would prevent needing that 
referral if I guess if we did think, if there isn’t 
more we can do in our practice setting” 
(EGDP18). 
9. Goals “To relieve them of their pain and monitor them 
for progression or not” (EMGDP3).  
“To get the patient sort of symptom free and to 
manage the condition” (GMP8). 
“Obviously we want to get the patient out of 
pain and…resolve that pain as quickly and 
effectively as possible erm so that would 
probably be the goal” (NGDP5). 
10. Memory, 
attention, and 
decision 
processes 
“There’s [are] probably…different [TMD] 
conditions so there’s with reduction and there’s 
the one disc displacement without reduction. 
Erm gosh I’m trying to think of the name now, 
I’m trying to think of the sheet. Erm there’s with 
and without limited opening so there’s 2 
different types and then there’s obviously all the 
arthritic problems as well” (NGDP15). 
“I have heard things [about DDwoR evidence-
based management] but you’ve getting a very 
honest interview here because I haven’t done 
any special additional reading prior to it. Yes 
there is some evidence. I can’t tell you what it is 
and I’d have to look it up again and I should 
know” (OMFS11). 
“I would need to ask advice [about DDwoR] 
and if I’m told to do something I will do it then I 
will remember it for next time. So if that were 
the case then if it were possible I could 
remember it and do it next time” 
(A&E/GMP17). 
11. Environmental 
context and 
resources 
“I think the only thing might be that quite often 
when we first present a time that you have to 
take the full history, do the full examination and 
explain the management can be quite tight, and 
document it properly” (EMGDP3). 
“I think it just depends if they [patients] pay… 
because if they don’t want to pay for a soft splint 
then it’s difficult to manage them to your full 
potential” (EGDP18).   
 
12. Social 
influences  
“I’d probably have a go at making a [DDwoR] 
diagnosis given that I’d been guided by the 
dental hospital… I would have a go at the 
diagnosis but erm under guidance” (EGDP10). 
 
“If there was something erm out of the ordinary 
that I was concerned about yeah I would 
[discuss it with colleagues], especially with the 
people erm that work within the practice” 
(EGDP12). 
“It’s more getting advice [from secondary care 
on a DDwoR patient]. Erm, you know I’m very 
willing to give anything a go if the advice on the 
phone is right I want you to do this or do this or 
do this” (EMGDP2).  
“We have a forum here where we discuss 
patients we wish to refer and that inevitably 
triggers a bit of discussion about whether you’ve 
done everything before referring for a second 
opinion” (GMP7). 
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Theoretical 
Domains 
Quotes representing the influences (theoretical domains) on clinicians’ decisions in DDwoR management 
Clinical decision-making process 
Diagnosis decisions  Treatment decisions Referral decisions 
13. Emotions “I would be worry in the fact that I was 
uncertain of the [DDwoR] diagnosis and I 
would never sort of want to be sending 
somebody away with something like that if I 
didn’t know what was going on” (A&E16). 
 “I think if...they’re [patients] quite distressed 
about the condition, very worried erm that might 
push me a little bit more to refer…a bit sooner” 
(EMGDP2). 
14. Behavioural 
regulation 
“It’s helpful [to receive a feedback from 
secondary care] to know if a diagnosis has been 
made erm and I need so that from my learning 
experience that, you know, matching the 
symptoms to what the final diagnosis was” 
(EGDP12). 
 
“Definitely, yeah [I think it’s important to 
receive a feedback from secondary care]…to 
know the treatment that they are providing, so 
that might help in the future to manage the 
patient who is having the treatment there, so it 
would be helpful to know what to do in a 
primary care setting in terms of long-term 
management of that patient or just to know what 
to do if it happened again or you came across 
someone else that it happened to” (EGDP18). 
“I’d find that [receiving a feedback] really, 
really useful. Erm definitely so we can see what 
diagnosis was concluded upon and see what 
treatment was provided and how the patient’s 
faring, yeah definitely I think that’s important I 
like to see what the outcome at the dental 
hospital was and then what the patient believes 
it to be as well and they come in and compare 
the two erm so I find that quite interesting” 
(NGDP5). 
15. Nature of 
behaviour 
“I think in my head it seems a more serious 
condition [DDwoR]. Erm I think it’s affecting 
the patient’s day to day life a lot more rather 
than the former [TMD]” (NGDP14). 
 “[I am] not as confident [to manage DDwoR] as 
other forms of TMD…with normal opening just 
with pain… Erm if there’s somebody with a 
closed lock it’s almost like the condition has 
gone just that one step further erm so I think I 
would be more inclined to refer those patients 
sooner rather than later into hospitals, into 
secondary care” (NGDP14). 
Table 6.9: Summary influences and their representative quotes on frontline clinicians’ decisions in DDwoR management. 
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1. Knowledge 
The main finding from this domain was that the clinicians at the frontline considered 
TMD as a mild self-limiting problem but they lacked clinical knowledge about DDwoR 
to diagnose and treat. This exerts a major negative influence on their decision-making 
process in DDwoR management. 
2. Skills 
The main finding from this domain was that the dental practitioners seemingly had more 
skills to diagnose and treat TMD than the medical practitioners but that all the clinicians 
at the frontline lacked the three essential skills (diagnostic, treatment, and referral skills) 
required for DDwoR management (Table 6.10). This exerts a major negative influence 
on their decision-making process in DDwoR management.   
Skills identified Details 
1. Diagnostic skills  
 
a) History taking skills. 
b) Clinical examination skills (intra- and extra- oral 
examination). 
c) Differential diagnosis skills (symptoms-mimic conditions and 
red flags). 
2. Treatment skills  a) Conservative treatment skills (including manual 
manipulation). 
b) Follow-up/review skills. 
3. Referral skills  
 
a) Appropriate referral skills.  
b) Urgent referral skills (identify red flag signs and symptoms 
for referral urgency). 
Table 6.10: Skills required for TMD/DDwoR management. 
3. Social/Professional role and identity 
The main finding from this domain was that the clinicians at the frontline, apart from 
those in A&E, perceived having the responsibility, at least initially, to diagnose and 
treat mild common TMD, but the frontline clinicians had differing perceptions 
regarding their role and responsibility to manage acute uncommon TMD conditions 
such as DDwoR. This interesting disparity indicates that this domain, in reality, can 
exert a positive or negative influence on the frontline clinicians’ decision-making 
process in DDwoR management. 
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4. Beliefs about capabilities 
The main finding from this domain was that the dental practitioners had greater beliefs 
in their ability to diagnose and treat TMD than the medical practitioners but all seemed 
able to treat, at least initially, the mild common TMD, whilst all the clinicians at the 
frontline lacked ability and confidence to diagnose and treat acute DDwoR. This exerts 
a major negative influence on their decision-making process in DDwoR management.    
5. Beliefs about consequences 
The main finding from this domain was that the frontline clinicians’ beliefs about 
consequences of DDwoR prognosis and their beliefs about consequences of 
misdiagnosis, mistreatment, and/or referral decisions can exert a major negative or 
positive influence on their decision-making process in DDwoR management. 
6. Optimism 
The main finding from this domain was that most clinicians were optimistic regarding 
TMD patients’ response to conservative management but some clinicians seemed less 
optimistic regarding DDwoR patients’ response to conservative management. This 
exerts a negative influence on their decision-making process in DDwoR management. 
That said, this domain seems unlikely to change the frontline clinicians’ decisions to 
manage DDwoR because the majority had limited, if any, experience with it. 
7. Reinforcement 
The main finding from this domain was that the clinicians in NHS primary dental care 
lacked financial incentives to manage patients with TMD or DDwoR. This exerts a 
negative influence on their decision-making process in DDwoR management.  
8. Intentions 
The main finding from this domain was that many clinicians had the intentions and 
intrinsic motivation to manage TMD and DDwoR at the frontline and avoid referrals. 
This exerts a positive influence on their decision-making process in DDwoR 
management. That said, this domain, seems unlikely to change the frontline clinicians’ 
decisions to manage DDwoR because the majority already motivated to manage the 
patients but their limited knowledge and skills were the main barriers. 
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9. Goals 
The main finding from this domain was that many clinicians set a goal of improving 
patients’ symptoms within a specific time-frame and the majority prioritise the 
importance of early management for patients with DDwoR at the first-point of contact. 
This exerts a positive influence on their decision-making process in DDwoR 
management. That said, this domain seems unlikely to change the frontline clinicians’ 
decisions to manage DDwoR because the majority already aimed to manage DDwoR 
early at the frontline but their limited knowledge and skills hinder them from achieving 
this goal. 
10. Memory, attention, and decision processes 
The main finding from this domain was that the dental practitioners paid greater 
attention to TMD characteristic signs and symptoms than the medical practitioners but 
all the clinicians at the frontline had difficulty memorising and identifying the 
pathognomonic signs and symptoms of DDwoR, which was reflected in their decision 
processes. This exerts a major negative influence on their decision-making process in 
DDwoR management.    
11. Environmental context and resources 
The main finding from this domain was that the time and funding are the main 
environmental barriers of primary care for TMD and to a lesser extent DDwoR. This 
exerts a negative influence on clinicians’ decision-making process in DDwoR 
management. 
12. Social influences 
The main finding from this domain was that the professionals and patients’ social 
influences and interactions can exert a positive or negative influence on the frontline 
clinicians’ decision-making process in DDwoR management.  
13. Emotions 
The main finding from this domain was that the own emotions of clinicians at the 
frontline appeared to be less affected when they were confronted with common mild 
TMD causing limited influence on their decisions, but the frontline clinicians’ emotions 
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seemed to be affected when they encountered uncommon acute severe DDwoR. This 
exerts a major negative influence on their decision-making process in DDwoR 
management.    
14. Behavioural regulation 
The main finding from this domain was that most clinicians had increased knowledge 
and experience over the years in TMD’s self-limiting nature and its chronicity but those 
at the frontline lacked growing knowledge and experience in DDwoR due to the relative 
rarity of the condition. All the clinicians at the frontline, however, had the motivation to 
receive feedback about their referred patients and the majority had also intrinsic 
motivation to change and improve their practice. This can exert a positive or negative 
influence on their decision-making process in DDwoR management.  
15. Nature of behaviour 
The main finding from this domain was that the nature of clinicians’ behaviour seemed 
to differ considerably depending on clinicians’ familiarity with the type and severity of 
clinical situation which had an impact on their decision-making processes. The majority 
of clinicians at the frontline seemed to try to diagnose and treat, at least initially, a 
patient who presented with ‘chronic’ mild TMD before making a referral decision, but 
all appeared to experience a high degree of uncertainty if they encountered a patient 
with acute severe DDwoR. For these patients they were more likely to seek an urgent 
advice and/or make an early referral decision.  
In summary, the TDF-based analysis suggests that all the 15 theoretical domains 
influenced the clinicians’ decisions in managing patients with TMD or DDwoR. The 
domains, however, vary in their likely influence, and strength, to change healthcare 
professionals’ clinical behaviour. The domains that appeared most likely to change 
clinicians’ decision-making behaviour when managing patients with DDwoR were: 
knowledge; skills; professional role and identity; beliefs about capabilities; beliefs about 
consequences; memory, attention, and decision processes; environmental context and 
resources; social influences; emotions; behavioural regulation; nature of behaviour, 
whilst the domains that appeared least likely to change clinicians’ behaviour to manage 
patients with DDwoR were: optimism; intentions; goals. In comparison, the domains 
likely to change clinicians’ behaviour when managing patients with TMD seem to be 
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relatively similar to DDwoR management but they differ in their influential strengths to 
change clinicians’ behaviour. Specifically, the behavioural regulation and 
environmental context and resources domains are more likely to change clinicians’ 
behaviour in TMD than DDwoR management whilst the emotions and nature of 
behaviour domains are less likely to change clinicians’ behaviour in TMD management.  
6.4.4 Summary of main findings 
This study, to the research team’s knowledge, is the first study that has used the TDF to 
explore the healthcare professionals’ clinical decision-making process in 
temporomandibular disorders management in order to identify influences on clinicians’ 
decisions regarding a particular subtype of temporomandibular disorders ‘DDwoR’. The 
TDF-based analysis has highlighted the complexity of clinicians’ decision-making 
processes. Data analysis has demonstrated that all theoretical domains emerged 
influencing clinical practice. In addition, it has demonstrated that the decision-making 
process varies among clinicians, but is mainly based on their professional qualifications 
and practice setting. Furthermore, the decision-making processes appeared to be related 
to, and differed according to, the individual clinician’s familiarity with the type and 
severity of clinical condition. 
For TMD, apparent differences in decision-making processes were identified between 
medically- and dentally-qualified practitioners. These were clearly related to insufficient 
education and training about the oral and maxillofacial related disorders in the UK 
undergraduate and postgraduate medical courses as compared to their dental 
counterparts (McCann et al., 2005; Goodson et al., 2013; Mahalingam et al., 2015). 
Given the fact that many patients in the UK may consult a medical practitioner rather 
than a dental practitioner for a non-odontogenic oral and maxillofacial problem (Bell et 
al., 2008), it seems pertinent to ensure that teaching related to TMD is included in the 
medical undergraduate curriculum and postgraduate training courses in order to ensure 
that medical practitioners possess the necessary knowledge and skills for TMD 
management. Recently, a syllabus of a brief educational course in maxillofacial 
emergencies for staff in the UK A&E departments is planned to be piloted in the future 
(Elledge and McAleer, 2015). 
The identified influences on clinicians’ decisions for TMD management were 
numerous, but the most influential factors seemed to be related primarily to ‘non-
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clinical’ environmental barriers of primary TMD care, namely time constraints, and 
financial barriers, in addition to lack of robust evidence-based guidelines. Most of the 
identified barriers of TMD care replicate the main findings of a previous qualitative 
study (Durham et al., 2007) and can be extrapolated to many other common chronic 
‘biopsychosocial’ conditions (Wagner et al., 2001; Ostbye et al., 2005). 
For DDwoR, important disparities were identified in decision-making processes 
between clinicians at the frontline (A&E, GMPs, & GDPs) and those providing a 
specialist (OMFS) service. These disparities appear to be directly linked to differences 
in knowledge and experience among clinicians. From the analysed data, it becomes 
quite clear that the main influencing factors on clinicians’ decisions at the first point of 
contact were related primarily to frontline clinicians’ lack of knowledge and experience 
in this ‘rarer’ disorder specifically. Again these findings can be extrapolated to many 
other uncommon acute conditions (Atherton et al., 1999; Girdler and Smith, 1999; 
Greenwood, 2008; Muller et al., 2008; Arsati et al., 2010; Skapetis et al., 2011). 
The literature suggests that clinical knowledge is one of the key determinants of clinical 
decision-making process (Maudsley and Strivens, 2000; Botti and Reeve, 2003). The 
lack of knowledge about DDwoR specifically among the majority of the clinicians at 
the frontline, including the GDPs in the study sample, can be attributed to the following 
multiple reasons.  
One of the main reasons is undoubtedly the low incidence of DDwoR. This, however, 
cannot be rationalised as the sole reason because, as mentioned, TMJ dislocation 
disorder has probably a comparable incidence and many clinicians at the frontline 
reported limited experience with this disorder too, but despite that most of them 
reported sufficient knowledge about TMJ dislocation and its management. 
Another potential reason is the inadequate undergraduate teaching in the UK dental 
schools about the different subtypes of TMD and their specific management. This was 
not unexpected for a ‘particular’ generation of dentists (graduated more than 30 years 
ago) who might have limited knowledge about different subgroups of TMD (Baharvand 
et al., 2010) because the most reliable criteria for TMD subgroups diagnoses 
(RDC/TMD) were published after 1990s (Dworkin and LeResche, 1992). It was, 
however, also found among the relatively ‘younger’ dentists in the study sample. In 
contrast, a recent questionnaire study evaluated the achieved competences in 
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COFP/TMD teaching at two European dental schools found that 91% and 100% of 
final-year Swedish and Italian dental students respectively were able to correctly 
diagnose DDwoR from a clinical case scenario (Alsafi et al., 2014). This difference may 
highlight the inadequacy of undergraduate teaching about DDwoR in the UK dental 
schools. In fact, the UK dental schools may cover DDwoR disorder currently but not 
necessarily the details on its diagnosis and treatment. One reason for this could be 
attributed to the UK General Dental Council’s broad non-specific definition of TMD for 
the current undergraduate dental curriculum (GDC, 2008), resulting in variations in 
undergraduate TMD teaching in dental schools.  
Another possible reason is the use of generic ‘TMD’ term in both clinical practice and 
published literature. As previously mentioned, this may cause limited knowledge about 
different subtypes of temporomandibular disorders and their specific diagnoses and 
treatments. 
Overall, there could be different reasons for professionals’ limited knowledge about 
TMD in general and DDwoR in particular but it seems that the main reason behind that 
is the lack of interest in the biopsychosocial TMD amongst the vast majority of 
clinicians. This lack of interest is highlighted by some participants in this study and was 
shown in previous studies (Aggarwal et al., 2012; Reissmann et al., 2015). 
Consequently, the ‘uninterested’ clinicians may not improve their knowledge and/or 
skills to manage such kind of patients in their clinical practice. 
Making decisions in emergency situations, however, does not rely solely on clinicians’ 
knowledge but also on their past clinical experience with these situations (Cioffi, 2001). 
Experience has been defined as “a conscious event that is lived through, or undergone, 
as opposed to one that is imagined or thought about” (APA, 2007). When encountering 
a new clinical situation, clinicians often use their past clinical experiences in their 
decision-making process by comparing and matching the present encountered situation 
to previous experienced situations held in their memory in order to make a decision 
(Benner, 1982; Cioffi, 2001). However, as seen in the previous sections, the majority of 
frontline clinicians had never encountered a patient with acute DDwoR due to low 
incidence of the condition.  
The lack of experience with DDwoR coupled with the limited knowledge about 
DDwoR among frontline clinicians seemingly had several ‘inter-related’ influences on 
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their decision-making process leading them to make an early referral decision when 
confronted with an acute DDwoR. The impact of frontline clinicians’ limited 
knowledge, skills, and experience with DDwoR on other influences (i.e., domains) are 
summarised as follows: 
 First, it caused reduced self-confidence of frontline clinicians’ ability to 
manage DDwoR impacting not only their beliefs about capabilities but also 
their beliefs about consequences of DDwoR management.  
 Second, it affects the frontline clinicians’ perceptions in their role to manage 
DDwoR.  
 Third, it made remembering of, and focusing attention to, DDwoR 
characteristic signs and symptoms difficult and challenging for frontline 
clinicians, impacting their decision-making processes.  
 Fourth, it increased the frontline clinicians’ emotionality leading them to 
express different concerns and worries when encountering such ‘unusual’ 
presentations.  
 Fifth, it resulted in a lack of intrinsic motivation and intentions among 
frontline clinicians to increase their knowledge and develop their skills to 
manage DDwoR.  
 Sixth, it lessened the frontline clinicians’ optimism about DDwoR 
management. 
 Seventh, it caused the frontline clinicians to seek social support and advice 
from more experienced clinicians.  
 Eighth, it impacted on the frontline clinicians’ behavioural regulation given 
that the DDwoR patients are rarely encountered; that is, the infrequent 
presentation of uncommon acute DDwoR patients, as opposed to more 
common mild TMD, did not improve frontline clinicians’ growing 
experience, shaping knowledge, and skills development for DDwoR 
management.  
 Finally, it directly influenced the frontline clinicians’ nature of behaviour to 
refer DDwoR early as compared to other TMD. 
 Additional interrelationships of influences (i.e., domains) for DDwoR 
management were also identified between the following: clinicians’ beliefs 
about consequences and their emotions; clinicians’ beliefs about capabilities 
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and their optimism; clinicians’ role and their goals; clinicians’ intentions and 
their goals; environmental context and reinforcement.  
All these interrelationships between the domains for DDwoR management are depicted 
in Figure 6.7 (TDF-model).  
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Figure 6.7: Theoretical model representing the interrelationships between the theoretical domains influencing the professionals’ clinical decision-
making process in DDwoR management. 
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The intimate relationships between the theoretical domains revealed by the TDF-based 
analysis (Figure 6.7) indicate that all the domains can have an influence on the 
clinicians’ decision-making processes in managing DDwoR but that they vary in their 
influential strength on clinicians’ decisions. The strongest influential domains appeared 
to be the professionals’ knowledge and skills (and their related construct: ‘experience’).  
As shown in the theoretical model (Figure 6.7), the ‘core’ barriers to DDwoR patients’ 
receiving care at the first point of contact were clinicians’ knowledge about disorder, 
experience with it, and skills required to diagnose and treat it. This means that there is a 
need to overcome these three barriers of care. Undergraduate and postgraduate 
educational and training courses are probably the key to improve the professionals’ 
knowledge and skills in order to circumvent limited professionals’ experience (the main 
barrier for experience-based knowledge and skills development). Although, there is no 
substitute for experience, simulation practical courses (e.g., by simulated case scenario 
or hypothetical human patient) have been suggested to overcome the deficiency in 
professionals’ experience (Bond et al., 2004; Croskerry, 2005a). Simulation is not a 
‘real’ clinical experience (Croskerry, 2005a) but it may help clinicians at the frontline to 
acquire clinical competencies and overcome their limited experience with DDwoR.  
In summary, the numerous influences on clinicians’ decisions in DDwoR management 
were identified, tabulated, and summarised domain by domain as problems-solutions 
and barriers-enablers in Table 6.11 and Table 6.12 respectively. These need to be 
addressed in the future intervention design in order to support the clinicians’ decisions 
for managing DDwoR at the first point of contact. 
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Theoretical Domain Identified problems Possible solutions 
1 Knowledge - Insufficient education  - Update undergraduate  
medical and dental 
curricula  
- Postgraduate medical and 
dental educational and  
training courses 
- Develop evidence-based 
guidelines 
2 Skills - Lack of proper training  - Hands-on postgraduate 
training programmes 
 Experience - Lack of experience  - Simulation courses 
3 Social/Professional 
role and identity 
- Generalists’ perception  - Increase responsibility 
perception as first-line 
clinicians 
4 Beliefs about 
capabilities  
- Lack of confidence  
- Lack of perceived ability  
- Increase self-efficacy 
- Set graded practice/tasks 
under 
supervised/supported 
conditions 
5 Beliefs about 
consequences 
- Outcome expectancy of 
disorder progress 
- Misdiagnosis 
consequences  
- Mismanagement 
consequences  
- Other barriers of care 
(fear of litigations and 
medico-legal 
consequences) 
- Increase awareness about 
the disorder natural 
course, its 
pathophysiology, and its 
diagnosis and response to 
conservative treatment. 
- Increase awareness about 
the red flags signs and 
symptoms 
6 Optimism - Pessimism  - Increase awareness about 
the disorder natural 
course and good response 
to conservative 
management 
7 Reinforcement - Lack of incentives 
(remuneration) to manage. 
- Dental contracting 
arrangements to ensure 
remuneration by some 
level of payment for NHS 
primary dental care 
clinicians 
8 Intentions - Lack of motivation to 
enhance knowledge in 
uncommon DDwoR 
- None identified 
9 Goals - Fear of setting goals  - Establish standardised, 
pragmatic, and achievable 
goals  
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Theoretical Domain Identified problems Possible solutions 
10 Memory, attention, 
and decision 
processes 
- Difficulty to remember 
the characteristic features 
of DDwoR and its 
management evidence as 
well 
- Lack of attention to 
DDwoR pathognomonic 
signs and symptoms  
- Early referral decision 
process 
- Electronic easily 
accessible tool to resolve 
memory and attention 
problems and to assist 
clinicians in their 
decision-making 
processes to manage 
DDwoR 
11 Environmental 
context and 
resources 
- Time constraints  
- Financial barriers  
- Lack of certain resources 
in some primary care 
practices such as: OPG 
machine, patient 
information leaflet, and 
physiotherapy devices. 
- Modify NHS contract for 
remunerating the primary 
dental care clinicians to 
compensate for the time 
needed for treating 
TMD/DDwoR 
- Supply primary care 
practices with the 
necessary resources 
12 Social influences  - Patients’ influences  
- Other barriers of care 
(Patients’ expectations as 
generalists not specialists) 
- None identified 
13 Emotions - Worries and concerns  
- Fear and anxiety  
- Negative affect: Feeling 
useless/helpless 
- Patient emotion/distress 
influence 
- Educational and training 
courses about such acute 
conditions and the red 
flag signs and symptoms 
14 Behavioural 
regulation 
- No growing experience 
- Lack of feedback 
especially in single-access 
emergency care setting 
- Enhance the feedback 
process between 
healthcare services 
15 Nature of 
behaviour 
- Unfamiliarity with the 
acute severe clinical 
conditions 
- Enhance knowledge and 
experience with acute 
TMD. 
Table 6.11: Summary findings of identified problems and possible suggested solutions 
for TMD/DDwoR management. 
 308 
 
Theoretical Domain Barrier Enabler 
1 Knowledge - Lack of knowledge of 
DDwoR disorder 
- Lack of procedural 
knowledge  
- Lack of knowledge about 
red flags  
- Lack of interest 
- Easy contact with 
secondary and tertiary 
care clinicians 
2 Skills - Lack of skills required for 
DDwoR management 
- None identified  
 Experience  - Lack of experience  - None identified  
3 Social/Professional 
role and identity 
- Generalists’ perception  - First-line professionals’ 
identity   
4 Beliefs about 
capabilities  
- Lack of confidence  
- Lack of perceived ability  
- None identified  
5 Beliefs about 
consequences 
- Outcome expectancy of 
disorder progress 
- Misdiagnosis 
consequences  
- Mismanagement 
consequences 
- Positive referral 
consequences 
- Other barriers of care 
(fear of litigations and 
medico-legal 
consequences) 
- Negative referral 
consequences  
6 Optimism - Pessimism  - None identified  
7 Reinforcement - Lack of incentives 
(remuneration) 
- Self-reward (personal 
satisfaction) 
8 Intentions - Lack of intention to 
increase knowledge in 
uncommon DDwoR 
- Intrinsic motivation to 
improve practice 
- Intention/willing to help 
patient 
- Practitioner’s previous 
experience 
- Learning manipulation 
technique 
9 Goals - Professionals’ 
unpredictability to 
management outcomes 
- Fear of setting ‘formal 
goals 
- Management priority and 
importance  
- Symptoms’ management 
Goal: Goal/target setting 
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Theoretical Domain Barrier Enabler 
10 Memory, attention, 
and decision 
processes 
- Memory problem related 
to low incidence of 
disorder. Difficulty to 
remember the 
characteristic features of 
DDwoR and its 
management evidence. 
- Lack of attention to 
DDwoR pathognomonic 
signs and symptoms  
- Early referral decision 
process 
- First-time experience 
memory 
11 Environmental 
context and 
resources 
- Time constraints  
- Financial barriers  
- Lack of certain resources 
in primary care practices 
such as: OPG machine, 
patient information leaflet, 
and physiotherapy devices 
- Availability of necessary 
resources 
- Organisational 
influences/pressure to 
management commitment 
and avoid referrals 
12 Social influences  - Patients’ influences 
(social pressure) 
- Other barriers of care 
(patients’ perceptions and 
expectations of primary 
care clinicians as 
generalists not specialists) 
- Professionals’ influences: 
Professional’s phone 
advice (Social support):  
- Team-work (social 
support) 
- Involving patient (patient 
preference, informed and 
shared decision) 
13 Emotions - Worries and concerns  
- Fear and anxiety  
- Negative affect: Feeling 
useless/helpless 
- Patient emotion/distress 
influence 
- Empathy with the patient’s 
suffering. 
- Limited effects of 
practitioners' emotions or 
work stress on their 
management decisions 
14 Behavioural 
regulation 
- No growing experience - Self-monitoring 
- Generating alternatives for 
acute TMD conditions  
- Motivation to 
change/willing to receive 
feedback about referred 
patients 
- Clinicians’ suggestions to 
help themselves for 
DDwoR management 
15 Nature of 
behaviour 
- Salient/critical clinical 
situation 
- None identified  
Table 6.12: Identified barriers and enablers for DDwoR management. 
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6.4.5 Strengths and limitations of the qualitative study 
This study, as with other qualitative-TDF studies, had strengths and limitations related 
mainly to study design, study sample, and methods used. 
This study, unlike many ‘TDF’ studies, is the first study that has used the TDF to 
explore the whole clinical decision-making process in order to identify factors 
influencing clinicians’ decisions. This study was strengthened by using two approaches, 
rather than a singular approach, to analyse the qualitative data. Firstly, the pattern of 
clinical decision-making process for each individual practitioner was analysed and 
depicted in a graphical map. This served three purposes: (1) it facilitated the 
understanding of clinicians’ management pathways (Appendix I); (2) it allowed 
comparisons between and among different groups of practitioners (Appendix M); (3) it 
helped the development process of the generic map (Figure 6.6). Secondly, the TDF-
based analysis of data was used to identify influences on clinicians’ decisions. By using 
the TDF, the study findings provided new information about influential factors on 
clinicians’ decisions that may otherwise be overlooked if the theoretical framework was 
not used. Using a framework based on a wide range of psychological theories in data 
analysis permits the identified factors, as informed by theoretical domains, to be linked 
to relevant behaviour change techniques to be subsequently implemented in future 
intervention and, ultimately, support clinicians’ decisions to improve patient care.  
Some limitations, however, were identified with the use of theoretical framework in this 
study. One limitation is the use of TDF as a guiding framework for data analysis. This 
structured approach may restrict the emergence of ‘free’ themes (McCluskey and 
Middleton, 2010; McSherry et al., 2012). Although the initial generation of ‘free’ 
unrestricted codes should overcome this possible limitation, there is still a possibility of 
identifying other aspects of clinical practice and experience that might have emerged if 
another approach for data analysis had been used. This, however, seems unlikely given 
the comprehensiveness and inclusiveness of the TDF. Actually, the use of TDF 
facilitated analysis and no factors influencing the clinicians’ decisions have emerged 
that could not be thematically mapped to theoretical domains.  
Another limitation of the TDF is that it was designed to be applied to topics where there 
is a high-quality evidence-based clinical practice guideline. It has been suggested that 
the TDF might be less useful in topics where the high-quality evidence and guidelines 
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are lacking because the identified ‘behavioural determinants’ can vary by variations in 
participants’ attitudes (Francis et al., 2009; McSherry et al., 2012). This, however, did 
not seem to be an issue in our context because our study aimed to identify the 
influencing factors on the whole decision-making process and did not aim to identify 
purely the behavioural determinants (influences) of a specific ‘targeted’ behaviour. 
A further limitation of using the TDF could be the lack of clarity in the definitions of 
the theoretical domains and some overlap between constructs associated with the 
domains. This has proved to be a main problem in data analysis in previous studies 
(Islam et al., 2012). In an attempt to resolve this problem in our study, we referred back 
to the ‘psychological’ definitions of the domains and constructs (APA, 2007) and to the 
theoretical domains interview (TDI) questions. This, however, was challenging when 
one construct within the ‘memory, attention, and decision processes’ domain (i.e., 
decision processes) was found to be relevant to whole decision-making process and 
when some constructs of TDF domains were found to be relevant to other domains (e.g., 
action planning construct in ‘goals’ and ‘behavioural regulation’ domains). In addition, 
the TDF was also criticised for not specifying the domains’ relationships (Duncan et al., 
2012; McSherry et al., 2012). In this study, several relationships between the domains 
were identified and mapped (Figure 6.7), suggesting that there are links between 
theoretical domains influencing clinicians’ decisions. This highlights the need to 
explore further the identified relationships between the domains. To give an example, if 
the professionals’ knowledge and skills in DDwoR management are improved, would 
this affect the professionals’ beliefs about their capabilities to manage DDwoR? Further 
research is needed to explore the relations between the theoretical domains in order to 
better understand the influences on professionals’ behaviour. 
The study design and methodology used had also strengths and limits. First, the semi-
structured interview method was utilised in this study to collect the data. This type of 
data collection method allows the researcher to explore ‘in-depth’ the relevant issues 
with a ‘singular’ practitioner (Fitzpatrick and Boulton, 1994). Other data collection 
methods can be used such as observation of clinicians or focus group discussions, but 
both seemed impractical for the purposes of this particular study. Observation is time 
intensive generally and would be impractical not only due to time constraints of the 
project but also because of the infrequent presentation of DDwoR cases in clinical 
practice. Focus groups may not allow in-depth focused one-to-one discussion and may 
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not be balanced and dominated by one vociferous participant especially in our study 
where we wanted views from a range of healthcare professionals and hierarchy could 
have affected responses. Second, the two modes of qualitative interview were used in 
this study: face-to-face and telephone (Novick, 2008). However, comparison between 
telephone and face-to-face interviews in a study by Sturges and Hanrahan (2004) 
revealed that the mode of the interview did not significantly affect the generated data 
and that telephone interviews can have several advantages over the face-to-face 
interviews. In this study, telephone interviews were conducted to avoid sampling bias 
when the clinicians were reluctant to participate in a face-to-face interview or when the 
clinicians agreed to participate but were unable to attend to the Dental Hospital. Third, 
as this is a qualitative study, the findings from the qualitative data analysis regarding the 
identified influencing factors cannot be generalisable and represent only the 
participants’ perceptions and views about what might influence their clinical decisions. 
The identified factors, therefore, may not represent the actual influences on clinicians’ 
decisions in real practice (Francis et al., 2009; Tavender et al., 2014). To give an 
example, a lack of time to manage TMD may, in reality, reflect a lack of interest in 
TMD management. It has been suggested that relying solely on participants’ 
perceptions is inadequate for effective intervention implementation (Boscart et al., 
2012). This limitation may indicate the need to amalgamate the qualitative study 
findings with the findings from other study designs for effective intervention 
implementation. 
The composition of the sample used in this study also demonstrated some strengths and 
weaknesses. The sampling strategy used was purposive, criterion-based, maximum 
variation sampling. Other qualitative sampling strategies are available and suggested in 
the literature (Patton, 2002), most commonly theoretical sampling (i.e., sampling is 
theoretically guided by the emerging concepts) (Glaser and Srauss, 1967). Theoretical 
sampling, however, was not used because this study was ‘pre-informed’ by the 
theoretical domains of behaviour change (Michie et al., 2005). In fact, it has been 
suggested that developing an intervention that is based on identified domains and takes 
into account the potential roles of all professionals involved in care of patients is most 
likely to be ‘successful’ (Patey et al., 2012). The sampling strategy used in this study 
strengthened our findings because it gave us the perspectives from the key professional 
groups responsible for DDwoR management at multiple levels across the care pathways 
(primary, secondary, and tertiary care). Subsequently, this helps understanding the 
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multi-level DDwoR care path and contrast between ‘first-line’ and ‘second-line’ care 
groups around DDwoR management. The ‘second-line’ study sample, however, 
included only clinicians working in the specialist oral surgery and maxillofacial surgery 
services. The OMFS clinicians may have different perspectives and ideologies from 
other specialities with respect to TMD/DDwoR management (Durham et al., 2007), 
which may bias the qualitative data. In fact, this study could have been further 
strengthened by recruiting participants from other specialities routinely involved in care 
of TMD/DDwoR patients such as: restorative dentists, oral medicine dentists, 
physiotherapists, and ENT clinicians. Clinicians from different specialties, however, 
were not included because the primary aim of this project was to specifically examine 
the clinicians’ understandings about DDwoR disorder at the first point of contact and 
compare that with those at the specialist service; although their management ideas about 
DDwoR would have provided an interesting comparison with the current data and may 
also have added further insight about the DDwoR care pathway. 
The study sample had further limits. Firstly, more than 100 clinicians were contacted 
and invited to participate but only about 20% agreed to participate. This low rate is 
attributed to different potential reasons including: change in practice/clinician contact 
details (e.g., some clinicians contacted had moved to non-North East Trusts), clinician’s 
busy schedule and lack of time, or clinician’s lack of interest in COFP/TMD. The latter 
factor was shown to be one of the reasons for clinicians’ declining to participate in a 
previous survey study in the UK (Aggarwal et al., 2012) and may cause a potential 
selection bias in this study because the interviewed participants may represent a 
subgroup of clinicians who have a higher degree of interest in TMD compared with the 
non-responding clinicians, thus limiting the generalizability of study findings; although 
this is less of an issue for DDwoR as all the invited clinicians were not pre-informed 
about it. Secondly, by using a TDF-based topic guide and analysis, there was a 
possibility of reaching the saturation prematurely if the participants shared similar 
opinions (Patey et al., 2012). To overcome such potential limitation, the study sample 
was maximum variation to ensure participants’ diversity for a range of variables (e.g., 
gender, years since graduation, clinical practice, qualification, undergraduate school, 
and practice region), thereby covering a broad range of differing opinions. Thirdly, the 
sample was restricted to the North East region of England which may again limit the 
generalizability of study findings elsewhere. For example, the barriers of TMD care in 
the UK healthcare system may differ from other parts of the world. Nevertheless, most 
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of the barriers for DDwoR care raised by the study’s participants seem likely to be 
encountered in other similar healthcare systems in other countries. Finally, this study 
aimed specifically to examine the professionals’ understanding of DDwoR. As such, 
qualitative interviews with DDwoR patients would help understand the DDwoR 
patient’s journey and potentially inform the design of a future intervention for patients. 
All the aforementioned limitations regarding the study sample, however, were difficult 
to be overcome due to limited resources and time scale of this project. 
6.5 Conclusions 
The healthcare professionals’ clinical decision-making processes for TMD and DDwoR 
management were influenced by numerous factors. The domains identified as likely to 
change clinicians’ behaviour to manage patients with TMD and DDwoR were relatively 
similar but they differ in their influential strengths to change clinicians’ behaviour. 
Twelve of the fifteen theoretical domains were identified as of potential importance and 
relevance for future intervention to improve clinical decision-making processes for 
DDwoR management. Of the 12 domains identified, however, the most frequent and 
clearly influential on clinicians’ decisions were knowledge and skills domains (and their 
relevant construct ‘experience’). There is a need to enhance the professionals’ 
knowledge and skills in managing acute TMD conditions such as DDwoR to 
circumvent the professionals’ limited experience with DDwoR. Nevertheless, all the 
factors identified represent theoretically-based targets for an intervention to support, and 
thereby improve, the clinicians’ decisions around DDwoR management at the first point 
of contact.
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Chapter 7. Conclusions 
7.1 Studies’ Conclusions 
This thesis aimed to inform the development of a future intervention in order to aid the 
clinicians at the frontline managing DDwoR disorder. To achieve this aim, three 
objectives were addressed via three separate studies.  
7.1.1 Systematic review of locking duration effects  
The first of the listed objectives of this thesis was to assess the effects of locking 
duration on the clinical outcomes of therapeutic interventions used for patients with 
acute and chronic DDwoR. From the conducted systematic review, however, neither the 
transition point from acute to chronic DDwoR nor the effects of locking duration on 
treatment outcome could be determined. Nonetheless, there was low grade evidence of 
the need for early intervention in the DDwoR management pathway with the simplest, 
cheapest, quickest, and most practical first diagnostic and therapeutic approach, 
probably a mandibular manipulation. 
7.1.2 Systematic review of therapeutic interventions effects 
The second objective of this thesis was to assess the clinical effectiveness of therapeutic 
interventions used for managing patients with DDwoR. From the conducted systematic 
review, there was weak evidence that all the reviewed interventions, whether 
conservative or surgical, achieved comparable therapeutic effects in managing DDwoR. 
This strengthened the evidence for managing patients with DDwoR initially with the 
simplest, least costly, and least invasive interventions, probably education and self-
management with early manipulation. 
7.1.3 Qualitative study of clinicians’ decisions 
The final objective of this thesis was to explore the clinicians’ decision-making process 
in managing DDwoR at the frontline and to identify influences on their decisions. From 
the conducted qualitative study, a number of influences on frontline clinicians’ 
decisions were identified but they were related chiefly to their limited knowledge, skills, 
and experience with DDwoR. This suggests the need to enhance the clinicians’ 
knowledge and skills in managing DDwoR to circumvent the clinicians’ limited 
experience with DDwoR. 
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7.2 Summary Conclusion 
In summary, this thesis provides evidence for intervening early in DDwoR patients with 
the most minimal intervention and the need to enhance the professionals’ knowledge 
and skills in order to support their decisions to diagnose and treat, at least initially, 
patients with DDwoR at the frontline. The various implications of this project are 
detailed in the next chapter (Chapter 8). The components of proposed intervention to aid 
clinicians’ decision-making should be based on the concluded evidence from this 
project and are summarised in Section 8.2. 
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Chapter 8. Implications for Clinical Practice, Future Clinician-based        
Intervention Implementation, and Future Research 
8.1 Implications for clinical practice 
Patients with TMD may present to clinicians complaining of different signs and 
symptoms related to the different underlying subtypes of TMD. Amongst all TMD, 
patients with DDwoR may present not only with significant pain but also with mouth 
opening limitation of mechanical cause. The initial management of DDwoR, as for the 
whole TMD, however, is shown in this project to be somewhat similar: minimal-
interventional reversible conservative management. That said, the clinicians managing 
patients with DDwoR should make particular considerations to the following: 
8.1.1 Diagnosis of DDwoR  
The clinicians’ diagnosis process should involve the following: 
 A thorough knowledge about the differential diagnoses for limited mouth 
opening (Table 2.7). 
 A systematic diagnostic approach in order to achieve an accurate diagnosis for a 
patient presenting with pain and/or limited opening. This involves, in addition to 
comprehensive history and careful clinical examination, appropriate 
investigations if necessary and particular attention to the presence of ‘trismus’ 
red flags (Table 2.9).  
8.1.2 Treatment of DDwoR  
In order to achieve the basic treatment goals for patients with DDwoR: relieving pain, 
improving opening, and restoring jaw function, the current available evidence from the 
systematic reviews, albeit weak, suggests that the clinicians should treat patients with 
symptomatic DDwoR in a stepped ‘timely-management’ approach, as follows: 
1. First-line management: Start the management initially with the most minimal, 
simplest, least invasive, and least expensive interventions of education and self-
management with ‘early’ manipulation, as follows:  
Patient education: Its main aim is to educate and reassure the patient about the 
DDwoR disorder. It includes the following: 
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 A reassurance about the symptoms of DDwoR are not indicative of a serious or 
sinister pathology. 
 A reassurance about the self-limiting nature of the DDwoR disorder and its 
‘favourable’ prognosis (natural course): it is likely to improve in the majority of 
cases with time alone or with non-interventional simple care. It is not, however, 
always “curable” and can recur or fluctuate in symptomatology over time. 
 A clear explanation to the patient in simple understandable terms about the 
clinical ‘closed lock’ condition, its signs and symptoms, and its potential 
causative biopsychosocial factors. 
 A simple clarification to the patient about the mechanism of the articular disc in 
TMJ and the normal rotating and translating condylar movements and the 
normal masticatory apparatus functions. 
 Education about the harmful effects of long-term use of over-the-counter 
medications and mouth guards and the lack of evidence for irreversible occlusal 
treatments. 
 An explanation in a neutral manner about the potential risks associated with 
surgical interventions and the limited available evidence base to support its 
effectiveness. Further to this, it should be highlighted that current evidence has 
not demonstrated its superiority over simpler, less costly, and less risky non-
invasive interventions. 
Self-management programme: Its main aim is to prevent further injury to the 
musculoskeletal structures and allow for healing to occur by increasing patients’ self-
efficacy in managing their own DDwoR condition. The programme may include several 
different self-care strategies, as described in the literature, but all generally involve 
instructing and advising the patients with respect to the benefits of the following: 
 Rest (jaw and muscle relaxation). 
 ‘Pain-free’ soft diet, decaffeinated diet, and balanced chewing. 
 Parafunctional habits awareness and modification.  
 Diaphragmatic breath training, sleep improving, and posture training.  
 Home physiotherapy programme including self-exercises, self-massages, and 
hot/cold packs application. 
 Pharmacotherapy such as oral and/or topical analgesics and anti-inflammatories. 
 Psychosocial therapy such as optimistic counselling and biofeedback. 
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To achieve a successful outcome of patient education and self-management, the 
clinicians must have good communication skills, be competent in exclusion of red flags, 
be capable of selecting the appropriate treatment strategy, and must be able to explore 
patients’ beliefs, expectations, and own goals before initiating long-term management 
strategies. The clinicians should also clarify to the patients that the success of self-
management is dependent largely on them, particularly on their cooperation, adherence, 
motivation, and active participation. 
Mandibular manipulation: Its main aim is to improve DDwoR symptoms early in the 
chronology of the condition. Various ‘unlock’ manipulation techniques, with/without 
adjunctive treatments, are described in the literature, but the available evidence supports 
the application of either the ‘anterior teeth’ technique for self-manipulation suggested 
by Yoshida et al. (2011) or the ‘posterior teeth’ technique described by Farrar (1978) 
and modified in this thesis (Figure 2.9). Before applying this treatment approach in 
clinical practice, however, the clinicians require: 
 A full understanding about the anatomy of condyle-disc complex and the 
specificity of DDwoR pathophysiology and the potential beneficial effects of 
early application of manual manipulation.  
 A sufficient knowledge and training about the manipulation techniques.  
 An adequate knowledge about the possible need for patient analgesia pre-
manipulation and splint treatment post-manipulation.   
The outcome of this first-line management can be probably reviewed within the first 3 
months.  
2. Second-line management: Escalate management only if needed via rehabilitation 
by splint therapy, physiotherapy, or a combination of both. Various splint types and 
physiotherapies are available and suggested in the literature. 
The outcome of this second-line management can be probably reviewed within 3-6 
months. 
3. Final-line management: Defer TMJ surgery to around 9-12 months or more of 
comprehensive conservative treatment and apply it only in the face of objective 
clinical need (i.e., persistent severe pain and/or disability) and have already 
confirmed the biomedical cause of symptoms (i.e., confirmed the DDwoR clinical 
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diagnosis by soft tissue TMJ imaging) and engaged in a carefully constructed 
programme of conservative management. Start surgery, only if required, by using 
the most minimally-invasive technique, arthrocentesis.  
There could be, however, individual level differences in DDwoR patients’ biomedical 
complaints (e.g., presence/absence of pain or mouth opening limitation) or psychosocial 
variables which may change the suggested stepped management plan and create a 
necessity for a specific treatment but this stepped approach is generally the most 
realistic. 
8.1.3 Referral of DDwoR 
The frontline clinicians are recommended to refer DDwoR patients in the following 
circumstances: 
 Refer immediately: if there are any concerns about red flags or if there are 
severe pain and/or limited opening symptoms. 
 Refer after one month: if there are persistent high-level symptoms despite initial 
management. 
 Refer after three months: if there is limited symptomatic improvement despite 
conservative management. 
The suggested recommendations are based on the best available evidence to-date but 
they should be interpreted with caution due to limited quality of current evidence. 
Future well-conducted research may change or confirm these. 
8.2 Implications for future clinician-based intervention implementation 
The findings from the qualitative study suggest the need for a future behavioural 
intervention to support clinicians in DDwoR management at the frontline. The proposed 
intervention needs to be based on the identified factors, as informed by the TDF, 
influencing the clinicians’ decisions. The intervention design should follow the 
‘TIDieR’ checklist guide proposed for better reporting of behaviour change 
interventions (Hoffmann et al., 2014). The key components of the proposed intervention 
for DDwoR management were suggested by study participants to be simple, easy, clear, 
concise, and practical to help them diagnose and treat DDwoR patients. Participants 
preferred the electronic intervention to be delivered via an eHealth rather than a 
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mHealth platform so that clinicians can use it on the practice’s computer rather than on 
their personal mobile devices. Further features about the future intervention design are 
detailed in Table 8.1.  
Item No  Item 
1 Brief name P/LMO intervention for Painful/Limited Mouth Opening 
management 
2 Why To aid the healthcare professionals diagnose and treat patients with 
painful limited mouth opening conditions, specifically DDwoR. 
3 What Materials and Procedures  
 Simple diagnostic guide (easy, clear, concise, quick and 
practical) to help recognize closed lock condition and diagnose 
DDwoR. The guide should also include differential diagnostic 
signs and symptoms and red flags to help differentiate DDwoR 
from other conditions with similar ‘trismus’ symptom.  
 Patient information leaflet to include self-care instructions that 
can be printed out and provided to the patients. 
 Virtual online videos associated to the intervention for e-
learning/training (certified professional training videos rather 
than conventional YouTube videos) about:  
1) How to examine the closed lock patient to make the DDwoR 
diagnosis. 
2) Simple explanation about TMJ anatomy, mechanism of the 
condyle-disc complex, and DDwoR condition and its natural 
course to both patients and professionals. In addition to 
educational videos about self-management including 
instructions to patients about how to care their TMD 
condition. 
3) How to perform the practical manoeuvre of 'unlock' 
manipulation technique for acute DDwoR and also probably 
the relocation manipulation technique for acute TMJ 
dislocation.  
 Optional feature of the intervention (according to professional 
specific need): training courses either in a face-to-face setting 
where clinicians would have hands-on ‘real’ training or 
simulation web-based case scenario to learn how to 
appropriately use proper skills for manipulating the jaw. 
 A brief bulletin or lecture series to be delivered to all practices. 
 A questionnaire to assess professionals’ performance and 
feedback them. 
 Attractive for use by rewarding the professionals with CPD 
hours/points. 
 In addition to all relevant domains identified earlier in Table 6.8. 
4 Who 
(provider) 
The intervention will be delivered electronically via internet to 
professionals. The face-to-face training session could be organised 
by GDC (counting for continuous professional development ‘CPD’) 
and delivered by specialists in TMD.   
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Item No  Item 
5 How The modes of intervention delivery will be provided electronically 
and individually to professionals. Mode of e-intervention delivery 
can be via eHealth or mHealth media but the participants preferred 
the intervention to be delivered on desktop computer screen or iPad 
(eHealth) rather than on smart phone (mHealth). The face-to-face 
training session could be provided by specialists in TMD.    
6 Where The intervention can be used electronically individually by 
professionals at their clinical practice. The face-to-face training 
session could be held in academic dental schools or dental teaching 
hospitals.   
7 When and 
How Much 
The intervention can be used electronically by professionals at any 
time. The face-to-face training session could be organised once or 
twice a year as a full-time study day specified for diagnosing and 
treating DDwoR. 
8 Tailoring Not applicable 
9 Modifications Not applicable 
10 How well The intervention adherence and fidelity is not assessed yet but it can 
be assessed by involving a questionnaire for professionals’ 
feedback and evaluation of the intervention. Records can also be 
kept, electronic ones, on the features of the intervention used, how 
often, for how long each time; this can later be evaluated against 
other measures such as numbers of diagnostics, initial treatments 
and referrals.   
Table 8.1: Template for future intervention description for DDwoR management. This 
is based on items included in the Template for Intervention Description and Replication 
(TIDieR) checklist (Hoffmann et al., 2014). 
8.3 Implications for future research 
Different implications for future research were identified from each of the three studies. 
8.3.1 Systematic review of locking duration effects 
In the systematic review of locking duration effects, neither the transition point from 
acute to chronic DDwoR nor the effects of locking duration on treatment outcome could 
be determined and remained controversial. One of the likely reasons is the lack of a 
standardised diagnostic classification for DDwoR that characterises the clinical staging 
of DDwoR on the basis of locking duration (i.e., time since DDwoR onset). Future 
diagnostic classifications for DDwoR should seek to address and define the acute versus 
the chronic period in relation to duration of locking, given that it is one of the few 
factors that can be easily addressed from patient’s history especially in acute closed lock 
because patients can often recall the sudden-onset locking of short duration. This 
classification may then advance understanding and help target the available therapies 
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for acute and chronic DDwoR more effectively. To examine the effects of locking 
duration on the outcome of therapeutic interventions for DDwoR in future trials, 
standardisation is needed for the following:  
 Definition of acute and chronic DDwoR in order to allow stratification of 
treatment groups.  
 Other prognostic factors that may predict DDwoR management outcome. 
 Multidimensional outcome measures that are of importance in DDwoR.  
 Pragmatic success criteria that are of importance for DDwoR patients in order to 
yield more rigorous research. 
Further recommendations for future trials of DDwoR management are suggested below. 
8.3.2 Systematic review of therapeutic interventions effects 
In the systematic review of therapeutic interventions effects, weak evidence was found 
to initially manage DDwoR with the simple non-invasive conservative interventions, 
specifically education, self-management, and early mandibular manipulation. The 
evidence for managing DDwoR with the minimally-invasive surgical intervention 
through arthrocentesis and lavage was contradictory. Future high-quality pragmatic 
RCTs are required to examine the effects of these interventions in order to provide more 
robust evidence of their efficacy or lack of it. Given the low incidence of DDwoR 
amongst TMD and the difficulty in recruiting patients with a DDwoR ‘acute/chronic’ 
diagnosis, a multi-centre RCT may be the most appropriate. The recommended research 
design for future RCTs is described in-detail in Appendix N. 
8.3.3 Qualitative study of clinicians’ decisions 
In the qualitative study of clinicians’ decisions, a number of problems (Table 6.11) and 
barriers (Table 6.12) for TMD/DDwoR care were revealed by the study participants; 
most importantly, insufficient knowledge and training and lack of time and financial 
incentives to manage TMD/DDwoR. Therefore, there is a necessity for the following:  
 Smart commissioning in NHS dentistry and reform of the current NHS dental 
contract to involve adequate remuneration of GDPs for the time required for 
TMD/DDwoR management in primary care. 
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 Update and revise the current undergraduate curriculum in the UK dental and 
medical schools to involve more detailed education about the different common 
subtypes of TMD.  
 Offer evidence-based postgraduate courses for dental and medical practitioners 
about TMD/DDwoR management. 
If these arrangements are addressed in the future, they will undoubtedly change the 
current clinical practice and possibly improve the healthcare delivery.  
The qualitative TDF-informed method was used to understand the professionals’ 
clinical decision-making processes around TMD/DDwoR management in order to 
identify possible factors (i.e., domains) influencing these processes. The main outcome 
of the qualitative study is the first step in an intervention development and 
implementation process. To complete this process, there is a need for the following 
sequential steps: 
 Design, using the qualitative data, a valid questionnaire (Appendix O) to employ 
with a representative sample of clinicians in order to determine the frequency of 
influencing domains for changing practice (Huijg et al., 2014a). This step is an 
optional step and the developed questionnaire can be utilised, instead, to assess 
the professionals’ performance and provide feedback as well as to evaluate the 
piloted intervention. 
 Engagement with computer scientists for developing an active web-based 
eHealth and/or mHealth intervention. 
 Engagement with potential users (i.e., clinicians) for refining the draft version 
(Table 8.1) of the pilot intervention (e.g., checking intervention feasibility by 
focus group discussion). 
 Open pilot intervention trial. 
 Randomised controlled trial.
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Appendices 
Appendix A: Characteristics and quality of all the included studies in systematic 
review of locking duration study (Chapter 4) 
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A-1: Characteristics and quality of included mandibular manipulation (unlock manipulation ‘UM’ or pumping manipulation ‘PM’) studies 
Study 
(Year) 
Study 
design 
Participants’ characteristics 
Main Intervention 
assessed  
Longest 
follow-up 
duration 
(months) 
Success criteria 
Study findings in 
relation to locking 
duration (LD) 
Overall 
success 
rate % 
(ITT use) 
Study 
design 
quality 
Sample 
size 
(drp/exc) 
Study 
diagnosis 
Gender 
Age  
(years) 
Locking duration 
(months) 
M F Range Mean Range Mean ± SD 
Chiba and 
Echigo 
(2005) 
CR 1 
DDwoR 
(ACL) 
- 1 21 - 0.33 - 
Farrar’s UM a under 
LA + ARS 
137 
Decreased pain, 
cMMO≥40mm, & 
DR on MRI 
- - IV 
Correa et al. 
(2009) 
CR 1 DDwoR - 1 18 - 36 - 
UM under LA 
+ ARS, NSAIDs, 
cryotherapy 
24 cMMO>40mm - - IV 
Foster et al. 
(2000) 
PNCoSt 
55 
(19) 
22 CL 
DDwoR 
& 14 IL 
7 48  15-52 24 3-48 13 
Forced UM under 
GA  
+ Self-care ± Splint 
3 
MMO≥35mm & 
subjective 
improvement 
Range of LD (6-48) was 
similar in SG & UG. 
CL: 40.9% 
(no ITT) 
III-3 
Helkimo and 
Hugoson 
(1988) 
PCS 10 DDwoR 3 7 17-63 29.4 1-36 12.2 
Farrar’s UM under 
N2O/O2 sedation + 
SS 
6 
Improvement in: 
pain,  jaw 
dysfunction (Di: I-
II), LM, & 
MMO≥40mm 
Longer LD in UG 20 
(12-36) than in SG 10.8 
(1-30). 
60% IV 
Hernandez 
and Karibe 
(2004) 
CR 1 DDwoR - 1 - 28 0.25 - 
UM under LA 
+ Med, PT (US), SS, 
Self-exercises 
1 MMO≥40mm - - IV 
Jagger (1991) PCS 12 DDwoR 4 8 15-43 21.8 1-9 3 UM (own technique) - MMO≥35mm 
LD is not an important 
factor for UM success 
66.7% IV 
Kai et al. 
(1993) 
PCS 12 b DDwoR 1 11 11-61 30.33 0.1-2 0.5±0.53 UM or PM + ARS 1 
Improvement in 
clinical symptoms 
& MMO≥40mm 
58.3% DR on 
arthrography 
66.7% IV 
Kurita et al. 
(1999) 
PNCoSt 
74/215 
assessed 
by MRI 
DDwoR 7 67 - 32.5 - 11.4 
Farrar’s UM 
+ ARS or NSAID or 
SS 
Few wks DR on MRI 
No significant difference 
in LD between 
successful DR (10±19.1) 
and no DR (12.8±24.6). 
18% 
(no ITT) 
9% 
(ITT) 
III-3 
Liu et al. 
(2012b) 
RNCoSt 36 
23 CL 
DDwoR 
& 13 IL 
6 30 13-31 19.8 < 3 - 
UM under LA  
+ ARS 
6 
Improvement in: 
pain, MMO, & 
jaw dysfunction.  
- 
DDwoR: 
69.6% 
IV 
Martini et al. 
(1996) 
PCS 
13/1500 
reported 
DDwoR - - 19-56 31.4 0.23-180 
36.02±53.4
7 
UM (own technique) 
+ ARS, PT 
2-24 
Absence of pain, 
MMO≥35mm, & 
DR on MRI 
LD is not related to UM 
success. 
99.7% IV 
Minagi et al. 
(1991) 
PCS 35 DDwoR 2 33 12-68 35.94 0.25-18 3.26±4.09 UM (own technique) - MMO≥40mm 
No difference in success 
rate between <1mo 
(50%) & >1mo (53%) 
LD. 
51.4% IV 
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Study 
(Year) 
Study 
design 
Participants’ characteristics 
Main Intervention 
assessed  
Longest 
follow-up 
duration 
(months) 
Success criteria 
Study findings in 
relation to locking 
duration (LD) 
Overall 
success 
rate % 
(ITT use) 
Study 
design 
quality 
Sample 
size 
(drp/exc) 
Study 
diagnosis 
Gender 
Age  
(years) 
Locking duration 
(months) 
M F Range Mean Range Mean ± SD 
Mongini et 
al. (1996) 
PCS 
 
75 
(7) 
 
DDwoR 7 68 13-43 27.8 0.25-120 13.3±21.84 
Extra-oral UM  
under LA 
+ ARS, SS, Med, PT 
18-147 
No pain or pain 
present only on 
jaw movement & 
MMO≥35mm  
No difference in LD 
between SG & UG.  
4.4% DR on MRI. 
86.8% 
(no ITT) 
IV 
Muhtarogulla
ri et al. 
(2013) 
PNCoSt 22 DDwoR 3 19 14-48 27.1 - 3.25 
UM + ARS  
if unsuccessful DR: 
SS+ Self-exercises 
6 
No pain on 
palpation, 
MMO≥40mm, 
normal LM & PM 
15.9% DR on MRI 100% III-3 
Murakami et 
al. (1987) 
PCS 10 DDwoR 1 9 14-46 28.9 1-9 4.7 PM + CS + ARS 6 
AAOMS criteria: 
increase in cMMO 
No difference in LD 
between SG & UG.  
PM helps to unlock the 
CL up to about 6mo. 
70% IV 
Murakami et 
al. (1995) c 
PCoSt 108 
W: III 
(CL) 
20 88 - 31.43 - 
5.0±8.8 
NSurg: 
Med/UM/PS, N=63  
6 
VAS pain<20, 
MMO>38 mm, 
LM & PrM> 
6mm, & improved 
DAL 
Patients with >7mo LD 
did not respond to 
arthrocentesis 
NSurg: 
55.6% 
(Md:15.9% 
UM:18.9% 
PS: 33.3%) 
AC: 70% 
AS: 91% 
III-2 5.6±6.9 AC, N=20 
6.8±10.2 AS, N= 25 
Ohnuki et al. 
(2006) c 
RCoSt 85 DDwoR 9 76 13-73 41.8 - 
5.1±6.8 SS, N=11 
12 
VAS pain<20 & 
MMO>38mm 
No significant difference 
between SG regarding 
LD. 10% DR on MRI 
among all groups with 
no difference between 
groups. 
Med: 0% 
SS: 12.9% 
PM: 44.6% 
AC: 22% 
AS:100% 
III-3 
10.4±13.1 PM, N=33 
6.6±8 AC, N=9 
14.2±22.2 AS, N=32 
Ozawa et al. 
(1996) 
RCS 40 DDwoR 4 36 16- 68 38.15 
 
0.1-120 
 
19.58±33.9
98 
PM  
ACL (0.1-0.27),N=5 
CCL (2-120),N=35 
0.07-3 
(ACL:2-
3dy 
CCL:2-
3mo) 
Improvement in 
pain & 
MMO≥35mm 
Higher success rate in 
ACL (100%) than in 
CCL (37.1%). PM able 
to release ACL only. 
68.6% IV 
Ross (1989) PCS 3 DDwoR 
- 1 35 - 33 - 
Farrar’s UM  
(+ splint, PT) 
2 Increased MMO, 
decreased pain 
- 
- 
IV 
- 2 15-27 - 6-120 - PM (+PT) 5-9 - 
Segami et al. 
(1990) 
PCS 28 DDwoR 3 25 14-57 25.4 0.07-24 4.7 
Farrar’s UM or PM  
+ ARS & NSAIDs 
2 
No or slight pain 
& MMO≥40mm 
No relation between MM 
technique (UM or PM) 
& LD. 36.7% DR on 
arthrography.  
100% IV 
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Study 
(Year) 
Study 
design 
Participants’ characteristics 
Main Intervention 
assessed  
Longest 
follow-up 
duration 
(months) 
Success criteria 
Study findings in 
relation to locking 
duration (LD) 
Overall 
success 
rate % 
(ITT use) 
Study 
design 
quality 
Sample 
size 
(drp/exc) 
Study 
diagnosis 
Gender 
Age  
(years) 
Locking duration 
(months) 
M F Range Mean Range Mean ± SD 
Simmons 
(2002) 
CR 1 DDwoR - 1 - 14 0.5 - 
PM under IV-
sedation + ARS 
24 
Improvement in:  
cMMO, LM, PrM, 
subjective 
improvement, & 
DR on MRI 
- - IV 
Singh et al. 
(2010) 
CR 1 
DDwoR 
(Chronic) 
- 1 - 32 24 - 
UM under LA with 
CS +  IMF screws & 
elastics + ARS 
0.25 
Improvement in:  
VAS pain, cMMO 
- - IV 
Totsuka et al. 
(1989) 
PCS 33 
CL 
DDwoR 
4 29 12-60 29 0.13-24 4 
PM ‘Farrar’s 
method’ 
(+ ARS+SS) 
2-24 
Improved 
MMO>38mm, 
LM, PrM, 
mandibular 
movements 
without pain 
Duration : S/F 
≤1mo: 7/5 
2-3mo: 5/4  
4-6mo: 2/5 
7-12mo: 0/2 
12-24mo: 1/2 
60% unlocked less than 
3mo. Only 25% 
unlocked more than 3mo 
46% 
(15/33) 
IV 
Van Dyke 
and Goldman 
(1990) 
PCS 41 
DDwoR 
(Acute) 
- - - - ≤1.5-2 - 
UM under IM-LA 
(own tech) + ARS 
- MMO≥40mm - 92.7% IV 
Yoshida et 
al. (2005a) 
RCT 305 DDwoR 76 229 18-74 - 
0.033-
<12 
- 
UM (own technique)  
+ NSAID, N=204 
NSAID only, N=101 
0.25 
VAS pain<20, 
MMO≥36mm, 
LM≥6mm, & DR 
on MRI 
UM success rate drops 
significantly with the 
increase in LD: 1-2dy 
(100%), <1wk (98.3%), 
<2wk (94.6%), <3wk 
(90%), <1m (57.1%), 
<2mo (16.7%), <6mo 
(0%). 
UM: 84.3% 
NSAID: 0% 
II-2 
Yoshida et 
al. (2013); 
Yoshida et 
al. (2011) 
RCT 148 DDwoR - 148 19-75 40 
0.033-9 1.57 Self-UM, N=74 
10 min 
Absence of pain 
& MMO>38mm  
LD was shorter in SG 
(1.18) than in UG (2.92).  
S-UM:68% 
Ctrl:4% 
II-2 
0.067–11 1.73 No treatment, N=74 
TOTAL 
20studies - DDwoR - - - - 0.03-180 8.93 UM - - DR average success 
rate: 44% (range: 
4.4%-99.7%) 
67.6% - 
6studies - DDwoR - - - - 0.07-120 7.31 PM - - 65.98% - 
Study design abbreviations: RCT: randomised controlled trial, qRCT: quasi-randomised controlled trial, PCoSt: prospective comparative study, RCoSt: retrospective comparative 
study, PNCoSt: prospective non-comparative study, RNCoSt: retrospective non-comparative study, FSt: follow-up study, PCS: prospective case series, RCS: retrospective case 
series, BACS: before-after case series, BACR: before-after case report, CR: case report. 
 329 
 
Abbreviations used in tables 9.1.1 to 9.1.6: AAOMS: American association of oral and maxillofacial surgery, AC: arthrocentesis, ACL: acute closed lock, ADP: anchored disc 
phenomenon, ARS: anterior repositioning splint, AS: arthroscopy, CBT: cognitive behavioural therapy, CCL: chronic closed lock, Ch: chronic, CL: closed lock, CMI: 
craniomandibular index, cMMO: comfortable ‘painless’ maximum mouth opening, CS: corticosteroids, Ctrl: control, DAL: daily activity limitation, DDwoR: disc displacement 
without reduction, DFD: downward flexure deformation, DLA: daily living activity, DR: disc recapturing, drp: drop-outs, dy: day, exc: excluded, Exr: exercises, F: female, GA: 
general anaesthesia, IAOMS: international association of oral and maxillofacial surgery, ID: internal derangement, IL: intermittent locking, IM: intra-muscular, IMF: inter-maxillary 
fixation, IQ: interquartile, ITT: intention-to-treat analysis, IV: intra-venous, j: joint, LA: local anaesthesia, LDF: limitation in daily function, LM: lateral movement, M: male, Med: 
medication, MFIQ: mandibular function impairment questionnaire, mm: millimetres, MMO: maximum mouth opening, mo: month, MR: muscle relaxant, MRI: magnetic resonance 
imaging, N: number of patients, NR: not reported, NSurg: non-surgical, NSAIDs: non-steroidal anti-inflammatory drugs, OAdj: occlusal adjustment, OS: open surgery, PM: 
pumping manipulation, PrM: protrusive movement, PS: pivot splint, P-HS: pumping sodium hyaluronate, PT: physiotherapy, Reh: rehabilitation, S&S: signs and symptoms, SD: 
standard deviation, SG: successful group, HS: sodium hyaluronate, SM: self-management, SS: stabilization splint, Sub-ac: sub-acute, TENS: transcutaneous electrical nerve 
stimulation, Tx: tenoxicam, UFD: upward flexure deformation, UG: unsuccessful group, UM: unlock manipulation, US: ultrasound, VAS: visual analogue scale, VGIR: visually 
guided irrigation, W: Wilkes staging of internal derangement, wk: week, yr: year. 
a Description of Farrar’s UM technique (Farrar, 1978) is available in Chapter 2 (Figure 2.8). 
b Separate data provided are for DDwoR patients only. 
c Study data are also provided in other tables according to main treatment modality assessed. 
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A-2: Characteristics and quality of included self-management (SM) and physiotherapy (PT) studies 
Study 
(Year) 
Study 
design 
Participants’ characteristics 
Main interventions 
assessed 
Longest 
follow-up 
duration 
(months) 
Success criteria 
Study findings 
in relation to 
locking 
duration (LD) 
Overall 
success 
rate % 
(ITT use) 
Study 
design 
quality 
Sample 
size 
(drp/exc) 
Study 
diagnosis 
Gender 
Age 
(years) 
Locking duration 
(months) 
M F Range Mean Range Mean ± SD 
 
Braun (1987) 
 
CR 1 DDwoR - 1 - 71 0.75 - 
Self-exercises + 
Iontophoresis 
1.5 
Absence of pain, 
MMO>40mm, 
LM>7mm, improved 
jaw function, & eating 
normal diet 
- - IV 
Cleland and 
Palmer 
(2004) 
BACR 1 DDwoR - 1 - 24 19 - SM + PT 3 
VAS pain<20, 
MMO≥40mm, & 
improved jaw function 
- - IV 
Craane et al. 
(2012a) 
RCT 
49 
(7) 
DDwoR 2 47 - 36.6 wks-yrs - 
sExercises, N= 23 
Education only, N= 26 
13 
Improvement in: VAS 
pain, MMO, & MFIQ 
- 
- 
(ITT) 
II-1 
Haketa et al. 
(2010) a 
RCT 
52 
(14) 
DDwoR 6 46 - 37.6 Over 0.5 - 
Self-care+ SS, N=25 
Self-care+ Self-
exercise, N=19 
2 
Improvement in: VAS 
pain, MMO, & LDF 
- 
- 
(ITT) 
II-1 
Minakuchi et 
al. (2004); 
Minakuchi et 
al. (2001) a 
RCT 
69 
(8) 
DDwoR 7 62 - 34 - 
3.89±5.56 Education only, N=21 
2 
Improvement in: VAS 
pain, MMO, & DAL 
- 
- 
(ITT) 
II-1 2.81±5.09 
Self-care/NSAIDs, 
N=23 
3.12±5.03 
SS+ Exercises + Self-
care/NSAIDs, N=25 
Nicolakis et 
al. (2001) 
BACS 
20 
(2) 
 5 15 - 37.3 1.2-60 15.6 
Active & passive jaw 
exercises 
6 
Improvement in: VAS 
pain, MMO, & DLA 
- 
85% 
(ITT) 
III-3 
Schiffman et 
al. (2007); 
Schiffman et 
al. (2014b) a 
RCT 
108 
(12) 
W: III-IV 
DDwoR 
8 98 - 31.72 
Non-ch 
<6 - ch≥6 
- 
SM + Med, N=29 
SS + PT + CBT, N=25 
AS + CS, N=26 
OS, N=26 
60 
Self-reported success 
(Patient satisfaction) 
- 
SM: 72% 
Reh: 81% 
AS: 76.2% 
OS: 83.3% 
(ITT) 
II-1 
Srisintorn 
(1992) 
CR 1 DDwoR - 1 - 29 2 - 
Self-care/NSAID + 
Self-exercises 
12 cMMO≥40mm - - IV 
Yuasa et al. 
(2001) 
RCT 
60 
(NR) 
DDwoR 
(15ACL, 
45CCL) 
12 48 16-69 
Median
28 
0.53-
25.07 
Median 
2.33 
NSAIDs + self-
exercise, N=30 
1 
AAOMS & IAOMS 
modified criteria: 
VAS pain≤33 & 
MMO≥35mm 
CCL (>1 mo) 
responded better 
to treatment than 
non-treatment in 
comparison with 
ACL (≤1 mo) 
SM: 60% 
Ctrl: 33% 
(ITT) 
II-1 
0.63-41.8 3.27 No treatment, N=30 
Total 
2 studies - DDwoR - - - - wks-yrs - PT (Stretching exr.) - - - - - 
7 studies - DDwoR - - - - 0.5-25 - 
SM (self-
care/Med/Exr) 
- - - 66% - 
a Study data are also provided in other tables according to main treatment modality assessed. 
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A-3: Characteristics and quality of included splint (± other conservative) therapy studies 
Study 
(Year) 
Study 
design 
Participants’ characteristics 
Main intervention 
assessed 
Longest 
follow-up 
duration 
(months) 
Success criteria 
Study findings in 
relation to locking 
duration (LD) 
Overall 
success 
rate % 
(ITT use) 
Study 
design 
quality 
Sample 
size 
(drp/exc) 
Study 
diagnosis 
Gender 
Age  
(years) 
Locking duration 
(months) 
M  F  Range Mean Range Mean ± SD 
Choi et al. 
(1994) 
PCS 10 DDwoR - 10 14-55 27 0.75-5 2±1.61 SS + PT 3-4 MMO≥40mm 
DR on MRI is 
unlikely to happen 
in CCL 
100% IV 
Diracoglu 
et al. 
(2009) a 
qRCT 
120 
(10) 
DDwoR 16 104 15-63 34.1 Max. of 0.7 - 
AC, N=54 
SS + PT, N= 56 
6 
Improvement in: 
VAS pain, MMO, 
LM, & PM 
Both are effective 
for early DDwoR 
but AC is superior 
for pain relief 
- 
(no ITT) 
III-1 
Haketa et 
al. (2010) a 
RCT 
52 
(14) 
DDwoR 6 46 - 37.6 Over 0.5 - 
SS + Self-care, N=25 
Self-care + Self-
exercise, N=19 
2 
Improvement in: 
VAS pain, MMO, & 
LDF 
- 
- 
(ITT) 
II-1 
Harth 
(2012) 
CR 1 DDwoR - 1 - 53 2 - 
Decompression splint 
+ Exercises 
21 cMMO>38mm - - IV 
Ismail et al. 
(2007) 
RCT 26 
21 b 
DDwoR 
3 23 - 42.8 Less than 6 - 
SS, N=13 
SS + Exercises, N=13 
3 
Improvement in: 
pain & MMO 
- - II-2 
Israel and 
Syrop 
(1997) 
CRs 2 DDwoR - 2 14-28 - 0.03-0.5 - 
Splint + Self-care/Med 
+ PT  
0.5-12 
No pain, 
MMO≥35mm, 
eating normal diet, 
& patient 
satisfaction 
- - IV 
Iwase et al. 
(2005) 
RNCoSt 52 DDwoR 8 44 - 32.1 ≤12 - >12 25.71±56.11 
SS+ Self-Exercises+ 
NSAIDs 
- 
VAS pain≤30,  
cMMO≥30mm, & 
patient satisfaction 
Non-responders: 
80%>12m 
symptoms’ duration 
& 20%≤12m 
Responders: 
75.7%>12m & 
24.3%≤12m 
71.2% IV 
Kai et al. 
(1998) 
PNCoSt 35 DDwoR - 35 15-63 37.3 0.5-48 4.9 SS 25-42 
Improvement in: 
pain & 
MMO≥40mm 
- 55.9% III-3 
Kuwahara 
et al. 
(1990) 
PCS 8 
DDwoR 
(Acute) 
- - 13-59 - 0.5-6 - Disc recapturing splint 6-16 MMO>35mm - 100% IV 
Le Bell and 
Forssell 
(1993) 
PCS 
22 
(2) 
DDwoR 5 17 17-68 
Median 
27 
< 1 - <12 - 
SS + OAdj  
(<1mo, N=15 
<6mo, N=5 
>6mo but <12mo, 
N=2 ) 
24 
Improvement in: 
pain & jaw 
movements 
(Helkimo 
anamnestic & 
dysfunction indices: 
Ai: 0 or 1, Di: II)  
- 
95.5% 
(ITT) 
IV 
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Study 
(Year) 
Study 
design 
Participants’ characteristics 
Main intervention 
assessed 
Longest 
follow-up 
duration 
(months) 
Success criteria 
Study findings in 
relation to locking 
duration (LD) 
Overall 
success 
rate % 
(ITT use) 
Study 
design 
quality 
Sample 
size 
(drp/exc) 
Study 
diagnosis 
Gender 
Age  
(years) 
Locking duration 
(months) 
M  F  Range Mean Range Mean ± SD 
Lee et al. 
(2013) a 
RCoSt 43 DDwoR 3 40 - 21.9 At least 3 - 
AC + HS & SS, N=17 
SS then AC + HS, 
N=13 
SS only, N=13 
6 
AAOMS criteria: 
VAS pain<30 & 
cMMO≥38mm or 
increase 
cMMO≥10mm 
- - III-3 
Linde et al. 
(1995) 
RCT 
33 
(2) 
DDwoR 5 26 17-68 
Median 
37 
0.5-192 
Median  
6 
SS, N=16 
TENS, N=15 
1.5 
VAS Pain reduction 
≥50%, 
MMO≥40mm, 
LM≥7mm, & 
PrM≥7mm 
- 
SS: 53%, 
TENS: 6% 
(no ITT) 
II-2 
Minakuchi 
et al. 
(2001); 
Minakuchi 
et al. 
(2004) a 
RCT 
69 
(8) 
DDwoR 7 62 - 34 - 
3.89±5.56 Education, N=21 
2 
Improvement in: 
VAS pain, MMO, & 
DAL 
- 
- 
(ITT) 
II-1 2.81±5.09 
Self-care/NSAIDs, 
N=23 
3.12±5.03 
SS+ Exercises + Self-
care/NSAIDs, N=25 
Murakami 
et al. 
(1995) a 
PCoSt 108 
W: III 
(CL) 
20 88 - 31.43 - 
5.0±8.8 
NSurg: Med/UM/PS, 
N=63  
6 
VAS pain<20, 
MMO>38 mm, LM 
& PrM> 6mm, & 
improved DAL 
Patients with >7mo 
LD not responded to  
arthrocentesis 
NSurg: 
55.6% 
(Md:15.9% 
UM:18.9% 
PS: 33.3%) 
AC: 70% 
AS: 91% 
III-2 5.6±6.9 AC, N=20 
6.8±10.2 AS, N= 25 
Murakami 
et al. 
(2002) 
FSt c 
63 
(7) 
W: III 
(CL) 
8 42 13- 75 33.2 - 5.0±8.8 
Med (NSAIDs + MR), 
or UM, or PS 
120 
Improvement in: 
VAS pain, Jaw 
function, & DAL 
- 
89.3% 
(ITT) 
IV 
Ohnuki et 
al. (2006) a 
RCoSt 85 DDwoR 9 76 13-73 41.8 - 
5.1±6.8 SS, N=11 
12 
VAS pain<20 & 
MMO>38mm 
No significant 
difference between 
SGs regarding LD. 
SS: 12.9% 
PM: 44.6% 
AC: 22% 
AS: 100% 
III-3 
10.4±13.1 PM, N=33 
6.6±8 AC, N=9 
14.2±22.2 AS, N=32 
Schiffman 
et al. 
(2007); 
Schiffman 
et al. 
(2014b) a 
RCT 
108 
(12) 
W: III-IV 
DDwoR 
8 98 - 31.72 
Non-ch <6 
- ch≥6 
- 
SM + Med, N=29 
SS + PT + CBT, N=25 
AS + CS, N=26 
OS, N=26 
60 
Self-reported 
success  
(Patient satisfaction) 
- 
SM: 72% 
Reh: 81% 
AS: 76.2% 
OS: 83.3% 
(ITT) 
II-1 
Shoji 
(1995) 
CR 1 
DDwoR 
Chronic 
- 1 - 16 6 - SS 1.5 
Reduced pain & 
MMO≥35mm 
- - IV 
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Study 
(Year) 
Study 
design 
Participants’ characteristics 
Main intervention 
assessed 
Longest 
follow-up 
duration 
(months) 
Success criteria 
Study findings in 
relation to locking 
duration (LD) 
Overall 
success 
rate % 
(ITT use) 
Study 
design 
quality 
Sample 
size 
(drp/exc) 
Study 
diagnosis 
Gender 
Age  
(years) 
Locking duration 
(months) 
M  F  Range Mean Range Mean ± SD 
Stiesch-
Scholz et 
al. (2002b) 
PNCoSt 55 DDwoR 7 48 15–77 41.96  <0.25 - >6 - 
PS 
Acute(<3), N=19 
Sub-acute (3–6), N=19 
Chronic (>6), N=17 
45-50 
VAS pain=0, 
MMO≥40mm, 
improved LM, PrM, 
& chewing ability 
The success rate of 
treatment decreased 
with longer LD: 
acute (84.2%), Sub-
acute (63.2%), & 
chronic (64.7%).  
DR in 3 patients 
with <1wk. 
72.7% III-3 
Stiesch-
Scholz et 
al. (2005) 
RCT 40 DDwoR 5 35 18-64 33.65 - 
3.83±3.45 SS, N=20 
3 
Improvement in: 
pain, MMO, LM, & 
PrM 
- - II-1 
4.68±2.9 PS, N=20 
Tanaka et 
al. (2000) 
CR 1 
W: IV 
DDwoR 
- 1 - 22 60 - Splint + Exercises 60 
Improved pain & 
MMO 
- - IV 
Vineet and 
Gnanasund
aram 
(2011) 
CR 1 DDwoR - 1 40 - 12 - Med (analgesics) + SS - - - - IV 
Yoshida et 
al. (2005b) 
PNCoSt 40 DDwoR - 40 16-64 29.85 - 
51.6±57.6 SS-UFD, N=20 
6 
No pain or pain 
present only on jaw 
movement & 
increased MMO 
- 
Overall: 
57.5% 
UFD: 20% 
DFD: 95% 
III-3 
33.6±39.6 SS-DFD, N=20 
TOTAL 
12 
studies 
- DDwoR - - - - 0.25-192 15.53 Splint only - - - 60.1% - 
11 
studies 
- DDwoR - - - - - 10.28 Splint + others - - - 84.1% - 
a Study data are also provided in other tables according to main treatment modality assessed. 
b DDwoR patients in study sample ≥ 80%. 
c Follow-up report of Murakami et al. (1995).
 334 
 
A-4: Characteristics and quality of included arthrocentesis (AC) studies 
Study 
(Year) 
Study 
design 
Participants’ characteristics 
Main interventions 
assessed 
Longest 
follow-up 
duration 
(months) 
Success criteria 
Study findings in 
relation to locking 
duration (LD) 
% Overall 
success 
rate 
(ITT use) 
Study 
design 
quality 
Sample 
size 
(drp/exc) 
Study 
diagnosis 
Gender 
Age  
(years) 
Locking duration 
(months) 
M  F  Range Mean Range Mean ± SD 
Aktas et al. 
(2010b) 
PCoSt 25 DDwoR 2 23 17–64 30.4 
 
0.1-24 
 
6.76 
AC alone, N=13 
AC + SH, N=12 
12 
AAOMS criteria: 
VAS pain≤30mm, 
MMO ≥35mm, & 
improved jaw 
function 
Mean LD was higher 
in UG 9.6 (1–24) than 
SG 3.92 (0.1-24) 
Overall 
80% 
AC:84.6%, 
AC+SH: 
75% 
III-2 
Aktas et al. 
(2010a) 
RCT 21 DDwoR 4 17 15-52 26.43 0.1–24 5.29 
AC alone, N= 14 
AC + TX., N= 7 
6 
AAOMS criteria: 
VAS pain≤30mm, 
MMO ≥35mm, 
improved jaw 
function 
- 
Overall 
83.3% 
AC:85.7%,  
AC+TX: 
71.4% 
II-2 
Alpaslan and 
Alpaslan 
(2001) 
RCT 15 a 
DDwoR 
(CL) 
1 14 15-53 31.90 2-72 18.5 
AC alone, N=4 
AC + HS, N=11 
3-28 
Improvement in: 
pain, MMO, LM, & 
jaw function 
- - II-2 
Alpaslan et 
al. (2008) 
RCT 
67 
(12) 
DDwoR - - 18-51 30.1 0.03-18 6.73 
AC alone, N=14 
AC + soft splint, 
N=9 
AC + hard splint, 
N=22 
6 
Improvement in: 
pain, MMO, & LM 
- 
- 
(no ITT) 
II-2 
Bhargava et 
al. (2012) 
CR 1 DDwoR - 1 - 32 3 - AC + CS 1 
MMO≥35mm & 
VAS pain=0 
- - IV 
Dhaif and Ali 
(2001) 
RNCoSt 
62 
(22) 
ADP 9 53 16-50 28.9 0.75-12 11.43±8.35 AC, N=40 36 
VAS pain<2, 
MMO≥38mm, 
LM≥5mm, 
PrM≥5mm, 
improved DLA 
- 95% IV 
Dimitroulis 
et al. (1995a) 
FSt b 46 ADP 2 44 25-39 32.5 1-84 13 AC 6-30 
Improvement in: 
VAS pain, VAS jaw 
dysfunction 
(chewing ability), & 
MMO 
- 97.8%  IV 
Diracoglu et 
al. (2009) c 
qRCT 
120 
(10) 
DDwoR 16 104 15-63 34.1 
Max. of 
0.7 
- 
AC, N=54 
SS + PT, N= 56 
6 
Improvement in: 
VAS pain, MMO, 
LM, & PrM 
Both are effective for 
early DDwoR but AC 
is superior for pain 
relief 
- 
(no ITT) 
III-1 
Emshoff and 
Rudisch 
(2004) d 
PNCoSt 29 
DDwoR 
(ID III) 
7 22 17-69 34.6 
Non-
ch≤6-
Ch>6<24 
8.76 
AC 
(Non-chronic, N=15 
Chronic, N=14) 
2 
Absence of DDwoR 
S&S and 
VAS Pain 
reduction≥85% 
Symptoms’ duration 
was lower in SG 
(5.28±4.03) than in 
UG (12.23±6.83). 
37.9% III-3 
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Study 
(Year) 
Study 
design 
Participants’ characteristics 
Main interventions 
assessed 
Longest 
follow-up 
duration 
(months) 
Success criteria 
Study findings in 
relation to locking 
duration (LD) 
% Overall 
success 
rate 
(ITT use) 
Study 
design 
quality 
Sample 
size 
(drp/exc) 
Study 
diagnosis 
Gender 
Age  
(years) 
Locking duration 
(months) 
M  F  Range Mean Range Mean ± SD 
Emshoff and 
Rudisch 
(2007) d 
PNCoSt 37 
DDwoR 
(ID III) 
6 31 17-69 28.3 - 8.68±6.9 AC 2 
MMO≥35 mm & 
pain reduction >50% 
No statistical 
significant difference 
in duration of 
symptoms between SG 
(9.25±5.53) and UG 
(7.95±8.5). 
56.8% III-3 
Emshoff et 
al. (2000) d 
PNCoSt 15 
DDwoR 
(ID III) 
- 15 18-71 38.7 1-9 5.7 AC 2 
Improvement in: 
VAS pain & MMO 
- - III-3 
Emshoff et 
al. (2003b) d 
PNCoSt 38 
DDwoR 
(ID III) 
6 32 17-69 33.8 - 7.13±6.1 AC 2 
Absence of DDwoR 
symptoms (VAS 
pain & MMO) 
No statistical 
significant difference 
in duration of 
symptoms between SG 
(7.38±5.78) and UG 
(6.68±6.8). 
63.2% III-3 
Emshoff 
(2005) d 
PNCoSt 64 
DDwoR 
(ID III) 
6 58 17-69 33.4 
Non-ch 
≤6 - ch>6 
12.31 AC 2 
Absence of DDwoR 
symptoms (VAS 
pain & MMO) 
Mean symptoms’ 
duration was lower in 
SG (10.15±9.35) than 
UG (14.48±21.25) but 
the difference was not 
statistically significant. 
53.1% III-3 
Emshoff et 
al. (2006) d 
PNCoSt 28 
DDwoR 
(ID III) 
8 20 17-69 30.9 
Less than 
12 
- AC 2 
Improvement in: 
VAS Pain on jaw 
function & MMO 
- - III-3 
Gateno 
(1994) c 
CRs 2 
DDwoR 
(ACL) 
- 2 25-31 - 0.5-0.7 - AC 3 
MMO≥38mm & 
VAS pain≤4 
- - IV 
Ghanem 
(2011) 
PCoSt 20 
DDwoR 
(ACL) 
- 20 24-54 34 
Less than 
1 
- 
AC + CS, N=10 
AC + CS & SS, 
N=10 
12 
Improvement in: 
VAS Pain, MMO, 
LM, PrM, & jaw 
dysfunction 
AC+SS are the 
treatment of choice for 
ACL (<1mo) with 
bruxism 
Overall: 
60%  
AC: 30%  
AC+SS: 
90%  
III-2 
Hosaka et al. 
(1996) 
FSt e 
20 
(1) 
W: III 
(CL) 
- - - 31.2 - 5.6±6.9 AC 36 
VAS pain<2, 
MMO> 38mm, 
LM>6mm, 
PrM>6mm, normal 
diet & improved jaw 
function, daily 
activity. 
- 78.9% IV 
Kaneyama et 
al. (2007b) 
PCS 14 ADP 5 9 15-70 34.3 0.5-12 4±4.1 AC 1-12 
No or mild pain, 
MMO>38mm, 
eating normal diet 
Symptoms’ duration 
was longer in SG (0.5-
12) than UG (1-4). 
64.3% IV 
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Study 
(Year) 
Study 
design 
Participants’ characteristics 
Main interventions 
assessed 
Longest 
follow-up 
duration 
(months) 
Success criteria 
Study findings in 
relation to locking 
duration (LD) 
% Overall 
success 
rate 
(ITT use) 
Study 
design 
quality 
Sample 
size 
(drp/exc) 
Study 
diagnosis 
Gender 
Age  
(years) 
Locking duration 
(months) 
M  F  Range Mean Range Mean ± SD 
Kaneyama et 
al. (2007a) 
PNCoSt 66 DDwoR 4 62 14-73 36 1-24 2 
 
AC + CS 
 
2-13 
No or mild VAS 
pain, MMO>38mm, 
LM>6mm, & 
PrM>6mm 
- 77% III-3 
Kaneyama et 
al. (2004) 
PCS 17 DDwoR 5 12 17-76 40 0.8-60 19 AC + CS 3 
No or mild VAS 
pain, MMO>38mm, 
LM>6mm, & 
PrM>6mm 
No correlation 
between duration of 
symptoms and clinical 
symptoms  
88% IV 
Lee et al. 
(2013) c 
RCoSt 43 DDwoR 3 40 - 21.9 At least 3 - 
AC + HS & SS, 
N=17 
SS then AC + HS, 
N=13 
SS only, N=13 
6 
AAOMS criteria: 
VAS pain<30 & 
cMMO≥38mm or 
increase 
cMMO≥10mm 
- - III-3 
Mohanavalli 
et al. (2011) 
CR 1 CL - 1 - 28 
More 
than 12 
- AC + CS 9 
VAS pain=0, 
MMO≥40 mm, LM 
& PrM≥ 6mm, & 
improved function 
- - IV 
Murakami et 
al. (1995) c 
PCoSt 108 
W: III 
(CL) 
20 88 - 31.43 - 
5.0±8.8 
NSurg: Med. or UM 
or PS, N=63  
6 
VAS pain<20, 
MMO>38 mm, LM 
& PrM> 6mm, & 
improved DAL 
Patients with >7mo 
LD not responded to 
arthrocentesis 
NSurg: 
55.6% 
(Md:15.9% 
UM:18.9% 
PS: 33.3%) 
AC: 70% 
AS: 91% 
III-2 5.6±6.9 AC, N=20 
6.8±10.2 AS, N= 25 
Ness (1996) RCS 15 CL - - - - 
0.23–1 0.6 ACL AC +CS 
(ACL<4 mo, N=6 
CCL>4 mo, N=9) 
- 
MMO >40 mm, no 
or mild pain, and 
normal eating 
- 64% IV 
4–109 38.1 CCL 
Nishimura et 
al. (2004); 
Nishimura et 
al. (2001) 
PNCoSt 100 
95 f 
DDwoR 
11 89 13-73 
Median 
31 
0.07-36 5.67 
 
 
AC + CS 
 
 
0.25 
No or mild VAS 
pain & 
MMO>38mm 
Mean LD was lower in 
SG 4.33 (0.033-36.5) 
than UG 8.43 (0.13-
36.7) but the 
difference was not 
statistically significant. 
70.9% III-3 
Nitzan et al. 
(1991b) 
PCS 17 ADP 3 14 16-65 32.6 2-60 11.8±12.9 AC + CS 4-14 
VAS pain≤4 of 15, 
VAS jaw 
dysfunction≤4 of 15, 
MMO≥35mm, PrM 
& LM>7mm, & 
patient satisfaction  
One patient with the 
longest duration of 
symptoms (60 mo) 
showed marked 
increase in MMO but 
no significant decrease 
in pain & jaw 
dysfunction. 
91% IV 
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Study 
(Year) 
Study 
design 
Participants’ characteristics 
Main interventions 
assessed 
Longest 
follow-up 
duration 
(months) 
Success criteria 
Study findings in 
relation to locking 
duration (LD) 
% Overall 
success 
rate 
(ITT use) 
Study 
design 
quality 
Sample 
size 
(drp/exc) 
Study 
diagnosis 
Gender 
Age  
(years) 
Locking duration 
(months) 
M  F  Range Mean Range Mean ± SD 
Nitzan 
(1994) 
PCS 29 ADP 8 21 - - - 13.9 AC + CS 
Mean  
22.2 
Improvement in: 
VAS Pain, VAS jaw 
dysfunction, & 
MMO 
- 96.5% IV 
Nitzan et al. 
(1997) 
PNCoSt 39 ADP 8 31 14-53 28.9 0.5-48 11.43±8.35 AC 6-37 
Improvement in: 
VAS Pain & VAS 
jaw dysfunction, 
MMO≥35mm, PrM 
& LM≥5mm, & 
patient satisfaction 
Increased duration of 
symptoms seemed to 
affect joint function 
and deteriorate it. 
95% III-3 
Ohnuki et al. 
(2006) c 
RCoSt 85 DDwoR 9 76 13-73 41.8 - 
5.1±6.8 SS, N=11 
12 
VAS pain<20 & 
MMO>38mm 
No significant 
difference between 
SGs regarding LD. 
SS: 12.9% 
PM: 44.6% 
AC: 22% 
AS: 100% 
III-3 
10.4±13.1 PM, N=33 
6.6±8 AC, N=9 
14.2±22.2 AS, N=32 
Ross (1989) PCS 7 DDwoR 1 6 17-34 25.3 1.5-36 10.43±12.7 AC (± splint/PT) 0.5-3 
Increased MMO, 
decreased pain 
- 71.43% IV 
Sahlstrom et 
al. (2013) 
RCT 
45 
(8) 
DDwoR 4 41 - 34.9 ≤3 - 
LA only, N=25 
AC, N=20 
3 
Reduction in VAS 
pain≥30% during 
jaw movement 
- 
LA: 76% 
AC: 55%  
(ITT) 
II-1 
Sakamoto et 
al. (2000) 
PCS 18 DDwoR 1 17 17-67 33.3 2.3-46 14±12.8 AC 3 
AAOMS criteria: 
MMO≥40mm & 
VAS pain<33 
Symptoms’ duration in 
SG (8.4±5.4) was 
significantly shorter 
than in UG 
(19.6±15.6). 
50% IV 
Sanroman 
(2004) c 
PCoSt 
26 
(2)  
ADP 6 20 16-35 24.3 0.23-3 1.21 
AS + SH, N=16 
AC + SH, N=8 
24-36 
VAS pain≤ 2 of 15, 
MMO≥35mm,  
LM≥7mm 
& PrM≥10mm  
- 100% III-2 
Santos et al. 
(2013) 
CR 1 DDwoR - 1 19 - 2 - 
AC+CS  
(+ Med/SM, SS, PT) 
6 
MMO>40mm 
without pain 
- - IV 
Sato et al. 
(1997b) 
PCoSt 76 DDwoR 2 74 11-74 29.9 
0.1-60 5.9 
Pumping HS g, N= 
26 
6 
AAOMS Criteria: 
little or no pain, 
MMO≥35 mm, LM 
or PrM> 4mm, 
eating normal diet & 
improved jaw 
function. 
- 
P-SH: 
73.1% 
Ctrl:36% 
III-2 
0.1-48 6.5 No treatment, N=50 
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Study 
(Year) 
Study 
design 
Participants’ characteristics 
Main interventions 
assessed 
Longest 
follow-up 
duration 
(months) 
Success criteria 
Study findings in 
relation to locking 
duration (LD) 
% Overall 
success 
rate 
(ITT use) 
Study 
design 
quality 
Sample 
size 
(drp/exc) 
Study 
diagnosis 
Gender 
Age  
(years) 
Locking duration 
(months) 
M  F  Range Mean Range Mean ± SD 
Sato et al. 
(2001a) 
RCoSt 
146 
(25) 
DDwoR 9 107 - - 3> - 3≤ - 
Pumping HS g, N= 
59/72 
No treatment, N= 
62/74 
12 
AAOMS Criteria: 
 Little/no pain & 
MMO≥35mm 
Patients with LD for 
<3 mo are more likely 
to benefit from 
treatment than those 
with locking duration 
for ≥3 m. 
P-SH: 75% 
Ctrl: 63.5% 
(ITT) 
III-3 
Sato and 
Kawamura 
(2008) 
PCoSt 59 DDwoR - 59 13-61 34.95 
0.2-336 31.6 
Pumping HS g + 
Self-exercises, N=23 
12 
AAOMS Criteria: 
 Little/no pain, 
MMO≥35mm 
- 
Overall: 
69.49% 
P-SH+ Ex: 
60.9% 
P-SH only: 
75% 
III-2 
0.03-440 36.4 Pumping HS, N=36 
Sembronio et 
al. (2008b) 
PNCoSt 33 DDwoR 2 31 21-73 41.8 0.25-24 8.5 
AC + HS + UM 
(ACL<1, N=8  
CCL>1, N=25) 
12 
VAS pain< 2, 
MMO >38 mm, 
ADL <4/16, & 
improved jaw 
function, chewing & 
swallowing, & 
eating normal diet  
Higher success rate in 
ACL (87.5%) than 
CCL (68%).  
DR was possible only 
in ACL and no DR in 
all CCL cases. 
72.7% III-3 
Thomas et al. 
(2012) 
PCS 32 ACL 5 27 18-27 23 1-3 - AC 6 
Improvement in: 
VAS pain, VAS jaw 
dysfunction 
(chewing ability), & 
MMO. 
- 90.6% IV 
Yura et al. 
(2011) 
PNCoSt 50 
DDwoR 
(CCL) 
5 45 12-71 
Median 
44 
3-48 
Median 
4 
AC (under high 
pressure) + CS 
2 
Improvement in: 
MMO≥40mm, VAS 
pain at 
opening≤5mm, & 
VAS pain on 
biting=0 
- - III-3 
TOTAL 
36 
studies 
- All CL - - - - 0.03-109 9.89 AC - - - 72.6% - 
29 
studies 
- DDwoR - - - - 0.03-109 10.08 AC - - - 65.3% - 
7  
studies 
- ADP - - - - 0.23-84 9.54 AC - - - 91.4% - 
a Separate data provided are for CL patients only. 
b Follow-up report of Nitzan and Dolwick (1991) study. 
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c Study data are also provided in other tables according to main treatment modality assessed. 
d Studies seem to share part of their CL study sample in multiple publications. 
e Follow-up study of Murakami et al. (1995) study. 
f DDwoR patients in study sample ≥ 80%. 
g Excluded from the total due to intervention difference. 
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A-5: Characteristics and quality of included arthroscopy (AS) studies 
Study 
(Year) 
Study 
design 
  Participants’ characteristics 
Main interventions 
assessed 
Longest 
follow-up 
duration 
(months) 
Success criteria 
Study findings in 
relation to locking 
duration (LD) 
Overall 
success 
rate % 
(ITT use) 
Study 
design 
quality 
Sample 
size 
(drp/exc) 
Study 
diagnosis 
Gender 
Age  
(years) 
Locking duration 
(months) 
M F Range Mean Range Mean ± SD 
Casares et al. 
(1999) 
PNCoSt 26 
ADP 
(static 
disc) 
- 26 20-56 37.5 3-24 7.8 AS 10 
Pain free & 
MMO>30mm  
A relationship between 
LD and adhesions type 
was found  
92.3% III-3 
Chen et al. 
(2010) 
PCS 352 
W: III-IV 
343/419ja 
50 302 15-72 33.3 2-240 24.1 
AS coblation with disc 
suturing 
3 
Improvement in 
S&S and MRI 
findings   
- 92.8% IV 
Clark et al. 
(1991) 
PNCoSt 18 
17 
DDwoR 
& 1 ADP 
1 17 15-52 27 
Sub-ac 
=3-9 to 
ch>9 
12.4±12 AS 21-30 
Improvement in: 
VAS pain, jaw 
function, & MMO 
LD was not a predictor 
of arthroscopy success 
or failure. 
83.3% III-3 
Dimitroulis 
(2002) 
PCS 56  
49 
DDwoR 
9 47 15-70 36 1.5-12 3.4 AS + CS 1.5 
Improvement in: 
VAS pain, MMO, 
& patient 
satisfaction 
- 66% IV 
Furst et al. 
(2001) 
RCT 32 
26 
DDwoR 
2 30 - - - 
42.5±36.1 AS only 
0.07 Pain reduction - - II-2 
18.5±17 AS + bupivacaine 
61.4±61.3 AS + morphine 
63.3±79.7 
AS + bupivacaine & 
morphine 
Gateno 
(1994) b 
CR 1 CL - 1 - 24 3 - AS - 
No pain & 
MMO>40mm 
- - IV 
Go et al. 
(1996) 
PCS 10 CL - 10 20-59 31.2 0.75-3.75 2.2 AS 4-68 
No or mild pain & 
MMO>30mm 
- 80% IV 
Hamada et 
al. (2003) c 
PNCoSt 
69 
(39) 
DDwoR 
(CCL) 
5 25 20-64 41.6 1-72 15.5 
AS (2nd VGIR) + SH, 
N=30 
- 
VAS pain<20 & 
<60% of 
preoperative level, 
increased cMMO, 
& cMMO≥38mm 
- 
60% 
(no ITT) 
III-3 
Hamada et 
al. (2005) c 
PNCoSt 
68 
(20) 
DDwoR 
(CCL) 
9 39 20–70 42.8 2–127 
Median 
9.5 
AS (2nd VGIR), N=48 3–36 
VAS pain=0 & 
cMMO≥38mm 
No significant 
correlation between 
duration of symptoms 
and treatment outcome 
with fibrous adhesion. 
62.5% 
(no ITT) 
III-3 
Hamada et 
al. (2006a)c 
PNCoSt 
64  
(3) 
DDwoR 
(CCL) 
9 52 19-70 40.7 2-127 
Median 
7 
AS (1st VGIR), N=64 12 
VAS pain<20 & 
<60% of 
preoperative level, 
increased cMMO, 
& cMMO≥38mm 
No significant 
difference in the 
duration of symptoms 
between SG 8 (2-108) 
and UG 5 (2-127). 
72.1% 
(no ITT) 
III-3 
 341 
 
Study 
(Year) 
Study 
design 
  Participants’ characteristics 
Main interventions 
assessed 
Longest 
follow-up 
duration 
(months) 
Success criteria 
Study findings in 
relation to locking 
duration (LD) 
Overall 
success 
rate % 
(ITT use) 
Study 
design 
quality 
Sample 
size 
(drp/exc) 
Study 
diagnosis 
Gender 
Age  
(years) 
Locking duration 
(months) 
M F Range Mean Range Mean ± SD 
Hamada et 
al. (2006b)c 
PNCoSt 
36 
(2)  
DDwoR 
(CCL) 
6 30 27-59 46.5 
IQ 
3–17 
Median  
7.5 
AS (VGIR), N=36 - 
VAS pain<20 & 
<60% of 
preoperative level, 
increased cMMO, 
& cMMO≥38mm 
No significant 
difference in the 
duration of symptoms 
between SG 8 (5.5–17) 
and UG 6 (3–8). 
69.4% 
(no ITT) 
III-3 
Hamada et 
al. (2008a); 
Hamada et 
al. (2008b) c 
PNCoSt 
58 
(2) 
DDwoR 
(CCL) 
8 48 29-56 
Median 
46 
IQ 
3-12.5 
Median  
7 
AS (1st VGIR), N=56 6-13 
VAS pain<20 & 
<60% of 
preoperative level, 
increased cMMO, 
& cMMO≥38mm 
No significant 
difference in duration 
of symptoms between 
SG 8 (5.8–12.3) and 
UG 6 (3–8). 
67.9% 
(no ITT) 
III-3 
Holmlund et 
al. (2001) 
RCT 
22 
(2) 
CCL 2 18 22–53 34.5 
2-24 8.5 OS, N=10 
12 
VAS pain<20, 
MMO>35mm, 
PrM>5mm, 
MFIQ<7  
No difference in 
improvement between 
patients having <6 mo 
& >6 mo symptoms’ 
duration in both 
groups. 
OS: 70%, 
AS: 50% 
(no ITT) 
II-2 
2–60 20.5 AS, N=10 
Kim et al. 
(2009) 
PCS 15 DDwoR 3 12 15-64 32.1 3-72 21.4 AS (ultrathin) + SH 10-40 
VAS pain ≤20 & 
<60% of 
preoperative level, 
increased 
MMO≥5mm, & 
no recurrence of 
symptoms.  
- 80% IV 
Kondoh et al. 
(2003a)c 
PNCoSt 20 DDwoR 4 16 20-69 44 1-72 17.4 AS (VGIR) + SH 6 
VAS pain<20 & 
<60% of 
preoperative level, 
& cMMO>38mm  
- 80% III-3 
Kumagai et 
al. (2010) c 
PNCoSt 45 
DDwoR 
(CCL) 
13 32 24-65 36.5 
More 
than 3 
- AS (VGIR), N=45 2-23 
VAS pain <20 and 
<60% of 
preoperative level, 
& cMMO≥38mm 
- 71.1% III-3 
Kurita et al. 
(1998a) 
PNCoSt 14 DDwoR 1 13 20-72 44.6 9-163 24.9 AS + CS 13–66 
AAOMS & 
IAOMS criteria: 
No or slight 
dysfunction 
(MMO≥35mm, 
VAS≤33) 
No difference in LD 
between SG 27 (9-
163) & UG (10 & 14). 
85.7% III-3 
Lewis (1987) CR 1 
DDwoR 
(CCL) 
- 1 - 48 12 - AS 0.25 
Little pain & 
MMO=35mm 
- - IV 
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Study 
(Year) 
Study 
design 
  Participants’ characteristics 
Main interventions 
assessed 
Longest 
follow-up 
duration 
(months) 
Success criteria 
Study findings in 
relation to locking 
duration (LD) 
Overall 
success 
rate % 
(ITT use) 
Study 
design 
quality 
Sample 
size 
(drp/exc) 
Study 
diagnosis 
Gender 
Age  
(years) 
Locking duration 
(months) 
M F Range Mean Range Mean ± SD 
Machon et al. 
(2012) 
PNCoSt 50 
Chronic 
DDwoR 
- - - - 
(<12 - 
>12) 
- 
AS, N=50 
(<12 mo, N=28; 
>12 mo, N= 22) 
6 
No or minimal 
pain (0 or 1 out 6), 
& MMO>35mm 
Higher success rate 
(89%) in patients with 
shorter duration of 
symptoms <12 mo 
than the rate (72%) in 
those with longer 
symptoms’ duration 
>12 mo. 
82% III-3 
Murakami 
(1990) 
PCS 32 DDwoR 4 28 14-70 39 1-18 6.6 AS 2-60 
Little or no 
complaints and 
good jaw opening 
& function 
Patients with ≥6 mo 
LD had poor response 
to AS. Higher pain 
relief in patients with 
<6mo LD as compared 
to patients with longer 
duration. 
84.4% IV 
Murakami et 
al. (1995) b 
PCoSt 108 
W: III 
(CL) 
20 88 - 31.43 - 
5.0±8.8 
NSurg: Med. or UM or 
PS, N=63  
6 
VAS pain<20, 
MMO>38 mm, 
LM & PrM> 
6mm, & improved 
DAL 
Patients with >7mo 
LD did not respond to 
arthroscopy. 
NSurg: 
55.6% 
(Md:15.9% 
UM:18.9% 
PS: 33.3%) 
AC: 70% 
AS: 91% 
III-2 5.6±6.9 AC, N=20 
6.8±10.2 AS, N= 25 
Nakaoka et 
al. (2009) 
PNCoSt 
56 
(16) 
CCL - - 
IQ 
29–55 
Median 
43 
IQ 
5–12 
median 
7 
AS (2nd VGIR), N=40 - 
VAS pain<20 & 
<60% of 
preoperative level, 
increased cMMO, 
& cMMO≥38mm 
No significant 
difference in 
symptoms’ duration 
between SG 8 (5.5–
12.5) and UG 5 (3–
12). 
72.5% 
(no ITT) 
III-3 
Nitzan et al. 
(1990) 
PCS 20 
8 
DDwoR 
- 20 19-40 26.3 6-96 34.8±26.04 AS + CS 6-24 
Improvement in: 
VAS Pain, VAS 
jaw dysfunction, 
& MMO 
- 
DDwoR  
87.5% 
IV 
Ohnuki et al. 
(2003) 
RNCoSt 43 
40 
DDwoR 
4 39 15-68 41.4 - 12.6±20.1 AS + CS + SH 12 
VAS pain<20 & 
MMO>38mm  
No statistically 
significant difference 
in LD between SG 
(14.2±22.2) and UG 
(7.9±11.4). 
74.4% IV 
Ohnuki et al. 
(2006) b 
RCoSt 85 DDwoR 9 76 13-73 41.8 - 
5.1±6.8 SS, N=11 
12 
VAS pain<20 & 
MMO>38mm 
No significant 
difference between 
SGs regarding LD. 
SS: 12.9% 
PM: 44.6% 
AC: 22% 
AS: 100% 
III-3 
10.4±13.1 PM, N=33 
6.6±8 AC, N=9 
14.2±22.2 AS, N=32 
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Study 
(Year) 
Study 
design 
  Participants’ characteristics 
Main interventions 
assessed 
Longest 
follow-up 
duration 
(months) 
Success criteria 
Study findings in 
relation to locking 
duration (LD) 
Overall 
success 
rate % 
(ITT use) 
Study 
design 
quality 
Sample 
size 
(drp/exc) 
Study 
diagnosis 
Gender 
Age  
(years) 
Locking duration 
(months) 
M F Range Mean Range Mean ± SD 
Politi et al. 
(2007) b 
RCT 20 
DDwoR 
(CCL) 
6 14 25-67 42.8 
6-27 15.1 OS , N=10 
12 
VAS pain≤20, 
MMO≥35mm, 
PrM>5mm, 
MFIQ ≤ 7  
- 
OS: 80%, 
II-2 
8-24 14.7 AS + SH, N=10 AS: 70% 
Saitoa et al. 
(2010) 
PNCoSt 
64 
(3) 
CCL 9 52 19-70 40.7 2-127 
Median 
7 
AS (VGIR) 3-40 
VAS pain<20 & 
<60% of 
preoperative level, 
& cMMO≥38mm  
No statistically 
significant difference 
in LD between SG 8 
(2-108) and UG 5 (2-
127).  
72.1% 
(no ITT) 
III-3 
Sanders 
(1986) 
PCS 21 d DDwoR 1 20 11-49 27.1 1-120 19.62±24.2 AS + CS 7-10 
Little pain & 
improved MMO 
- 95.2% IV 
Sanroman 
(2004) b 
PCoSt 
26 
(2)  
ADP 6 20 16-35 24.3 0.25-3 1.21 
AS + SH, N=16 
AC + SH, N=8 
24-36 
VAS pain≤ 2 of 
15, MMO≥35mm,  
LM≥7mm 
& PrM≥10mm  
- 100% III-2 
Schiffman et 
al. (2007); 
Schiffman et 
al. (2014b) b 
RCT 
108 
(12) 
W: III-IV 
DDwoR 
8 98 - 31.72 
Non-
ch<6 - 
Ch≥6 
- 
SM + Med., N=29 
SS + PT + CBT, N=25 
AS + CS, N=26 
OS, N=26 
60 
Self-reported 
success  
(Patient 
satisfaction) 
- 
SM: 72% 
Reh: 81% 
AS: 76.2% 
OS: 83.3% 
(ITT) 
II-1 
Yoshida et 
al. (2008) 
PCS 55 DDwoR - - - - 2-10.5 4.25 AS (thin fiber & laser) 3 
Improvement in: 
VAS pain, MMO, 
& patient 
satisfaction. 
- 94.5% IV 
Zhang et al. 
(2009a) 
RNCoSt 1506 
W: III-IV 
1479 a 
28
1 
12
25 
12–73 29.79 0.5-96 6.97 
AS  
Adhesion group, 
N=490 
Non-adhesion group, 
N=1230 
- - 
LD was significantly 
higher in adhesion 
(6.97±8.38) than non-
adhesion (5.42±4.34) 
group. 
- IV 
TOTAL 
32 
studies 
- All CL - - - - 0.25-163 19.04 AS - - - 79% - 
30 
studies 
- DDwoR - - - - 0.5-163 20.37 AS - - - 77.7% - 
2 studies - ADP - - - - 0.25-24 4.51 AS - - - 96.2% - 
a DDwoR patients in study sample ≥ 80%. 
b Study data are also provided in other tables according to main treatment modality assessed. 
c Studies seem to share part of their CL study sample in multiple publications. 
d Separate data provided are for CL patients only. 
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A-6: Characteristics and quality of included open surgery (OS) studies 
Study 
(Year) 
Study 
design 
  Participants’ characteristics 
Main interventions 
assessed 
Longest 
follow-up 
duration 
(months) 
Success criteria 
Study findings in 
relation to locking 
duration (LD) 
Overall 
success 
rate % 
(ITT use) 
Study 
design 
quality 
Sample 
size 
(drp/exc) 
Study 
diagnosis 
Gender 
Age  
(years) 
Locking duration 
(months) 
M F Range Mean Range Mean ± SD 
Holmlund et 
al. (2001) b 
RCT 
22 
(2) 
CCL 2 18 22–53 34.5 
2-24 8.5 OS (Discectomy), N=10 
12 
VAS pain<20, 
MMO>35mm, 
PrM>5mm, 
MFIQ<7  
No difference in 
improvement 
between patients 
having <6mo & 
>6mo symptoms’ 
duration in both 
groups. 
OS: 70%, 
AS: 50% 
(no ITT) 
II-2 
2–60 20.5 AS, N=10 
Kondoh et al. 
(2003b) 
PCS  7 a 
DDwoR 
(CL) 
- 7 20-51 32.57 14-42 24.57±9.22 
Disc Reshaping without 
repositioning 
60 
Improvement in: 
pain & MMO 
- 
DDwoR 
100% 
IV 
Ozkan et al. 
(2012) 
RNCoSt 46 a 
Uni/bilat. 
DDwoR 
8 38 18-63 34.7 - 22.9 
High condylectomy ± 
disc repositioning, 
discectomy, or 
osteoplasty. 
18-156 
Improvement in: 
pain, MMO, & 
patient satisfaction 
- - IV 
Politi et al. 
(2007) b 
RCT 20 
DDwoR 
(CCL) 
6 14 25-67 42.8 
6-27 15.1 
OS (High condylectomy 
& disc repositioning), 
N=10 12 
VAS pain≤20, 
MMO≥35mm, 
PrM>5mm, 
MFIQ ≤ 7  
- 
OS: 80%, 
AS: 70% 
II-2 
8-24 14.7 AS + SH, N=10 
Schiffman et 
al. (2007); 
Schiffman et 
al. (2014b) b 
RCT 
108 
(12) 
DDwoR 
(W: III-
IV) 
8 98 - 31.72 
Non-
ch<6 - 
ch≥6 
- 
SM + Med, N=29 
SS + PT + CBT, N=25 
AS + CS, N=26 
OS (Arthroplasty), 
N=26 
60 
Self-reported 
success  
(patient 
satisfaction). 
- 
SM: 72% 
Reh: 81% 
AS: 76.2% 
OS: 83.3% 
(ITT) 
II-1 
Turley 
(1993) 
CR 1 
DDwoR 
(CL) 
- 1 - 23 5 - 
Arthroplasty 
(discectomy with 
sialistic implant 
replacement) 
72 
MMO≥40mm, 
improved function, 
& stable occlusion 
- - IV 
Widmark et 
al. (1997) 
RCS 
20 
(4) 
DDwoR 1 15 21-71 37 18-150 48 Discectomy 6-42 
Improvement in: 
VAS Pain & jaw 
function (CMI) 
- 
88% 
(no ITT) 
IV 
Zhang et al. 
(2010) 
PNCoSt 81 
W: III-IV  
69 c 
23 58 23-74 38.5 0.5-60 12.06 
Disc repositioning by 
bone anchores 
0.25 DR on MRI - 96.3% III-3 
TOTAL 8 studies - DDwoR - - - - 0.5-150 21.86 OS - - - 86.3% - 
a Separate data provided are for CL patients only. 
b Study data are also provided in other tables according to main treatment modality assessed. 
c DDwoR patients in study sample ≥ 80%.
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Appendix B: PROSPERO protocol for the systematic review of therapeutic 
interventions for DDwoR (Chapter 5) (Al-Baghdadi et al., 2012)12. 
 
                                                 
12 First page of the registered protocol is attached. The full-text published protocol is available online at 
the PROSPERO database: 
http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42012003153. 
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Appendix C: Inclusion/Exclusion criteria for studies in the systematic review of 
therapeutic interventions for DDwoR (Chapter 5). 
Inclusion criteria Exclusion criteria 
Types of studies Types of studies 
Randomised clinical trials (RCTs) that involve 
patients with TMJ DDwoR and comparing any 
form of conservative (non-surgical) or surgical 
interventions against each other, placebo or no 
treatment.  
Quasi-randomised studies, such as those allocating 
patients by using alternate days of the week, birth 
date, or consecutive attendance considered only if 
the baseline demographic details (e.g., severity of 
condition) of each comparable group were 
approximately similar. Included quasi-random 
trials were, however, subject to a sensitivity 
analysis. 
Studies which involve other heterogeneous groups 
of TMD patients (e.g. osteoarthritis, myofacial 
pain, disc displacement with reduction) in addition 
to patients with DDwoR were considered only if 
separate data were provided for DDwoR patients. 
If the separate data had not been provided but the 
percent of DDwoR patients in the study sample 
was more than 70%, the study was examined to be 
included. 
Studies comparing different types or techniques 
of similar intervention group (such as trials 
comparing different techniques of arthroscopy, 
different techniques of arthrocentesis, or those 
comparing between different types of occlusal 
splints). 
Studies evaluating a treatment modality after an 
initial surgical intervention (such as trials 
evaluating different medications or splints after 
arthroscopy or arthrocentesis). 
Types of participants Types of participants 
Patients of any age, gender, and of all degree of 
severity with clinical and/or radiological diagnosis 
of TMJ DDwoR as diagnosed according to: 
American Association of Orofacial Pain (AAOP) 
guidelines for acute or chronic DDwoR (de Leeuw, 
2008); research diagnostic criteria for 
temporomandibular disorders (RDC/TMD) for 
DDwoR with (IIb) or without (IIc) limited mouth 
opening (Dworkin and LeResche, 1992); Wilkes 
staging for internal derangement (stage III or IV) 
(Wilkes, 1989); or any other compatible criteria for 
DDwoR diagnosis. Confirming the disc position by 
soft tissue imaging was not a prerequisite to 
include the study. 
Studies which involve participants with confirmed 
diagnosis of DDwoR disorder with comorbid 
disorders. 
Patients with systemic diseases. 
Types of interventions Types of interventions 
Different forms of conservative (non-surgical) and 
surgical therapeutic interventions such as: patient 
education, self-management, psychosocial therapy, 
pharmacological therapy, physiotherapy, splint 
therapy, intra-articular medication injection, 
arthrocentesis, arthroscopic surgery, and open joint 
surgery. 
Studies that evaluate these therapeutic 
interventions against each other, placebo or no 
treatment were included. Standardized 
combinations of treatments were also included. 
Studies comparing different types or techniques 
of similar intervention group. 
Studies evaluating a treatment modality after an 
initial surgical intervention. 
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Appendix D: Data extraction sheet for studies included in the systematic review of 
therapeutic interventions for DDwoR (Chapter 5). 
DATA EXTRACTION FORM 
Study ID  Report ID  
EXTRACTED NON-NUMERICAL DATA 
Methods (study design) Allocation: 
Blindness: 
Duration: 
Setting and study Location: 
Participants Number: 
Gender: 
Age: 
Diagnosis: 
Diagnostic criteria: 
Imaging: 
Co-morbidity: 
Symptoms’ duration:  
Previous TMD treatment: 
Inclusion criteria: 
Exclusion criteria: 
Interventions Number of groups: 
Pre-intervention (all patients): 
Interventions: 
1. Group 1:  
2. Group 2:  
3. Group 3:  
4. Group 4: 
Post-intervention (all patients): 
Follow-up time points  
Outcomes TMJ Pain: 
MMO: 
Other mandibular movements: 
QoL/mandibular function: 
Therapy cost: 
Operation/admission duration: 
Adverse events: 
Drop-outs Number: 
Reasons: 
Intention-to-treat (ITT) analysis: 
Funding source and  
conflicts of interest 
 
Authors’ conclusion  
Authors’ comments  
Reviewers’ comments   
EXTRACTED NUMERICAL DATA 
Results Outcomes (Tool and unit of measurement, Scales’ upper and lower limits) 
SR Primary outcomes: 
 
- Short-term ≤ 3 months 
- Long-term > 3 months 
SR Secondary outcomes: - Short-term ≤ 3 months 
- Long-term > 3 months 
RISK-OF-BIAS 
Domain Judgement Support for judgement 
Random sequence generation (selection 
bias) 
 
Quote or Comment:  
Allocation concealment (selection bias)  Quote or Comment:  
Blinding (performance bias and detection 
bias) (All outcomes) 
 
1) Participants and health-care providers:  
2) Outcome assessor:  
     (a) Patient-reported outcomes:  
     (b) Clinician-measured outcomes:  
3) Data analyst:  
Incomplete outcome data (attrition bias)  
(All outcomes) 
 
Quote or Comment:  
Selective outcome reporting (reporting 
bias) 
 
Quote or Comment:  
Other bias  Quote or Comment:  
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Appendix E: Characteristics of included studies in the systematic review of therapeutic interventions for DDwoR (Chapter 5). 
Study 
(year)h 
Study design Participants 
Interventions 
Follow-up 
time-points 
Main 
assessed 
outcomes 
Adverse 
events 
Dropouts 
(groups) Allocation Blinding 
Setting, 
Country 
Fund 
Sample 
size 
(PA 
used)a 
Age 
(years) 
Gender 
Locking 
duration 
Diagnostic 
criteria 
Soft 
tissue 
imaging 
Lundh et 
al. (1992) 
Random NR 
University, 
Sweden 
Yes 
51 
(No) 
Mean 
29 
5m,46f NR 
Eriksson 
criteriab 
Arthrogr. 
Splint, N=25 
Control, N=26 
6, 12 mo Pain NR No 
Petersson 
et al. (1994) 
Random 
Single-
blind 
University, 
Sweden 
NR 
34 
(No) 
Mean 
33 
5m,29f NR 
Eriksson 
criteriab 
Arthrogr. 
Arthrocentesis, 
N=16/17 
Arthrography, N=17 
2 mo 
Pain, MMO, 
LM, PrM, 
Self-
questionnaire 
No 
Total=1 
(AC=1) 
Linde et al. 
(1995) 
Random NR 
University, 
Sweden 
Yes 
33  
(2 exc) 
(No) 
Median
37 
5m,26f 
Median 
6mo 
(range 
2wk-
16yr) 
Own study 
criteria 
No 
TENS, N=16/17 
Splint, N=15 
6 wk 
Pain, MMO, 
LM, PrM, 
Frequency 
and severity 
of complaints 
Yes 
(TENS: 
unclear) 
Total=2: 
(TENS=1, 
unclear=1) 
Fridrich et 
al. (1996) 
Random NR 
University, 
USA 
NR 
19 (15 
DDwoR) 
(No) 
Mean 
31 
19f NR 
Own study 
criteria 
MRI 
Arthroscopy, N=11 
Arthrocentesis, N=8 
1 wk, 1, 3, 
6, 12, 24 
mo 
Pain, MMO, 
LM, PrM, 
dietary 
alterations 
No 
Total=15 at 
24 mo 
(unclear) 
Schiffman 
et al. (1996) 
Random 
Double-
blind 
University, 
USA 
Yes 
27 
(No) 
Mean 
29 
3m,24f NR 
AACMDs 
and own 
criteriac 
None 
Active iontoph., 
N=9 
Control iontoph., 
N=9 
Placebo iontoph., 
N=9 
1 wk 
Pain (SSI), 
Function 
(CMI), 
MMO, LM 
Yes (N: 
unclear) 
None 
Goudot et 
al. (2000) 
Random NR 
University, 
France 
NR 
62 (54 
DDwoR) 
(No) 
Mean 
38 
75%f > 6mo 
Own study 
criteria 
MRI 
Arthroscopy, N=33 
Arthrocentesis, 
N=29 
12 mo Pain, MMO 
Total=4: 
(AS=2, 
AC=2) 
None 
Holmlund 
et al. (2001) 
Random NR 
University, 
Sweden 
NR 
22  
(2 exc) 
(No) 
Mean 
34.5 
2m,18f 
Mean 
14.5mo 
(range 2-
60mo) 
Own study 
criteria 
None 
Open surgery 
(Discectomy), N=10 
Arthroscopy, 
N=10/12 
3, 12 mo 
Pain, MMO, 
PrM, MFIQ 
Yes (N: 
unclear, 
As=1) 
Total=2: 
(AS=2) 
Minakuchi 
et al. (2001) 
Report: 
Minakuchi 
et al. (2004) 
Random 
Single-
blind 
University, 
Japan 
Yes 
69 
(No) 
Mean 
34 
7m,62f 
Mean 
98dy 
±SD 
156.8dy 
Own study 
criteria 
MRI 
Education, N=21 
Self-management, 
N=23 
Combination 
therapy, N=25 
2, 4, 8 wk 
Pain, MMO, 
DAL, self-
questionnaire 
NR 
Total=10 
(Educ=2; 
SM=2; 
Comb=4; 
Unclear=2) 
(ITT used) 
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Study 
(year)h 
Study design Participants 
Interventions 
Follow-up 
time-points 
Main 
assessed 
outcomes 
Adverse 
events 
Dropouts 
(groups) Allocation Blinding 
Setting, 
Country 
Fund 
Sample 
size 
(PA 
used)a 
Age 
(years) 
Gender 
Locking 
duration 
Diagnostic 
criteria 
Soft 
tissue 
imaging 
Yuasa et al. 
(2001) 
Report: 
Yuasa et al. 
(2003) 
Random NR 
University, 
Japan 
NR 
60 
(Yes) 
Median
28 
12m,48f 
Median 
84dy 
(range 
16-
1254dy) 
AAOMS & 
IAOMS 
criteriad 
MRI 
Self-management, 
N=30 
No treatment, N=30 
2, 4 wk 
Pain, MMO, 
interference 
with daily life 
None 
Yes 
(unclear) 
(LOCF 
use) 
Maloney et 
al. (2002)e 
Random NR 
University, 
USA 
Yes 
24 
DDwoR 
(No) 
NR NR NR RDC/TMD MRI 
Therabite+Splint, 
N=10 
WTDs+Splint, N=7 
Splint, N=7 
4 wk 
Pain, MMO, 
LM, PrM 
NR No 
Peroz et al. 
(2004)e 
Multi-
centre 
Random 
Double-
blind 
University, 
Germany 
Yes 
31 
DDwoR 
(No) 
Mean 
44 
83%f ≥ 6mo RDC/TMD 
MRI in 
some 
patients 
Active PEMF, 
N=13/14 
Placebo PEMF, 
N=17 
9 dy, 6 wk, 
4 mo 
Pain, MMO, 
LM, PrM, 
RDLA 
NR 
Total=1: 
(Active 
PEMF=1) 
Yoshida et 
al. (2005a) 
Random NR 
University, 
Japan 
NR 
305 
(No) 
Range 
(18-74) 
76m,229f 
(range 
1dy-
<1yr) 
Own study 
criteria 
None 
MM+NSAID, 
N=204 
NSAID, N=101 
Unclear (1 
wk) 
Pain, MMO NR NR 
Ismail et al. 
(2007) 
Random 
only data 
analyst 
University, 
Germany 
NR 
26 (21 
DDwoR) 
(Yes) 
Mean 
43 
3m,23f < 6mo RDC/TMD MRI 
Exercises+Splint, 
N=13 
Splint, N=13 
1 wk, 1, 2, 
3 mo 
Pain, MMO, 
PrM 
NR No 
Politi et al. 
(2007) 
Random NR 
University, 
Italy 
NR 
20 
(No) 
Mean 
43 
6m,14f 
Mean 
14.9mo 
(range 6-
27mo) 
Own study 
criteria 
MRI 
Open surgery 
(Condylectomy), 
N=10 
Arthroscopy, N=10 
12 mo 
Pain, MMO, 
PrM, MFIQ 
Yes (N: 
unclear) 
No 
Schiffman 
et al. (2007) 
Report: 
Schiffman 
et al. 
(2014b) 
Random 
Single-
blind 
University, 
USA 
Yes 
108  
(2 exc) 
(Yes) 
Mean 
32 
8m,98f 
< 6mo 
and    ≥ 
6mo 
Wilkes  
(III or IV) 
MRI 
Self-management, 
N=27/29 
Combination 
therapy, N=23/26 
Arthroscopy, 
N=24/27 
Open surgery 
(Arthroplasty), 
N=24/26 
3, 6, 12, 18, 
24, 60 mo 
Pain (SSI), 
Function 
(CMI), 
Therapy Cost 
Total=1 
(OS=1) 
Total=12: 
(Comb=3, 
AS=4, 
OS=5) 
(ITT used) 
Diracoglu 
et al. (2009) 
Alternatef 
(qRCT) 
Single-
blind 
University, 
Turkey 
NR 
120 
(No) 
Mean 
34 
16m,104f  ≤ 3wk 
Own study 
criteria 
MRI 
Arthrocentesis, 
N=54/60 
Combination 
therapy, N=56/60 
1, 3, 6 mo 
Pain, MMO, 
LM, PrM 
NR 
Total=10 
(unclear) 
Haketa et 
al. (2010)g 
Random 
Single-
blind 
University, 
Japan 
Yes 
52 
(Yes) 
Mean 
38 
6m,46f > 2wk 
Own study 
criteria 
MRI 
Self-management, 
N=19/24 
Splint, 25/28 
1, 2 mo 
Pain, MMO, 
LDF 
None 
Total=14: 
(SM=9; 
Splint=5) 
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Study 
(year)h 
Study design Participants 
Interventions 
Follow-up 
time-points 
Main 
assessed 
outcomes 
Adverse 
events 
Dropouts 
(groups) Allocation Blinding 
Setting, 
Country 
Fund 
Sample 
size 
(PA 
used)a 
Age 
(years) 
Gender 
Locking 
duration 
Diagnostic 
criteria 
Soft 
tissue 
imaging 
Yoshida et 
al. (2011) 
Report: 
Yoshida et 
al. (2013) 
Random NR 
University, 
Japan 
NR 
148 
(No) 
Mean 
40 
148f 
Mean 
50dy 
(range 1-
360dy) 
Own study 
criteria 
None 
Self-MM, N=74 
No treatment, N=74 
10 min 
MMO, LM, 
PrM 
NR NA 
Craane et 
al. (2012a)g 
Random 
Single-
blind 
University, 
Belgium 
No 
49 
(Yes) 
Mean 
37 
2m,47f 
several 
wk to 
several yr 
RDC/TMD 
(IIb, IIc) 
MRI in 
only 6/49 
Jaw exercise, 
N=20/23 
Education, N=22/26 
3, 6, 12, 26, 
52 wk 
Pain, MMO, 
MFIQ 
NR 
Total=7: 
(Exr=3; 
Educ=4) 
(ITT used) 
Sahlstrom 
et al. 
(2013)g 
Random 
Single-
blind 
University, 
Sweden 
No 
45 
(Yes) 
Mean 
35 
4m,41f 
Median 
24mo 
(range 3-
360mo) 
RDC/TMD MRI 
Arthrocentesis, 
N=14/20 
Extra-articular LA, 
N=23/25 
1, 3 mo 
Pain, MMO, 
JFLS 
None 
Total=8: 
(AC=6; 
LA=2) 
(ITT used) 
Abbreviations: AC: arthrocentesis, Arthrogr: arthrography, AS: arthroscopy, CMI: craniomandibular index, Comb: combination therapy of splints + physiotherapy + 
medication/education, Ctrl: control, DAL: daily activity limitations, Dx: diagnosis, dy: days, Educ: education, exc: excluded; Exr: exercises, f: female, FOC: frequency of 
complaints, iontoph.: iontophoresis, ITT: intention-to-treat analysis, JFLS: jaw functional limitation scale, LA: local anaesthetic, LDF: limitation of daily functions, LM: lateral 
movement, LOCF: last observation carried forward,  m: male, MM: mandibular manipulation, MFIQ: mandibular function impairment questionnaire, MMO: maximum mouth 
opening, min: minutes, mm: millimetres, mo: months, MRI: magnetic resonance imaging, N: number, NA: not applicable, NR: not reported, NSAIDs: non-steroidal anti-
inflammatory drugs, OS: open surgery, PA: power-analysis, PEMF: pulsed electromagnetic fields, PrM: protrusive movement, PT: physiotherapy, q-RCT: quasi-randomised clinical 
trial, RDC/TMD: research diagnostic criteria of temporomandibular disorders, RDLA: restriction of daily life activities, SD: standard deviation, self-ex: self-exercise, SM: self-
management, self-MM: self- mandibular manipulation, SSI: symptoms severity index, TENS: transcutaneous electric nerve stimulation, wk: weeks, WTDs: wooden tongue 
depressors, yr: years.  
a A priori power-analysis was done in 7 RCTs. In the remaining 13 trials, a post-hoc power-analysis was performed using the G*3power statistical software (version 3) and 8 trials 
were found under-powered (<80%) for their level of significance for the two primary outcomes (pain and MMO) (Petersson et al., 1994; Linde et al., 1995; Schiffman et al., 1996; 
Holmlund et al., 2001; Minakuchi et al., 2001; Maloney et al., 2002; Peroz et al., 2004; Politi et al., 2007). 
b Criteria suggested by Eriksson and Westesson (1983). 
c Criteria suggested by American academy of craniomandibular disorders (AACMDs) in addition to own study’s authors criteria (Schiffman et al., 1989; McNeill, 1990).  
d Criteria suggested by American association of oral and maxillofacial surgeons (AAOMS) and international association of oral and maxillofacial surgeons (IAOMS) (Dolwick et al., 
1984; Goss, 1993). 
e Separate data for DDwoR patients are available and/or obtained from the contacted authors (personal e-mail communication). 
f Patients were allocated to undergo either arthrocentesis or conservative treatment (a combination of splint and physiotherapy) according to their admission to the TMJ clinic 
(consecutively 1 to each group). 
g Statistical data (unpublished) were provided by the study authors (personal e-mail communication). 
h Studies are in chronological order.
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Appendix F: Characteristics of excluded studies in the systematic review of 
therapeutic interventions for DDwoR (Chapter 5). 
Study Reason for exclusion 
Aktas et al. (2010b) 
Allocation: unclear; Participants: DDwoR; Interventions: evaluates the effect of 
sodium hyaluronate (SH) after arthrocentesis. The interventions are 
arthrocentesis with sodium hyaluronate and arthrocentesis without sodium 
hyaluronate. 
Aktas et al. (2010a) 
Allocation: random; Participants: DDwoR; Interventions: evaluates the effect 
of tenoxicam after arthrocentesis. The interventions are arthrocentesis with 
tenoxicam and arthrocentesis without tenoxicam. 
Alpaslan and 
Alpaslan (2001) 
Allocation: random; Participants: DDwR and DDwoR; Interventions: evaluates 
the effect of sodium hyaluronate (HS) after arthrocentesis. The interventions 
are arthrocentesis with sodium hyaluronate and arthrocentesis without sodium 
hyaluronate. 
Alpaslan et al. 
(2008) 
Allocation: random; Participants: DDwoR; Interventions: evaluates the effect 
of soft and hard splints after arthrocentesis. The interventions are arthrocentesis 
with soft splint and arthrocentesis with hard splint. 
Arinci et al. (2009) 
Allocation: unclear; Participants: DDwR and DDwoR; Interventions: evaluates 
arthroscopy with or without BTX-A injection to the lateral pterygoid muscle. 
The interventions are arthroscopy with BTX-A injection and arthroscopy 
without BTX-A injection. 
Bertolami et al. 
(1993) 
Allocation: random; Participants: no separate extractable data for DDwoR 
group. 
Bertolucci and 
Grey (1995a); 
Bertolucci and 
Grey (1995b)  
Allocation: random; Participants: no clear criteria for DDwoR clinical and 
radiological diagnosis and the participants presented with a primary diagnosis 
of active degenerative disease (DDwoR seems to be only a secondary 
diagnosis). In addition, violation to study protocol recognized as one patient 
complained from side effects excluded and replaced by another new participant 
from the population during the conduct of the study. 
Bryant et al. (1999) 
Allocation: random; Participants: TMJ arthralgia and internal derangement; 
Interventions: evaluates the effect of morphine and naloxone after arthroscopy. 
The interventions are arthroscopy with morphine ± naloxone and arthroscopy 
without morphine. 
Carmeli et al. 
(2001) 
Allocation: random; Participants: no specific diagnosis for TMJ disc 
displacement. 
Ekberg (1998); 
Ekberg and Nilner 
(1999); Ekberg and 
Nilner (2002); 
Ekberg et al. 
(2002); Ekberg et 
al. (1998) 
Allocation: random; Participants: the comparable DDwoR subgroups were 
small and no separate data reported. 
Elsholkamy et al. 
(2013) 
Allocation: unclear; Participants: DDwoR; Interventions: evaluates the effect of 
sodium hyaluronate (SH) after arthrocentesis. The interventions are 
arthrocentesis with sodium hyaluronate and arthrocentesis without sodium 
hyaluronate. 
Emes et al. (2013) 
Allocation: random; Participants: internal derangement (Wilkes stages II-V); 
Interventions: compares the effect of second arthrocentesis + SH versus intra-
articular tenoxicam injection without second arthrocentesis. All the participants 
were treated previously by a surgical intervention (arthrocentesis). 
Furst et al. (2001) 
Allocation: random; Participants: DDwR and DDwoR; Interventions: evaluates 
the effect of morphine and bupivacaine after arthroscopy. The interventions are 
arthroscopy with morphine and/or bupivacaine and arthroscopy without 
morphine and/or bupivacaine. 
Ghanem (2011) 
Allocation: unclear; Participants: DDwoR; Interventions: evaluates the effect of 
stabilisation splint after arthrocentesis. The interventions are arthrocentesis 
with stabilisation splint and arthrocentesis without stabilisation splint. 
Gray et al. (1991) 
Allocation: random; Participants: no specific diagnosis for TMJ pain and 
dysfunction. 
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Study Reason for exclusion 
Gray et al. (1994b); 
Gray et al. (1995) 
Allocation: random; Participants: no specific diagnosis for TMJ pain and 
dysfunction. 
Gu et al. (1998) Allocation: unclear; Participants: DDwR and DDwoR. 
Hall et al. (2005a) Allocation: not random. 
Hamed (2012) 
Allocation: random; Participants: DDwR and DDwoR; Interventions: evaluates 
the effect of tramadol and Cox-2 inhibitor after arthrocentesis. The 
interventions are arthrocentesis with tramadol and arthrocentesis with Cox-2 
Inhibitor. 
Hammuda et al. 
(2013) 
Allocation: random; Participants: DDwoR; Interventions: evaluates the effect 
of Ozone after arthrocentesis. The interventions are arthrocentesis with 
ozonized water and arthrocentesis with normal saline solution. 
Hirota (1998) 
Allocation: random; Participants: TMJ internal derangement; Interventions: 
sodium hyaluronate (SH) injection; Outcomes: synovial fluid analysis study. 
Kaplan et al. 
(1989) 
Allocation: random; Participants: TMJ internal derangement; Interventions: 
evaluates the omnipaque and hypaque contrast agents in TMJ arthrography. 
Katyayan et al. 
(2014) 
Allocation: random; Participants: only few patients diagnosed with DDwoR 
and no separate data provided. 
Kulekcioglu et al. 
(2003) 
Allocation: random; Participants: no comparable groups for DDwoR subgroup. 
Long et al. (2009) 
Allocation: random; Participants: DDwoR; Interventions: evaluates the effect 
of injecting sodium hyaluronate (HS) into the inferior versus superior TMJ 
space. The interventions are sodium hyaluronate injection to superior joint 
space and sodium hyaluronate injection to inferior joint space. 
Machon et al. 
(2012) 
Allocation: not random; Participants: DDwoR; Interventions: evaluates early 
versus late intervention by arthroscopy. 
Marini et al. (2010) 
Allocation: random; Participants: DDwoR or OA. No separate data for DDwoR 
and the percentage of DDwoR in the sample was < 70% to include the study. 
Matsumoto et al. 
(2011) 
Allocation: random; Participants: closed lock; Interventions: evaluates two 
different puncture techniques for pumping manipulation treatment 
(conventional versus image-guided). The interventions are conventional 
puncture technique to superior joint space and image-guided puncture 
technique to superior joint space. 
McCain et al. 
(1989) 
Allocation: random; Participants: TMJ disorders; Interventions: evaluates the 
effect of sodium hyaluronate (HS) after arthroscopy. The interventions are 
arthroscopy with sodium hyaluronate and arthroscopy without sodium 
hyaluronate. 
McNamara et al. 
(1996) 
Allocation: random; Participants: no separate data for DDwoR. 
Miyamoto et al. 
(1999) 
Allocation: random; Participants: DDwoR; Interventions: evaluates two 
different techniques of arthroscopy (lysis and lavage versus anterolateral 
capsular release). The interventions are arthroscopy with lysis and lavage only 
and arthroscopy with lysis and lavage plus anterolateral capsular release. 
Morey-Mas et al. 
(2010) 
Allocation: random; Participants: DDwR and DDwoR; Interventions: evaluates 
the effect of sodium hyaluronate (HS) after arthroscopy. The interventions are 
arthroscopy with sodium hyaluronate and arthroscopy without sodium 
hyaluronate. 
Murakami et al. 
(1995) 
Allocation: not random. 
Nascimento et al. 
(2013) 
Allocation: random; Participants: only one patient diagnosed with DDwoR. 
Nguyen et al. 
(2001) 
Allocation: random; Participants: no specific diagnosis for TMJ pain. 
Nilsson and 
Ekberg (2010); 
Nilsson et al. 
(2009); Nilsson et 
al. (2011) 
Allocation: random; Participants: only two patients diagnosed with DDwoR. 
Nunez et al. (2006) 
Allocation: randomised cross-over study; Participants: no specific diagnosis for 
TMJ pain and limitation in mouth opening. 
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Study Reason for exclusion 
Oliveras-Moreno et 
al. (2008) 
Allocation: random; Participants: diagnosed with TMJ DDwR (Wilkes stage 
II). 
Prager et al. (2007) 
Allocation: random; Participants: DDwR and DDwoR; Interventions: evaluates 
the effect of buprenorphine after arthrocentesis. The interventions are 
arthrocentesis with buprenorphine and arthrocentesis without buprenorphine. 
Reid et al. (1994) Allocation: random; Participants: no separate data for DDwoR. 
Sanroman (2004) 
Allocation: not random; Participants: diagnosed with anchored disc 
phenomenon (ADP). 
Sato et al. (1997b) Allocation: not random. 
Sato et al. (2001b) Allocation: not random. 
Sato and 
Kawamura (2008) 
Allocation: not random. 
Schmitter et al. 
(2005c) 
Allocation: random; Participants: DDwoR; Interventions: evaluates two 
different types of splint (centric versus distraction). The interventions are 
centric splint and distraction splint. 
Stegenga et al. 
(1993c) 
Allocation: random; Participants: no separate data for DDwoR. 
Stiesch-Scholz et 
al. (2002a) 
Allocation: not random. 
Stiesch-Scholz et 
al. (2005) 
Allocation: random; Participants: DDwoR; Interventions: evaluates two 
different types of splint (stabilization versus pivot). The interventions are 
stabilization splint and pivot splint. 
Wahlund (2003); 
Wahlund et al. 
(2003) 
Allocation: random; Participants: no specific diagnosis for TMJ disc 
displacement subgroup. 
Yucel et al. (2014) Allocation: not random. 
Ziegler et al. (2010) Allocation: random; Participants: no specific diagnosis for TMJ pain. 
Zuniga et al. (2007) 
Allocation: random; Participants: no specific diagnosis; Interventions: 
evaluates the effect of morphine and bupivacaine after TMJ arthroplasty. The 
interventions are arthroplasty with morphine and/or bupivacaine and 
arthroplasty without morphine and/or bupivacaine. 
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Appendix G: Summary of findings for secondary outcomes of the systematic review of therapeutic interventions for DDwoR (Chapter 5). 
Comparison 
(Study) 
Secondary 
outcome 
Follow-up 
(short/long-
term) 
No. of 
Patients 
(Trials) 
Relative effect (95%CI) 
p value for 
between-group 
difference e 
Overall 
Risk of 
Bias 
Outcome 
measuring 
tool/scale 
1. UM vs. No treatment 
(Yoshida et al., 2011) 
Protrusiona 10 min (ST) 148 (1 RCT) MD 0.00 (-0.43 to 0.43) NS High mm 
Contralaterala 10 min (ST) 148 (1 RCT) MD 2.00 (1.54 to 2.46) p<0.001 favours UM High mm 
Ipsilaterala 10 min (ST) 148 (1 RCT) MD 2.00 (1.46 to 2.54) p<0.001 favours UM High mm 
2. Jaw exercises vs. 
Education only 
(Craane et al., 2012a) 
pMMO 3 mo (ST) 45 (1 RCT) MD -3.20 (-7.00 to 0.60) NS Unclear mm 
pMMO 13 mo (LT) 42 (1 RCT) MD -3.60 (-7.42 to 0.22) NS Unclear mm 
Function 3 mo (ST) 42 (1RCT) MD 4.20 (-2.68 to 11.08) NS Unclear MFIQ 
Function 13 mo (LT) 42 (1RCT) MD 0.40 (-6.28 to 7.08) NS Unclear MFIQ 
3. Self-management vs. 
Education only 
(Minakuchi et al., 2001) 
pMMO 2 mo (ST) 44 (1 RCT) MD -1.70 (-7.18 to 3.78) NS Unclear mm 
cMMO 2 mo (ST) 44 (1 RCT) MD -0.40 (-6.36 to 5.56) NS Unclear mm 
Function 2 mo (ST) 44 (1 RCT) MD -0.50 (-2.48 to 1.48) NS Unclear DAL 
4. Self-management vs. 
Splint  
(Haketa et al., 2010) 
cMMO 2 mo (ST) 44 (1 RCT) MD 6.20 (2.06 to 10.34) p<0.01 favours SM Unclear mm 
Functionb 2 mo (ST) 44 (1 RCT) MD -3.62 (-6.81 to -0.43) p<0.01 favours SM Unclear LDF 
5. Splint vs. TENS 
(Linde et al., 1995) 
Protrusion 6 wk (ST) 31 (1 RCT) MD -1.22 (-2.73 to 0.29) NS High mm 
Total lateral 6 wk (ST) 31 (1 RCT) MD -0.98 (-4.33 to 2.37) NS High 
Baseline 
change 
Complaints 
frequency 
6 wk (ST) 31 (1 RCT) RR 6.40 (0.87 to 47.12) NS High 
N reduction 
of FOC 
6. Combination therapyc 
vs. Education only 
(Minakuchi et al., 2001) 
pMMO 2 mo (ST) 46 (1 RCT) MD 1.00 (-4.09 to 6.09) NS Unclear mm 
cMMO 2 mo (ST) 46 (1 RCT) MD 1.30 (-4.43 to 7.03) NS Unclear mm 
Function 2 mo (ST) 46 (1 RCT) MD 1.30 (-0.90 to 3.50) NS Unclear DAL 
7. Combination therapy 
vs. Self-management 
(Minakuchi et al., 2001; 
Schiffman et al., 2007)     
pMMO 2 mo (ST) 48 (1 RCT) MD 2.70 (-2.96 to 8.36) NS Unclear mm 
cMMO 2 mo (ST) 48 (1 RCT) MD 1.70 (-4.14 to 7.54) NS Unclear mm 
Function 2 mo (ST) 48 (1 RCT) MD 1.80 (-0.13 to 3.73) NS Unclear DAL 
Function 3 mo (ST) 51 (1 RCT) MD -0.05 (-0.13 to 0.03) NS Unclear CMI 
Function 60 mo (LT) 50 (1 RCT) MD 0.00 (-0.09 to 0.09) NS Unclear CMI 
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Comparison 
(Study) 
Secondary 
outcome 
Follow-up 
(short/long-
term) 
No. of 
Patients 
(Trials) 
Relative effect (95%CI) 
p value for 
between-group 
difference e 
Overall 
Risk of 
Bias 
Outcome 
measuring 
tool/scale 
8. Jaw exercise + splint vs. 
Splint 
(Maloney et al., 2002; 
Ismail et al., 2007) 
Protrusion 1-3 mo (ST) 50 (2 RCTs) MD 1.83 (0.51 to 3.16) 
p<0.01 favours exr + 
sp 
High mm 
Right lateral 1 mo (ST) 24 (1 RCT) MD 1.35 (-0.71 to 3.41) 
 
NS 
 
High mm 
Left lateral 1 mo (ST) 24 (1 RCT) MD 3.72 (2.20 to 5.24) 
p<0.001 favours exr + 
sp 
High mm 
9. Active PEMF vs. 
Placebo PEMF 
(Peroz et al., 2004) 
pMMO 6 wk (ST) 31 (1 mRCT) MD -3.53 (-9.52 to 2.46) NS Low mm 
pMMOb 4 mo (LT) 30 (1 mRCT) MD 0.00 (-5.27 to 5.27) NS Unclear mm 
Function 6 wk (ST) 31 (1 mRCT) MD 18.38 (2.80 to 33.96) p<0.05 favour placebo Low RDLA 
Functionb 4 mo (LT) 30 (1 mRCT) MD 10.70 (-7.04 to 28.44) NS Unclear RDLA 
10. Active iontoph. vs. 
Placebo iontoph. 
(Schiffman et al., 1996) 
pMMO 1 wk (ST) 18 (1 RCT) MD -2.20 (-9.86 to 5.46) NS Unclear mm 
Contralateral 1 wk (ST) 18 (1 RCT) MD -2.00 (-4.70 to 0.70) NS Unclear mm 
Function 1 wk (ST) 18 (1 RCT) MD -0.04 (-0.19 to 0.11) NS Unclear CMI 
11. Arthrocentesis vs. 
Arthrography 
(Petersson et al., 1994) 
Protrusion 2 mo (ST) 33 (1 RCT) MD -0.20 (-2.05 to 1.65) NS Unclear mm 
12. Arthrocentesis versus 
LA ATN block 
(Sahlstrom et al., 2013) 
cMMO 3 mo (ST) 37 (1 RCT) MD -5.93 (-11.55 to -0.31) p<0.05 favours LA Unclear mm 
pMMO 3 mo (ST) 37 (1 RCT) MD -2.20 (-7.49 to 3.09) NS Unclear mm 
Function 3 mo (ST) 36 (1 RCT) MD 1.10 (0.14 to 2.06) p<0.05 favours LA Unclear JFLS 
13. Arthrocentesis vs. 
Combination therapy 
(Diracoglu et al., 2009) 
Protrusion 3 mo (ST) 110 (1 qRCT) MD 0.81 (0.10 to 1.52) p<0.05 favours AC High mm 
Protrusion 6 mo (LT) 110 (1 qRCT) MD 0.38 (-0.23 to 0.99) NS High mm 
Right lateral 3 mo (ST) 110 (1 qRCT) MD 1.13 (0.49 to 1.77) p<0.001 favours AC High mm 
Right lateral 6 mo (LT) 110 (1 qRCT) MD 0.47 (-0.14 to 1.08) NS High mm 
Left lateral 3 mo (ST) 110 (1 qRCT) MD 0.63 (-0.00 to 1.26) p=0.05 towards AC High mm 
Left lateral 6 mo (LT) 110 (1 qRCT) MD 0.94 (0.11 to 1.77) p<0.05 favours AC High mm 
14. Arthroscopy vs.           
Self-management 
(Schiffman et al., 2007) 
Function 3 mo (ST) 52 (1 RCT) MD -0.06 (-0.15 to 0.03) NS Unclear CMI 
Function 60 mo (LT) 51 (1 RCT) MD 0.01 (-0.08 to 0.10) NS Unclear CMI 
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Comparison 
(Study) 
Secondary 
outcome 
Follow-up 
(short/long-
term) 
No. of 
Patients 
(Trials) 
Relative effect (95%CI) 
p value for 
between-group 
difference e 
Overall 
Risk of 
Bias 
Outcome 
measuring 
tool/scale 
15. Arthroscopy vs. 
Combination therapy 
(Schiffman et al., 2007) 
Function 3 mo (ST) 45 (1 RCT) MD -0.01 (-0.09 to 0.07) NS Unclear CMI 
Function 60 mo (LT) 47 (1 RCT) MD 0.01 (-0.07 to 0.09) NS Unclear CMI 
16. Open surgery vs.         
Self-management 
(Schiffman et al., 2007) 
Function 3 mo (ST) 49 (1 RCT) MD -0.06 (-0.14 to 0.02) NS Unclear CMI 
Function 60 mo (LT) 51 (1 RCT) MD 0.03 (-0.06 to 0.12) NS Unclear CMI 
17. Open surgery vs. 
Combination therapy 
(Schiffman et al., 2007) 
Function 3 mo (ST) 42 (1 RCT) MD -0.01 (-0.08 to 0.06) NS Unclear CMI 
Function 60 mo (LT) 47 (1 RCT) MD 0.03 (-0.06 to 0.12) NS Unclear CMI 
18. Arthroscopy vs. 
Arthrocentesis 
(Goudot et al., 2000) 
Adverse 
effects 
12 mo (LT) 4 (1 RCT) RR 0.88 (0.13 to 5.85) NS High 
Adverse 
events 
19. Open surgery vs. 
Arthroscopy 
(Holmlund et al., 2001; 
Politi et al., 2007; 
Schiffman et al., 2007) 
Protrusion 12 mo (LT) 40 (2 RCTs) RR 0.90 (0.75 to 1.09) NS High PrM>5mm 
Function 12 mo (LT) 40 (2 RCTs) MD 1.58 (-3.95 to 0.79) NS High MFIQ 
Function 3 mo (ST) 43 (1 RCT) MD 0.00 (-0.08 to 0.08) NS Unclear CMI 
Function 60 mo (LT) 48 (1 RCT) MD 0.02 (-0.07 to 0.11) NS Unclear CMI 
Other secondary outcomes 
 Therapy cost 
Self-management 
(Schiffman et al., 2014b). 
Therapy cost d 60 mo (LT) 
Each patient  
(1 RCT) 
Mean $1385 
(Range $410–$3555) Patients treated by 
self-management 
strategy incurred 
significantly lower 
average costs than 
combination therapy, 
arthroscopy, and open 
surgery patients. 
Unclear 
$ These 
costs do not 
include 
imaging 
costs, 
which were 
the same 
for all 
treatment 
strategies. 
Combination therapy 
(Schiffman et al., 2014b). 
Therapy cost d 60 mo (LT) 
Each patient  
(1 RCT) 
Mean $2379 
(Range $1375–$5240) 
Unclear 
Arthroscopic surgery 
(Schiffman et al., 2014b). 
Therapy cost d 60 mo (LT) 
Each patient  
(1 RCT) 
Mean $7890 
(Range $5830–$15.940) 
Unclear 
Open joint surgery 
(Schiffman et al., 2014b). 
Therapy cost d 60 mo (LT) 
Each patient  
(1 RCT) 
Mean $13.128 
(Range $11.085– $15.280) 
Unclear 
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Comparison 
(Study) 
Secondary 
outcome 
Follow-up 
(short/long-
term) 
No. of 
Patients 
(Trials) 
Relative effect (95%CI) 
p value for 
between-group 
difference e 
Overall 
Risk of 
Bias 
Outcome 
measuring 
tool/scale 
 Admission/operative duration 
Open surgery 
(Holmlund et al., 2001) 
Operative 
duration 
12 mo (LT) 10 (1 RCT) Mean 70 minutes - High Minutes 
Arthroscopy 
(Holmlund et al., 2001) 
Operative 
duration 
12 mo (LT) 10 (1 RCT) Mean 25 minutes - High Minutes 
Open surgery 
(Holmlund et al., 2001) 
Admission 
duration 
12 mo (LT) 10 (1 RCT) Mean 3 days - High Days 
Arthroscopy 
(Holmlund et al., 2001) 
Admission 
duration 
12 mo (LT) 10 (1 RCT) Mean 1 hour - High Hours 
Open surgery 
(Politi et al., 2007) 
Admission 
duration 
12 mo (LT) 10 (1 RCT) 
Mean 5 days 
- High 
Days 
Arthroscopy 
(Politi et al., 2007) 
Admission 
duration 
12 mo (LT) 10 (1 RCT) 
Mean 5 days 
- High 
Days 
Abbreviations: AC: arthrocentesis, AS: arthroscopy, ATN LA block: auriculotemporal nerve local anaesthesia block, CI: confidence interval, CMI: craniomandibular index, cMMO: 
comfortable maximum mouth opening, DAL: daily activity limitations, Educ: education, exr+sp: exercises plus splint, FOC: frequency of complaints, JFLS: jaw functional limitation 
scale, LDF: limitation of daily functions, MD: mean difference, MFIQ: mandibular function impairment questionnaire, mins: minutes, mm: millimetres, mo: months, mRCT: multi-
centre randomised clinical trial, N: number of patients, NS: non-significant, OS: open surgery, PEMF: pulsed electromagnetic fields, pMMO: passive maximum mouth opening, 
PrM: protrusive movement, qRCT: quasi-randomised clinical trial, RDLA: restriction of daily life activities, RR: risk ratio, SM: self-management, TENS: transcutaneous electric 
nerve stimulation, UM: unlock manipulation, wks: weeks, WTDs: wooden tongue depressors. 
a Mean and SD were calculated from median, range according to Hozo et al. (2005).  
b Unpublished data provided by the study authors via e-mail communication. 
c Combination therapy: combination of (splint + physiotherapy + medication ± cognitive behavioural therapy) conservative interventions. 
d These costs did not include the imaging costs, which were similar for all patients in the trial. 
e Statistical significance (p-value<0.05) for between-group statistical differences. 
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Appendix H: Statistical analysis for within-group difference from baseline for 
primary outcomes of each individual intervention of the systematic review of 
therapeutic interventions for DDwoR (Chapter 5). 
H-1: Change from baseline for TMJ pain intensity (during jaw function) primary 
outcome. 
Studya  
(Year) 
Intervention 
Follow-
up time-
point 
Pre- 
treatment 
Post- 
treatment 
Changeb 
from baseline 
p-valuec for 
within-group 
difference 
from baseline 
Overall 
Risk-of-
Bias Mean ± SD Mean ± SD Mean ± SD 
Yoshida et al. 
(2005a) 
MM 1 wk (ST) 45.5 29 -16.5 NR High 
NSAID only 1 wk (ST) NR NR NR NR High 
Yoshida et al. 
(2011) 
MM Unassessed 
outcome 
NA NA NA NA NA 
No treatment 
Craane et al. 
(2012a)d 
Jaw exercises 3 mo (ST) 51.15 ± 12.91 21.63 ± 16.77 -29.52 ± 14.96 p<0.05 Unclear 
Education 3 mo (ST) 54.14 ± 15.93 17.82 ± 16.09 -36.32 ± 16.01 p<0.05 Unclear 
Jaw exercises 13 mo (LT) 51.15 ± 12.91 8.10 ± 10.46 -43.05 ± 11.75 p<0.05 Unclear 
Education 13 mo (LT) 54.14 ± 15.93 7.48 ± 9.55 -46.66 ± 13.13 p<0.05 Unclear 
Minakuchi et 
al. (2001) 
Comb. therapy 2 mo (ST) 47.7 ± 25.2 26.2 ± 19.5 -21.5 ± 22.53 p<0.001 Unclear 
Self-management  2 mo (ST) 55.8 ± 25.8 24.6 ± 25.7 -31.2 ± 25.75 p<0.001 Unclear 
Education 2 mo (ST) 59.0 ± 24.0 29.0 ± 25.5 -30 ± 24.76 p<0.001 Unclear 
Yuasa et al. 
(2001) 
Self-management  1 mo (ST) Median 53.5 Median 25.5 Median -20 p<0.01 Unclear 
No treatment 1 mo (ST) Median 57 Median 22 Median -6 p<0.05 Unclear 
Haketa et al. 
(2010) 
Self-management  2 mo (ST) 63.1 ± 21.4 21.3 ± 26.4 -41.8 ± 24.04 p<0.001 Unclear 
Splint 2 mo (ST) 58.9 ± 28.2 36.5 ± 28.7 -22.4 ± 28.45 p<0.001 Unclear 
Lundh et al. 
(1992) 
Splint 12 mo (LT) NR NR NR NR High 
Control  12 mo (LT) NR NR NR NR High 
Linde et al. 
(1995) 
Splint 6 wk (ST) 51 NR NR p<0.001 High 
TENS 6 wk (ST) 63 NR NR p<0.001 High 
Maloney et al. 
(2002)e 
Exercises + Splint 1 mo (ST) 49.41 ± 29.26 32.35 ± 26.37 -17.06 ± 27.85 p<0.05 High 
Splint 1 mo (ST) 44.29 ± 32.07 38.57 ± 24.10 -5.72 ± 28.37 NS High 
Ismail et al. 
(2007) 
Exercises + Splint 3 mo (ST) 45 ± 20 NR -28 ± 21 p<0.05 Unclear 
Splint 3 mo (ST) 42 ± 22 NR -23 ± 22 p<0.05 Unclear 
Peroz et al. 
(2004)f 
Active PEMF 6 wk (ST) 44.82 ± 22.15 32.64 ± 25.54 -12.88 ± 23.91 p<0.01 Low 
Placebo PEMF 6 wk (ST) 48.50 ± 33.58 32.41 ± 25.94 -16.09 ± 30.00 p<0.01 Low 
Active PEMF 4 mo (LT) 44.82 ± 22.15 39.08 ± 25.82 -5.74 ± 24.10 p<0.05 Unclear 
Placebo PEMF 4 mo (LT) 48.50 ± 33.58 19.59 ± 25.43 -28.91 ± 29.79 p<0.05 Unclear 
Schiffman et 
al. (1996)g 
Active iontoph. 1 wk (ST) 0.57 ± 0.1 0.47 ± 0.2 -0.10 ± 0.16 NS Unclear 
Placebo iontoph. 1 wk (ST) 0.52 ± 0.2 0.50 ± 0.2 -0.02 ± 0.20 NS Unclear 
Schiffman et 
al. (2007) 
Self-management  3 mo (ST) 0.61 ± 0.23 0.33 ± 0.22 -0.28 ± 0.23 p<0.0001 Unclear 
Comb. therapy 3 mo (ST) 0.72 ± 0.17 0.42 ± 0.27 -0.30 ± 0.23 p<0.0001 Unclear 
Arthroscopy 3 mo (ST) 0.70 ± 0.19 0.34 ± 0.25 -0.36 ± 0.22 p<0.0001 Unclear 
Open surgery 3 mo (ST) 0.76 ± 0.22 0.26 ± 0.24 -0.50 ± 0.23 p<0.0001 Unclear 
Self-management  60 mo (LT) 0.61 ± 0.23 0.23 ± 0.25 -0.38 ± 0.24 p<0.0001 Unclear 
Comb. therapy 60 mo (LT) 0.72 ± 0.17 0.23 ± 0.23 -0.49 ± 0.20 p<0.0001 Unclear 
Arthroscopy 60 mo (LT) 0.70 ± 0.19 0.26 ± 0.20 -0.44 ± 0.20 p<0.0001 Unclear 
Open surgery 60 mo (LT) 0.76 ± 0.22 0.28 ± 0.25 -0.48 ± 0.24 p<0.0001 Unclear 
Petersson et al. 
(1994)h 
Arthrocentesis 2 mo (ST) 56.75 ± 20.14 33.63 ± 27.02 -23.12 ± 23.83 p<0.01 High 
Arthrography 2 mo (ST) 61.12 ± 18.23 49.65 ± 27.99 -11.47 ± 23.62 NS (p=0.06) High 
Sahlstrom et 
al. (2013)d 
Arthrocentesis 3 mo (ST) 60.6 ± 26.7 55.0 ± 30.7 -5.6 ± 28.77 NS Unclear 
ATN LA block 3 mo (ST) 58.1 ± 23.2 30.4 ± 22.6 -27.7 ± 22.90 p<0.0001 Unclear 
Diracoglu et al. 
(2009) 
Arthrocentesis 3 mo (ST) 62.6 ± 23.5 31.5 ± 25.2 -31.1 ± 23.3 p<0.01 High 
Comb. therapy 3 mo (ST) 56.6 ± 24.7 50.8 ± 24.2 -6.2 ± 15.8 p<0.01 High 
Arthrocentesis 6 mo (LT) 62.6 ± 23.5 15.1 ± 18.2 -47.4 ± 21.4 p<0.01 High 
Comb. therapy 6 mo (LT) 56.6 ± 24.7 43.9 ± 23.1 -12.2 ± 17.6 p<0.01 High 
Fridrich et al. 
(1996) 
Arthroscopy 6-24mo (LT) 64.5 17 -47.5 p<0.05 High 
Arthrocentesis 6-24mo (LT) 66 23 -43 p<0.05 High 
Goudot et al. 
(2000) 
Arthroscopy 12 mo (LT) 57 ± 9 19 ± 24 -38 ± 24 p<0.0001 High 
Arthrocentesis 12 mo (LT) 56 ± 8 9 ± 21 -47 ± 21 p<0.0001 High 
Holmlund et al. 
(2001) 
Open surgery 12 mo (LT) 62 ± 28.2 6 ± 12.7 -56 ± 21.87 p<0.001 High 
Arthroscopy 12 mo (LT) 71 ± 9.9 25 ± 32.1 -46 ± 23.75 p<0.01 High 
Politi et al. 
(2007) 
Open surgery 12 mo (LT) 80 ± 13.3 13 ± 12.5 -67 ± 13.15 p<0.01 High 
Arthroscopy 12 mo (LT) 79 ± 12 19 ± 18.5 -60 ± 15.59 p<0.01 High 
Abbreviations: ATN LA block: auriculotemporal nerve local anaesthesia block, LT: long-term, MM: 
mandibular manipulation, mo: months, NA: not-applicable, NR: not-reported, NS: non-significant, 
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NSAID: non-steroidal anti-inflammatory drug, PEMF: pulsed electromagnetic fields, ST: short-term, 
TENS: transcutaneous electric nerve stimulation, wk: weeks.  
a Studies are ordered in accordance with the study order in the summary of findings table (Table 5.3). 
b Mean change and Standard deviation (SD) for mean change were reported in only three studies (Goudot 
et al., 2000; Ismail et al., 2007; Diracoglu et al., 2009). In the remaining studies, difference in means and 
SD for difference were calculated using an Excel sheet (version 14.0) by applying the following 
formulae: [𝑀𝑒𝑎𝑛change from baseline = 𝑀𝑒𝑎𝑛post – 𝑀𝑒𝑎𝑛pre], and [𝑆𝐷change from baseline = 
√(𝑆𝐷𝑝𝑟𝑒)2 + (𝑆𝐷𝑝𝑜𝑠𝑡)2/2 ] respectively according to guidance in the literature (Cohen, 1988; 
Markiewicz et al., 2008; Fritz et al., 2012; Katsnelson et al., 2012). 
c Statistical significance (p-value<0.05) for within-group statistical difference from baseline as reported in 
the studies. In Petersson et al. (1994), the p-value was not reported, but was calculated by the Paired T-
Test for summarised data (mean differences) using Minitab statistical package (version 16). 
d Unpublished statistical data were provided by the study authors (personal e-mail communication). 
e Therabite + splint group and WTDs + splint group were merged together as one group  jaw exercises + 
splint. 
f Separate data for DDwoR patients are available and/or obtained from the contacted authors (personal e-
mail communication). 
g Only comparison between active iontophoresis by dexamethasone + lidocaine and placebo iontophoresis 
by normal saline was considered and reported. 
h Estimated from Figure 2 in the published trial.
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H-2: Change from baseline for maximum mouth opening (unassisted/active MMO) 
primary outcome. 
Studya  
(Year) 
Intervention 
Follow-
up time-
point 
Pre- 
treatment 
Post- 
treatment 
Changeb 
from baseline 
p-valuec for 
within-group 
difference 
from baseline 
Overall 
Risk-of-
Bias Mean ± SD Mean ± SD Mean ± SD 
Yoshida et al. 
(2005a) 
MM 1 wk (ST) 26.5 33.25 +6.75 NR High 
NSAID only 1 wk (ST) 28.4 28.4 0 NS High 
Yoshida et al. 
(2011)d 
MM 10min (ST) 27 ± 3.83   38 ± 3.83 +11 ± 3.83  p<0.001 High 
No treatment 10min (ST) 29 ± 2.5 30 ± 3.17   +1 ± 2.85 p<0.01 High 
Craane et al. 
(2012a)e 
Jaw exercises 3 mo (ST) 35.8 ± 7.4  39.4 ± 6.3   +3.6 ± 6.87 p<0.05 Unclear 
Education 3 mo (ST)  36.2 ± 7.1  42.5 ± 6.9 +6.3 ± 7.0  p<0.05 Unclear 
Jaw exercises 13 mo (LT) 35.8 ± 7.4  42.7 ± 5.7   +7.8 ± 6.2 p<0.05 Unclear 
Education 13 mo (LT)  36.2 ± 7.1  46.5 ± 7.1 +10.1 ± 8.2  p<0.05 Unclear 
Minakuchi et 
al. (2001) 
Comb. therapy 2 mo (ST) 33.6 ± 9.68  42.4 ± 10.1  +8.8 ± 9.89  p<0.001 Unclear 
Self-management  2 mo (ST)  36.1 ± 9.98  39.6 ± 10.2  +3.5 ± 10.09 p<0.001 Unclear 
Education 2 mo (ST)  36.7 ± 10.36  41 ± 8.39  +4.3 ± 9.43 p<0.001 Unclear 
Yuasa et al. 
(2001) 
Self-management  1 mo (ST) Median 29 Median 37.5 Median +7  p<0.0001 Unclear 
No treatment 1 mo (ST) Median 30 Median 33.5  Median +1.5 p<0.05 Unclear 
Haketa et al. 
(2010) 
Self-management  2 mo (ST)  32.2 ± 5.5 41.0 ± 5.4   +8.8 ± 5.45 p<0.001 Unclear 
Splint 2 mo (ST) 30.3 ± 7.7   35.0 ± 5.8 +4.7 ± 6.82  p<0.001 Unclear 
Lundh et al. 
(1992) 
Splint Unassessed 
outcome 
NA NA NA NA NA 
Control  
Linde et al. 
(1995) 
Splint 6 wk (ST) NR NR +5.9 ± 4.18  p<0.0001 High 
TENS 6 wk (ST) NR NR +6.06 ± 6.72 p<0.01 High 
Maloney et al. 
(2002)f 
Exercises + Splint 1 mo (ST) 28.06 ± 3.51 34 ± 4.61  +5.94 ± 4.1 p<0.01 High 
Splint 1 mo (ST) 28.29 ± 6.05  29.86 ± 6.47 +1.57 ± 6.26 NS High 
Ismail et al. 
(2007) 
Exercises + Splint 3 mo (ST)  30.1 ± 5.4 40.8 ± 4.1   +10.4 ± 5.4 p<0.05 Unclear 
Splint 3 mo (ST) 28.6 ± 5.8   35.9 ± 4.8 +7.3 ± 6.2  p<0.05 Unclear 
Peroz et al. 
(2004)g 
Active PEMF 6 wk (ST) 32.25 ± 9.5  36.71 ± 8.36  +4.46 ± 8.95  p<0.05 Low 
Placebo PEMF 6 wk (ST)  35 ± 7.7  39.18 ± 7.87  +4.18 ± 7.79 p<0.05 Low 
Active PEMF 4 mo (LT) 32.25 ± 9.5  38 ± 7  +5.57 ± 8.34  p<0.05 Unclear 
Placebo PEMF 4 mo (LT)  35 ± 7.7 39 ± 7.1  +4.0 ± 7.41 p<0.05 Unclear 
Schiffman et 
al. (1996)h 
Active iontoph. 1 wk (ST) 32.2 ± 6.5  38.2 ± 10.2  +6 ± 8.55  p<0.05 Unclear 
Placebo iontoph. 1 wk (ST) 34 ± 7.8  36.3 ± 5.6   +2.3 ± 6.8  NS Unclear 
Schiffman et 
al. (2007) 
Self-management  3 mo (ST) NR NR NR p<0.0001 Unclear 
Comb. therapy 3 mo (ST) NR NR NR p<0.0001 Unclear 
Arthroscopy 3 mo (ST) NR NR NR p<0.0001 Unclear 
Open surgery 3 mo (ST) NR NR NR p<0.0001 Unclear 
Self-management  60 mo (LT) NR NR NR p<0.0001 Unclear 
Comb. therapy 60 mo (LT) NR NR NR p<0.0001 Unclear 
Arthroscopy 60 mo (LT) NR NR NR p<0.0001 Unclear 
Open surgery 60 mo (LT) NR NR NR p<0.0001 Unclear 
Petersson et al. 
(1994) 
Arthrocentesis 2 mo (ST) 27.4 ± 6.0  32.6 ± 10.8  +5.2 ± 8.74  p<0.05 High 
Arthrography 2 mo (ST) 30.7  ± 8.1 35.6  ± 8.1 +4.9 ± 8.1 p<0.05 High 
Sahlstrom et 
al. (2013)e 
Arthrocentesis 3 mo (ST) 34.4 ± 7.2  37.8 ± 7.4 +3.4 ± 7.3  NS Unclear 
ATN LA block 3 mo (ST) 33.1 ± 9.1 42.7 ± 8.1  +9.6 ± 8.61 p<0.05 Unclear 
Diracoglu et al. 
(2009) 
Arthrocentesis 3 mo (ST) 31.20 ± 7.03 35.13 ± 6.72  +3.92 ± 6.10  p<0.01 High 
Comb. therapy 3 mo (ST)  29.89 ± 4.82  33.20 ± 7.61  +4.17 ± 7.80 p<0.01 High 
Arthrocentesis 6 mo (LT) 31.20 ± 7.03 37.89 ± 6.53  +6.68 ± 6.20  p<0.01 High 
Comb. therapy 6 mo (LT)  29.89 ± 4.82  35.54 ± 6.41  +6.20 ± 6.50 p<0.01 High 
Fridrich et al. 
(1996) 
Arthroscopy 6-24 mo (LT) 30 ± 8.7  47.5 ± 4.7  +17.5 ± 6.99  p<0.0001 High 
Arthrocentesis 6-24 mo (LT) 33  ± 12.2 41 ± 4.9 +8 ± 9.3 p<0.05 High 
Goudot et al. 
(2000) 
Arthroscopy 12 mo (LT) 29 ± 4.8   38.6 ± 4.2  +9.6 ± 5.8  p<0.0001 High 
Arthrocentesis 12 mo (LT)  29.4 ± 3.1  33.8 ± 4.4   +4.3 ± 4.4 p<0.0001 High 
Holmlund et al. 
(2001) 
Open surgery 12 mo (LT) NR NR NR p<0.001 High 
Arthroscopy 12 mo (LT) NR NR NR p<0.01 High 
Politi et al. 
(2007) 
Open surgery 12 mo (LT) NR NR NR p<0.01 High 
Arthroscopy 12 mo (LT) NR NR NR p<0.01 High 
Abbreviations: ATN LA block: auriculotemporal nerve local anaesthesia block, LT: long-term, min: 
minutes, MM: mandibular manipulation, mo: months, NA: not-applicable, NR: not-reported, NS: non-
significant, NSAID: non-steroidal anti-inflammatory drug, PEMF: pulsed electromagnetic fields, ST: 
short-term, TENS: transcutaneous electric nerve stimulation, wk: weeks.  
a Studies are ordered in accordance with the study order in the summary of findings table (Table 5.3). 
b Mean change and Standard deviation (SD) for mean change were reported in five studies (Linde et al., 
1995; Goudot et al., 2000; Ismail et al., 2007; Diracoglu et al., 2009; Craane et al., 2012a). In the 
remaining studies, difference in means and SD for difference were calculated using an Excel sheet 
(version 14.0) by applying the following formulae: [𝑀𝑒𝑎𝑛change from baseline = 𝑀𝑒𝑎𝑛post – 𝑀𝑒𝑎𝑛pre], and 
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[𝑆𝐷change from baseline = √(𝑆𝐷𝑝𝑟𝑒)2 + (𝑆𝐷𝑝𝑜𝑠𝑡)2/2 ] respectively according to guidance in the literature 
(Cohen, 1988; Markiewicz et al., 2008; Fritz et al., 2012; Katsnelson et al., 2012). 
c Statistical significance (p-value <0.05) for within-group statistical difference from baseline as reported 
in the studies. In Fridrich et al. (1996), the p-value was not reported, but was calculated by the Paired T-
Test for summarised data (mean differences) using Minitab statistical package (version 16). 
d Mean (SD) were calculated from the reported median (range) in the published trial according to Hozo et 
al. (2005). 
e Unpublished statistical data were provided by the study authors (personal e-mail communication). 
f Therabite + splint group and WTDs + splint group were merged together as one group  jaw exercises + 
splint. 
g Separate data for DDwoR patients are available and/or obtained from the contacted authors (personal e-
mail communication). 
h Only comparison between active iontophoresis by dexamethasone + lidocaine and placebo iontophoresis 
by normal saline was considered and reported. 
 362 
 
Appendix I: Newcastle University’s ethical approval for qualitative study (Chapter 
6). 
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Appendix J: Standardised invitation letter, participant information sheet, and 
consent form for qualitative study (Chapter 6). 
J-1: Standardised invitation letter 
Invitation Letter 
Dear Dr. ……., 
We would like to invite you to take part in our research study. This study forms part of a 
PhD thesis entitled “Clinical Decision-Making in the Management of 
Temporomandibular Joint Disorders”.  
The research aims to build an understanding of the clinical decision-making process in 
the management of temporomandibular joint disorders. This will help identify 
problematic areas in the clinical decision-making process that might benefit from new 
evidence generation or find the basis for a virtually delivered decision support tool for 
clinicians in their therapeutic decisions in the management of temporomandibular joint 
disorders.  
The research involves a single interview with a trained interviewer in which we will ask 
you your opinion, perspectives, and experiences of managing Temporomandibular Joint 
Disorders. The interview is not to explicitly critique your practice or knowledge, but to 
help enhance our understanding of the problems frontline clinicians face in relation to 
managing this group of disorders. The interview will take approximately one hour and 
you will be remunerated for any reasonable expenses and also for your time at a set rate. 
More information about the purpose of this study and its conduct is provided in the 
attached information sheet. Please read through the information sheet carefully and 
contact us if you need further clarification before you decide whether or not to take part.   
If you are interested in taking part please let us know by sending your reply to this e-
mail: m.k.s.al-baghdadi@newcastle.ac.uk and we will arrange a mutually convenient 
time to take informed consent from you and conduct the interview. 
 
      Signature 
 
Kind Regards 
Mohammed Al-Baghdadi 
On the behalf of TMJ management clinical decision-making research team 
Newcastle Dental Hospital 
0191 208 7017 
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J-2: Participant information sheet 
Participant Information Sheet:     
 
Study title: Clinical decision-making in the management of 
temporomandibular joint disorders 
Qualitative interviews 
Principal investigator – Dr Justin Durham 
Chief investigator – Dr Mohammed Al-Baghdadi 
 
We would like to invite you to take part in our research study. Before you decide, we 
would like you to understand our research topic and why the research is being done and 
what it would involve for you. This invitation is to interview you to share your opinion 
and perspectives about temporomandibular disorders management and will form a part 
of a PhD thesis titled “Clinical Decision-Making in the Management of 
Temporomandibular Joint Disorders”. 
Please read the following information carefully and contact us if there is anything that 
requires further explanation before you decide whether or not to take part. Ask us if 
there is anything that is not clear or if you would like more information. Take time to 
decide whether or not you wish to take part. 
Part 1 tells you the purpose of this study and what will happen to you if you take part. 
Part 2 gives you more detailed information about the conduct of the study. 
 
 
Part 1 
 
What is the purpose of the study? 
Temporomandibular disorders (TMDs) are an area of controversy and their management 
regarded as challenging for many dental and medical practitioners. This study aims to 
explore, understand and therefore attempt to eventually provide support for the clinical 
decision-making in TMDs management.  
 
Why have I been invited? 
We are looking for a wide range of professionals with different levels of clinical 
expertise among different dental and medical specialities who may be contacted by 
TMDs patients as a first point of contact. There may be more than twenty clinicians to 
interview in this study. You fit the criteria outlined above.  
 
Do I have to take part? 
It is up to you to decide to join the study, while we very much hope that you will take 
part, you are free to decide not to. We will describe the study and go through this 
information sheet. If you agree to take part, we will then ask you to sign a consent form. 
If you do, you are still free to withdraw at any time and without giving a reason.  
 
What will happen to me if I take part? 
You will be invited to an interview for about one hour with the research student named 
above. 
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Expenses and payments: 
We appreciate your time is valuable and therefore will reimburse you £77 for one hour 
of your time. If you have to travel to see us for the interview, as opposed to undertaking 
the interview at your place of work, we will reimburse reasonable travel expenses on the 
production of a receipt. No other payments will be made. 
 
What will I have to do?  
If you agree to participate you will be asked to sign a consent form. In agreeing to 
participate you will be invited to an interview with research student. The semi-
structured interview will take place over one hour and are explicitly not intended to 
critique your practice; its aim is to gather enough data from a wide range of clinicians so 
that we can accurately portray any recurrent problems with managing TMDs. You will 
be encouraged to talk about your practice e.g.; your mainstay of treatment and how you 
define success, as much as is possible and we will ensure that the topic guide is covered 
by occasionally asking specific questions related to specific TMDs subgroup. 
 
What are the possible benefits of taking part? 
It is hoped that, in the future, the information gained by this study will allow us to 
design an intervention to support clinicians in managing patients with specific 
subgroups of TMDs, which will help improve patients’ health care. Apart from the 
knowing that you have been part of the research there would be no other direct benefit 
to yourself. 
  
What if there is a problem? 
Any complaint about the way you have been dealt with during the study will be 
addressed. The detailed information on this is given in Part 2.  
If you have a complaint please contact Dr Justin Durham at the Newcastle Dental 
School, Level 5, Framlington Place, Newcastle NE2 4BW. 
 
Will my taking part in the study be kept confidential?  
Yes.  All the data from your participation in this study will be kept confidential. The 
details are included in Part 2. 
 
Contact details: 
If you require any further information please contact: 
Dr Mohammed Al-Baghdadi  
Oral and Maxillofacial Surgery 
C/O Sue Wilkinson 
Oral and Maxillofacial Surgery Secretary Level 3 
School of Dental Sciences 
Newcastle University 
Framlington Place 
Newcastle upon Tyne 
NE2 4BW 
0191 208 7017 
m.k.s.al-baghdadi@ncl.ac.uk 
 
This completes Part 1 of the Information Sheet. 
 
If the information in Part 1 has interested you and you are considering participation, 
please continue to read the additional information in Part 2 before making any 
decision. 
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Part 2 
 
What will happen if I don’t want to carry on with the study? 
If you wish to withdraw from the study at any point just tell the research team and your 
involvement will end immediately. The team will ask if it is possible to include your 
data in the analysis of the study. You are; however, free to withdraw your data from the 
study at any point. If you withdraw consent for your interview to be analysed, the 
recording and the written transcript for the interview will be destroyed and discarded. 
 
What if there is a problem? 
If you have a concern about any aspect of this study, you should ask to speak with the 
researchers who will do their best to answer your questions (0191 208 7828). 
 
Complaints:  
In the event that something does go wrong and you are harmed during the research 
study, there are no special compensation arrangements.  If you are harmed and this is 
due to someone’s negligence then you may have grounds for a legal action for 
compensation against Newcastle University but you may have to pay your legal costs.  
 
Will my taking part in this study be kept confidential? 
The interviews will be recorded digitally and transcribed verbatim by a professional 
company, once transcribed the recordings will be wiped from the recorder and 
computer.  
All the information you give during this study will be annonymised through the use of a 
code number unique to you. Your interview transcript will have this code number on 
thereby ensuring your confidentiality. A list of participants’ age (years of experience), 
gender, and title against their code numbers will be recorded in a separate secure 
‘master coding sheet’ to be held along with your consent form.  In relation to personal 
identifiable data, the hard-copy transcripts will be kept with an indication of your years 
of experience, gender, occupation, and area of country; no names will be retained with 
the transcriptions.  
Any audio recordings from the study and their related transcriptions will be identified 
by your individual code number only and will not be linked to your name in any way. 
Your data will be analysed by the research team of this study. Once analysed, the results 
of this study may be published in a scientific journal or presented at a research 
conference, possibly with literal quotes from yourself, however your identity and 
institution will be kept anonymous. In either case your name will not be mentioned as 
part of the publication. Your practice and ideologies will not at any time be attributed to 
you and no reference will be included to the names of practitioners interviewed in paper 
nor will your practice be reported to any external organisations. 
 
What will happen to the results of the research study? 
When the study is complete the researcher will process the information gathered and the 
results published in a recognised journal and presented scientific meetings.  
 
Who is organising and funding the research?   
This study has been organised by the School for Dental Sciences, Newcastle University, 
and is being carried out as part of a clinical PhD programme funded from PhD bench 
fees by the Higher Committee for Education Development in Iraq (HCED). The 
researcher is not being paid for this research. 
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Who has reviewed the study?  
Most research is looked at by independent group of people, called a Research Ethics 
Committee, to protect your interests. This study has been reviewed and given 
favourable opinion by Newcastle University Research Ethics Committee. It has also 
been subject to review by the postgraduate student’s PhD supervisors. 
 
Further information and contact details 
If there is anything not clear in this information sheet and/or should you wish to make 
further contact, please find the contact details for contacting the investigators: 
 
Dr Justin Durham 
Room 5.019, Level Five. 
School of Dental Sciences, 
Newcastle University 
Newcastle upon Tyne 
NE2 4BW 
0191 208 7828 
 
Dr Mohammed Al-Baghdadi 
Oral and Maxillofacial Surgery 
C/O Sue Wilkinson, Oral and Maxillofacial Surgery Secretary Level 3 
School of Dental Sciences 
Framlington Place 
Newcastle University 
Newcastle upon Tyne 
NE2 4BW 
0191 208 7017 
m.k.s.al-baghdadi@ncl.ac.uk 
 
 
 
You will be given copies of this information sheet together with a signed consent 
form to keep.  
 
 
 
 
 
 
 
 
 
Thank you for considering participating or for taking time to read this sheet. 
 
 
 
Study: Clinical decision-making in the management of temporomandibular joint disorders  
Version-1 1st January 2013
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J-3: Consent form 
Centre Number: 
Study Number: 
Participant Identification Number for this study:  
CONSENT FORM 
Title of Project: Clinical Decision-Making in the Management of Temporomandibular 
Joint Disorders 
Name of Researcher: Mohammed Al-Baghdadi 
Please INITIAL all boxes  
1. I confirm that I have read and understand the information sheet dated 1st January 
(Version-1) for the above study.  I have had the opportunity to consider the 
information, ask questions and have had these answered satisfactorily. 
 
2. I understand that my participation is voluntary and that I am free to withdraw at 
any time without giving any reason, without my legal rights being affected. 
 
3. I understand that all the information related to my identity will be kept strictly 
confidential. The procedures regarding confidentiality of my data have been clearly 
explained (e.g. use of pseudonyms, anonymisation of data) to me.   
 
4. The use of the data in research, publications, sharing and archiving has been 
explained to me. 
 
5. I understand that other researchers will have access to this data only if they agree to 
preserve the confidentiality of the data and if they agree to the terms I have 
specified in this form. 
 
6. I agree to interviews conducted with me being audio-recorded and I understand that 
transcripts of my interview will be annonymised, but that I may be anonymously              
quoted verbatim in published literature.  
 
7. I agree to take part in the above study.    
 
                     
Name of Participant     Signature       Date 
 
                     
Name of Researcher     Signature       Date  
 
Study: Clinical decision-making in the management of temporomandibular joint disorders  
Version-1 1st January 2013 
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Appendix K: Topic guide for qualitative study (Chapter 6). 
Guide for TDF-interview13:  
 To get started, please can you tell me a little bit about yourself? I mean your job, training, 
clinical interests. 
 When I mention the term “chronic orofacial pain” what does that mean to you? (Knowledge) 
- What do you know about the chronic conditions that may occur in the orofacial region? 
(Knowledge)  
- Do you have any thoughts as to how these chronic pain conditions occur? I mean the 
aetiology of chronic pain? (Knowledge) 
- What do you feel your role is in treating such chronic conditions? (Professional role & 
identity) 
 If we move on to focus on one particulate type of COFP which is: the Temporomandibular 
Disorders, please could you tell me a little bit about your thoughts and experiences with 
these disorders? (Knowledge; Experience) 
- What are your perspectives on the aetiology of Temporomandibular Disorders? 
(Knowledge) 
- In your practice, how often do you come across new patients with TMD? (Experience) 
- How easy or difficult do you find to diagnose a patient with TMD? (Beliefs about 
capabilities) 
- Do you usually mange those patients? How? If the patient not responds to your initial 
management, do you consider alternative approaches? Why/why not? (Skills) 
- When you would start to think about referring? Why you think sending them will be better 
for them? What factors might guide your decision to refer? To whom you usually prefer to 
refer those patients? Do you think that the specialists can cure those patients? (Skills; Beliefs 
about consequences) 
- Could you remember any particular pat you find difficulty in managing? Any particular 
patient you need further investigations to reach a diagnosis? (Memory, attention, & 
decision processes) 
- For how long you review/follow-up this patient (wait before referral)? Why you decided on 
such a time-frame? (Goals) 
- Do you use any guidelines to help you in managing TMD patients? (Knowledge) 
- What factors or thought processes might guide your decision to manage a patient with TMD? 
(Memory, attention, & decision processes) 
- Do you set goals for yourself or your practice with regard to managing TMD patients? What 
are your measures of clinical success? (Goals) 
                                                 
13 Throughout the interviews, the topic guide was developed by adding questions and revised slightly to 
address issues related to interview length and questions’ clarity and repetitiveness.  
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- Do you feel, in general, you have success in the way you manage TMD? (Optimism) 
- How much expertise or experience do you think the general practitioner needs to have to 
manage TMD effectively? Why do you think that? (Skills) 
- Would you discuss your views on potential management with others (e.g., your colleagues) 
to reach an opinion about how to manage such patients? Does this influence your decision on 
how to manage your TMD patients? How? (Social influences) 
- What about the patients, would you discuss the management options with them to reach an 
opinion about how to manage them? To what extent does this discussion facilitate or hinder 
the management? How? (Social influences) 
- Do the patients’ emotions or their concerns or apparent distress ever affect your decision to 
manage them or not? (Social influences) 
- What about your emotions, Do your own emotions or work stress ever affect your decision 
to manage or your treatment plan for those patients? (Emotions) 
• If we move on to focus on discussing a specific subgroup of TMJ disorders: DDwoR, also 
known as closed lock, please can you tell me what you understand by this term? 
(Knowledge) 
- In your practice, had you ever come across such a patient with closed lock condition? Can 
you describe what you did with such…? (Experience) 
- OR: that’s fine, since you haven’t seen such a case, if I tell you that such a patient is when a 
patient presented to your clinic with lots of TMJ pain and limited mouth opening. Imagine 
such a patient with a painful limited opening coming to your clinic tomorrow and talk to me 
through:  
- What you might do with such a patient with these signs and symptoms? Why you do that? 
(Skills) 
- How you start to think about the diagnosis? How confident you feel when you diagnose such 
a patient? (Beliefs about capabilities) 
- What are the sources of information you look for in such a patient? (Memory, attention, & 
decision processes) 
- In the future, if you confronted with such a patient, where would you go if you want to get 
more information on such a closed lock condition? (Environmental context & resources) 
- Would you be worried when you diagnose DDwoR? Why? What you would worry about 
missing? Like what? (Beliefs about consequences; Emotions) 
- From your perspectives, what other conditions might have similar limited opening symptom 
and cause confusion in diagnosis? (Knowledge) 
- Would you thought about using other investigations/diagnostic methods such as radiographs 
to help you with the diagnosis? Do you think it is important to take an X-ray to TMJ? What 
investigations would you order at this consultation for such a case? Why/why not? 
(Knowledge; Skills) 
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- Would you try to manage such patient? Why? Can you describe how you decided what to 
include in your treatment plan for this patient? (Skills; Beliefs about capabilities) 
- How easy or difficult do you feel it would be to manage such a patient? (Beliefs about 
capabilities) 
- Is managing such a patient (i.e. painful LMO) possible from your perspective as a …... 
practitioner? (Professional role & identity) 
- What skills do you feel are required to treat such patient successfully? Do you feel you 
possess these?  
- How important do you feel it is to personally manage patient in primary care? (Skills) 
- What are the advantages of managing patient in primary care? What are the disadvantages? 
(Beliefs about consequences) 
- Do you prefer to refer? Why/why not? If prefer to refer, why is that for DDwoR but you 
would try to manage other TMD? To whom you usually prefer to refer such a patient? 
Specialty? (Beliefs about capabilities; Nature of behaviour) 
- Do you want think it is important to receive a feedback about such a patient from secondary 
care? Why? (Behavioural regulation ) 
- What do you think it will happen to the patients if you don’t treat and refer them, from both 
positive & negative sides? (Beliefs about consequences) 
- Do you have any idea what are the sorts of treatment might be given to such a pat in 
secondary care? (Knowledge) 
- Do your own emotions ever affect your decision to manage the patient? (Emotions) 
- Does managing such a pat evoke/ elicit an emotional response (worry or concern) in you 
(e.g., stress)? (Emotions) 
- Do the patient’s emotions/concerns (e.g., apparent distress) ever affect your decision to 
manage the patient? (Social influences) 
- Are you aware of any particularly good evidence about managing DDwoR? (Knowledge) 
- Okay, if I tell you that: There is current research and the evidence from this research 
suggests that DDwoR/CL can be managed with conservative interventions such as patients’ 
education and self-care instructions and early jaw manipulation. With that in mind, in terms 
of aiming to manage this condition in primary care, what do you think might need to be done 
differently to help with DDwoR management in primary care? (Behavioural regulation; 
Nature of behaviour) 
- So, if a virtually delivered tool/intervention14 designed (e.g., a mobile phone 
application/online internet) to help you in managing such a painful LMO condition, would 
you think then it will be possible for you can use such a tool to help you diagnosing & 
managing those patients? (Behavioural regulation) 
                                                 
14 Question about the feasibility of using an electronic-tool was added following the seventh interview.  
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 If we talk about another condition which is the TMJ dislocation15, did you confronted with 
such a case before? How often? (Experience) 
- Can you describe how you (do you know how?) manage such a case? How? Would you 
try/be confident to manipulate the jaw? What you did with such a case? If know, Why knows 
about it not CL? (Knowledge) 
- From where you learned/got such a kind of information (about manipulation technique) do 
you think? (Environmental context & resources) 
 As you think back over your clinical experience, has your approach to manage the TMJ 
problems in your patients changed? Why/why not? (Behavioural regulation) 
- In the future, what could influence you to change your current clinical management of TMDs 
in general? (reduce referral) (Intentions) 
- From your perspective, are there any problems/difficulties in providing care for patients with 
DDwoR or TMDs in general in primary care? What would help you to overcome these 
problems/difficulties? (Environmental context & resources) 
- Are there any competing tasks or time constraints that might influence your treatment plan 
to/whether or not you treat/ TMD patients? (Environmental context & resources) 
- Are there any incentives that motivate you to manage TMD/DDwoR patients? 
(Reinforcement) 
- In your practice, are the resources available to facilitate your work and to help you when you 
diagnose and manage such TMD patients? (e.g., equipment or devices) (Environmental 
context & resources) 
- You’ve mentioned a number of problems with managing TMD, would you be able to 
identify the top two problems that general practitioners need help with in order to encourage 
TMD management in primary care? What would help you to overcome these 
problems/difficulties? (Behavioural regulation) 
 Is there is anything else you would like to tell me about managing patients with DDwoR or 
TMD in general? You are Free to make comments.  
 
 
 
That’s all the questions I have for you, Thanks very much. 
                                                 
15 Questions about the acute TMJ dislocation condition were added following the first interview to 
compare it with the acute DDwoR condition. 
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Appendix L: Worked example of mapping the clinical decision-making process for the first interviewee (EMGDP1) of qualitative study 
(Chapter 6). 
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Appendix M: Professionals’ clinical decision-making processes’ maps of qualitative study (Chapter 6). 
M-1: GMPs’ management pathway  
  
 
                                                                                                                                                                                                                                                                                                                                                                              
 
               
                                                                               
   
                                                                                                           
 
                                                                                                                         
                                                                                                                                        
                                 
 
                                              
                                                                                                                           
  
                                                      
Within few weeks to 3 months 
TMD  
(Mild, usual, 
common signs 
& symptoms) 
- History and clinical 
examination. 
- May be some 
investigations ‘if needed’ 
to rule-out other 
pathologies. 
Uncertain about diagnosis 
or general ‘TMD’ 
diagnosis. 
CL (DDwoR) 
(Severe pain & 
LMO) 
TMJ Dislocation 
(Wide mouth 
opening and 
unable to close) 
No specific knowledge about manual manipulation 
technique for its management (Q4). 
Seek advice via phone 
or refer early to: 
DH or GH (OMFS or 
A&E) (Q3). 
- History and clinical 
examination.
- Rule-out other 
pathologies. 
Uncertain about diagnosis 
- History and clinical 
examination. 
- Rule-out other 
pathologies. 
Seek advice via phone 
or refer early to: 
DH (oral surgery) or GH 
(OMFS or A&E). 
Signpost patients to 
their dentists or if not-
responding, refer to: 
DH or GH (OMFS) 
(Q2). 
Initial conservative management (Q1): 
- Education explanation and reassurance. 
- Medications: analgesics and/or anti-
inflammatories. 
- Sometimes provision of over-the-counter mouth 
guards. 
Patient’s presentation Diagnosis Treatment Referral 
 
If emotional/distressed 
patient or in severe pain: 
Refer early. 
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Representative quotes of GMPs’ decision-making process 
Quote 1: “if they [TMD patients] wanted Ibuprofen then...and that’s fine so they’re seen in a couple of 
weeks, regular Ibuprofen, if that doesn’t help you try a stronger anti-inflammatory like Naproxen. If they 
had started the Naproxen you could try asking them to buy a mouth guard over the counter, try that every 
night and see them in 2 weeks and those are the two – three main forms of treatment that I would tend to 
use erm and if you tried those in various forms and maybe a little bit of codeine and that doesn’t help 
then you have to – I suppose you have to tell the patient whether you need to refer them or not” (GMP9). 
Quote 2: “When they [TMD patients] come to see me, if they’ve not seen anybody else, I do always ask 
them if they see their dentist regularly and encourage them to do that” (GMP7). 
Quote 3: “That’s probably the sort of patient [DDwoR] I’d ring the maxfax on-call about and just get 
advice as to whether it’s something I should be referring on that day or what to do about it” (GMP9).  
Quote 4: “If it’s dislocated presumably at some stage it will be an advantage to reduce it, to relocate it 
but erm I’m merely that’s from kind of first principles rather than any observation of previous case” 
(GMP7).   
 376 
 
M-2: GDPs’ management pathway  
  
CL (DDwoR) 
(Severe pain & 
LMO) 
TMJ Dislocation 
(Wide mouth 
opening and 
unable to close) 
Mostly know about manual manipulation technique 
for its management: either relocate it or seek 
advice/refer (based on confidence) (Q8) 
- Pre-MM pain relief & Post-MM advice for 24hrs. 
Obvious diagnosis 
Seek advice over the 
phone or refer early to: 
DH (oral surgery) or to 
GH (OMFS) 
Mostly seek advice via 
phone or refer early to: 
Dental Hospital ‘DH’ 
(either to oral surgery or 
restorative departments) 
or to General Hospital 
‘GH’ (OMFS department) 
- History and clinical 
examination. Difficult to 
examine intra-orally due 
to LMO 
- Rarely OPG ‘if 
needed/available’ to rule-
out other pathologies/ 
causes of pain/LMO 
symptoms. 
Uncertain about diagnosis 
(Q5). 
Mostly no treatment or rarely may start initial 
conservative management to relief acute symptoms 
(Q6&7): 
- Explanation and self-care instructions.  
- Medications: analgesics and/or anti-
inflammatories to relief pain. 
- Jaw exercises advice: self-exercises may be with 
wooden tongue depressors (WTDs). 
- Soft splint but uncertain/unsure about its role and 
may be difficult to take impression due to LMO 
symptom. 
 
Majority 
Minority 
Vary from as early as 2 weeks to about 6 months 
If not-responding to 
conservative 
measures: 
Refer to DH mostly 
restorative department. 
(Q3) 
Respond well 
Initial conservative management (Q1): 
- Education explanation and reassurance. 
- Self-care instructions and advice:  
- Medications: analgesics and/or anti-inflammatories 
Stronger analgesics/sedatives for severe pain. 
- Jaw exercises and other physiotherapeutic 
interventions such as hot/cold packs, massages. 
- Soft splint (either at the same stage or as next 
stage treatment measure). Sometimes provision of 
splint is a sort of diagnostic measure. 
- Rarely: Stabilization splint (based on clinician’s 
skills/training) (Q2).  
 
Reassurance and review only 
TMD  
(Mild, usual, 
common signs 
& symptoms) 
- History and clinical 
examination. 
Asymptomatic clicking 
without pain ‘DDwR’ 
- History and clinical 
examination. 
- PAs & OPG ‘if 
needed/available’ to rule-
out dentoalveolar cause 
of pain. 
General ‘TMD’ diagnosis 
(mostly myofacial pain 
and/or DDwR) 
Patient’s presentation Diagnosis Treatment Referral 
 
If emotional/distressed 
patient or in severe pain: 
Refer early (Q4) 
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Representative quotes of GDPs’ decision-making process 
Quote 1: “For simple basic management [to TMD patients] I would advise…against wide opening first 
of all, yawning things like that. Advise against chewy foods, chewing gums especially, tough meats. 
Parafunctional habits, nail biting, trying to educate those types of things, provide analgesic advice, you 
know, advise on anti-inflammatory depending on medical history. Erm I’d say that was having 
improvements and then sort of we have a sheet of advice sort of for erm exercises for them to try and sort 
of reduce the symptoms of the condition and that would probably be my first stage of management so 
basic management… [If the patient is not responding to initial management] my next stage would be to 
try a soft splint” (NGDP5). 
Quote 2: “I am aware of stabilisation splints, hard splints and I’ve had training on them but I’ve never 
actually done one. But if I got a treatment plan from secondary care that said to provide one I’d be happy 
to do so” (EMGDP3). 
Quote 3: “Alternative approach. Erm if I try, if I’ve gone through all the things that I feel I can advise, 
like the soft diet, the rest, the pain killers, the splint then I’ve got to admit I do tend to refer erm because I 
don’t feel confident in any…, you know, anything else that, you know, but if they’re still suffering then I 
would refer to the dental hospital” (EGDP18).  
Quote 4: “If they [patients] look like they’re in a lot of distress then I guess erm if, you know, maybe you 
would refer a bit sooner than if they didn’t because they might not want to try, you know, what you’re 
suggesting might sound very simple and not effective and sometimes you think they do feel better being 
referred to get a specialist opinion when they’re suffering with so much pain” (EGDP18).  
Quote 5: “Q: How do you start to think about the diagnosis of this [DDwoR] condition? R: Yeah I think 
it’s eliminating any obvious things that I could think of that could be causing it, erm making sure there’s 
been no trauma like I said or any dental, any problems with their teeth or any infections and then just I 
suppose eliminating things like that and then, you know, if I’ve really felt I’ve gone through everything 
and with nothing I can think of that might be causing it then that’s when I would refer” (EGDP18). 
Quote 6: “I would go on to again giving them sort of advice on the condition [DDwoR] itself and 
explaining the condition, what it is. Erm providing them with an information and exercise sheet er so sort 
of exercises that can be performed. Erm if it’s a severe pain I would probably be looking at trying to 
make them a stabilisation splint as soon as possible. Erm but if they’ve got very limited opening on that 
occasion it might [not] be possible to take an impression but if it is then I would be trying to take an 
impression and get them that splint made as soon as possible. Erm I would have give them advice on 
analgesics, er hot and cold compresses, erm and then sort of review, er get the splint made up as soon as 
possible for them to provide them with the splints and review after a few weeks to see if we’ve had any 
improvements at all with that condition” (NGDP5). 
Quote 7: “It’s not difficult to manage them [DDwoR patients] in the sense that I could see them but I 
don’t think I necessarily would be able to do erm very much other than advise them and then refer at the 
appropriate time” (EGDP12). 
Quote 8: “if somebody comes in and they’ve dislocated their jaw it’s propped open, they can’t close, erm 
I’ve never done it but I think what you do is you put… you basically get hold of the patient’s jaw, you put 
your thumbs on their molars with your fingers underneath here [referring to chin] and you push down 
with your thumbs as you rotate slightly forwards. So you push down and then back so you’ve pushed – 
yeah you push down and then back and then move your thumbs out the way quick and close them and 
basically say don’t open wide, don’t do anything, don’t smile, don’t laugh for the next kind of day” 
(NGDP14).   
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M-3: A&E clinicians’ management pathway  
  
TMD  
(Mild, usual, 
common signs 
& symptoms) 
Signpost patients to 
more appropriate 
clinicians: GP/dentist/ 
GH (OMFS or ENT). 
- History and clinical 
examination. 
- OPG and/or other 
investigations ‘if needed’ 
to rule-out other 
pathologies. 
General ‘TMD’ diagnosis 
CL (DDwoR) 
(Severe pain & 
LMO) 
Initial conservative management (Q1): 
- Pain medication (Analgesics) and may be hot/cold 
packs. 
TMJ Dislocation 
(Wide mouth 
opening and unable 
to close) 
Mostly know about manual manipulation technique for 
its management: either relocate it or seek advice/refer 
(based on confidence) 
Pre-MM pain relief & Post-MM advice for 24hrs (Q3). 
Seek advice or refer 
early to: GH (OMFS or 
ENT) (Q2). 
- History and clinical 
examination. 
- OPG and/or other 
investigations ‘if needed’ to 
rule-out other pathologies/ 
causes of pain/LMO. 
Uncertain about diagnosis 
Either no treatment or start initial management with 
analgesics and/or IV sedation to relief severe pain. 
 
Obvious diagnosis 
Seek advice or refer 
early to: GH (OMFS). 
Patient’s presentation Diagnosis Treatment Referral 
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Representative quotes of A&Es’ decision-making process 
Quote 1: “If it was a chronic problem I may offer them some pain relief if they didn’t have any then and 
there but a lot of the time for chronic pain I would have to be realistic with them and explain that from an 
A&E point of view there’s probably little I can do for a long-term benefit and that I would have to 
signpost them to a more appropriate person” (A&E6). 
Quote 2: “if the patient has limited opening and an anatomical defect I would phone maxfac and say I’ve 
got this going on what should I do. Again that takes 2 or 3 minutes to do that by the time you’ve actually 
got through to someone to answer the plea” (A&E/GMP17). 
Quote 3: “Well with those [TMJ dislocation] patients it’s a case of erm analgesia and muscle relaxation 
and then just the reduction and then just the general advice afterwards of trying to reduce their mouth 
opening for, also not open their mouth wide for 24 hours and then if they’re still undergoing treatment 
just to notify whoever’s treating them that they’re still having problems” (A&E16). 
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M-4: OMFS clinicians’ management pathway   
 
 
Within 12-24 months 
Within 1-3 months 
Minority 
Within 3-6 months 
Few 
Reassurance only 
Mostly 
Occasionally 
CL 
(DDwoR) 
Clinical diagnosis only by 
history & examination findings 
(Q8). 
- May be OPG/CT to rule-out 
other causes of LMO  
- Sometimes ordering MRI 
investigations for disc 
position (unless needed to: 
plan arthrocentesis, reassure 
clinician ‘rule-out serious 
pathology).  
TMJ dislocation 
& subluxation 
(Q10) 
Practical knowledge and experience in TMJ 
dislocation & subluxation management. 
Initial conservative management, similar to other 
TMDs ‘above’ but more focus on (Q9):  
- Reassurance and explain condition (spontaneous 
resolution with time) and role of the disc. 
- Topical non-steroidal gel over the joints. 
- Sometimes early ‘unlock’ manipulation. 
  
Improved   
If not-improved with all 
conservative measures:  
Referral to a consultant 
with sub-specialist interest: 
For surgical management:  
- Order MRI scan for 
planning joint surgery:  
- Arthrocentesis. 
- Arthroscopy  
Obvious diagnosis 
Most Majority 
Patient’s presentation Diagnosis Treatment (Ladder Management) Referral 
 
TMD 
Clicking or crepitus 
only (without pain) 
- History and clinical 
examination (Q1). 
- OPG ‘if needed’ to 
rule-out dental cause 
of pain. 
Specific ‘TMD’ 
diagnosis: Muscular or 
Joint-related disorders 
or others (Q2&3). 
 
Initial management Non-
surgical/conservative 
(Q4&5): 
- Education, explanation, 
counselling, and reassurance. 
- Self-care instructions and 
advice (Information booklet).  
- Medications (Analgesics 
and/or Anti-inflammatories) 
- Jaw exercises and other 
physiotherapeutic instructions 
such as hot/cold packs. 
- Soft splint. 
- Referral to: restorative 
dentists if occlusal problem. 
 
If not-improved with all 
conservative measures (only 
a few patients) (Q6&7):  
Referral to a consultant 
with sub-specialist interest: 
For joint surgery:  
- Order MRI scan if 
requested for planning joint 
surgery:  
- Arthrocentesis. 
- Arthroscopy  
- Emenictomy  
- Joint replacement  
For jaw muscles: 
Botulinum Toxin inj.  
 
Some level of improvement  
Improve
d  
Review back, if not-improved: 
- Tweaking in analgesics. 
- Topical diclofenac gel (Voltarol) (anti-
inflammatory effect).  
Still refractory, then next stage: 
- Recheck diagnosis: Order a DPT (to 
screen joint pathology, fracture, 
differential diagnosis, dental pain) 
- Anti-depressant Amitriptyline, 
Gabapentin) by consultants. 
- Referral to: physiotherapy, acupuncture. 
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Representative quotes of OMFSs’ decision-making process 
Quote 1: “Well obviously you take a full history as you would do anyway, examination and the history 
often gives a characteristic pattern so it can often be kind of like a dull ache type pain. You can even get 
sharper pains as well particularly if they’ve come in with an acute flair up of the condition [TMD] erm 
and then the social history will pick out, you know, you can sort of raise your suspicions as to it being a 
psychological aspect of it” (OMFS4). 
Quote 2: “Well I tend to in my mind split it [TMD] up into three main problems I guess. Erm and that 
would be something that they’re maybe having pain from the musculature around the joint or that there’s 
maybe a problem with the disc itself or there may be a problem with the joint itself so erm and I’d find 
that the majority by far usually fit into group one or group one and two” (OMFS19). 
Quote 3: “I think it’s relatively straightforward to decide that it’s a TMJ problem in most cases…so 
diagnostically it’s relatively straightforward but not always” (OMFS11). 
Quote 4: “I would generally try and give them [TMD patients] a little explanation, erm maybe with some 
really terrible diagrams I draw and erm then we have a skull to hand so to try and explain the anatomy 
really and erm but if it was just a muscular thing maybe to discuss with them the things that they might be 
doing to erm them making the problem worse” (OMFS19). 
Quote 5: “[I] describe the exercise and the one I tend to go through is the one where you curl your 
tongue to the back of your mouth and open with your tongue touching the top of your palate. If you repeat 
that 5 times and you do that in itself for 5 times a day and suggest that normally it’s quite a good thing to 
do when you’re watching TV so you can practice” (OMFS4). 
Quote 6: “If the [TMD patients] come back and they haven’t been able to wear the soft splint or things 
haven’t got much better then I tend to refer them to physiotherapy” (OMFS20).  
Quote 7: “we have got a good pain clinic and they provide good support as well so if we’re struggling to 
manage a patient with chronic pain we can refer on through our chronic pain team in the hospital” 
(OMFS11). 
Quote 8: “The history from the patient and then examination findings have reduced it to a sizeable 
distance. I’d anticipate er there’d be some tenderness over the jaw joint, I’d anticipate a deviation 
towards the affected side on opening which may then erm correct itself on late opening but they would be 
the typical findings I’d expect to find”; “I mean there are clearly, you know – very rarely there might be a 
pathological process going on. Erm if the patient is developing an ankylosis erm that would have a 
different history...and if that [limited mouth opening] was due to a tumour again that would be incredibly 
rare. The other issue I suppose is that at the other end of the spectrum they may not have a disorder 
within the jaw joint, they might not have an internal derangement they may simply have a pain and 
muscle spasm or...muscular discomfort which is restricting the mouth opening, and obviously then there’s 
the infective causes, you know, if a patient has got an untreated abscess but again there would be 
elements in the history that would point towards I’d say this is probably a nasty pericoronitis from a 
wisdom tooth or parapharyngeal abscess. There’s [are] usually other diagnostic clues that would rule 
that out” (OMFS11).   
Quote 9: “With the closed lock, erm I think it would be – essentially I’d reassure them, I’d encourage 
them to continue with soft diet if they had muscle pain or if they had pain over the joint or the muscles I’d 
encourage them to use an Ibuleve or a topical non-steroidal gel on the joints and the muscles on the 
affected side. Erm and I suppose that would be my suggestion to them and because there may well be 
spontaneous resolution just with erm I think it’s probably the time as much as anything else which may 
encourage that to settle” (OMFS11). 
Quote 10: “This is [TMJ dislocation] less common than the closed lock I would say” (OMFS11).
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 Appendix N: Detailed design of recommended research from the systematic reviews studies (Chapter 4 and Chapter 5). 
Research recommendations based on a gap in the management of temporomandibular joint disc displacement without reduction (DDwoR) 
Core 
elements 
Issues to consider Status of research for this review 
Evidence 
(E) 
What is the current 
state of evidence? 
A systematic review identified 20 RCTs which matched the eligibility criteria, but most were assessed as ‘unclear to high' risk of 
bias. The current evidence, albeit weak, suggests that the patients with TMJ DDwoR can be improved with only minimal 
intervention. 
Population 
(P) 
Diagnosis, disease 
stage, comorbidity, risk 
factor, sex, age, ethnic 
group, specific 
inclusion or exclusion 
criteria, clinical setting 
Adult patients of any age or gender, of all degree of severity, and had a primary diagnosis of acute or chronic DDwoR according to 
AAOP, RDC/TMD (IIb or IIc), Wilkes stages (III or IV), or any compatible criteria. Preferably use the recently recommended 
diagnostic criteria (DC/TMD) for DDwoR with/without limited mouth opening. 
Consideration needs to be given to prognostic factors that may affect DDwoR treatment response such as the closed lock chronicity. 
Developing a valid and standardised diagnostic criterion to define the duration of locking in relation to acute and chronic DDwoR 
clinical stages should be considered. Future research should identify subgroups of patients presenting with acute and chronic 
DDwoR. This would allow stratification of acute and chronic DDwoR sample to different treatment groups, thereby, allowing further 
comparison across subgroups to be studied. 
Intervention 
(I) 
Type, frequency, dose, 
duration, prognostic 
factor 
Any non-surgical or surgical therapy for DDwoR. 
Future research needs to address the minimal non-invasive interventions, in particular patient education and self-management and 
early ‘unlock’ mandibular manipulation.  
Regarding patient education and self-management and combination therapy, future research should describe the intervention 
components in sufficient details (e.g., using TIDieR checklist) and needs also to clarify how the individual active components in the 
treatment strategies involving the combination of different conservative interventions interact and improve the outcomes. 
Regarding mandibular manipulation (MM), there is no consensus on the most effective and practical technique of manual 
manipulation applied, the time after which the MM should not be attempted, who delivers the intervention (patient or clinician), and 
what, if any, post-MM conservative intervention is further needed to ensure the long-term successful ‘stable’ results. Future research 
should also include pre- and post-manipulation TMJ imaging in order to assess its effect on disc position. Future studies need to be 
conducted in primary or emergency settings to explore whether early intervention by MM can improve DDwoR symptoms on the 
long-term. This is certainly appearing to be the case for early MM intervention to manage short-onset DDwoR (‘acute’ closed lock).  
The minimally invasive surgical intervention by arthrocentesis and lavage needs to be compared with the non-invasive conservative 
interventions in high-quality pragmatic RCTs.  
 383 
 
Research recommendations based on a gap in the management of temporomandibular joint disc displacement without reduction (DDwoR) 
Core 
elements 
Issues to consider Status of research for this review 
Comparison 
(C) 
Type, frequency, dose, 
duration, prognostic 
factor 
Placebo/sham treatment with frequency, dose and duration comparable to the intervention. 
Comparison with inactive treatment or other alternative therapeutic modality. 
Comparison with no treatment ‘time effect’ (e.g., waiting list) to be compared in future trials (true control) to clarify the ‘real’ effect 
of the therapeutic interventions against DDwoR natural course for a long follow-up period.  
Outcome 
(O) 
Which clinical or 
patient related 
outcomes will the 
researcher need to 
measure, improve, 
influence or 
accomplish? 
Which methods of 
measurement should be 
used? 
Standardised multidimensional outcome measures that are of importance in DDwoR need to be assessed. These include the 
following: 
Pain associated with TMJs, involving not only pain intensity but also multi-dimensional pain assessment, probably by following the 
suggested IMMPACT recommendations for outcomes assessment in pain clinical trials (Dworkin et al., 2005; Dworkin et al., 2008). 
Extent of mandibular movements including: maximum moth opening (active and passive), protrusive movement, and lateral 
movements toward the unaffected and affected sides rather than reporting the direction of the lateral movement (right or left). There 
is a need to address and determine the minimal clinically important difference (MCID) in MMO from the patient’s perspective after 
receiving a therapeutic intervention (preferably from biopsychosocially representative samples of patients with DDwoR). 
Functional limitations and health-related quality of life (QoL) or patient satisfaction outcomes should be considered as an important 
comorbidity. Future trials need to encompass all the aspects (i.e. physical, social, and psychological) of QoL probably by following 
the suggested QoL criteria by Locker and Allen (2007). 
Number of visits or days absent from work 
Adverse events (harmful adverse events should be clearly addressed and reported in future trials. Even if not observed, adverse 
events should be clearly stated as ‘no finding of any adverse effects for the interventions used’). 
Operative and admission durations for surgical trials. 
Patient compliance with treatment or instructions and advice provided especially for self-care interventions. 
Therapy costs: Cost-effectiveness trials are needed to evaluate the opportunity costs of using a particular intervention over other 
alternatives. 
Developing a valid and standardised outcome measures and clinical assessments would contribute to the development of future 
research. Future research should take in consideration the various factors which could affect the evaluation of the subjective and 
objective outcomes such as: age, gender, ethnicity, stature, and personal perceptions.  
Consensus on standardised, but ‘pragmatic’, success criteria are also needed to yield more rigorous research 
Time stamp 
(T) 
Date of literature 
search or 
recommendation 
November 2013 
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Research recommendations based on a gap in the management of temporomandibular joint disc displacement without reduction (DDwoR) 
Core 
elements 
Issues to consider Status of research for this review 
Study type 
What is the most 
appropriate study 
design to address the 
proposed question? 
Design: randomised controlled trial 
Allocation: concealment of allocation sequence 
Blinding: participants, researchers, outcomes assessors, data analysts 
Data analysis: appropriate ITT-analysis (i.e. including all the randomised participants in the reported statistical analysis) 
Setting: primary care practices, emergency departments, and TMJ clinics. 
RCTs should follow the CONSORT guidelines (www.consort-statement.org) with a priori calculated sample size and adequate 
follow-up and clearly defined interventions with standardised outcome measures are favoured. RCTs with a large sample size in 
order to increase the statistical power to identify the minor difference in effects between the comparative interventions on a large 
scale. Given the low incidence of DDwoR amongst TMD and the difficulty in recruiting patients with a DDwoR ‘acute/chronic’ 
diagnosis, a multi-centre RCT may be the most appropriate manner, by which, the researchers can examine too the effect of CL 
duration on the outcome of initial non-invasive simple treatments in DDwoR. The sample size of the RCTs should also be calculated 
beforehand to ensure that the study has adequate statistical power. 
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Appendix O: TDF-questionnaire from the qualitative study (Chapter 6). 
Domain Item (specific belief question)16 Yes   No  
Knowledge 
I am aware of the DDwoR condition    
I know how to diagnose DDwoR making specific attention to its 
pathognomonic signs and symptoms 
 
 
I am aware about other conditions causing limited mouth opening 
symptom and I know how to differentiate DDwoR from these 
conditions  
 
 
I know how to manage DDwoR   
I know the content and objectives of specific DDwoR treatment 
options 
 
 
I am familiar with the DDwoR management evidence   
 
Skills 
I am familiar with the DDwoR and I have experience to manage it   
I have the skills to diagnose and manage DDwoR   
I have been trained how to provide specific DDwoR treatment 
options 
 
 
I have practiced mandibular manipulation in DDwoR    
 
Social/ 
Professional 
role and 
identity 
Managing patients with DDwoR is part of my work as a [profession: 
GP, A&E….etc.] 
 
 
As a [profession], it is my job to diagnose patients with DDwoR   
It is my responsibility as a [profession] to manage patients with 
DDwoR 
 
 
Referral patients with DDwoR is consistent with my [profession]   
 
Beliefs about 
capabilities 
I am confident that I can diagnose patients with DDwoR even when 
there is little time 
 
 
I am confident that I can manage patients with DDwoR    
I am confident that I can manage patients with DDwoR if I have 
training  
 
 
I am confident that I can manage DDwoR even if I have never been 
confronted with it previously 
 
 
 
Optimism 
With regard to managing patients with conservative management, I 
usually expect the best 
 
 
With regard to managing patients, I’m always optimistic about the 
future 
 
 
 
Beliefs about 
consequences 
If I misdiagnose the DDwoR patient in primary care, it will harm 
the patient 
 
 
If I manage the DDwoR patient in primary care, it will benefit the 
patient 
 
 
If I didn’t manage and refer the patient with DDwoR to secondary 
care, it will have more disadvantages for the patient 
 
 
If I didn’t manage and refer the patient with DDwoR to secondary 
care, it will have more advantages for the patient 
 
 
 
Reinforcement 
If I manage the DDwoR patient, I feel like I am making a difference    
If I manage the DDwoR patient, I get financial reimbursement   
  
                                                 
16 DDwoR items for measuring TDF are based on TDF domains’ questionnaire (Huijg et al., 2014a; Huijg 
et al., 2014b). 
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Domain Item (specific belief question)16 Yes   No  
Intentions 
I will definitely want to manage DDwoR in the future if I am 
confronted with it frequently 
 
 
I will definitely want to receive feedback about referred DDwoR 
patients in the future  
 
 
I intend to improve my knowledge and skills regarding the DDwoR 
management  
 
 
I have strong intention to manage DDwoR in the future if I get 
training 
 
 
 
Goals 
I have management goals    
It is very important to treat patients with DDwoR in primary care   
I have a clear plan of how I will diagnose, treat, and/or refer patients 
with DDwoR 
 
 
 
Memory, 
attention and 
decision 
processes 
I will often forget how to diagnose patients with DDwoR if I am not 
confronted with them regularly 
 
 
If there is evidence about DDwoR management, I will often forget 
to use it if I am not confronted with DDwoR patients regularly 
 
 
When I need to concentrate to diagnose patients with DDwoR, I 
have no trouble focusing my attention on pathognomonic signs and 
symptoms 
 
 
I have a clear plan of when to take a decision to treat or to refer 
patients with DDwoR 
 
 
 
Environmental 
context and 
resources 
Within the environmental context there is sufficient financial 
support for diagnosing and managing patients with DDwoR 
 
 
Within the environmental context there is sufficient time for 
diagnosing and managing patients with DDwoR 
 
 
Within the environmental context there are good resources available 
for diagnosing and managing patients with DDwoR 
 
 
I can usually get professional advice over the phone if I am 
confronted with DDwoR 
 
 
 
Social 
influences 
Within the practice, there is good team work and colleague social 
support for diagnosing and managing patients with DDwoR 
 
 
Within the practice, I can usually get social support from colleague 
if I am confronted with the critical incident of DDwoR 
 
 
Discussion with the patients always facilitates the DDwoR 
management  
 
 
 
Emotion 
The patients’ emotion/stress/distress has no effect on my 
decision/treatment plan for DDwoR management 
 
 
My own emotion or work-stress/load has no effect on my 
decision/treatment plan for DDwoR management 
 
 
 
Behavioural 
regulation 
 
 
I keep track of my overall progress towards patients’ management   
I always self-monitor my knowledge/skills to manage patients   
If there is DDwoR management evidence, it will help me to manage 
patients with DDwoR 
 
 
If there is a DDwoR e-tool, it will help me to diagnose and manage 
patients with DDwoR 
 
 
  
Nature of 
behaviour 
Managing patients with DDwoR, as managing patients with TMD, 
is something I do automatically 
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Appendix P: Peer-reviewed publications and international conferences 
presentations. 
P-1: Peer-reviewed publications.  
1. Systematic review of locking duration (Al-Baghdadi et al., 2014b)17
 
                                                 
17 First page of the published paper is attached. The full-text paper and its appendices are available at the 
Journal of Oral Rehabilitation, year 2014, volume 41, issue 1, pages 24-58. 
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2. Systematic review of therapeutic interventions (Al-Baghdadi et al., 2014a)18 
                                                 
18 First page of the published paper is attached. The full-text paper and its appendices are available (open 
access) at the Journal of Dental Research, Special Clinical Issue, month/year July 2014, volume 93, issue 
7, pages 37-51. 
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P-2: International conferences presentations. 
1. International Conference of Orofacial Pain and Temporomandibular Disorders (ICOT) and AAOP 38th scientific meeting, 2014 USA.  
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2. International Association for Dental Research (IADR) 92nd General Session, 
2014 South Africa. 
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2. International Association for Dental Research (IADR) 93rd General Session, 
2015 USA. 
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